#*Effect of pioglitazone on arteriosclerosis in comparison with that of glibenclamide
#@Ikuyoshi Watanabe,Shigemasa Tani,Takeo Anazawa,Toshio Kushiro,Katsuo Kanmatsuse
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1446888625753843676140261495820055589371655720035
#%576848753513662094367798702820758720441366971068
#%576848753513662094367798702820758720441366971068

#*Glucose intolerance and all-cause mortality in Japanese migrants
#@G.A. Gimeno,Katsumi Osiro,Luisa Matsumura,Cicotto Massimino,R.G. Ferreira
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index786847356944750247223372122039895643803125225133
#%1160072039023882475789152574546430962134917454221

#*Introduction of diabetes passports involving both patients and professionals to improve hospital outpatient diabetes care
#@R.F. Dijkstra,J.C.C. Braspenning,Z. Huijsmans,R.P. Akkermans,E. Ballegooie,P. Have,T. Casparie,R.P.T.M. Grol
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index524786348940510172395443464804355305881543849445
#%509632128684000909477418366440137128174321428113
#%1278610100618228277251788929680118573106479793608

#*Camel milk as an adjunct to insulin therapy improves long-term glycemic control and reduction in doses of insulin in patients with type-1 diabetes
#@R.P. Agrawal,R. Beniwal,D.K. Kochar,F.C. Tuteja,S.K. Ghorui,M.S. Sahani,S. Sharma
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index903716525009365030521613856375941146679499050520

#*Action and research are needed for evaluation of optimal definitions of anthropometric parameters and metabolic syndrome for Asians
#@Anoop Misra,Singh Wasir,K. Vikram
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1049083521225946194633393371804861445030540442219

#*Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis
#@Ivan Tk
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1203614747134385044742216220469582555108074166693
#%1438361308239152205343302480156715263383345379538
#%1126708038596492840536232840700080341312773394329
#%503007577084342462291597456074021905294277637315
#%28897663414398495696105770531585844798758132364

#*Genetics of type 2 diabetes mellitus
#@T. Malecki
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1136344016781035463551567270092867896970718242028
#%1401607269839429390408309751866937438263484975134
#%1102880864833037643035743539547463658107628255008
#%60512907453454176265345998030834731277703665491
#%894357928535669243826399597138322404178574680502
#%927614198217650014150524726056504235907188177403
#%1330139075156247831362276825775720771830783280624

#*Pathophysiology of type 2 diabetes: Rationale for different oral antidiabetic treatment strategies
#@Francesco Giorgino,Luigi Laviola,Anna Leonardini
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1308084386936204070980551690784130700948558595306
#%1018419343282322914666097930831323695834829397713
#%295762779268794792690053359562404828159588422372

#*Early use of insulin in type 2 diabetes
#@Roy Eldor,Erwin Stern,Zvonko Milicevic,Itamar Raz
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index535959596833485828717770057633558123866009318485
#%405358859455161293643593699516554537835781930299
#%1366568076898090969905012930742914397583749264789

#*Prevention and treatment of diabetic nephropathy
#@Istvn Wittmann,A. Molnr,Pter Degrell,Zoltn Wagner,Mnika Tamask,Boglrka Laczy,Pl Brasny,Lszl Wagner,Judit Nagy
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index727902680509347546371471162856408615026372951586
#%701226865595645657133035320955597158247442795124
#%523569668697687660926956818483474961707706852739
#%635894664578588444100407649163603459372962459637
#%214258861207655807068317464427679190263948313877

#*Learning from large cardiovascular clinical trials: Classical cardiovascular risk factors
#@Peter Kempler
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index340102460101869163573117365919377666143574075586
#%567041784963798729085920837180056367716144866151

#*Can the atherosclerosis prevention targets be achieved in type 2 diabetes?
#@Jan krha,Anu Ambos
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index531355987878059376815108441171560893847972457916

#*Introduction to Lilly Award Session
#@Krzysztof Strojek
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index500166163422510078278318113592518103431893514307

#*Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients
#@Yu. Mayorov,V. Naumenkova,B. Antsiferov,I. Dedov
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index959414162395775137365700021460410696348962405103
#%1290100661173209927699374087704693760410673113855

#*Correlation of serum ghrelin levels with body mass index and carbohydrate metabolism in patients treated with atypical antipsychotics
#@E. Palik,K.D. Birks,G. Faludi,I. Kardi,K. Cseh
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index812804167022503027426474879477056403336644751917
#%21289436496846075670654955772691900449330503037
#%460261142442579376473124564460721473304679549209

#*Role of endothelial dysfunction in the development of cardiorenal syndrome in patients with type 1 diabetes mellitus
#@V. Shestakova,R. Jarek-Martynowa,S. Ivanishina,S. Kuharenko,N. Yadrihinskaya,A. Aleksandrov,I. Dedov
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1137919802797302309333426739699747127842252866534
#%1361331887457544839829381861102913770300034831711
#%1272187825916332769128061918826029819543184988337

#*Can type 2 diabetes mellitus be considered preventable?
#@Gyrgy Jermendy
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index68892316945799024798700490864264872730702040391
#%1382418450614098050663389260378438796173418950574
#%530742815982948056355266956550925744819808900472
#%78352572084905341639090636593345442635067376666
#%559965829598753497222300600463824656811767149287
#%842498980017533687207488737127263878632351325165
#%1250864906461616790272219848121470773032844219689

#*HDL-C and the diabetic patient: Target for therapeutic intervention?
#@S. Rosenson
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index717280131776946215850401932629894860984478603657
#%939993850779776795284050394047082997225180209303
#%418897923679580209609489839520188035595304150419
#%218832808340256916950100344164183339077024015869
#%260919482886569242994217629351888574404015774552
#%591408067707494651754577994500370984921255745270
#%626748748799929359649677681084224108191289036644
#%692842812275363153364017727054722650014314645844
#%674063616321896048845370665697049414004136789565
#%242728606034356673587915706309583727674689448736
#%1291273136695637279136884424860364575077837856694
#%405050710033576449884283573206641623260901447195

#*Targeting dyslipidemiathe key to CHD risk reduction in the diabetic population?
#@John Betteridge,S. Rosenson
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index718856506787483306559123480562195789218958571059
#%401286625098467276995208975466797164325280118723

#*The prevention of diabetic microvascular complications of diabetes: Is there a role for lipid lowering?
#@A. Leiter
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index64865389266734299526703529223388502985798790208
#%597427274536570873221493587908764029851994050137
#%495451762774645616663662475038497338564624177052
#%993986588726556843437191851657012829926087573865
#%399127220577660716701086921159612147398073658523
#%399127220577660716701086921159612147398073658523
#%1004467331217795033394001466623905602592569826965
#%1208758310829822413430940470082178891846626274639
#%725320704037633755931246057703405540938815685090
#%162699855047543866156263773463581041946063461714
#%870651381524712065084403491855958404044803635696
#%267880217618385855682187744070059747732190624958
#%401286625098467276995208975466797164325280118723
#%1301345081668782392566533220402030078912851260560
#%399185476235353690588217013253628418304482449781
#%1123868835138167919118739257338133615518826386448
#%1453701669791752255950152524391803911071395977701
#%591408067707494651754577994500370984921255745270

#*Long-term risk reduction: Who needs treatment?
#@John Betteridge
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1417295556280680761848173249654472264628884337488
#%429445204087131090811571066670064910401230055013
#%298948132451392872508877290061772889371096263221
#%388265915305538131258113760487077870312106959751
#%1080724601574409653141456132544805730826379336558
#%806999650028062183539294847549091501669413301243

#*Effective care of patients with type 2 diabetes and dyslipidemia: A nurse's perspective
#@Maria Adiseshiah
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1457581799445282898702392938347080691738672608942
#%1209915928043767877988071234305244160407052781159

#*Cardiovascular risk: Prevention and treatment of the metabolic syndrome
#@Jaakko Tuomilehto
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index946019232750110139904604496733071073458322156489
#%243436552734739657963075245289481699762806756344
#%218832808340256916950100344164183339077024015869
#%806999650028062183539294847549091501669413301243

#*Apolipoprotein e4 allele and the risk of CAD death in type 2 diabetes mellitus with ischaemia electrocardiographic change
#@Xiang Guang-da,Yang Xiang-jiu,Zhao Lin-shuang,Chen Zhi-song,He Yu-sheng
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index760092742469904604205150156378358931023989791791
#%43383849243323794759883438633286463022493258736
#%937918402132162120007884034578640141683753519913
#%649162783785961910035141402676339474714449902837
#%786366982970551210057835660620618727052687108548

#*Anticardiolipin and anti-2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus
#@lhan Tarkun,Abdullah Hachanefiolu,Pnar Tarkun,Berrin etinarslan,Zeynep Cantrk
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index19337495346497080483754697291260072084988047063
#%578976195770136758657141653171942951785713889791
#%1217681997008911548433828637310144539381524777642
#%675014772761481388622378585760293376381525836736
#%727599698526661002044016606837987975543458402512
#%41332412026534562764859085664864965550807376756

#*Socioeconomic status and diagnosed diabetes incidence
#@M. Robbins,Viola Vaccarino,Heping Zhang,V. Kasl
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1388199999888270658206031281977117061372576944264
#%78285236376191397827511030914042818389231204745
#%1056084816628410466552681444115554903094640978457
#%927994519499885252761350094189516446798200990873

#*Factors affecting the quality of diabetes care in primary health care centres in Tunis
#@Hugh Alberti,Nessiba Boudriga,Mounira Nabli
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index673761998366805438054856413518395548543231309767
#%963960834262717034476397152928439180637185707344

#*Molecular scanning of the betacellulin gene for mutations in type 2 diabetic patients
#@Takayuki Nakagawa,Hiroto Furuta,Tokio Sanke,Setuya Sakagashira,Hiroko Shimomura,Yoshinori Shimajiri,Tadashi Hanabusa,Masahiro Nishi,Hideyuki Sasaki,Kishio Nanjo
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1020663134955801006294966046072099160470605707370
#%1023144161363027020434814178944431071953662292184

#*Apolipoprotein E polymorphism in type 2 diabetic patients of Talca, Chile
#@Elba Leiva,Vernica Mujica,Roxana Orrego,Mara Prieto,Miguel Arredondo
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index396004306583322364871485931485942289379792708074
#%882728254378246145445378286698929601967584386724
#%469260224567105733999936506787307516399426882738
#%1079443792446999460553112031980710707635786271266
#%348230081727467246817117407930075527581185420427

#*Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study
#@P. Pozzilli,S. Manfrini,R. Buzzetti,E. Lampeter,I.De. Leeuw,D. Iafusco,M. Prisco,C. Ionescu-Tirgoviste,S. Kolouskov,T. Linn,J. Ludvigsson,L. Madcsy,A.Seremak. Mrozikiewicz,P.M. Mrozikiewicz,T. Podar,J. Vavrinec,B. Vialettes,N. Visalli,T. Yilmaz,P.D. Browne
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1265864307511371339705190914123072791202449308068
#%576321518471523766746124345714915791238223783834

#*Efficacy of glimepiride in Japanese type 2 diabetic subjects
#@Kouichi Inukai,Masaki Watanabe,Youhei Nakashima,Takahiro Sawa,Nobuki Takata,Masahiko Tanaka,Hideyuki Kashiwabara,Kensuke Yokota,Masao Suzuki,Susumu Kurihara,Takuya Awata,Shigehiro Katayama
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index361327165879539019616555912534743464903834701991
#%596898125923849231924908060245854385304729208949
#%1050887944314955068479677126720803952285540759640
#%1347131148159653833870809454228854616978879559695
#%455035088570047233635922846275300873837934425440

#*A community-based study for the utility values associated with diabetic retinopathy among type 2 diabetics in Kinmen, Taiwan
#@Tao-Hsin Tung,Shih-Jen Chen,Fenq-Li Lee,Jorn-Hon Liu,Ching-Heng Lin,Pesus Chou
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index709769260625530670288498471248302179676397507009
#%665610936413132940267867742860220840713497321521
#%665610936413132940267867742860220840713497321521
#%716520328448192650573240139345849775873525883372
#%716520328448192650573240139345849775873525883372
#%716520328448192650573240139345849775873525883372
#%208508422503756012924751470598965294652107445281
#%1134316742908806820439970403555300672044123021553
#%899795249477142576113145567298572145610719995276
#%899795249477142576113145567298572145610719995276
#%899795249477142576113145567298572145610719995276

#*Increased levels of platelet-derived microparticles in patients with diabetic retinopathy
#@Nahoko Ogata,Masahito Imaizumi,Shosaku Nomura,Akira Shozu,Miwa Arichi,Masato Matsuoka,Miyo Matsumura
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index196838641589565691497665747198091901003432958198
#%407915446278403681057359809783846443872575045580
#%606283717481354310725767594712515082769315744867
#%606283717481354310725767594712515082769315744867
#%717234718829152615703553801271268603843069810134
#%776766438720687381063018461111628430125676824917
#%408059917926705555937829541628510960145693982358
#%916731828225309594883991984687652295915729617937

#*Psoas and spinal epidural abscess in a diabetic patientcase report
#@Ravnik Oblak,Ciril Oblak,Saso Stankovic
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1157871236674644682263534564084800744497285745865
#%26576361320202139798868282952725625919226442781
#%1105205373595776716991612187484415701452285228796
#%878611025059656814906905100688037036105882558891
#%769208042450537124266532843041803600468536215352

#*Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients
#@Katarzyna Komosiska-Vassev,Krystyna Olczyk,Pawe Olczyk,Katarzyna Winsz-Szczotka
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1377127060820671036594813862432677462193221054570
#%412059482936576929420087873521920932717326731767
#%1059128011133246495028315560091798038373879561174
#%1098144179829421639042084536125523179231106568885
#%438176643345779365639681253497200026709032816517
#%292385803284376221171346865253571167138778881615

#*Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes
#@M. Albareda,M. Rigla,J. Rodrguez-Espinosa,A. Caballero,A. Chico,R. Cabezas,G. Carreras,A. Prez
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index848408969137929524000598615684065090009180312405
#%289027791129748336241840707143555662007543336487
#%289027791129748336241840707143555662007543336487

#*The relationship between insulin resistance assessed by HOMA-IR and serum osteoprotegerin levels in obesity
#@Betul Ugur-Altun,Armagan Altun,Murat Gerenli,Armagan Tugrul
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1278297041888648409079272912841909557878568669286
#%426592292347829868409787671921335972324881294464
#%192552450144384117605393996848852182560846108803
#%641348617866864373891920013059264305956382906137
#%509594842920952678725508142429248068685566069190

#*A potential role of apolipoprotein B in the risk stratification of diabetic patients with dyslipidaemia
#@I. Al-Bahrani,S. Bakhiet,A. Bayoumi,A. Al-Yahyaee
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index914648796044779684674798625495787354279435566392
#%927601381282682453432000868210080527024128619811

#*What do we (not) know about apoB, type 2 diabetes and obesity?
#@J. Smith,Al Amri,D. Sniderman
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index192825799730872198669475229176612659847814478600

#*Possible novel index determined by the glucose clamp test for selection of a suitable therapy for each type 2 diabetic patient
#@Shin-ichi Gorogawa,Hideaki Kaneto,Munehide Matsuhisa,Kentaro Ohtoshi,Dan Kawamori,Yoji Hazama,Kazutomi Yoshiuchi,Yoshimitsu Yamasaki
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index844582092801133305070754171853083111700615995384
#%1131174694770240417260945298793702210143378615388

#*A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome
#@Giuseppe Derosa,F.G. Cicero,Antonio Gaddi,D. Ragonesi,N. Piccinni,Elena Fogari,Sibilla Salvadeo,Leonardina Ciccarelli,Roberto Fogari
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index722324045201855584036178511288085153570257111798
#%1444741601684317290348245239166398347312501231135
#%712438885954629145286036467008406397447780972661
#%108292107460112887584597717887562947831404363957
#%919769993787866952693479348278031401226733313050
#%1247745198140437669825903616087382145626722275717
#%807309505482295288577904931711318609777471426945
#%199210359002794575776092865529761652470289044072
#%217426656728435012484085093460287903122538345995
#%919769993787866952693479348278031401226733313050

#*Predictive values of anthropometric measurements for multiple metabolic disorders in Asian populations
#@Kuninori Shiwaku,Erdembileg Anuurad,Byambaa Enkhmaa,Akiko Nogi,Keiko Kitajima,Masayuki Yamasaki,Toshimi Yoneyama,Tsendsuren Oyunsuren,Yosuke Yamane
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index690325874269266795336149405451579070955616357106
#%526279405968943525220698573844620927125407645274
#%1458271037216576384527571392813680069384164557635

#*Characteristics of childhood and adult-onset type 1 diabetes in a multi-ethnic population
#@Melanie Rodacki,Lenita Zajdenverg,Prendin Tortora,Aarao Reis,S. Albernaz,Bencke Goncalves,Adolpho Milech,Paulo Oliveira
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index339690298532618608311656867370867434127384047811
#%544643936078938244140673751103060391725053800747
#%1220191711254120573774747836748667236834536817547
#%669126262583682416385491043121082089965864225200

#*Treatment regimen determines the relationship between depression and glycemic control
#@S. Surwit,A.L. Tilburg,I. Parekh,D. Lane,N. Feinglos
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index814501079846700669200851426849797200067126829801

#*Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy
#@Gary Scheiner,A. Boyer
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index89080950212820466866399416822028886674906676610

#*Ten-year mortality and glucose tolerance status in an elderly Finnish population
#@Liisa Hiltunen
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1094955879540622866161065291596800629687725405450
#%389183818447950744750252313914907225599666605149
#%836005315623309225542154454304809577325511997650
#%836005315623309225542154454304809577325511997650
#%537280460312778589586956532136873912740572240050
#%457046621009670538258873941261393006674590189647

#*Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF- and IL-6
#@Soon Park,Yul Park,Rina Yu
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index87383739713472712970037314075127437866487833925
#%170530705379996803102866393793503564509299977100
#%564461314931590743749585083887418615279865055764
#%1021002299222599989778245421123926371941613289901
#%738977292009237589120074175938382365380637344185
#%459838760870297062394418132842063469833876711368
#%377540217445836200324260906171352376060362824630
#%1166557327713141423135815809046803909623826435359

#*Association between fasting glucose and C-reactive protein in a Japanese population: the Minoh study
#@Noriyuki Nakanishi,Tsunehito Shiraishi,Mariko Wada
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index823107126058939527712248900457593597868065689220
#%1378232309151013105142487145858927163597592381276

#*Metabolic response to oral lipid overload in diabetes and impaired glucose tolerance
#@de Ugarte,Lcia Portal,Amlia Dias,DAgord Schaan
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index184583850823910715096388613909298101146174820430
#%1157279433864169680098573077458223127834286788141
#%597427274536570873221493587908764029851994050137
#%594263520694251325153861220505639648047190368136
#%841759995633641013304458757005861990591294566701

#*Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in White, Black, Amerindian and Mixed Hispanics in Zulia State, Venezuela
#@Hermes Florez,Egl Silva,Virginia Fernndez,Elena Ryder,Tulio Sulbarn,Gilberto Campos,Gustavo Calmn,Emilio Clavel,Sumaya Castillo-Florez,Ronald Goldberg
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1433791179649179945553475094057085830871790482413
#%1438361308239152205343302480156715263383345379538
#%1423892929555877017921308731812653178818920776011
#%417766593200355128364595364000005086684040970422
#%495101644775567982162285683502468873933010366002
#%495101644775567982162285683502468873933010366002

#*Evaluation of apolipoprotein E secretion by macrophages in type 2 diabetic patients: role of HDL and apolipoprotein A-I
#@Kazumi Yamato,Naoki Tamasawa,Hiroshi Murakami,Jun Matsui,Jutaro Tanabe,Toshihiro Suda,Minoru Yasujima
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index772553838676818287224465529932054721373257746489

#*Dietary soy prevents brain Na +, K +-ATPase reduction in streptozotocin diabetic rats
#@Renata Franzon,Fbria Chiarani,H. Mendes,Adriane Bell-Klein,T.S. Wyse
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index415026715443990398290993733705626509275468540133
#%759035588883980746492748886779289356172845299972
#%503877985020759876697708157995464630267209317309
#%1404435246814164736705106379147819055708839744714
#%281807225397364914123310269080839074620640652189
#%1310164048301535133432443620405594496396887249088
#%344754649061241890139164863753657789832991552708

#*Incidence of Type 1 diabetes in children in Cceres, Spain, during 19881999
#@R.E. Lora-Gmez,F.M. Morales-Prez,F.J. Arroyo-Dez,J. Barquero-Romero
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index139418906350065887278535630806732994182463359868
#%1226584833421610962366973092840557175858617404670
#%1132208393943449079944859987362732135606809910441

#*Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes
#@Seok Kang,Jin Kim,Woo Ahn,Won Park,Soo Cha,Kil Lim,Rae Kim,Chul Lee
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index700543556941930640882204839683510043582170238059
#%298800650402824987447050946154775496969633499851
#%816591260436891813559029104723117848397323725184
#%1061114610203975914862488171473793516458660279299
#%1441884277201828283161453866605586607992514163002
#%194115478835396190708928778256277387515112930583
#%741592171609659670587764513902041271128544194915

#*High prevalence of metabolic syndrome in Hong Kong Chinesecomparison of three diagnostic criteria
#@Tin-Choi Ko,Stewart Cockram,Chun-Chung Chow,Vincent Yeung,Wing-Bun Chan,Wing-Yee So,Nor Chan,Chun-Ngor Chan
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index346553285745418134252681859239189827513652749234
#%394074846014723954118281930976347277725688325607
#%939914378393524584616443353957699986502049672958
#%218832808340256916950100344164183339077024015869

#*Postprandial hypertriglyceridemia and carotid intimamedia thickness in north Indian type 2 diabetic subjects
#@Jamal Ahmad,Basharat Hameed,Gautam Das,A. Siddiqui,Ibne Ahmad
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index392811672066811326739525157357092862683686783185
#%1074059765057976800649630756757955502926827062881
#%475496918731103195820641422673555273791770169966
#%475496918731103195820641422673555273791770169966
#%10707252567382812568302225801780250022167623403

#*Effects of Goshajinkigan on insulin resistance in patients with type 2 diabetes
#@Tomoko Uno,Isao Ohsawa,Mizuho Tokudome,Yuzo Sato
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index921005169630008256170860871296288543711908288572
#%225420155770614823263551511452153053076411237843

#*Increased gene expression of antioxidant enzymes in KKAy diabetic mice but not in STZ diabetic mice
#@Atsuyo Fujita,Hideyuki Sasaki,Kenichi Ogawa,Kunihisa Okamoto,Shohei Matsuno,Eisaku Matsumoto,Hiroto Furuta,Masahiro Nishi,Taisei Nakao,Takuo Tsuno,Hisaji Taniguchi,Kishio Nanjo
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1340779203365089972038082159900135413990217134126
#%574220431567762178139170415099967641660064193927
#%165709667539061428629486526748770860448180762452
#%1403763027417994643087616683344415689880782057917
#%92805081706595045165158577125395358163717942239
#%438176643345779365639681253497200026709032816517
#%130985902264439244359890378069853302339046812818
#%130985902264439244359890378069853302339046812818
#%1067696520288181756912634202160097173788881417516

#*Glucose intolerance and associated factors in the multi-ethnic population of the United Arab Emirates: results of a national survey
#@M. Malik,A. Bakir,Abi Saab,G. Roglic,H. King
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index447570740366864965035300359436596789956610868106

#*Beta cell function and response to treatment in Nigerians with Type 2 diabetes mellitus
#@J.M. Oli,A.A. Adeyemo,G.O. Okafor,E.N. Ofoegbu,B. Onyenekwe,C.J. Chukwuka,G. Chen,Y. Chen,A.P. Doumatey,T.O. Aje,C.N. Rotimi
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index700283363919170664258484034107262389145857903869

#*Pathophysiologic heterogeneity in the development of type 2 diabetes mellitus in Korean subjects
#@Wook Kang,Joon Kim,Myung-Shik Lee,Kwang-Won Kim,Moon-Kyu Lee
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1035630632353132825605501487092498371038941011798
#%390371137728887586911880288885235639516434221172
#%390371137728887586911880288885235639516434221172
#%624098005603232940422874858686253566445296039438

#*Identification of a novel WFS1 mutation (AFF344-345ins) in Japanese patients with Wolfram syndrome
#@Kouichi Inukai,Takuya Awata,Kiyoaki Inoue,Susumu Kurihara,Youhei Nakashima,Masaki Watanabe,Takahiro Sawa,Nobuki Takata,Shigehiro Katayama
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index82048244057557167112587573234516120671027132258
#%416514052955060695562479256396723934371627112587
#%25078523797597216491722910283772855302234342989
#%25078523797597216491722910283772855302234342989
#%225931074909875165822722480527436022730445062019
#%859415381470481149765265463526199919915460562224

#*Insulin inhibits glucagon-induced glycogenolysis normally in perivenous hepatocytes of Wistar fatty rats
#@Yoshihiro Ikezawa,Keiichi Yamatani,Hiroshi Ohnuma,Makoto Daimon,Hideo Manaka,Hideo Sasaki
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index2365373407719528783101439514614410212421920021
#%887227182619052357399763478404554736879811836895
#%354923545964011488951357187553679931155092549704
#%876437939124284339666628613215923594279797812331

#*Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 diabetes
#@Won Lee,Eun Song,Sun Shin,Min Ahn,Suk Ha,Jung Kim,Suk Nam,Kwan-Woo Lee
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index469684864063605785628610744327956910904139715332
#%13531867530564030428033510201397423657433093610
#%37845483190923010549119210467430092685426243820
#%306222996887620570133295175353504323334825762796

#*Serum triglycerides as a marker of insulin resistance in non-diabetic urban Indians
#@C. Snehalatha,K. Satyavani,S. Sivasankari,V. Vijay,A. Ramachandran
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1385672516883441690690849323151848497259581874672
#%860022615160432358769576638139277096798571837825
#%913547063223681706221811181929370312982335221983

#*Corrigendum to Dexamethasone suppresses the expansion and transdifferentiation of transplanted porcine neonatal pancreas cell clusters (NPCCs) into -cell in normal nude mice [Diabetes Res. Clin. Pract. 66S (2004) S97S101]
#@S.-H. Ko,H.-S. Kwon,S.-H. Suh,J.-H. Yang,S.-R. Kim,Y.-B. Ahn,K.-H. Song,S.-J. Yoo,H.-S. Son,B.-Y. Cha,K.-W. Lee,H.-Y. Son,S.-K. Kang,C.G. Park,K.-H. Yoon
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1095567893173561138057678170734797123069548300142

#*Depressive symptoms of type 2 diabetics treated with insulin compared to diabetics taking oral anti-diabetic drugs: A Korean study
#@J.H. Noh,J.K. Park,H.J. Lee,S.K. Kwon,S.H. Lee,J.H. Park,K.S. Ko,B.D. Rhee,K.H. Lim,D.J. Kim
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index149126751242630835380740392034687408159048401959
#%177578599514655468148003811130660507714458099853

#*Associations of microalbuminuria and blood pressure with carotid, aortic and femoral atheromatous plaques in elderly Finns
#@Ulla Rajala,Mauri Laakso,Markku Pivnsalo,Outi Pelkonen,Aimo Ruokonen,Ilkka Suramo,Sirkka Keinnen-Kiukaanniemi
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index772523849570397118010291292351330916770221974506
#%994260621769770026678320956999014840330275855513
#%785700516365389230276916934881130803871084038315
#%158852284332138595114453421414292260654403566005
#%115293088569777531010671871178574454072193935786
#%115293088569777531010671871178574454072193935786
#%543392940072172135993561210410679410705969340567
#%543392940072172135993561210410679410705969340567
#%1305372912053979810929894754461647293315149530446

#*A case of type 2 diabetes with a large abscess of the gastric wall successfully treated with a glycemic control and systemic antibiotics
#@Yasunori Iwashima,Naomi Shibata,Mizuho Okada,Takeshi Yoshida,Masakazu Haneda
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index713401396079387295131316962679428000711390078990
#%723417475627477840724271429644760302295155303679
#%1157273098307945848862275724391654963406905406802

#*Pioglitazone prevents reactive hypoglycemia in impaired glucose tolerance
#@Kaoru Arii,Kikuko Ota,Tadashi Suehiro,Yukio Ikeda,Kanae Nishimura,Yoshitaka Kumon,Kozo Hashimoto
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index880559602178654884417271162650301901713012223558

#*N-(carboxymethyl)valine residues in hemoglobin (CMV-Hb) reflect accumulation of oxidative stress in diabetic patients
#@Satoshi Shimada,Yasushi Tanaka,Chie Ohmura,Yoshifumi Tamura,Tomoaki Shimizu,Hiroshi Uchino,Hirotaka Watada,Takahisa Hirose,Tomiko Nakaniwa,Shinya Miwa,Ryuzo Kawamori
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index681048973770003214324309582162498727068793111903
#%1403763027417994643087616683344415689880782057917
#%1126467494670836545698436413193133520432989085406

#*Hepatic insulin resistance induced by chronic hindlimb ischemia
#@Masahiro Hatazaki,Munehide Matsuhisa,Yoshihisa Nakatani,Kazutomi Yoshiuchi,Akio Kuroda,Yoji Hazama,Hideaki Kaneto,Yoshimitsu Yamasaki,Masatsugu Hori
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index263098439400213055240595080846505616168814200325
#%985248617543026113321337994677433038337155957768
#%115584905416462231069009464307064000409522622078
#%400209030703084920098638617888482621278004294742
#%545925039767205557007085570043817075116532990283

#*Hospital admission for selected single virus infections prior to diabetes mellitus
#@J. Goldacre,J. Wotton,David Yeates,Valerie Seagroatt,Andrew Neil
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index432449193423372044470301731818836031174203427060

#*Increased erythropoiesis and subclinical inflammation as part of the metabolic syndrome
#@T. Mardi,S. Toker,S. Melamed,A. Shirom,D. Zeltser,I. Shapira,S. Berliner,O. Rogowski
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index83869533018918877137317747365613741711964719551
#%1305724429404999735514348359013202717231495381122
#%1345160866158719465045745495947652441112319329936

#*A case of mitochondrial diabetes associated with 3243 bp tRNA Leu(UUR) mutation with few complications, regardless of 16-year disease duration
#@Yoshihiko Suzuki,Matsuo Taniyama,Yoshihito Atumi,Kempei Matsuoka,Ohta Shigeo
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index392653704586249620926805628739836943520948481215

#*ATP enhances exocytosis of insulin secretory granules in pancreatic islets under Ca 2+-depleted condition
#@Dai Shimono,Shimpei Fujimoto,Eri Mukai,Mihoko Takehiro,Koichiro Nabe,Gheorghe Radu,Makiko Shimodahira,Rieko Kominato,Yo Aramaki,Yuichi Nishi,Shogo Funakoshi,Yuichiro Yamada,Yutaka Seino
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index183834392491768758109863671577311866896250521484

#*Diabetes worsens the outcome of acute ischemic stroke
#@M. Kaarisalo,Ismo Rih,Juhani Sivenius,Pirjo Immonen-Rih,Aapo Lehtonen,Cinzia Sarti,Markku Mhnen,Jorma Torppa,Jaakko Tuomilehto,Veikko Salomaa
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1407583952481831655699894444274561413492819483743
#%1350678060414081321940733185592773450364718687436

#*Gestational diabetes in Iran: incidence, risk factors and pregnancy outcomes
#@Maryam Keshavarz,Wah Cheung,Reza Babaee,Kalalian Moghadam,Esmail Ajami,Mohammad Shariati
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index590645445684801123552394644140315458638733256509
#%1090460230437817134117861149447661145122317549926
#%1045286267561997353927539924728175534647739078266
#%585119314123866454797450354617958920805617922335
#%946403906898716791310236132382293550028922358030
#%527887821306701671055325157830335468357783707011

#*WRN gene 1367 Arg allele protects against development of type 2 diabetes mellitus
#@Masashi Hirai,Susumu Suzuki,Yoshinori Hinokio,Takahiro Yamada,Shinsuke Yoshizumi,Chitose Suzuki,Jo Satoh,Yoshitomo Oka
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index36289903653968284169767012101396150954427661522
#%1291437739237155722735823160190759942184833824477

#*Cameroon local diet-induced glucose intolerance and dyslipidemia in adult Wistar rat
#@Ren Kamgang,Youmbi Mboumi,Mengue Ndill,Ngogang Yonkeu
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1212201777406268153563692980020029394672744916266

#*IL-15 is elevated in serum patients with type 1 diabetes mellitus
#@Sebastian Kuczyski,Hanna Winiarska,Magorzata Abramczyk,Krystyna Szczawiska,Bogna Wierusz-Wysocka,Marzena Dworacka
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index298717537253471883887190264311890794283732540644
#%1253103146381808140632949966494603184140348712699
#%1057557963069419180473119850210185368341770049311
#%757030674662280232741307836424748839852082667589

#*Clinical features of non-diabetic renal diseases in patients with type 2 diabetes
#@Atsuhito Tone,Kenichi Shikata,Mitsuhiro Matsuda,Hitomi Usui,Shinichi Okada,Daisuke Ogawa,Jun Wada,Hirofumi Makino
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index932534173818479229217545879822252369997920690552
#%627599488485473959596106161004635697604401397353
#%531875217198292876042189076041947993778423585469

#*Retraction of Recent advance in hepatic insulin gene therapy [Diabetes Res. Clin. Pract. 66 (Suppl. 1) (2004) S3S10]
#@Chul Lee
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1086866039105824839592291275334898045850689017582

#*Therapy with insulin glargine (Lantus ) in toddlers, children and adolescents with type 1 diabetes
#@E. Colino,M. Lpez-Capap,L. Golmayo,M.A. lvarez,M. Alonso,R. Barrio
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1461416694923682400685998309553400382930353528378
#%133795322647927502563049840929115152622733212295

#*Insulin secretion and insulin sensitivity in Japanese subjects with impaired fasting glucose and isolated fasting hyperglycemia
#@Yuichi Nishi,Mitsuo Fukushima,Haruhiko Suzuki,Rie Mitsui,Naoya Ueda,Ataru Taniguchi,Yoshikatsu Nakai,Toshiko Kawakita,Takeshi Kurose,Yutaka Seino,Yuichiro Yamada
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1409774246366679244502068346117227476587584422346
#%211300411892540380311003802700905698950003682095
#%856537884140432138093842042156523599248953399383
#%484915302048216297982043338261390071563821490864

#*Heterogeneity of early-onset and ketosis-resistant diabetes in Korean subjectsis it possible to determine cut-off age of early-onset type 2 diabetes?
#@Byung-Wan Lee,Sang-Yong Kim,Ji-Youn Kim,Kyun-Yung Cho,Yun-Jae Chung,Yong-Ki Min,Jae-Hoon Chung,Moon-Kyu Lee,Myung-Shik Lee,Kwang-Won Kim
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1176112391356510558445966991053357993941915514436
#%672923644847167173082080713137925210327799704657
#%390371137728887586911880288885235639516434221172
#%390371137728887586911880288885235639516434221172
#%1153252314837653026549133983716329939105140812748
#%238833678911521896659698772768141671766599116145
#%238833678911521896659698772768141671766599116145

#*Disease management for the diabetic foot: Effectiveness of a diabetic foot prevention program to reduce amputations and hospitalizations
#@A. Lavery,P. Wunderlich,L. Tredwell
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1296902697319354408599654468727770019377433141925
#%113041243209595398876098044620557513063381192875

#*Socio-economic status and undiagnosed diabetes
#@P. Wilder,R. Majumdar,W. Klarenbach,Philip Jacobs
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index957270222456267378864653017511725208662990234909
#%636321227212329953654373304646090982160544190505
#%1295125032803457236214735387037096245624759466891

#*Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes
#@Glyn Belcher,Ceri Lambert,Gareth Edwards,Richard Urquhart,R. Matthews
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index497374437417074855403068751823532698494740453003
#%697999729707112882035165415974075911916741613288
#%236416214487227000341548656144457891317438729406
#%780602010986133872635748093868390837016143231704
#%745141609985269016498344671854280977424073433512
#%160039216157450223667140746425916565958448496452
#%776670628330209703924615966454572446131667009509

#*Rosiglitazone effects on blood pressure and metabolic parameters in nondipper diabetic patients
#@Roberto Negro,Tiziana Mangieri,Davide Dazzi,Antonio Pezzarossa,Haslinda Hassan
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index437932175010098967178918898403217872572457355344
#%830846967644493545213111813766930253374663531722
#%893028060441650629920240111460236745452751836801
#%327821286675085613509521487445833601825051368118
#%70130811232289574527911474218604399023063869729
#%9242323176733755494269528272922805951500350910

#*A comparison of the monofilament with other testing modalities for foot ulcer susceptibility
#@B. Miranda-Palma,J.M. Sosenko,J.H. Bowker,M.S. Mizel,A.J.M. Boulton
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index472449700622665041541747987005333536750740376340
#%903495506477675560405026948366438471888641788078

#*Prevalence and risk factors for erectile dysfunction in Japanese diabetics
#@Hideyuki Sasaki,Hiroshi Yamasaki,Kenichi Ogawa,Kishio Nanjo,Ryuzo Kawamori,Yasuhiko Iwamoto,Shigehiro Katayama,Masafumi Shirai
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index634078811669214314845187808312406179363543899062
#%1296546227995683838931343494821762910112302455130
#%983543244500727674769444515554309784558777343957
#%258136283255328673878734196945929386998950382879
#%924872573221874372111754711129627789170405865130
#%571735826460771993460880017525331542337230333002
#%412860142238418613092900080673127687270838359046
#%1329398551574069235546065465551956229544569026698

#*Renoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatment
#@Manuel Prez-Maraver,Jos Carrera,Teresa Mical,Manuel Sahun,Cayetano Vinzia,Joan Soler,Eduard Montanya
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index448622931269243872098195574847165841363187711278
#%1193677406988287182506384900415130663494381597222
#%431412729600776668789272016853046241948029539427
#%573478512450428404916363611713902062778565864313
#%278127858286973653161543618403114419263092873657

#*Hypertension in type 2 diabetes mellitus in Isfahan, Iran: Incidence and risk factors
#@Mohsen Janghorbani,Masoud Amini
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index274310322855768393636631788521320070872108074908
#%1087540520022519925312441722995171800560425631595

#*Derivation and validation of diabetes risk score for urban Asian Indians
#@A. Ramachandran,C. Snehalatha,V. Vijay,N.J. Wareham,S. Colagiuri
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1164333541494692873676613597281444907280130855950
#%591970307517695847210297464522381981181327346590

#*Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study)
#@B. Harris,Jean-Marie Eko,Yola Zdanowicz,Susan Webster-Bogaert
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index342160771889902249778067326556199263702032340792

#*Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients
#@Chin-Hsiao Tseng,Tien-Shang Huang
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1300937529167118625345065787306974535316641349151
#%697999729707112882035165415974075911916741613288
#%259225173713287506800010730665893143524608005266

#*Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats
#@Sema Bolkent,Sehnaz Bolkent,Refiye Yanardag,Sevim Tunali
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index83531448863350327780170369432039833395261059884
#%1193444170663970732778814989944534165576631703550
#%1301410664425427814379935981786614711922378865072
#%708383486008957877085355460837120426477329993245
#%1460407153014242214511416501654867859201828370391

#*C-reactive protein level as an independent risk factor of metabolic syndrome in the Korean population
#@S. Lim,H.K. Lee,K.C. Kimm,C. Park,C. Shin,N.H. Cho
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index86825939306245593863003437929920681930143578681
#%1239678428901684734281216596067885398422176059035
#%81238373166403892026757993466097781373576816671

#*Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus
#@Giuseppe Derosa,A. Avanzini,Diego Geroldi,Roberto Fogari,Renata Lorini,Annalisa Silvestri,Carmine Tinelli,Giorgio Rondini,Giuseppe dAnnunzio
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1442893856808186336094439953546494537642541604420
#%13531867530564030428033510201397423657433093610

#*Diabetic lipemia with eruptive xanthomatosis in a lean young female with apolipoprotein E4/4
#@Satoshi Shinozaki,Naoki Itabashi,Kumiko Rokkaku,Kenji Ichiki,Shoichiro Nagasaka,Koji Okada,Mitsuo Fujimoto,Mamitaro Ohtsuki,Shun Ishibashi
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1425130562296678937752691121890666116858466893140
#%386344803741440510366810121007344011238600081506
#%877106015659733043910700759704223936379917176158
#%623618089916177058237674967323235152326002942492
#%550839218361738678882886000403490562142625447185

#*The socioeconomic correlates of global complication prevalence in type 1 diabetes (T1D): A multinational comparison
#@G. Walsh,Janice Zgibor,Thomas Songer,Knut Borch-Johnsen,J Orchard
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index684051432511634394161243227344806533560278612306

#*Early pregnancy lipid concentrations and the risk of gestational diabetes mellitus
#@A. Enquobahrie,A. Williams,Chunfang Qiu,A. Luthy
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index958130548992999204773857436079900892180027511798
#%915727653060471346180239381537417559200085268162
#%387151064379764333805306433851139685671107817739
#%1222075336526156787286514253697904722655108233876
#%351703313849178316383033685066919532792795390225

#*Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus
#@Sora Ludwig,Sudharshan Dharmalingam,Sharon Erickson-Nesmith,Song Ren,Fuqin Zhu,M. Ma,Ruozhi Zhao,W. Fenton,A. Ofosu,te Velthuis,van Mierlo,X. Shen
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index981637229705080772792344115131911086076534956853
#%606283717481354310725767594712515082769315744867
#%606283717481354310725767594712515082769315744867
#%142731545908115924743182166928873462635511087622
#%1063925797686211976808556833342484531427039097936
#%659839944245607916696971968388726580821330547492
#%880868283884546157132822857050172404048442320728
#%1118549764837070159736206139504489697165206154957
#%232445806848696110466081627023623974539430656517
#%1020719168663257025464399985448214647786526886456

#*Serious diabetes-specific emotional problems and depression in a CroatianDutchEnglish Survey from the European Depression in Diabetes [EDID] Research Consortium
#@Franois Pouwer,Chas Skinner,Mirjana Pibernik-Okanovic,T.F. Beekman,Sue Cradock,Silvija Szabo,Zeljko Metelko,J. Snoek
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index994275654840152262746276706875740482290798046148
#%1251282708108432301476948318376186022980383299792

#*Economic burden on families of childhood type 1 diabetes in urban Sudan
#@Hind Elrayah,Mohamed Eltom,Ashraf Bedri,Abdelrahim Belal,Hans Rosling,Claes-Gran stenson
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index525215370116295315436355638591230275696970267928
#%785054618190218675791308759026204358020502417518

#*High prevalence of obesity and diabetes mellitus in Konya, a central Anatolian city in Turkey
#@D. Yumuk,Husrev Hatemi,Tunc Tarakci,Nurettin Uyar,Nurten Turan,Nazif Bagracik,Ali Ipbuker
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index961470346641606853593713724199540319023282068699
#%27096163423311949041485650293775586390756129282

#*Comparison of the quality of diabetes care in primary care diabetic clinics and general practice clinics
#@K.A.J. Khaja,R.P. Sequeira,A.H.H. Damanhori
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1101745034749861810803979414654775670876193314710
#%1371098850282156108215104951030536019284453182604

#*Aspirin sensitivity of platelet aggregation in diabetes mellitus
#@G. Albert,I. Hasnain,G. Ritter,Heinrich Joist,D. Mooradian
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1420308533722187591041714356728116952346569948611
#%1069281091254649760686411757228758578035542279529
#%80569167242191052576435286791903194174878450105

#*Abnormal peripheral circulation in type 2 diabetic patients with normal ankle-brachial index associates with coronary atherosclerosis, large artery stiffness, and peripheral vascular resistance
#@Masanobu Tsuchiya,Eiji Suzuki,Katsuya Egawa,Yoshihiko Nishio,Hiroshi Maegawa,Shigehiro Morikawa,Toshiro Inubushi,Atsunori Kashiwagi
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index365216837003422585742959849306988675335233568469
#%794021689793091337984621388763587103492209797655
#%633461680371896292474213356432768461383201339245
#%1608226095824641691220604657615928697498238491
#%1062419277271444057737754023953305346019300989991

#*Hand grip strength in patients with type 2 diabetes mellitus
#@Ercan Cetinus,Akif Buyukbese,Murat Uzel,Hasan Ekerbicer,Ahmet Karaoguz
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index858916212867384216329094105939383824999368980622
#%1043191904236236246857071447048690900271880986427
#%386822948079596324700700400140169218675270693658
#%953237579105037244717675481616934413076826396001
#%1331127855113398007448568796142846902707328338955
#%1179374283461567929088313240199513049001516014888

#*Long-term (1- and 2-year) effects of lifestyle intervention in type 2 diabetes relatives
#@K. Brekke,Per-Anders Jansson,A. Lenner
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1186428801436723530684320505823618748494406511998
#%1149292893479396788857469193097727548084089648766
#%266601698427817480156771903428434239697180464292
#%769707427489090225217189567617569127931463974535
#%756102127498847614224997771619478108851647241209
#%1068887555254616943713099863490264039188837694859

#*Prevalence and control of dyslipidemia among persons with diabetes in the United States
#@J. Jacobs,Thomas Kleisli,R. Pio,Shaista Malik,J. LItalien,S. Chen,D. Wong
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1221636437798176584925774481663677540948892224428
#%741472667357967036521698557437635045148869117616
#%1096763837897013973158154068912058003029692234165
#%1125090483701768695088434263475911921836184542546
#%1158647179917402664186892645294538643512729480813

#*Secular trends in mortality rates for diabetes in Australia, 19071998
#@Peng Bi,A Parton,Ken Donald
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index266120096768460383245458098485543869752509970313

#*An autoradiographic study of [ 18F]FDG uptake to islets of Langerhans in NOD mouse
#@Teemu Kalliokoski,Olli Simell,Merja Haaparanta,Tapio Viljanen,Olof Solin,Juhani Knuuti,Pirjo Nuutila
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1136616247613425706024977888109457936076685529100
#%1064582561359787714333812943026370987934377390854

#*Diabetes induces Na/H exchange activity and hypertrophy of rat mesenteric but not basilar arteries
#@J. Dilley,A. Farrelly,J. Allen,Karin Jandeleit-Dahm,E. Cooper,Grant Morahan,J. Little
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index203321265954141931043139289832965583370862888347
#%718641833152761860991191961480921946669462221471
#%215592390271408988928656105986338039528813336202
#%260433846872541996334050520760117513744669736250

#*Clinical characteristics of Japanese youth-onset type 2 diabetes with ketonuria
#@Jun Matsui,Naoki Tamasawa,Jutaro Tanabe,Nobuhiko Kasai,Hiroshi Murakami,Kota Matsuki,Toshihiro Suda
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index945765071574652760159023938405437935583220183230
#%85101372191573518643187046729758488217693954947
#%1404401825097809215017684971991092855126766552358
#%997216239685076405372393390759878014145321636738
#%997216239685076405372393390759878014145321636738

#*Type 1 diabetes developed in a type 2 diabetic patient with severe insulin resistance
#@Tadashi Suehiro,Fumiaki Osaki,Yukio Ikeda,Kaoru Arii,Fumi Nakayama,Kikuko Ota,Kozo Hashimoto
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index352823969424118800167271433510893939719849944048
#%1444004797962237787871068591574968897827384108031
#%106129192845100190994425469060920203237848506276

#*Leptin potentiates ADP-induced [Ca 2+] i increase via JAK2 and tyrosine kinases in a megakaryoblast cell line
#@Masanori Nakata,Ikuro Maruyama,Toshihiko Yada
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1446492199880783518948901491463080181818333442646
#%1185822330885153882248453441319871316163743673924

#*Secondary sulfonylurea failure: Comparison of period until insulin treatment between diabetic patients treated with gliclazide and glibenclamide
#@Jo Satoh,Kazuma Takahashi,Yumiko Takizawa,Hisamitsu Ishihara,Masashi Hirai,Hideki Katagiri,Yoshinori Hinokio,Susumu Suzuki,Ichiro Tsuji,Yoshitomo Oka
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index595050353735201512914589464075312916063672512073
#%393657166629531494617137493363115759524115809436
#%776670628330209703924615966454572446131667009509
#%715008734441339778059524855614350596376424210789
#%424769145508895941766672642441414141329164375424
#%1337619430985460415890491626993979901083737755048

#*Prevalence of diabetes in rural Victoria
#@David Simmons,Anne McKenzie,Simon Eaton,Jonathan Shaw,Paul Zimmet
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1377437551252641267423982173225963239122539309257
#%786997059890136289473390488119546392839317310396

#*Normocytic normochromic anemia due to autonomic neuropathy in type 2 diabetic patients without severe nephropathy
#@Takatoshi Saito,Katsuyoshi Tojo,Aya Morimoto,Naoko Tajima
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index1015081688398847117471114010457717428548839040843
#%1383618093254241189117602900585504378029570379337
#%1144017485702033947952388411081141974640753564655
#%1023537988430171942858711627888127549829337845409
#%483303417387462728086320956747073437418411656349

#*Type 1 diabetes and leg length
#@R.G. Moses
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index485278403118651374148421267499335288762709838524

#*A short-term admission improved brachialankle pulse wave velocity in type 2 diabetic patients
#@Akemi Yamamoto,Yasuyuki Katayama,Koji Tomiyama,Hiroshi Hosoai,Fumihiko Hirata,Hiroko Yasuda
#year2005
#confDiabetes Research and Clinical Practice
#citation0
#index232824785672383158212773890267146338156659167807
#%1029025427814728584470217220225360230822213915065
#%1256642356694394725275193779963654550278059379357
#%1186705578171654403110379976250189055769233719929
#%351998829791453545662981177446044722710838933056
#%904700593569821583042130070960486435078937248092

#*Hyperglycemia among persons with hepatitis C: Not the classical diabetic phenotype
#@E. Behrendt,B. Ruiz
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1152527586522501556777127034273779844981723229927
#%231142197255569191538021629732607720396255992037
#%279583887806987801369632323935016624106601364537
#%1020651240722495597113763597233589890895254184072
#%1113546003439604590706208013297333441609459960380
#%1413416836908401505830694855547434249497139800806
#%851419424696239827662272346082861959126419466462

#*Late diabetes complications and non-dipping phenomenon in patients with Type 1 diabetes
#@Peter Stella,Gy Tabak,C. Zgibor,J Orchard
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index161096203459640859434852996174014906569632787921
#%318387213895025702742292551403445336881611286042
#%730984606219552461470784668072027288578470715443

#*Nurse case management improves blood pressure, emotional distress and diabetes complication screening
#@A. Gabbay,Irina Lendel,M. Saleem,Gregory Shaeffer,M. Adelman,T. Mauger,Mary Collins,C. Polomano
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1198838675164825412735668110496905879476128256129

#*C-reactive protein is elevated in obese patients with the metabolic syndrome
#@Hermes Florez,Sumaya Castillo-Florez,Armando Mendez,Paul Casanova-Romero,Carmen Larreal-Urdaneta,David Lee,Ronald Goldberg
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index387540669369124946191039416691084164282132885430
#%116946116299964777866131895583497451680709896200
#%1107820164326875704963151622793424418275232651906

#*Recurrence of gestational diabetes mellitus: Rates and risk factors from initial GDM and one abnormal GTT value
#@Tomoyoshi Nohira,Seiichi Kim,Hiromi Nakai,Kazuhiro Okabe,Tomoo Nohira,Kuniyoshi Yoneyama
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index623007137356226965075595715036480466341903564585
#%1248884754632062938865073881079906332543692974966
#%157586833371456941523679511245816911292790745227

#*Serum carotenoid concentrations are inversely associated with serum aminotransferases in hyperglycemic subjects
#@Minoru Sugiura,Mieko Nakamura,Yoshinori Ikoma,Masamichi Yano,Kazunori Ogawa,Hikaru Matsumoto,Masaya Kato,Makoto Ohshima,Akihiko Nagao
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1453613910641836507950999087437591923997307959850
#%864537548515499263610093399682381194601240503582
#%512368622922700172109092396426508826217808518580
#%405809616466319117122435878047039192518660569251
#%418560649360016091242745674703801327381619952707
#%234366315517820226285496573703643431353740843344
#%828099597365511144284594727163684428187076803779
#%731462202590481614299903390079244584398975843207
#%901443277854881102677309322137051891504498493231
#%250738455794925689034400932104327605355141478774
#%507908293444312819988214861015236960371048450449
#%876437939124284339666628613215923594279797812331
#%311649852210232714532115354532780893757209060211

#*Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: Associations with blood pressure and HDL cholesterol
#@J. Woodman,A. Playford,F. Watts
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1285520904390329427608267784108671275015722936396
#%541064693948894516473795764388091059744612475304
#%1361036873042354079285223982361117166995825325120
#%588840605606434508470716625373413527596559646730
#%1321957889220966696531116062358864605535665781292
#%762193630285307555453415002050514359949045914678
#%2927955539701695492032852360216053691783657828
#%1377670027486395233906598444799553967256242597926
#%414858808569245572356286021483555111794901651110

#*Three-dimensional geometry analysis of the stomach in type II diabetic GK rats
#@Donghua Liao,Jingbo Zhao,Hans Gregersen
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index998949471304423560881050870127839883032498471045
#%164846923875410606664944385524358522648658385617
#%1110208560701170705686328024345034399466247033516
#%1026957031198233686874689118525012377989458167865
#%1256202573036366380085244561742845792806516996349
#%1256202573036366380085244561742845792806516996349
#%473023586720294215940674632162929548694140320263
#%1340965801154156807599629875115507220574624250875

#*The effect of dual PPAR / stimulation with combination of rosiglitazone and fenofibrate on metabolic parameters in type 2 diabetic patients
#@Selcuk Seber,Sema Ucak,Okcan Basat,Yuksel Altuntas
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index864110034254095825708737739163520916597076560341
#%393687601658056354920231760972859132196269332434
#%456199719037449771807855271933187800302809341115
#%474759398800266410796874036404452562626311592603
#%474759398800266410796874036404452562626311592603
#%199210359002794575776092865529761652470289044072
#%1192801073745082322938187672784279375654543042618
#%1071590161881069243201544289330593227888549679407
#%301760100150945756029611702327163999708194863101

#*Monocyte matrix and ADAM metalloproteinase expression in type 2 diabetes after aspirin therapy
#@Mike Sampson,Steven Wall,Mark Baugh,Jo Worley,Isabel Davies,David Hughes,Jelena Gavrilovic
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index560466147126447636350461145537477920463781074780
#%695164606322996185304471893418009396957180596450
#%272069843343924852280336555114090856988080877074
#%511820403967610347301896285865255236938896730921
#%563065188745080829887721781460180616705773936965

#*Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: A case-control study
#@Rafael Sim,Teresa Vidal,Jos Garca-Arum,Esther Carrasco,Marta Garca-Ramrez,M. Segura,Cristina Hernndez
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index13642198830353034993050106207309705049061320879
#%1341971400198420472171157471571326564473764055601
#%549963996882557992383959141390152024535883460730
#%773609504038353211736611680125978676424357865537
#%870670141170131269591666363899895021252387230258
#%113976506504882194476041021514511596897266835650
#%967277010166712944906754186539465793214233557276
#%316278461163529482740821300583635132367245589890

#*High prevalence of obesity and associated risk factors in urban children in India and Pakistan highlights immediate need to initiate primary prevention program for diabetes and coronary heart disease in schools
#@Anoop Misra,Abdul Basit,K. Vikram,Rekha Sharma
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index101785093756571938034678302662344484086951673811
#%1447361853434363988291233158284447693785612743316
#%783174782185648653213533285049266443245399632818

#*Two regimens of twice-daily premix insulin analogue: An observational study
#@G.R. Sridhar
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index572457192684658719373232346667183936192250438565

#*Corrigendum to Glucose intolerance and associated factors in the multi-ethnic population of the United Arab Emirates: Results of a national survey [Diab. Res. Clin. Pract. 69 (2005) 188195]
#@M. Malik,A. Bakir,Abi Saab,H. King
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index531402963746333454641371918098643574047795317954

#*Microalbuminuria: measurements, determinants and accompaniments
#@Om.P. Ganda
#year1991
#confDiabetes Research and Clinical Practice
#citation0
#index679389909219175306989515511333559325423585564740
#%1106189197656644528469711488526067913415821447050

#*Cytosolic calcium: a new factor in insulin resistance?
#@Boris Draznin
#year1991
#confDiabetes Research and Clinical Practice
#citation0
#index930617941756642762184996835520946145589601550134
#%778593342303561918824324680324902426830695158731
#%1046414502897988618729925733193883416215821939045
#%116586824508878728425133088085037162252066521301

#*A pilot clinical trial of a new oral hypoglycemic agent, CS-045, in patients with non-insulin dependent diabetes mellitus
#@Takeshi Kuzuya,Yasuhiko Iwamoto,Kinori Kosaka,Kazuo Takebe,Toshikazu Yamanouchi,Masato Kasuga,Hiroshi Kajinuma,Yasuo Akanuma,Sho Yoshida,Yukio Shigeta,Shigeaki Baba
#year1991
#confDiabetes Research and Clinical Practice
#citation0
#index488281865829697222508639431733469969012024619449
#%1404395222272852512727346738370724574065413864887
#%284612520748176421323150778161342397105304606625

#*Diabetic retinopathy and previous insulin therapy as compared with insulin requirement
#@J. Sieradzki,B. Mirkiewicz-Sieradzka,M. Szurkowska,B. Romanowska
#year1991
#confDiabetes Research and Clinical Practice
#citation0
#index1061880596365281908056429863139473050338187668639

#*Echocardiographic study of left ventricular function in type 1 diabetes mellitus: hypersensitivity of -adrenergic stimulation
#@L. Maraud,H. Gin,R. Roudaut,J. Aubertin,H. Bricaud
#year1991
#confDiabetes Research and Clinical Practice
#citation0
#index895091800032612405727239738550076051934779241606
#%759463480221710549215187968486753502626836342466
#%1360051399342000463371612184699665957816549682137
#%1419179951696563512820916115331841234962252584318

#*Coronary risk factors in newly diagnosed and previously diagnosed type 2 diabetic men with myocardial infarction
#@M. Sewdarsen,S. Vythilingum,I. Jialal,M.C. Kamdar
#year1991
#confDiabetes Research and Clinical Practice
#citation0
#index499889377106573443532478461797663070080498898732
#%793036956818862637736041028963795612471112262501
#%122271092993337852491109015145842974816032157897
#%741982356632916026887293329553658348840119929079
#%243028563813569050940430297513939109039267254893

#*Correlation between histopathological changes and mechanical dysfunction in diabetic rat hearts
#@Yoshihito Kita,Masami Shimizu,Norihiko Sugihara,Kuniyoshi Shimizu,Hiroyuki Yoshio,Shinsuke Shibayama,Ryoyu Takeda
#year1991
#confDiabetes Research and Clinical Practice
#citation0
#index612362186975618230489290072657373000469398336702
#%483303417387462728086320956747073437418411656349
#%1105006767126622339366750948258796291374163504691
#%164044944052242069580880808013830599523869909770
#%1177240727943245705718757386639738764754199619370
#%115289154288122838639618913215998004026019341956
#%752211490953396578088103907066798233126157561954
#%1368280429475276603609959643908489386838282369534
#%1040159342522050695687531625072824728236884093535

#*Retinal changes and alterations in blood pressure and albumin excretion rate (AER) during exercise in type 1 diabetes
#@K. Garg,Peter Chase,E. Jackson,Sherrie Harris,Guillermo Marshall,Sandy Hoops
#year1991
#confDiabetes Research and Clinical Practice
#citation0
#index771867432570694280348688222265238604820193299934
#%566290694663204665145000839960184381507496969020
#%136182985502091490091507020387611330210328116774
#%923230950899319989723698336167797582739997380458

#*Thirst and plasma levels of vasopressin, angiotensin II and atrial natriuretic peptide in patients with non-insulin-dependent diabetes mellitus
#@Kyuzi Kamoi,Miyuki Ishibashi,Tohru Yamaji
#year1991
#confDiabetes Research and Clinical Practice
#citation0
#index642811475236497091803153664129285206530768592002
#%847391178617209395442262172945622976638654780939

#*Nutritional profile of fibrocalculous pancreatic diabetes and primary forms of diabetes seen in Southern India
#@V. Mohan,C. Snehalatha,P.K. Bhattacharyya,A. Ramachandran,M. Viswanathan
#year1991
#confDiabetes Research and Clinical Practice
#citation0
#index507561241479025107833538216065285680679417734024
#%68219332946193585541324063850031753158379547747
#%657779375211454892493882879754627846305120453467

#*Metabolic characteristics and insulin resistance of impaired fasting glucose among the middle-aged and elderly Taiwanese
#@Liang-Kung Chen,Ming-Hsien Lin,Zhi-Jun Chen,Shinn-Jang Hwang,Shih-Tzer Tsai,Shu-Ti Chiou
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1092188121641455288891147688004469839427158894354
#%608599557601443201658711010464765932553998229738
#%608599557601443201658711010464765932553998229738

#*Interleukin-12p40 gene (IL-12B) polymorphism and Type 1 diabetes mellitus in Japanese: Possible role in subjects without having high-risk HLA haplotypes
#@Mei Yang,Shoichiro Nagasaka,Toshimitsu Yatagai,Tomoatsu Nakamura,Ikuyo Kusaka,San-e Ishikawa,Toshikazu Saito,Shun Ishibashi
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1192727938029142450455346657065657807409312714855
#%1285315270453067068865627652545166508592640563620
#%1041572192062285604833641335499725285491819035358

#*Probucol delays progression of diabetic nephropathy
#@Kei Endo,Yoh Miyashita,Hidehisa Sasaki,Masahiro Ohira,Atsuhito Saiki,Nobukiyo Koide,Masaki Otsuka,Tomokazu Oyama,Murano Takeyoshi,Yoshiaki Ito,Koji Shirai
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1234425336278186793460422730785609644858792063612
#%431412729600776668789272016853046241948029539427
#%1311403163868415738984494535035037073171566079273
#%1169979600690504348411592852311144791255874600171

#*Comparisons of the outcomes on control, type of management and complications status in early onset and late onset type 2 diabetes in Asia
#@Lee-Ming Chuang,Sidartawan Soegondo,Pradana Soewondo,Kim Young-Seol,Mafauzy Mohamed,Edith Dalisay,Ruby Go,Warren Lee,Tai Tong-Yuan,Sunthorn Tandhanand,Wannee Nitiyanant,Mai The-Trach,Clive Cockram,Yeo Jing-Ping
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index515290025853191197099915149936743742320644581150
#%758227582403127299743215273810807692468857691477
#%1348611913445627674425743417019350558830775563756
#%515252053113515299167470988678095691441282617750

#*A comparison of blood glucose meters in Australia
#@Matthew Cohen,Erin Boyle,Carol Delaney,Jonathan Shaw
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1275657202719090702383575952394983119025276527659
#%1184038930837288469277806993990944755970461724805
#%1042744264035945036003003354250995531990101780724

#*Extracellular superoxide dismutase gene polymorphism is associated with insulin resistance and the susceptibility to type 2 diabetes
#@Masanori Tamai,Hiroto Furuta,Hiromichi Kawashima,Asako Doi,Tohru Hamanishi,Hiroko Shimomura,Setsuya Sakagashira,Masahiro Nishi,Hideyuki Sasaki,Tokio Sanke,Kishio Nanjo
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index832393319297836990039491990759371062022211939421
#%13486075667209065232951983527432883282467523653
#%84613342272763883069658816491322862182925042704
#%339006858954742806602696456209836109292673963639

#*Serum lipoprotein (a) levels in patients with diabetic foot lesions
#@Krad nlhzarc,Sabahattin Muhtarolu,evki Kabak,Fahri Bayram,Fahrettin Keletimur
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index698810889865969676753711360019057857840150430999
#%337197708163411460455606418080594853847486420554

#*Waist circumference is the key risk factor for diabetes in Korean women with history of gestational diabetes
#@H. Cho,C. Jang,K. Park,W. Cho
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index340035279079324791840196450218319126054720600885
#%1168953092599551196250025467069138834072534232104

#*Pre-meal insulin aspart compared with pre-meal soluble human insulin in type 1 diabetes
#@P.D. Home,P. Hallgren,K.H. Usadel,T. Sane,J. Faber,V. Grill,H.H. Friberg
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index707902077053608907834739575725305064393287645619
#%984065047993390470326257911248465487534138989682
#%701787196052191727984636046236679810905159195013
#%1169293796816107314381672818036363250941017341287

#*Professional accountability for diabetes care in Taiwan
#@Fen-Yu Tseng,Mei-Shu Lai,Ci-Yong Syu,Cheng-Ching Lin
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1066639413747252171928946406273179615147554548866
#%816288063008886026562690004102967508680265408781
#%1396596511887939696537597425428496812390775485431
#%566824459045093364203746399348920582462591644183
#%323876508437449031803477107896245801843817062170
#%828090978311417755828945553845409413837776139108

#*Long-term glycaemic control with insulin glargine in Type 2 diabetes
#@Gertrud Kacerovsky-Bielesz,Ansgar Dressler,Regina Freunscht
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1336964695059999684814132117757908514584177289443

#*Mechanical horseback riding improves insulin sensitivity in elder diabetic patients
#@Masakazu Kubota,Masaru Nagasaki,Mizuho Tokudome,Youichi Shinomiya,Takahisa Ozawa,Yuzo Sato
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index562150060932838916786661865982619324770462029575
#%1141441987233934369041410284494692998984833245025
#%998163423168965255527678891385011545011087272867
#%360343779582322013886250986666541898972929593003

#*Late pregnancy blood pressure in nulliparas and subsequent abnormal glucose tolerance
#@Jouko Saramies,Sirkka Keinnen-Kiukaanniemi,Markku Koiranen,Jari Jokelainen,Benno Meyer-Rochow,Markku Timonen
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1156361578959368496559189925370845881180921162994

#*Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension
#@M. Sengul,Yksel Altuntas,Akn Krkl,Levent Aydn
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index686489620559117785632596746003803971646639334716
#%627599488485473959596106161004635697604401397353
#%760313407974168020886295920339898890766890804995
#%1403980060714035737435884437803942161533468226059
#%431412729600776668789272016853046241948029539427
#%1406079558725933450648481132733537522268366394789

#*Prevalence of diabetes in Murcia (Spain): A Mediterranean area characterised by obesity
#@Cerezo Valverde,Mara-Jos Tormo,Carmen Navarro,Miguel Rodrguez-Barranco,Rosario Marco,Jos-Manuel Egea,Domingo Prez-Flores,Jun-Bautista Ortol,Leandro Gonzlez-Sicilia,Javier Tbar,Manuel Snchez-Pinilla,Margarita Flores,Josefina Cava
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1238493761444858885847069673758032080571422578589
#%414596679935221442297375332530042968230769284852
#%20974908667366551872942389171008465367644595653
#%360278312286450051970294842253772899720125590097

#*A case of type 2 diabetes mellitus developing hypothyroidism discovered as a result of a discrepancy between glycated hemoglobin and glycated albumin values
#@Kenji Moriyama,Naotetsu Kanamoto,Yuji Hataya,Takuo Nanbu,Kiminori Hosoda,Hiroshi Arai,Kazuwa Nakao
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index108415521816253696892379654487119819378864715688
#%995483039477252890162324768673665618214247432271

#*Glomerular hyperfiltration in non-proteinuric and non-hypertensive Japanese type 2 diabetic patients
#@Yasuyuki Jin,Tatsumi Moriya,Keiji Tanaka,Madoka Matsubara,Yoshikuni Fujita
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1023458265479257262256947751914379974325752649709
#%483858437440412259832359729244313132001042556496
#%323371075784220702804310131638470684880073731115
#%1336648649261936088430305434940784467760876459805
#%1055847546156916319521056861100812596382898339653
#%800143097034544460624452249514496546839310453463
#%801531115227141757278691240795809795086635082725
#%401193258632165768306962064848180690330611623984
#%1049058920229205664382742623648110880908229604132

#*Relation of habitual snoring with components of metabolic syndrome in Korean adults
#@NamHan Cho,SoonJae Joo,JinKwan Kim,D. Abbott,JeHyeong Kim,Kuchan Kimm,Chol Shin
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index769490681541031808394277799094132205159932928763
#%1380420016642512513235623130219785681278842583981
#%932862286689261514386152577763809351808483508277
#%713540244543656635640617293931540976177290391992

#*Coping strategies in men and women with type 2 diabetes in Swedish primary care
#@C. Gfvels,P.E. Wndell
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index220827247919137292911356742133475503874341889050
#%177694896289598442042421938078290819012511099084
#%1053228357057001624362274462474301447987794049371
#%1337202440690088056196505068983693466672390244868

#*Risk factors for major limb amputations in diabetic foot gangrene patients
#@Susumu Miyajima,Akira Shirai,Shiori Yamamoto,Natsuko Okada,Tetsuya Matsushita
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1277292134941550193137709718514760131592273842653

#*Pancreatic exocrine and endocrine events occur concomitantly but independently during the course of fulminant type 1 diabetes
#@Toshio Kahara,Toshinari Takamura,Masaru Sakurai,Hirofumi Misu,Rika Usuda,Tetsuo Hayakawa,Yasuyuki Nishimura,Yukihiro Bando,Tadasu Nagaoka,Yukihiro Nagai,Shuichi Kaneko
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1427496884698808412455504175531828110684410168644

#*Recurrent bilateral dislocation of the shoulders due to nocturnal hypoglycemia: A case report
#@Abdurrahman zelik,Murat Diner,Haldun etinkanat
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index545052477930609976591744012163335759506863594149
#%877745835111754593593498692720002964999718126580
#%289113378855328044227028311355039882319251845219
#%433479834197500684768569445495966301012335359136

#*Interleukin-6174 G > C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patients
#@R. Testa,F. Olivieri,A.R. Bonfigli,C. Sirolla,M. Boemi,F. Marchegiani,M. Marra,S. Cenerelli,R. Antonicelli,A. Dolci,G. Paolisso,C. Franceschi
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1003868296739960269078345817949747869649637937572
#%1057374172435243366707948103669582425023924160
#%1329244909195752636889998764438717698541374779588

#*Glycated albumin is low in obese, non-diabetic children
#@Rimei Nishimura,Akira Kanda,Hironari Sano,Toru Matsudaira,Yumi Miyashita,Aya Morimoto,Takako Shirasawa,Takeshi Kawaguchi,Naoko Tajima
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index576014543183933311782298797543626940218279865244
#%959231419534254226753409696883367637222578877793
#%33134122640333840335717024352748233409831572114

#*Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients
#@O.H. Ryu,J. Lee,K.W. Lee,H.Y. Kim,J.A. Seo,S.G. Kim,N.H. Kim,S.H. Baik,D.S. Choi,K.M. Choi
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1166307438102604581768640823255981771525873753732
#%446534599465393725254719262489216477835077320676
#%1133593054589770757251915086864774463843945365130

#*Can we simplify the 100-g oral glucose tolerance test in pregnancy?
#@Melanie Rodacki,G.S. Lacativa,A.B. Lima,C. Peixoto,G.A. Loureiro,B. Wagman,Lenita Zajdenverg
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index691058565862611177455497176979357765002707709221
#%347165901288070027128815752702375773985739078209
#%347165901288070027128815752702375773985739078209
#%436220921492092668613091285053289536753115517955

#*Predictors for erectile dysfunction among diabetics
#@Hui Zheng,Wenli Fan,Guangwei Li,Theresa Tam
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1015682896258506930880052291445740126797620390874
#%27749254850150098113672889978741359498937497620
#%469821227232089569800313561354499963807921956096
#%443456452975210031660508821807962352032099596283

#*Hyperglycemia and type 2 diabetes among Filipino women in the Philippines, Hawaii, and San Diego
#@G. Araneta,J. Morton,Lina Lantion-Ang,Andrew Grandinetti,Anne Lim-Abrahan,Healani Chang,Elizabeth Barrett-Connor,L. Rodriguez,L. Wingard
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index634476906269908756350854524192575012797604992477
#%467905377287333834460591134043308819601685035641
#%105287210728046923670359272020923600781655220077
#%1241358283530080293186406245815498949670769666289

#*Alteration in risk factor accumulations of acute myocardial infarction during the last one decade: Analysis of patients admitted in Coronary Care Unit
#@Masami Sasaki,Takako Saito,Norifumi Kubo,Tomoyuki Saito,Aki Ikoma,Hiroyuki Tamemoto,Muneyasu Saito,Masanobu Kawakami,San-e Ishikawa
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1087389530997953967053163605005119265838475918694
#%1438361308239152205343302480156715263383345379538
#%204414839562654696353955633682894548541905481804

#*Gene therapy for diabetes mellitus in rats by intramuscular injection of lentivirus containing insulin gene
#@Keun Oh,Zi Li,Taik Kim
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index201287481415466916158276872585664960205488939463
#%285275380222029173743871764894148198621985162747
#%234677710346654484514583849923705716099856543403

#*Nicotinamide protected first-phase insulin response (FPIR) and prevented clinical disease in first-degree relatives of type-1 diabetics
#@R. Olmos,I. Hodgson,Alberto Maiz,Mnica Manrique,Daz Valds,Roco Foncea,M. Acosta,V. Emmerich,Soledad Velasco,P. Muiz,A. Oyarzn,C. Claro,J. Bastas,A. Toro
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index124300146664698946793714146350873393414034358277
#%205577228220889284775447884397124062804987176236
#%836729333936544217677785299688758649581082916421

#*Beneficial effects of nateglinide on insulin resistance in type 2 diabetes
#@Yoji Hazama,Munehide Matsuhisa,Kentaro Ohtoshi,Shin-ichi Gorogawa,Ken Kato,Dan Kawamori,Kazutomi Yoshiuchi,Yumiko Nakamura,Toshihiko Shiraiwa,Hideaki Kaneto,Yoshimitsu Yamasaki,Masatsugu Hori
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index974127081707539555018643475737391229484375439916
#%844582092801133305070754171853083111700615995384

#*Evaluation of diabetes care in the Otago region using a diabetes register, 19982003
#@J. Coppell,Karen Anderson,Sheila Williams,Patrick Manning,Jim Mann
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1399441503790461851767322430045761906798639268947
#%741472667357967036521698557437635045148869117616

#*Insulin resistance and impaired glucose metabolism in a predominantly Maori community
#@I. Mann,C. Tipene-Leach,L.R. Pahau,R. Joseph,Sally Abel,A. McAuley,J. Coppell,S. Booker,M. Williams
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index835391273568440819560824800480094275202321390664
#%192656187719348078911838862482417258485619675070
#%965623351764089213424175684108145815594666716422

#*Variation of the insulin receptor substrate gene (IRS-1) in African Pygmies and Bantus
#@C. Battaggia,F. Verginelli,R. Palmirotta,R. Mariani-Costantini,A. Cama,G. Destro-Bisol
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1084036263346971729687874365035696124327075810866
#%267460104875373512815988336147282228840858818711

#*Serum magnesium concentrations in type 1 diabetic patients: Relation to early atherosclerosis
#@Emre Atabek,Selim Kurtoglu,Ozgur Pirgon,Murat Baykara
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index481479019668764006689700966648883104575267601870
#%862657679846278038580576167863191047286304090527
#%568263704428717221824066386535906412307770645002
#%1446930595842919317916757477666769795705585535927
#%1080482858059280355316777607224191984414011488060

#*Effect of fast-food Mediterranean-type diet on type 2 diabetics and healthy human subjects platelet aggregation
#@C. Karantonis,Elizabeth Fragopoulou,Smaragdi Antonopoulou,John Rementzis,Costas Phenekos,A. Demopoulos
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index5843812596086550520788599823706309388718433722
#%872409629678194092190747205309337199641521683542
#%1272117602830670001314160055085624655486534899359
#%14006411879411423673947283437068425171195603186
#%558228899440352683328417039900299863059943509182
#%1251655894468287371583032872218142257528129060182

#*Psammomys obesus (sand rat), a new animal model of non-alcoholic fatty liver disease
#@Maximo Maislos,Vitali Medvedovskv,Ignacio Sztarkier,Arieh Yaari,Emanuel Sikuler
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1044398228500642125102773574361185377904328545051
#%677302208782134738259121342758481115681614732834

#*Brain natriuretic peptide and cardiac autonomic function in type 2 diabetic patients
#@Kunio Yufu,Naohiko Takahashi,Mikiko Nakagawa,Masahide Hara,Tetsunori Saikawa,Hironobu Yoshimatsu
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1071579017879898300694461985507689626037177024301
#%1240931317424294175882466528222664869229974652990
#%853829881689422385153745557403166643484683899138
#%577198282137494107728098041125984218567794884361
#%199979583228350769404783521402158646927767237279
#%791803557976382721086651924030820280049240066145
#%1134850636510981810886142719970823647224650673538
#%1387655723349942916304447967953284644718816128974
#%1167244789149087004248896642338441706241163388039
#%658122642805431565645904601137981091836779009799

#*Serum cholinesterase activity in diabetes and associated pathologies
#@Gilberto Lunkes,Franciele Stefanello,Danile Lunkes,Vera Morsch,Chitolina Schetinger,Fabbrin Gonalves
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index357550887302843971543558550619158448762351872408
#%1390767547099907495498470368123019264452888981682
#%1390767547099907495498470368123019264452888981682
#%1199632471447912958120232855945331222772858126979
#%979359980178221341961318291355270132267539515364
#%1038839550444049436899782657356462678996226883465

#*Glucose-stimulated insulin response in non-diabetic patients with lipoprotein lipase deficiency and hypertriglyceridemia
#@Naoki Tamasawa,Jun Matsui,Hiroshi Murakami,Jutaro Tanabe,Kohta Matsuki,Yoshiji Ogawa,Yasuyuki Ikeda,Atsuko Takagi,Toshihiro Suda
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index870753713306080823909572176574197993207507658446

#*The metabolic syndrome in Spanish migrants to Brazil: Unexpected results
#@M.D.C. Pousada,M.S. Britto,Thomaz Cruz,Lourdes Lima,Ines Lessa,C. Lemaire,H. Carvalho,T. Martinez-Larrad,Coll Torres,Manuel Serrano-Rios
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index374842294688673006806403270946221015542026322157

#*Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q10
#@Eduardo Salles,A. Moiss,R. Almeida,R. Chacra,S. Moiss
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index320535890670143721234144940276935079037816579821
#%574095825187333251298928853472781252974894942343
#%314200743651801879778246681116300138820608714429

#*Physical activity barriers in diabetes: Development and validation of a new scale
#@M.-C. Dub,P. Valois,D. Prudhomme,S.J. Weisnagel,C. Lavoie
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index547179093326453973106488376457984216543392799138
#%662899828840443541493623238585294592464653667910
#%712675805472452676441181365804900889168372938506
#%820201920530531336905567598302478431644209357301

#*Effect of rosuvastatin or atorvastatin on urinary albumin excretion and renal function in type 2 diabetic patients
#@Jonathan Sorof,Christian Berne,Annica Siewert-Delle,Leif Jrgensen,Philip Sager
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index885606541035562299797036371949905673278738521716
#%806999650028062183539294847549091501669413301243
#%156595203417787027565413564383538647545054357684
#%485133123865606747877104948316522928391160104311

#*Could statistical adjustments for age mask the insulinblood pressure relationship?
#@E. Schutte,Kerin ODea,E.H. Schwarz
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1102477129048575116255843984384805677359614739054

#*Nitric oxide might be involved in the chloroquine-improved insulin sensitivity: Old treatment for global danger
#@M.H. Ahmed
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index417860231601893037843208050120831696590554401820
#%661344805746250239050601831983739701676595676245
#%1135876172785554153929519369592901863294036794944

#*Impact of modified glucose target and exercise interventions on vascular risk factors
#@Kaberi Dasgupta,A. Grover,Deborah Costa,Ilka Lowensteyn,Jean-Franois Yale,Elham Rahme
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1388502389360950919198567664877199566783595150461
#%43505307937983020920402093334495207485220261755

#*Improvement in C-reactive protein and advanced glycosylation end-products in poorly controlled diabetics is independent of glucose control
#@S.H. Isa,I. Najihah,Wan Nazaimoon,N.A. Kamarudin,N.A. Umar,N.H. Mat,B.A.K. Khalid
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1309252111445263101317895540393344866288010643773

#*The ROC analysis for different time points during oral glucose tolerance test
#@Weibin Zhou,Hong Li,Yanyun Gu,Lu Yu,Junfeng Han,Weibin Xu,Weixia Jian,Jingyan Tian,Wenzhong Zhou,Di Zhang,Youping Liu,Jian Yang,Jiping Li,Guo Li,Min Luo
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index277712574262041710430516393482935000564719716125
#%530742815982948056355266956550925744819808900472
#%828856878549895652889621567972719595779394994713

#*Enhancement of serum lipoprotein lipase mass levels by intensive insulin therapy
#@Yoh Miyashita,Mariko Ebisuno,Masahiro Ohhira,Kei Endoh,Atsuhito Saiki,Nobukiyo Koide,Masaki Ohtsuka,Tomokazu Oyama,Kohji Shirai
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index828482182485704324910144729948093383897926989639
#%955988395618588331045131275253074690220070780608
#%943445413929490291105051608164037760300465308310
#%1058441079563236832905811800951353762257647838949
#%1286454733799329683626275240252906987892290006361
#%475021722854895630328605339288305472827812370338

#*Leanness and type 2 diabetes in a population of indigenous Australians
#@Julie Brimblecombe,Dorothy Mackerras,Joanne Garnggulkpuy,Elaine Maypilama,Leanne Bundhala,Rrapa Dhurrkay,Joseph Fitz,Louise Maple-Brown,Tomer Shemesh,G. Rowley,Kerin ODea
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index234728866660041186852782614966905134076820813198
#%162572144285142921771019337089657368622491165239
#%1435214536368794324485411259950707387470387748249

#*Corrigendum to Insulin detemir and insulin aspart: A promising basal-bolus regimen for type 2 diabetes [Diabetes Research and Clinical Practice 66 (2004) 193201]
#@K. Ralov,M. Bogoev,I. Raz,G. Leth,M.-A. Gall,N. Hncu
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index769709519695947448816979729557345179176066809025

#*Cervicofacial necrotizing fasciitis
#@Bettina Hohlweg-Majert,Nils Weyer,C. Metzger,Ralf Schn
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index367833348062873956180534571607587558557150702529
#%125438097551125340983558251350326438204628363056
#%1300260190811843037010029656699585057045577516517
#%420083591603913901812676238073542188051968630092
#%1102311017575484829113219404002540229301233012568
#%798593803308432686180406327732645623192371292193
#%776823334748279768273419167177339167386997563307
#%1066166086966700482025718746447914555052489299514

#*Effect of CYP2C9 genetic polymorphisms on the efficacy and pharmacokinetics of glimepiride in subjects with type 2 diabetes
#@Kazuko Suzuki,Tatsuo Yanagawa,Toshiaki Shibasaki,Nahoko Kaniwa,Ryuichi Hasegawa,Masahiro Tohkin
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index367584371087420615674171769232888575416054181925
#%1194214941893451568361826207104333394336588024125
#%1194214941893451568361826207104333394336588024125
#%951840223992110568819844014256586626249721886911
#%993748309886579911423558383705797741093445254890
#%1036584119518908362838635314463665422721384492297

#*Prevalence and predictors of microalbuminuria in patients with type 2 diabetes mellitus: A cross-sectional observational study in Oman
#@Abdullah Al-Futaisi,Ibrahim Al-Zakwani,Abdulaziz Almahrezi,Ruqaia Al-Hajri,Laila Al-Hashmi,Abdullah Al-Muniri,Mahfooz Farooqui
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1373588097250043841744279517410457493594034270212
#%415718921369716071186479817791551497296872631411

#*Sleep and body weight in diabetes mellitus: A large retrospective analysis from South India
#@G.R. Sridhar,Venkata Putcha
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1359978337669085920980311060547559315930481915905

#*Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy
#@N. Seki,N. Hashimoto,Y. Suzuki,K. Yagui,Y. Saito
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index393954842357257785039768452458435276081550741327
#%431412729600776668789272016853046241948029539427
#%755871722375814728343303563937320052951392512195
#%1059983309742946495752532098187028085487244307627
#%749874264283286324482540442929128524836853166603

#*Is early and late post-meal exercise so different in type 1 diabetic lispro users?
#@M.-C. Dub,S.J. Weisnagel,D. Prudhomme,C. Lavoie
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index836980691647596948515103902240231485846252293231
#%1244232393194910739515866051174498594041191604642

#*Letter regarding Comparison of blood glucose meters in Australia [Diab. Res. Clin. Pract., doi:10.1016/j.diabres.2005.05.13]
#@N.W. Cheung,D. Chipps,S. Hendon,M. McLean
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1169702178094608415301470580669277657458246774544
#%1275657202719090702383575952394983119025276527659

#*Apo e4 allele is associated with endothelium-dependent arterial dilation in women with type 2 diabetes
#@Xiang Guangda,Zhao Linshuang,Hou Jie,Yue Ling,Xiang Huijuan
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1457705997866780308984592346578338972652104191930

#*Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance
#@C. Oldroyd,C. Unwin,Martin White,C. Mathers,K.G.M.M. Alberti
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index141987134788408700971400737562569424832603657279
#%1068887555254616943713099863490264039188837694859

#*Response to the letter by Cheung et al
#@Matthew Cohen,Jonathan Shaw
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index990082501029728641963816291396443856338890986550

#*Normative values of carotid artery intima-media thickness in healthy Korean adults and estimation of macrovascular diseases relative risk using this data in type 2 diabetes patients
#@Sik Kim,Jin Kim,Jun Won,Jung Kim,Seok Kang,Woo Ahn,Soo Cha,Kil Lim,Rae Kim,Chul Lee,Bum Huh
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1073677347102714921712200538365033731607436880856

#*Clinical analysis of cognitive function in diabetic patients by MMSE and SPECT
#@Hirokatsu Niwa,Chika Koumoto,Tohru Shiga,Jun Takeuchi,Shinya Mishima,Tatsujirou Segawa,Toshiya Atsumi,Chikara Shimizu,Takao Koike,Narihito Yoshioka
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index219426177004915337774632026695592768871989422284
#%159784996327912562122839107923198804572048295994

#*Quality of care from the patient's perspective in pediatric diabetes care
#@Lena Hanberger,Johnny Ludvigsson,Sam Nordfeldt
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index467854547959615881389315410775723224095718278099
#%752676821431261604553125125261951928958166617573

#*Comparison of the obesity risk and related factors in employed and unemployed (housewife) premenopausal urban women
#@Canan Ersoy,Sazi Imamoglu
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index269459298504669133587734334725739124713099356566
#%558020051780142498068953756728967754387354763132
#%837198783763783816831346456434338031298081739614
#%27096163423311949041485650293775586390756129282
#%797970593651547145141923523638453195736642472323

#*The determinants of plasma plasminogen activator inhibitor-1 levels differ for American and Japanese men aged 4049
#@Tomoko Takamiya,Takashi Kadowaki,R. Zaky,Hirotsugu Ueshima,W. Evans,Tomonori Okamura,Atsunori Kashiwagi,Yasuyuki Nakamura,Yoshiyuki Kita,P. Tracy,H. Kuller,Akira Sekikawa
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index603219729441952647604152552525962288736109685446
#%540725103324363463580681342863010715173060900590
#%324779817037377894409235940677067847527359824862
#%269422036370717556703052986143291205732976290391
#%15087632596950242196111081193893955934845171263

#*The threshold value for insulin resistance (HOMA-IR) in an admixtured population
#@B. Geloneze,E.M. Repetto,S.R. Geloneze,M.A. Tambascia,M.N. Ermetice
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index302490936335555482975041668321168211433056318247

#*Clinical and immunological characteristics of type 1 diabetes mellitus in a northwestern Colombian population
#@G.J. Tobon,A. Arango,V. Abad,J. Garca,H. Cuervo,A. Velsquez,I.D. Angel,P. Vega,A. Abad,J.-M. Anaya
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index259414988862212913983881222585291734647601801054
#%1358912626428373864590686945034989399850300585829
#%641988125876210780166381462478866338075558700446

#*Geographic variation, physician characteristics, and diabetes care disparities in a metropolitan area, 20032004
#@Jeff McGinn,Cathy Davis
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index767868064276055720248442563207146639001334941559
#%481570781244869144784002259840012820397148090045

#*Insulinogenic indices from insulin and C-peptide: Comparison of beta-cell function from OGTT and IVGTT
#@Andrea Tura,Alexandra Kautzky-Willer,Giovanni Pacini
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1311680385786131395411499535198458569117182535997

#*Effect of PLC on functional parameters and oxidative profile in type 2 diabetes-associated PAD
#@Salvatore Santo,Neri Sergio,Pino Luigi,Marchese Giuseppe,Ferrante Margherita,Conti Gea,Fallico Roberto,Celotta Gabriella,Pennisi Giuseppe,Anzaldi Massimiliano
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1383158551010804206494276776785812514708669355455
#%414858808569245572356286021483555111794901651110
#%501342536700648241272360666565455538862275806457

#*Detection of ketonemia and its relationship with hyperglycemia in type 1 diabetic patients
#@Jordi Mesa,Dolores Salcedo,la Calle,Elas Delgado,Javier Nvoa,Federico Hawkins,S. Navarrete,Mnica Parramn,Domingo Acosta
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index253623901259415241577972254011092435099545335791
#%39016295825128839728622499099110225133269228234
#%203056098045482501357120503456826517816171826412

#*Prevalence of prediabetes in Kashmir valley using revised ADA criteria for impaired fasting glycemia
#@Hamid Zargar,Iftikhar Bashir,Rashid Masoodi,Iqbal Wani,Kariem Khan
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index180293866348513053336663933159153148331171252397

#*Alcoholic consumption: is it benefit for the poor control diabetes mellitus patients?
#@Viroj Wiwanitkit
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index887876825127426451179587245677694951814069631444

#*Chronic high glucose inhibits albumin reabsorption by lysosomal alkalinization in cultured porcine proximal tubular epithelial cells (LLC-PK 1)
#@Fukashi Ishibashi
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index272853052056488864643693738555004754975112355202
#%189967479156597242732377860985366543748056660731
#%495840625798076544614484876811195104451761955187

#*A case of slowly progressive type 1 diabetes with unstable glycemic control caused by unusual insulin antibody and successfully treated with steroid therapy
#@Akiko Matsuyoshi,Seiya Shimoda,Kaku Tsuruzoe,Kayo Taketa,Takeshi Chirioka,Fumi Sakamoto,Michiharu Sakakida,Nobuhiro Miyamura,Eiichi Araki
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index329979441994722890758572730923992612677606609209
#%975407973410605594359465353178193746524758478615
#%211228355808160809362420011863655819952822895465

#*A practical insulin infusion algorithm for the establishment of euglycaemia in both lean and obese patients with type 1 and type 2 diabetes
#@D.M. Stork,Willem Erkelens,F. Veneman
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index12013636268863932817907110587189099678434889178
#%1186864061116043955472129974093587219342628972591
#%800626516324600848197157226663893525750570922082
#%1242673040462793554147972294286276290276412335734

#*Prevalence of metabolic syndrome in obese Turkish children and adolescents
#@Emre Atabek,Ozgur Pirgon,Selim Kurtoglu
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index120164318105580360079948316181739986058637616391
#%933493311442604793092931333742851632435749340985
#%997216239685076405372393390759878014145321636738
#%420060091005362238770167151325128847182179887972
#%391642221958875625469995052339771156517198762242

#*Higher prevalence of autoantibodies to insulin and GAD 65 in Swedish compared to Lithuanian children with type 1 diabetes
#@Hanna Holmberg,Outi Vaarala,Vaiva Kuehne,Jorma Ilonen,ilvinas Padaiga,Johnny Ludvigsson
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index447822956421631336325199317367207252453199657300
#%647330001170284108818230276602992444163707299666
#%458758410457175482643495137065232083509279615136
#%681169719173561934380147769136275801100250931992

#*Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity
#@Guoyue Yuan,Libin Zhou,Jinfeng Tang,Ying Yang,Weiqiong Gu,Fengying Li,Jie Hong,Yanyun Gu,Xiaoying Li,Guang Ning,Mingdao Chen
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index950935218462113895987553557600568515851854455100
#%1347131148159653833870809454228854616978879559695
#%170530705379996803102866393793503564509299977100

#*Serum adiponectin is associated with fasting serum C-peptide in non-obese diabetic patients
#@Machi Furuta,Masanori Tamai,Tadashi Hanabusa,Yasuhisa Yamamoto,Kishio Nanjo,Tokio Sanke
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1302237423387309659268743447384714660323552609272
#%176150433092309855792472228519962213704579196368
#%857242410680689497381988393770385841841071549629
#%645940890519381428203135032597124876352352924438
#%877106015659733043910700759704223936379917176158
#%1370161709767113499558168651397450455320290089536
#%639985632551033912980344163437115694946281369965
#%1162046703957847572843451792892755136499630628698
#%720382138150717255854155551608756937747369115890

#*Comparative efficacy of glimepiride and/or metformin with insulin in type 2 diabetes
#@M. Kabadi,Mary Kabadi
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1254316073187794332842042293119941405435219375400
#%627680538267283824356732650236887374354670744162
#%1194214941893451568361826207104333394336588024125
#%1194214941893451568361826207104333394336588024125

#*Urinary TGF-1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy
#@Casaccia Bertoluci,Deise Uebel,Alexandre Schmidt,Santos Thomazelli,Ramos Oliveira,Helena Schmid
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index790196204706974330892803808294428322625602471683
#%431412729600776668789272016853046241948029539427

#*Association of the endothelial nitric oxide synthase (ecNOS) gene polymorphism with carotid atherosclerosis in type 2 diabetes
#@Hyun Park,Hye Kim,Ho Kim,Sik Kim,Sun Park,Sun Baek
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index987679135370028076162639893081946802661750129752
#%652180552968797605979107475970426733333131412247
#%652180552968797605979107475970426733333131412247
#%769875046381046202097392660097085115677277028770
#%555839614808591270813540234725834389084294378820
#%409967434868748581068446363146486820968025976139
#%1454832479221982708742278408066504424414818830690

#*Concerns about methodology and use of 3,5,7-cholestatriene as a marker of oxidative stress
#@J. King,J. Priesbe
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1304160171495073421959389903999550593678629804885
#%1126467494670836545698436413193133520432989085406
#%1332299777881867920697600548073646451919042298185
#%620312031167085065530526347479514836201512899113
#%1180623326191022631708839290868875738576777816411

#*The effect of resistance versus aerobic training on metabolic control in patients with type-1 diabetes mellitus
#@Claudia Ramalho,Maria Lima,Fabiana Nunes,Zanine Cambu,Cynara Barbosa,Aline Andrade,Adriana Viana,Marlene Martins,Valter Abrantes,Crsio Arago,Marcos Temstocles
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index575117478085867290383997915951487572376798444858
#%1416942197803082859197926187316090189682120256687

#*Actual usage and clinical effectiveness of insulin preparations in patients with Type 1 diabetes mellitus in Japan: CoDiC -based analysis of clinical data obtained at multiple institutions (JDDM 3)
#@Azuma Kanatsuka,Koichi Kawai,Koichi Hirao,Mariko Oishi,Hirofumi Takagi,Masashi Kobayashi
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index319109566176647633354522596888630207053431458363

#*PROPAT: A study to improve the quality and reduce the cost of diabetes care
#@J.J. Gagliardino,E. Olivera,G.S. Etchegoyen,M.L. Guidi,J.E. Caporale,A. Martella,La Hera,F. Siri,P. Bonelli
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index563663952211133352952952240690670904425928741097
#%1040506186653952898212329470499321685246454140680

#*GLP-1/exendin-4 facilitates -cell neogenesis in rat and human pancreatic ducts
#@Gang Xu,Hideaki Kaneto,D. Lopez-Avalos,C. Weir,Susan Bonner-Weir
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1226023771158719252270401332869598465182108679348

#*Effect of quercetin on altered vascular reactivity in aortas isolated from streptozotocin-induced diabetic rats
#@Machha Ajay,I. Achike,Mohd Mustafa,Rais Mustafa
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index881650575306160867343903442274300435200490343077
#%1309519113621162830219912241289268039951385951997
#%1029556011549816905244741848043208851207718419033
#%487862399697453616869010659439079712490490019508
#%1008894467492354515458250657709066048366059818913
#%241306590648887388575223522487280785503239607437
#%639459465573085237958292483786549807775653548223

#*Low serum dehydroepiandrosterone sulfate concentration is a predictor for deterioration of urinary albumin excretion in male patients with type 2 diabetes
#@Michiaki Fukui,Yoshihiro Kitagawa,Kenji Kamiuchi,Goji Hasegawa,Toshikazu Yoshikawa,Naoto Nakamura
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1429632302609118800480931201960801484679449331449
#%123639618329011954452952846000187264359505210533
#%329808062088743436229390354837413897976595637642

#*On A1c and its dependence on PG level
#@George Trevio
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index561773780859677360368343046194543448065332538151
#%1058552575633152386571379484286055731418337111081

#*Insulin resistance is associated with hypertensive response to exercise in non-diabetic hypertensive patients
#@Sungha Park,Jaemin Shim,Jin-Bae Kim,Young-Guk Ko,Donghoon Choi,Jong-Won Ha,Se-Joong Rim,Yangsoo Jang,Namsik Chung
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index743294402368294172289042860643682982559613728936
#%1178726358127435454447790941746584045261153758265
#%1206558140655673563980257002865337627972770778572
#%1385399355593673867306627751689943543010570515547

#*Effects of insulin-like growth factor I on the development of osteoblasts in hyperglycemia
#@Ying Fang,Zhong-Yi Wang,Yong Mao,Hai-Tao Xin,Guang-Li Ren,Xue-Fan Bai
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index449944343246067839557688179254021739541127253679
#%648401051666658739699969677420929555875882233736

#*Metabolic syndrome by the international diabetes federation definition in Hong Kong Chinese
#@G.T.C. Ko,C.S. Cockram,C.C. Chow,V.T.F. Yeung,W.B. Chan,W.Y. So,N.N. Chan,J.C.N. Chan
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index731951810301996354737974581221314481843404671356
#%346553285745418134252681859239189827513652749234
#%514318352060107528938244617801369820792917764955

#*Effect of stress management training on glycemic control in patients with type 1 diabetes
#@Abbas Attari,Mahnaz Sartippour,Massoud Amini,Sassan Haghighi
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index314644386065196687143565480657798576384868880074
#%1219519303292281469892604244843644778296142720067

#*Chronic blockade of the angiotensin II receptor has a differential effect on adipose and vascular PAI-1 in OLETF rats
#@Myeung-Ju Kim,Dae-Ho Lee,Deok-Bae Park,Hyun-Wook Kang,Chun-San An,Xiu-Ji Cui,Jung-Sook Kang,Jung-Lye Kim,Young-Jae Lee,Kee-Wook Jung
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1307755762025218652257868366663924353720798662422
#%1001993807317595096943265507451254511042296867722
#%822719485890070473053392292316156586105055179692
#%324779817037377894409235940677067847527359824862
#%1088335712899292178584350068710650603860148156742
#%1308119127332521114340135997811066891591696517057
#%1377554829915011772991410635017428971939761282614
#%1422279388914025366764484352760323345250333208883
#%1011638190320498122345216518344479615191158356241
#%290929148760822006572724141390100212678436853101
#%102769565861967344856037414517086840886956879636
#%102769565861967344856037414517086840886956879636
#%875137297761608217799006941374525721245011115246

#*Diabetic ketoacidosis complicated by axillary vein thrombosis
#@G.V. Gill,G. MacNamara,P. English
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1002402612054422093013721247198904634009262386093

#*Variation of mitochondrial gene and the association with type 2 diabetes mellitus in a Chinese population
#@Dong-Ling Tang,Xin Zhou,Xia Li,Lei Zhao,Fang Liu
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index843203109197169972308987813034717901021817298235
#%1136344016781035463551567270092867896970718242028
#%23314735123526796315850181600730135794651142938
#%23314735123526796315850181600730135794651142938

#*Exploring the relationships between diabetes and smoking: With the development of glucose equivalent concept for diabetes management
#@Pang Wen,D. Cheng,P. Tsai,Ling Hsu,Ting Chan,Cheng Hsu
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index187702416394518226519210687933991850614406712606
#%491097492974459149650245329016419025424596422482
#%750947515418795898899540354840155509292567308297
#%955435111464423087923374189605876501370734891449
#%563659808671810155975533953041700588228799213548
#%1031188938861165138676392097749047372739725025134
#%534240752201043448460561919545924031558266714087
#%90229471756574567171887310413860126801042272562
#%509268860753399877151495208572998318119530328893

#*Persistent impaired glucose tolerance has similar rate of risk factors as for diabetesResults of Indian Diabetes Prevention Programme (IDPP)
#@A. Ramachandran,C. Snehalatha,B. Mukesh,Mary Simon,Sathish Kumar,V. Vijay
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index322273678150740533963345247588256641661568903356
#%591970307517695847210297464522381981181327346590

#*The value of the screening test for gestational diabetes in pregnant Iranian women
#@Maryam Keshavarz,Wah Cheung,Reza Babaee
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1319507008460342683457031634533980248317712302049
#%946403906898716791310236132382293550028922358030
#%590645445684801123552394644140315458638733256509

#*Oral magnesium administration prevents thermal hyperalgesia induced by diabetes in rats
#@Parisa Hasanein,Mohsen Parviz,Mansoor Keshavarz,Kazem Javanmardi,Marzieh Mansoori,Nepton Soltani
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index548874238362561517479657506653823616407246931250
#%1170466364651437800670926971356446331131185529064
#%347425115177976426218922123184191136597093489401
#%92029506341158012484108729091955968131708334387
#%491028749855012584008832625918039615398887131832
#%262979210656062864047772106310249590187701546036
#%294120262791843053229166482965121410827782926213
#%1228893287821653354376376148059007710541923460555
#%1291536816257153995842486536693204144571209839714
#%1394810538087646071341726570364930664851042032427
#%1033509974052754163031503873852543801865808817443
#%483433420503872605513245034407228464890832306152
#%390027036902968527326322888410138518152473378665
#%1258251709145999407072967853615071263838811032430

#*Plasma lipid levels and nutritional intake in childhood- and adolescence-onset young type 1 diabetic patients in Japan
#@Mieko Saito,Hiromi Kuratsune,Hayami Nitta,Kazue Kawahara,Masahiro Hamano,Masafumi Matsuda,Kohei Kaku,Masaaki Eto
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1374958059678041583702628902985429053019588446906
#%617384541938126307364624021272367491868493307582
#%84184417026539116191715351034726745721457475774

#*Impact of diabetes on health-related quality of life in a population study in Japan
#@Isao Saito,Fujiko Inami,Toshiko Ikebe,Chinatsu Moriwaki,Akiko Tsubakimoto,Kunio Yonemasu,Hideki Ozawa
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index74391056359329992741053232553801408085738730278
#%70130811232289574527911474218604399023063869729
#%203504423004871745671925906962463231751896202636
#%597729893514837039160839267240659310256216106916
#%522254614076355971877677851688819705112055053821
#%651663513833039532131296571064096117248407481809

#*Chemotactic cytokine receptor 5 (CCR5) gene promoter polymorphism (59029A/G) is associated with diabetic nephropathy in Japanese patients with type 2 diabetes: A 10-year longitudinal study
#@Atsuko Mokubo,Yasushi Tanaka,Kunihiro Nakajima,Hirotaka Watada,Takahisa Hirose,Masahiko Kawasumi,Ken Sakai,Akio Kanazawa,Shiro Maeda,Kazuhiro Hosokawa,Yoshihito Atsumi,Kenpei Matsuoka,Ryuzo Kawamori
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index761866335148919073145374780965439225811594208134
#%1003413536866621245303666459145979491546966964728

#*Relation of alcohol use and smoking to glucose tolerance status in Japanese men
#@Yutaka Sakai,Taiki Yamaji,Shinji Tabata,Shinsaku Ogawa,Keizo Yamaguchi,Masamichi Mineshita,Tetsuya Mizoue,Suminori Kono
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index169267919619958558745487984021796449290084773205
#%1340327709566690820259044575781102648489002476178
#%130144438936650104472412068631741064010002826109
#%41054941598793682222646327715146662378765347094
#%1362953086748395477530211451177778488214394447941
#%379294880874569533121767407654556079932086645601

#*Efficacy of conversion from bedtime NPH insulin to morning insulin glargine in type 2 diabetic patients on basal-prandial insulin therapy
#@Hiroki Yokoyama,Junko Tada,Futayo Kamikawa,Sakiko Kanno,Yuki Yokota,Masae Kuramitsu
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index974805200289707624657149319035097252347654280267
#%136615243618364089170279399184929139973806344382

#*Relationship of skin temperature to sympathetic dysfunction in diabetic at-risk feet
#@Pi-Chang Sun,Hong-Da Lin,Eric Jao,Yan-Chiou Ku,Rai-Chi Chan,Cheng-Kung Cheng
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index428351703669799271660544561528078020039493895838
#%196552434367077126058163088536819678912716620596
#%650887802746731531444548857630628958176366357275
#%763010181840507431181458719713878906223047484566

#*A novel mutation of WFS1 gene in a Japanese man of Wolfram syndrome with positive diabetes-related antibodies
#@Akinobu Nakamura,Chikara Shimizu,So Nagai,Satoshi Taniguchi,Masaaki Umetsu,Toshiya Atsumi,Norio Wada,Narihito Yoshioka,Yuri Ono,Yukio Tanizawa,Takao Koike
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index817475452419494027030599696225832924449845920001
#%1237882466024448096713835914369519969534110302899

#*Glycaemic control, markers of endothelial cell activation and oxidative stress in children with type 1 diabetes mellitus
#@Dilara Seckin,Necip Ilhan,Nevin Ilhan,Sabahattin Ertugrul
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1215919379932894038839295893593406024901086141103
#%928565142871770215254439664402574905858429715205
#%1138706179720810147066714459447862291796102851443
#%370879302526699497243173189511052607749013079910
#%99145358586648871911789988923235220096108850529
#%346528498243364420360188614323101556200525091742

#*Macro- and microcirculation in the lower extremitiesPossible relationship
#@Vilma Urbani-Rovan,Alan Bernjak,Aneta Stefanovska,Katja Aman-Juvan,Andreja Kocijani
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index271181965438256481016652107024514589380120281631
#%379370633855148337188259891877551491551996938175
#%793390204097708296834496834542476848885498450666
#%986705514015755166995841887492453406800625649833
#%1034201434563599449761557857817898657696139710772
#%469211104372394039757366594532360039867229412393
#%1048105552967106827164533595872627305253625681751

#*A distinctive fatty acid profile in circulating lipids of Korean gestational diabetics: A pilot study
#@Yoeju Min,Joo-Hyun Nam,Kebreab Ghebremeskel,Ahm Kim,Michael Crawford
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index942336010939297741234153882343804992271617408871
#%757785002236955676994035815991295373354947076196
#%1066339606840891662416876395122287076913186256305
#%195705392200457938443522404575966211446953034429

#*Predictors of hyperglycaemic crises and their associated mortality in Jamaica
#@T. Chung,Gordon Perue,Ayesha Johnson,Novie Younger,S. Hoo,Wright Pascoe,S. Boyne
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1234950363834187724271636894324544750979949328833

#*Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients
#@Nagako Kitagawa,Yutaka Yano,C. Gabazza,E. Bruno,Rika Araki,Kazutaka Matsumoto,Akira Katsuki,Yasuko Hori,Kaname Nakatani,Osamu Taguchi,Yasuhiro Sumida,Koji Suzuki,Yukihiko Adachi
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1191441783441467555024182935660296169725662816288
#%196649218692702599937290972764716573465613725751
#%189443137105879751558673957111609300393849196317
#%542429865972367530037667826264413927111371972537
#%1105277180886816902377070833868614524700506487645
#%1107941759211772685509902971532664667246143949286

#*Role of hepatic AMPK activation in glucose metabolism and dexamethasone-induced regulation of AMPK expression
#@Y.I. Viana,Hideyuki Sakoda,Motonobu Anai,Midori Fujishiro,Hiraku Ono,Akifumi Kushiyama,Yasushi Fukushima,Yuzo Sato,Yoshiharu Oshida,Yasunobu Uchijima,Hiroki Kurihara,Tomoichiro Asano
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index170297301642941185830063871338631048733839229601
#%28985158171967504054784085147797596584146921675

#*Development of an ELISA for esRAGE and its application to type 1 diabetic patients
#@Shigeru Sakurai,Yasuhiko Yamamoto,Hironori Tamei,Hirokazu Matsuki,Ken-ichi Obata,Li Hui,Junnosuke Miura,Mari Osawa,Yasuko Uchigata,Yasuhiko Iwamoto,Takuo Watanabe,Hideto Yonekura,Hiroshi Yamamoto
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index501339625268403939664151454813959361250072627810
#%863923658489362826740217865450181041854722592745
#%666327856723659265309261198424206520171913034160
#%1013780793124572153681660679688096980707236893482
#%1150284805627011368930584849180530287370518470057

#*Changes in apoptosis and Bcl-2 expression in human hyperglycemic, term placental trophoblast
#@Fabio Sgarbosa,Fernando Barbisan,A.M. Brasil,Elaine Costa,M.P. Calderon,R. Gonalves,Estela Bevilacqua,V.C. Rudge
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index47996155300971212889174622686535859936838698280
#%195017717484068890446470413737993799380758629350
#%896417608365745563304927993742056849501628492960
#%1399414357987186662955391374072212105216160681271
#%806077175912185928232450427325466661139483841709
#%283300887962698192103337334680422624706973532735
#%551520361278509874475869425862813792935066823792
#%146303912583596346010526458220567155944742741713
#%1318560950949823589914618393313276417029172112678
#%763089788855094811883709653173485818930568716874

#*Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan
#@Cheong Wong,Zhiqiang Wang
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1172677228348686885501689655071745393817660190684
#%394074846014723954118281930976347277725688325607
#%1199854011141813300421471041023123959715902741052
#%63054821013796211110519383969823604828797582210
#%1156021227688085575137055496989322530275850548343
#%303972967056662443548712452420849406184164352577
#%71470854881575888313152190224248389835600777938
#%828090978311417755828945553845409413837776139108
#%103981815551790834925254376402454027140167350952
#%805951328931994740070054605965840724614725750387

#*Magnitude of dyslipedemia and its association with micro and macro vascular complications in type 2 diabetes: A hospital based study from Bikaner (Northwest India)
#@R.P. Agrawal,Poornima Sharma,Mahender Pal,A. Kochar,D.K. Kochar
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1120372778030141604292994845197740806120190069790

#*Inflammation, insulin resistance and carotid IMT in first degree relatives of north Indian type 2 diabetic subjects
#@Jamal Ahmad,Faiz Ahmed,A. Siddiqui,Basharat Hameed,Ibne Ahmad
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1151821500699036417543952085715271316421357872099
#%439556364680123409217810163030509487063605684232
#%1299132414953617378733412174120815819955689190808

#*Effect of corosolic acid on postchallenge plasma glucose levels
#@M. Fukushima,F. Matsuyama,N. Ueda,K. Egawa,J. Takemoto,Y. Kajimoto,N. Yonaha,T. Miura,T. Kaneko,Y. Nishi,R. Mitsui,Y. Fujita,Y. Yamada,Y. Seino
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index780700083042812890776462530858193343826627849507
#%856537884140432138093842042156523599248953399383
#%200924431943485952561098915116818326120869605199
#%366090009561027197118168673372835954789257233597
#%484915302048216297982043338261390071563821490864

#*The status of diabetes control and antidiabetic drug therapy in JapanA cross-sectional survey of 17,000 patients with diabetes mellitus (JDDM 1)
#@Masashi Kobayashi,Katsuya Yamazaki,Koichi Hirao,Mariko Oishi,Azuma Kanatsuka,Mikio Yamauchi,Hirofumi Takagi,Koichi Kawai
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index74108759385361979204156615352365733346388426847
#%741472667357967036521698557437635045148869117616

#*Doubts on the diagnosis of type 2 diabetes in patients with hepatitis C virus infection
#@Marcin Skowroski,Dorota Zozuliska,Jacej Juszczyk,Bogna Wierusz-Wysocka
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index989734599355448661996378128927769402606413540427
#%50329227852965444149470241338902408623226862307
#%1382608066294293072467339246757677263211480811068

#*Pulsatile insulin secretion in elderly patients with diabetes
#@S. Meneilly,D. Veldhuis,Dariush Elahi
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index895627482985457001964487338602577067075032548049
#%1161887002665813939723346947076015070435780405420

#*Diabetes and Ramadan: Review of the literature
#@B. Benaji,N. Mounib,R. Roky,N. Aadil,I.E. Houti,S. Moussamih,S. Maliki,B. Gressier,H. Ghomari
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1059359564626075255519669861352130281276947937577
#%1328013118359535644564310536685665884799657177151
#%918477653884555660933916819198909438471178353738

#*Maternal glycemia and neonates birth weight in Asian Indian women
#@V. Balaji,S. Balaji,V. Seshiah,Shyam Mukundan,Manjula Datta
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index951346678248064778510684062381229795620586493366

#*Hospital admissions in diabetic and non-diabetic patients: A case-control study
#@M. Tomlin,W. Tilyard,M. Dovey,G. Dawson
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index664318682213672966622956385991015215729624734291
#%599837043519258494668977948963356643112093680425

#*The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients
#@Sub Shim,Jin Kim,Seok Kang,Woo Ahn,Kil Lim,Chul Lee,Soo Cha
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index405058255139309267902463724207042132300370767059
#%1258487226959525013183485369172395268229992240270
#%79462056394886565094462057591847987886345893087
#%1084352163661962308897089262254492123886962232013

#*A single transplantation of the islets can produce glycemic stability and reduction of basal insulin requirement
#@Mariko Sassa,Kazuhito Fukuda,Shimpei Fujimoto,Kentaro Toyoda,Yoshihito Fujita,Shinichi Matsumoto,Teru Okitsu,Yasuhiro Iwanaga,Hirofumi Noguchi,Hideo Nagata,Yukihide Yonekawa,Takeshi Ohara,Masahiko Okamoto,Koichi Tanaka,Yutaka Seino,Nobuya Inagaki,Yuichiro Yamada
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1162080773818429787095011864650506175914730572736
#%481570781244869144784002259840012820397148090045

#*Haplotype combination of Calpain-10 gene polymorphism is associated with metabolic syndrome in type 2 diabetes
#@Seok Kang,Moonsuk Nam,Joo Kim,Jin Kim,Min Myoung,Yumie Rhee,Woo Ahn,Soo Cha,Chul Lee
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index666250183368361631043298103276334145160488793369
#%377549868103987761897521817157472032619117176238
#%377549868103987761897521817157472032619117176238
#%377549868103987761897521817157472032619117176238
#%293270215745256390646191345020521584341334806127
#%1330139075156247831362276825775720771830783280624
#%986392367178756465318150187480205601884036038265
#%220169577217004728874187181947822100007484330455
#%220169577217004728874187181947822100007484330455
#%831320956313104091792788485635907265519604362902
#%1030048744816536350389025853227989953780390980591
#%325040581011859195295908238935096747626280469467
#%700543556941930640882204839683510043582170238059

#*Plasma adiponectin levels and incident glucose intolerance in JapaneseBrazilians: A seven-year follow-up study
#@F. Vendramini,R.G. Ferreira,G.A. Gimeno,S. Kasamatsu,L. Miranda,S. Moiss
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1080649741668453638203521356014071893962444190097
#%1232501439374062361965134784980106293045174871350
#%639985632551033912980344163437115694946281369965
#%978899396104891859675943901184876915045934851101

#*Elevation of monocyte-derived microparticles in patients with diabetic retinopathy
#@Nahoko Ogata,Shosaku Nomura,Akira Shouzu,Masahito Imaizumi,Miwa Arichi,Miyo Matsumura
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index37851803014158330138887988317479751220108980044
#%1333905234325086873184533653695690099088753647736
#%606283717481354310725767594712515082769315744867
#%606283717481354310725767594712515082769315744867
#%196838641589565691497665747198091901003432958198
#%717234718829152615703553801271268603843069810134
#%776766438720687381063018461111628430125676824917
#%1313929787200067021360848177834971966852315715600
#%1313929787200067021360848177834971966852315715600

#*The current status of home and office blood pressure control among hypertensive patients with diabetes mellitus: The Japan Home Versus Office Blood Pressure Measurement Evaluation (J-HOME) study
#@Taku Obara,Takayoshi Ohkubo,Masahiro Kikuya,Kei Asayama,Hirohito Metoki,Ryusuke Inoue,Takuya Oikawa,Kayo Murai,Rie Komai,Tsuyoshi Horikawa,Junichiro Hashimoto,Kazuhito Totsune,Yutaka Imai
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1453018311210416891172662110725513513852457276022
#%70218598667391146204545516997968774433821747479
#%139469163415404825364646423108602503911353828620

#*A simplified protocol to screen for distal polyneuropathy in type 2 diabetic patients
#@A. Costa,F. Maraschin,H. Castro,L. Gross,Rogrio Friedman
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index607786973154666916424563218494473379613222441922
#%467726391988777075442838093148238882041216660749
#%1091859087579496220966009162171649239230261059543

#*Six year incidence and progression of diabetic retinopathy: Results from the Mauritius diabetes complication study
#@J. Tapp,Z. Zimmet,Alex Harper,J. McCarty,Pierrot Chitson,M. Tonkin,Stefan Sderberg,R. Taylor,K.G.M.M. Alberti,Jaakko Tuomilehto,E. Shaw
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index72969572712723319009239541198927767934618041867
#%1232851513331512222609129295656206252310160568210
#%399127220577660716701086921159612147398073658523
#%399127220577660716701086921159612147398073658523
#%1391077234097542426464500324333610756919966377654
#%286196599332252834596550815145515643220582800906

#*The role of polyol pathway in high glucose-induced endothelial cell damages
#@Tomokazu Oyama,Yoh Miyasita,Husako Watanabe,Kohji Shirai
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index244242822173351716344874756759463608038549335225
#%622363427512863739155763763551841085568828091946
#%1356024069298716903764680056638777368084939580465
#%509869229028469184553629972298414883040272337096
#%318944400314831266884336428494056351475611782501
#%153849894903872178553358825449238922991773468038
#%1231508274240588238995607777342414541930411404368
#%1231508274240588238995607777342414541930411404368
#%482203171624054592869227954156572449333905578944
#%182414245819320335950044885369523305769479451615

#*The sequential changes in the fasting plasma glucose levels within normoglycemic range predict type 2 diabetes in healthy, young men
#@Yong-Woo Park,Yoosoo Chang,Chul Sung,Seungho Ryu,Eunju Sung,Sool Kim
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index112390701702364726244970533960388967162402699512
#%370157455021203649697831131751341337346661081022

#*The Gly146Ala variation in human SF-1 gene: Its association with insulin resistance and type 2 diabetes in Chinese
#@Wei Liu,Min Liu,WuQiang Fan,Hajime Nawata,Toshihiko Yanase
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index801915827876886442937262418692542898671691594451
#%832276576041303201168871817466749010855302963356
#%235457911061555812511218013399909939750248073825
#%234454928767682378566962379733811089510626023664
#%1228726912043619549267759101224172459005042402531
#%353848714757968565425735179559237117226498585791

#*Diagnostic thresholds for diabetes: The association of retinopathy and albuminuria with glycaemia
#@R.J. Tapp,P.Z. Zimmet,C.A. Harper,M.P. Courten,D.J. McCarty,B. Balkau,H.R. Taylor,T.A. Welborn,J.E. Shaw
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index414614837172081545158434176241219036395702237392
#%814323646036547162031553391712573501872392673080
#%32464412214052972044071506224101671601106161512

#*Effect of a diet and exercise intervention on oxidative stress, inflammation and monocyte adhesion in diabetic men
#@K. Roberts,Dean Won,Sandeep Pruthi,San Lin,James Barnard
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index536987359457331207169343908976417464040358786395
#%756116858949913941145674086739005445396079697887
#%482625203020002662012578168539820634645662857314
#%693464945402665850353726690429530865216935392690
#%102228175607138033393379952908806185429642381526
#%992313587662925817858475564651420125907318112978
#%632214633058985869862558258369855546646165005190
#%333846029970768473281715172405523033074700232293
#%201023164091737315235781613592739923486990734764
#%1137034369489118999474169822861504492317365865517

#*Increased oxidative stress is associated with decreased circulating levels of adiponectin in Japanese metabolically obese, normal-weight men with normal glucose tolerance
#@Akira Katsuki,Mina Suematsu,C. Gabazza,Shuichi Murashima,Kaname Nakatani,Kenji Togashi,Yutaka Yano,Yukihiko Adachi,Yasuhiro Sumida
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index300549203170079989271671290458959022887923977563
#%465851402249112232575646891625001968763318852403
#%173068796121104773673572854557285518544821230679

#*Evaluation of a new blood glucose monitoring system with auto-calibration for home and hospital bedside use
#@Charles Kilo,T. Dickey,O. Joynes,B. Pinson,M. Baum,L. Parkes,R. Parker
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index123932713269385471098001393521289081992733504347
#%1034321277798709317650980772778247555971880193626
#%409562326928813714152669972341134724417512641817
#%568150017270434545539404471826851638608000780449

#*Psychosocial and non-psychosocial risk factors for the new diagnosis of diabetes in elderly women
#@Esben Strodl,Justin Kenardy
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1001386444193576308104084031006410794147041145742
#%428910814898161460372612834444137412044151306793

#*Childhood type 1 diabetes mellitus in Newfoundland and Labrador, Canada
#@Reza Alaghehbandan,D. Collins,Anne Newhook,Don MacDonald
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1377356487167455859787446308703681888731781407650
#%1278866563359634371330646917607430303047411714259

#*Genetic and clinical characteristics of Korean maturity-onset diabetes of the young (MODY) patients
#@Soon Hwang,Ho Shin,Won Yang,young Jung,Nam Huh
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index652008850293611720920332041840069638684853323297
#%605671281674546233915353984047009944352677174285

#*The influence of glucose self-monitoring on glycaemic control in patients with diabetes mellitus in Sudan
#@M. Abdelgadir,M. Elbagir,M. Eltom,C. Berne
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index469389527215642626581238407719382086082047269679
#%571604709686675411441801557041672648061417916634
#%678845079395426694508417313493540688690876622701
#%547823769575860608563361885627766771053703904282
#%785054618190218675791308759026204358020502417518
#%1182568266392731195837177959143295215748012374003
#%525215370116295315436355638591230275696970267928

#*Arterial wall thickening and stiffening in children and adolescents with type 1 diabetes
#@Emre Atabek,Selim Kurtoglu,Ozgur Pirgon,Murat Baykara
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index848813900393144689237900164661435377659840520125
#%13549187972841794329814525988131861502470555872
#%481479019668764006689700966648883104575267601870
#%1076111377875966366219511109837998329666636897327
#%642950781977460606828168229581902809888684834779
#%930565422815126417895528163576147534068051618637
#%684174774197313941026676391979932603189663741683

#*Microalbuminuria presents the same vascular risk as overt CVD in type 2 diabetes
#@Antonio Gimeno-Orna,Edmundo Molinero-Herguedas,Raquel Snchez-Vao,M. Lou-Arnal,Beatriz Boned-Juliani,J. Castro-Alonso
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1035450850439567490342175610750405472943606340180
#%806999650028062183539294847549091501669413301243
#%559965829598753497222300600463824656811767149287

#*Association of APOE (Hha1) and ACE (I/D) gene polymorphisms with type 2 diabetes mellitus in North West India
#@Pal Singh,Isma Naz,Ashley Gilmour,Monica Singh,Sarabjit Mastana
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index359789505531557513541833183653039718289774604036
#%1079443792446999460553112031980710707635786271266
#%645769949006762050538513305383517077210606361747
#%218258119884166981397285862095953633049623876454
#%348230081727467246817117407930075527581185420427
#%639174484698323421846647907833532094080260106869
#%78352572084905341639090636593345442635067376666
#%531528600363269184456973474746449019217384294564
#%1437206680708161502922633694646059397917765576225

#*Telecare in a structured therapeutic education programme addressed to patients with type 1 diabetes and poor metabolic control
#@M. Jans,M. Vidal,J. Viaplana,I. Levy,I. Conget,R. Gomis,E. Esmatjes
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index645490907401321370461616667600519003291748593006
#%859287698729835394415627338334753545657185813433
#%166765318292016279520915300048450203479685117896

#*Prognostic significance of the white coat hypertension in patients with type 1 diabetes mellitus
#@Lilliam Flores,Margarita Gimnez,Enric Esmatjes
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index817460846669677443895089452587260587226103257217
#%997734961949990904956570341373710496804401489163

#*Comparison of breakfast and bedtime administration of insulin glargine in children and adolescents with Type 1 diabetes
#@Glay Karagzel,Ali Satlm,Sema Akurin,ffet Bircan
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index543860855517473972963639368206618800547525450426
#%1040874670517599150787762755703764754417634783097

#*Automatic postural responses in individuals with peripheral neuropathy and anklefoot orthoses
#@Noel Rao,S. Aruin
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index424651466507991180811960119864171127469867876043
#%407857359363646420086644959661626145867945951199
#%1317744759676684582290811006672630263108576225343
#%1341126737060964710747179424210908938709135625761
#%437081374707650127051785850460682796472874439045
#%193820648658513684940747788565678879295357407028
#%706701100192228450178332337290482702227784327815
#%962305467593621598469627460892878653365786531964
#%1172763443450409136747911100409250852212690636456
#%1425144541648797098512058618221849113868027988345

#*Regression of cardiac hypertrophy in type 2 diabetes with hypertension by candesartan
#@Yasunori Iwashima,Mizuho Okada,Masakazu Haneda,Takeshi Yoshida
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index765651525113461344560227359192055000876711516622
#%1134277269182213049108654924544046071915446905701
#%369641072751648487157650080796526637642866882595
#%219951068730247266634539337525842782639940543841
#%842498980017533687207488737127263878632351325165

#*Food hardness as environmental factor in development of type 2 diabetes
#@Koji Nojima,Hiroshi Ikegami,Tomomi Fujisawa,Hironori Ueda,Naru Babaya,Michiko Itoi-Babaya,Kaori Yamaji,Masao Shibata,Toshio Ogihara
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index180262853592805897405654995586470465186659964160
#%1186872639445970874738041162295242018681310603590

#*Effects of high glucose on cellular activity of periodontal ligament cells in vitro
#@Sook Kim,Woo Park,Il Yeo,Ju Choi,Young Suh
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index684325526554760217244895757364145242470477614212
#%1104405475515030183575574154633456401815451760765
#%412223734555900491044515579761921111067121118876
#%648401051666658739699969677420929555875882233736

#*Association of gliclazide and left ventricular mass in type 2 diabetic patients
#@Nan-Hung Pan,Tsung-Ming Lee,Mei-Shu Lin,Chen-Ling Huang,Nen-Chung Chang
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index422593631108460092921601767687973677139487140344
#%122542883939989266270024407346082501626721056753
#%791803557976382721086651924030820280049240066145
#%814954920207027473616154293613619400931210493407
#%678738669152581140536783626464339291214990997984
#%924433858431277498224354240947922716701030294151
#%883719128686765096108994923473458839565429789202

#*Incidence of type-2 diabetes mellitus in a large population of Japanese male white-collar workers
#@Teruo Nagaya,Hideyo Yoshida,Hidekatsu Takahashi,Makoto Kawai
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index14045835026939094529024161889245883705836210026
#%202172878328219547884610753706571844904720590790
#%131173720189039943166735330486029328864114959708

#*Predictors of incident diabetes, metabolic syndrome in middle-aged adults: A 10-year follow-up study from Kinmen, Taiwan
#@Huey-Herng Sheu,Shao-Yuan Chuang,Wen-Jane Lee,Shih-Tzer Tsai,Pesus Chou,Chen-Huan Chen
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index332071411410640092691251374440938667265403902384
#%1438361308239152205343302480156715263383345379538
#%1215239847540835948072021450114063025180512227180
#%1239678428901684734281216596067885398422176059035
#%1272864811655343475629376813558706569820901830581
#%1272864811655343475629376813558706569820901830581
#%608027367961477215758757976231510100673358964715

#*Association between impaired glucose metabolism and quality of life: Results from the Australian diabetes obesity and lifestyle study
#@J. Tapp,W. Dunstan,Pat Phillips,Andrew Tonkin,Z. Zimmet,E. Shaw
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index738576457366605796072771444720653649334789925506
#%140912260458485665554268194588987175384235422530
#%268270138959802431226254930720134508738729585425
#%570445967373855139674779150600045050386927633867

#*Ambulatory blood pressure monitoring and progression of retinopathy in normotensive, normoalbuminuric type 1 diabetic patients: A 6-year follow-up study
#@Ticiana Rodrigues,Miriam Pecis,de Azevedo,Freitas Esteves,Luiz Gross
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index998631945900394196440882696890238975802967988843
#%1030550623843869714471825839002930685027030562953
#%1030550623843869714471825839002930685027030562953
#%1053862476297033373991722248356564656054996016537
#%1053862476297033373991722248356564656054996016537
#%407915446278403681057359809783846443872575045580

#*Correlations between measures of insulin sensitivity and weight loss
#@G. Thompson,M. Slezak
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1364371417711900660551768826027461171652502429756
#%602068512450906762607156348534619382965767333259
#%502491437653779069128224259537135349030259653786
#%294286771429554870975822863487518145987999840309
#%506300179236417274275213182442065805088367861242

#*Insulin resistance in Brazilian adolescent girls: Association with overweight and metabolic disorders
#@Merino Alvarez,e Vieira,Sanches Moura,Valeria Veiga
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index965506810568305241756946125001974095536961573407
#%182623455538053785592715052484926441522100158112
#%703235714857918062852360523406073131966474660645

#*C(106)T polymorphism of the aldose reductase gene and the progression rate of diabetic retinopathy
#@Pablo Olmos,Mara-Juliana Bastas,Valeska Vollrath,Luis Toro,Arturo Trincado,Pablo Salinas,Juan-Carlos Claro,Jos-Manuel Lpez,Ana-Mara Acosta,Juan-Francisco Miquel,Juan Castro
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1052089191517849078376458770906166595474037926306
#%481570781244869144784002259840012820397148090045
#%211270256270460176872732674129230312533581624260
#%430497454483203204118897451269530431724065803303

#*Effect of glucagon-like peptide-1 (737) on beta-cell function after islet transplantation in type 1 diabetes
#@Michelle Fung,David Thompson,Jean Shapiro,L. Warnock,K. Andersen,Dariush Elahi,S. Meneilly
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index236641548472327202828326519456601420997389533124
#%828856878549895652889621567972719595779394994713

#*Mitochondrial complex I activity is significantly decreased in a patient with maternally inherited type 2 diabetes mellitus and hypertrophic cardiomyopathy associated with mitochondrial DNA C3310T mutation: A cybrid study
#@Jing Chen,Yukiko Hattori,Kazuo Nakajima,Takayuki Eizawa,Takashi Ehara,Masamichi Koyama,Tetsuya Hirai,Youji Fukuda,Moritoshi Kinoshita,Atsushi Sugiyama,Jun-Ichi Hayashi,Toshimasa Onaya,Tetsuro Kobayashi,Masato Tawata
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index255105340988454668996443415103359947612663162858
#%879995631603257723560605448558081693393049045224
#%1157592633953295202275276972806574974688451517236
#%589607376016603974352681192042741443315017059473
#%573628915000243041762201420031404017993537498512
#%1085138437808893489428991630598308607564140883464

#*Effect of the 2004 Mid Niigata Prefecture earthquake on glycemic control in type 1 diabetic patients
#@Kyuzi Kamoi,Midori Tanaka,Tomoo Ikarashi,Masashi Miyakoshi
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index415438249022633037297204538688261184614582776829
#%343361607827869691703517311199802621563043080074
#%146634764567829382358958418007347784791302907191
#%1098753226924083840027935581361139418682874255425
#%940032087031527332493965248056829537022721513907
#%1185906071012139627548632147334373348792062895145
#%1185906071012139627548632147334373348792062895145

#*20-Hydroxyeicosatetraenoic acid is not associated with circulating insulin in lean to overweight humans
#@C. Ward,M. Hodgson,B. Puddey,J. Beilin,D. Croft
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index965537614689475263117663849291049241388138536617
#%613433414107277337323761330366433807011713827744
#%392273976093074564184899818250000669799868995552

#*DangguiBuxueTang decoction has an anti-inflammatory effect in diabetic atherosclerosis rat model
#@Hongmin Zhang,Shiwei Chen,Xifang Deng,Xuguang Yang,Xi Huang
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1022535936393508785227822799082676531457185428903
#%53717690190400100176353993379993722147259730321
#%967476414764796804955145482106638800906958239090
#%1119081534359047263884484794209193368966686611244

#*Effect of valsartan, an angiotensin II receptor blocker, on markers of oxidation and glycation in Japanese type 2 diabetic subjects: Blood pressure-independent effect of valsartan
#@Yoshifumi Saisho,Naoko Komiya,Hiroshi Hirose
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index369687768781238261834417957936090158232181749349
#%119120346910238448978639461401296905850246869550

#*Meta-analysis of the effect of exercise interventions on fitness outcomes among adults with type 1 and type 2 diabetes
#@J. Nielsen,R. Hafdahl,S. Conn,W. LeMaster,A. Brown
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index327159054096956884069585877532692789172292158858
#%564202107756324781375156314527007183180465810957
#%1499880760379459663764097664530945177463479377
#%173830048293099155172095652794495262154420708580
#%317050348458865495694719681257630055674274442456

#*Role of the mitochondrial m.16189T > C variant in type 2 diabetes mellitus in southern Brazil
#@D. Crispim,N.J.R. Fagundes,L.H. Canani,J.L. Gross,B. Tschiedel,I. Roisenberg
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index181591836173831849478010063037584451933792804192
#%225465880461480699299325867707482864612659489378

#*Nitric oxide as treatment for an emerging epidemic of obesity-related glomerulopathy
#@M.H. Ahmed,A. Khalil,M.M. Osman
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1452478849634952802817670130442699665979119608206
#%417860231601893037843208050120831696590554401820

#*Periodontitis: A complication of type 2 diabetes in Sri Lankans
#@T. Silva
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index95334316603345429305835679495486943517949363166

#*On A1c and its dependence on PG level
#@Oliver Gibson,Patrick McSharry,Lionel Tarassenko
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1229773306885263849902516824342807583072523404794
#%561773780859677360368343046194543448065332538151

#*Lipotoxicity versus adipotoxicityThe deleterious effects of adipose tissue on beta cells in the pathogenesis of type 2 diabetes
#@Roy Eldor,Itamar Raz
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index608887774860466673224463445786915112378559347089
#%205482879605682714091152743885205940042589099135
#%573327524122447088518353581315034226850735629497
#%436376200990208101653947270623132885944075363770
#%243870985376761962764271755512686458702182520676
#%243870985376761962764271755512686458702182520676
#%567725045070268789065380672587993637781780954063
#%1313080473294506104133765753735375245266392025434
#%1232501439374062361965134784980106293045174871350
#%126302732128882379734486270326585281230401329817
#%1399679396060342158335212480269508339921562234730
#%799005943719481675371819620011320520430605958054
#%523028725768770038461625944912561698239383497448
#%1339118030089354802237220255046308357942963267493
#%407663931282759564749171242769122046662542255595
#%1160416453309416620015235711221922376683081462300
#%1042976787392423941824066658209248857352785301622

#*Type 2 diabetes in children
#@Gyula Soltsz
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index853408413468417657133360179204023082147480634247
#%85039927729300363249776716691987456735811592250
#%994712436736572080994809529660798201215773333855
#%359700128128492081772980894820322479348169276188

#*Type 2 diabetes mellitus as inflammatory disease
#@Dorota Zozulinska,Bogna Wierusz-Wysocka
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index2742726023999716755524837705322536147791003900
#%839390648141656484991167768239160903246195480177
#%243436552734739657963075245289481699762806756344
#%1299132414953617378733412174120815819955689190808
#%415477460691339278654013301603709408339138986505
#%122350513380195447464631610530012265261010539038
#%990510998524575626900405172777448632105261145007
#%910098996006958389062011796774926493435252089708

#*How to start insulin treatment: Earlier or delayed insulin therapy
#@Sema Akalin
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index465834889866809804304961216691171058368509114862

#*Optimal insulin treatment for patients with type 2 diabetes
#@Gyrgy Jermendy
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1017281849249834473979547912725003333953196967890
#%481570781244869144784002259840012820397148090045
#%930998180487049015214275620982695414474568164621
#%784707659459912976938101575161536003168473356048
#%334699660748335939863538163124033888769630615793
#%630507425983902650216713361073070198705231366169
#%663407738275858355243101275360516307576355642278

#*Hypoglycaemic treatment in type 2 diabetic patients after myocardial infarction
#@Aleksandra Szymborska-Kajanek,Krzysztof Strojek
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index652107623028106041534671438784099012406839426566

#*Introduction to Lilly Award session
#@Marina Shestakova
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index943210488469724722082652425356281882042610687443

#*Inflammatory markers as risk factors for microangiopathy in type 1 diabetic patients on functional intensive insulin therapy from the onset of the disease
#@Aleksandra Araszkiewicz,A. Zozuliska,M. Trepiska,Bogna Wierusz-Wysocka
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index504788564666263959677078909684983954424313646614
#%1213970065150152242748918451103807760520145980868
#%308445412264981347509325789491040674287475761659
#%412859647928624522633347843309291966681444576865
#%1097230673122116155468480590685744445329070611472

#*The relationship between genetic and haemodynamic factors in diabetic nephropathy (DN): Casecontrol study in type 1 diabetes mellitus (T1DM)
#@M.V. Shestakova,O.K. Vikulova,N.M. Gorashko,O.E. Voronko,N.B. Babunova,V.V. Nosikov,I.I. Dedov
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index239168361332091756023384167121504466862919506417

#*Engineered antibodies: A new tool for use in diabetes research
#@J. Padoa,J. Crowther
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index683957407090188760149188692040251678136546228708
#%742021397475903486303719429268312316105964624542
#%119883777356528347524688443284746597460608445878
#%1103019663221336485192555927162365008340986107548
#%962868950135379697662068313731692087067307090188
#%47173539643637505972796358349103344845338110068
#%594542593033059785298707381313741626742954540499
#%3491757659321504123361963097664643362159701426
#%778298030122941598403149489355245840877068612716
#%266316710913472303321245968396138228615737021716
#%125628352901033119020623473343116667742691481766
#%27060813376574608899258986868868770216912575747

#*Therapy targeting -cell survival and function in type 2 diabetes mellitus
#@Niels Porksen
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index859169275964207554565335784269751232464051686364
#%324966752871458998743955987235477376461755839695
#%834008669807614413042261852543887450006736878958
#%462409323614008320301100272175599230087436251445

#*Predictors of glycemic control on insulin pump therapy in children and adolescents with type I diabetes
#@M. Nabhan,Laura Rardin,Jill Meier,A. Eugster,A. DiMeglio
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1008149410976652349242220502181867212172112487060
#%1324866122273629097497403807651043600587607963812
#%487116035727043577492224145212814314064112769366

#*Glucose levels in the normal range predict incident diabetes in families with premature coronary heart disease
#@S. Reynolds,R. Yanek,Dhananjay Vaidya,Samia Mora,F. Moy,D. Saudek,C. Becker,M. Becker
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1090789250088742183647474376587295870142545375134
#%370157455021203649697831131751341337346661081022
#%703508818430101970253387166232195718811428310423

#*Factors that influence improvement for patients with poorly controlled type 2 diabetes
#@Arthur Hartz,Sarah Kent,Paul James,Yinghui Xu,Michael Kelly,Jeanette Daly
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1439773605158003189304960503042785643418621866865

#*Prevalence of known and undetected diabetes and associated risk factors in central Kerala  ADEPS
#@Usha Menon,Vinod Kumar,Allison Gilchrist,T.N. Sugathan,K.R. Sundaram,Vasantha Nair,Harish Kumar
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index824895023874062553444067206888768667577769461028

#*Treatment-related stresses and anxiety-depressive symptoms among Chinese outpatients with type 2 diabetes mellitus in Hong Kong
#@Sing Lee,Alice Chiu,Adley Tsang,Chun-Chung Chow,Wing-Bun Chan
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index923259104912223749825307201304506420699465273950
#%4037593741693103137789770788720399914726415196

#*SUIT, secretory units of islets in transplantation: An index for therapeutic management of islet transplanted patients and its application to type 2 diabetes
#@Yuichiro Yamada,Kazuhito Fukuda,Shimpei Fujimoto,Masaya Hosokawa,Katsushi Tsukiyama,Kazuaki Nagashima,Mitsuo Fukushima,Haruhiko Suzuki,Kentaro Toyoda,Mariko Sassa,Shogo Funakoshi,Nobuya Inagaki,Ataru Taniguchi,Shun Sato,Shinichi Matsumoto,Koichi Tanaka,Yutaka Seino
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index254848282403574816068644548690362362141001074779
#%288907345983371529053357484337934697626933082147
#%215881723320091263776547510057744297881045044355
#%372879644681824625865400208786049917565819643142

#*Rapidly increasing diabetes-related mortality with socio-environmental changes in South Korea during the last two decades
#@Ju Choi,Min Cho,Ku Park,Chul Jang,Soo Park,Yeon Kim,Kyu Lee
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index646434791078639455222280011065058948189300221929
#%1102880864833037643035743539547463658107628255008
#%1374123158652302433170203309037991368924023428954
#%1391678818424462780198257900960799566460938816007

#*Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: Population-based survey findings
#@Sudha Cugati,Annette Kifley,Paul Mitchell,Jin Wang
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index146083812399371989426993833597331414601926987600
#%262782559797941756042821515356175299211703205063
#%989126705473911203173283044191804263154227173876
#%266120096768460383245458098485543869752509970313
#%27587063098192646115089377291360980974903950949
#%1391077234097542426464500324333610756919966377654
#%759491306133785156164383275874416014326528464999

#*The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension
#@Atsuhito Saiki,Masahiro Ohira,Kei Endo,Nobukiyo Koide,Tomokazu Oyama,Takeyoshi Murano,Yoh Miyashita,Kohji Shirai
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index917256553699886609640707854500466011241392316674
#%78352572084905341639090636593345442635067376666
#%955988395618588331045131275253074690220070780608
#%475021722854895630328605339288305472827812370338
#%943445413929490291105051608164037760300465308310
#%476775724491028809961008022418359275862456827717
#%955988395618588331045131275253074690220070780608
#%1058441079563236832905811800951353762257647838949
#%866286288152258073410307706722114522201530726030
#%842498980017533687207488737127263878632351325165
#%1286454733799329683626275240252906987892290006361

#*Effects of pioglitazone on beta-cell function in metabolic syndrome patients with impaired glucose tolerance
#@Juying Jin,Yerong Yu,Honglin Yu,Chun Wang,Xiangxun Zhang
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1138159493204188176777072844918440924369513549158
#%1376399892214428830294649454134536962368195315659
#%1236103591405615382934545717009417436492875023201

#*Coexistence of insulin resistance and inflammation effectively predicts cardiac disease but not stroke in Japanese patients with type 2 diabetes mellitus
#@Kazunari Matsumoto,Naruhiro Fujita,Masako Ozaki,Tan Tominaga,Yukitaka Ueki,Seibei Miyake
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index554041389490638333108730034167281396549043148388
#%1438361308239152205343302480156715263383345379538
#%777125853342177893815085839700628327237149358415
#%564461314931590743749585083887418615279865055764

#*Birth weight and type 1 diabetes among schoolchildren in TaiwanA population-based case-controlled study
#@Jung-Nan Wei,Hung-Yuan Li,Chia-Hsiung Chang,Fung-Chang Sung,Chung-Yi Li,Chau-Ching Lin,Chuan-Chi Chiang,Lee-Ming Chuang
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index770008775491073582607304442076546992119271087726
#%769604490906449205068340674275449262114216675509

#*Gestational diabetes: Validity of ADA and WHO diagnostic criteria using NDDG as the reference test
#@Magaly Santos-Ayarzagoitia,M. Salinas-Martnez,Z. Villarreal-Prez
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index613642219583968135859356915425713819398826305072
#%1448295967843193778486650025192007362809866177896
#%654861331777405102262928917650342669728198385427
#%748875203389957844986797772053098185287655348348

#*Reduction of digital plantar pressure by debridement and silicone orthosis
#@R.A. Slater,I. Hershkowitz,Y. Ramot,A. Buchs,M.J. Rapoport
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1364577705855016473153974776756902811119688114189
#%932737339896867514923795188251343692612728730178
#%566875791458934192228388194276538292761876379763

#*Daytime variations in glucose tolerance in people with impaired glucose tolerance
#@dos Santos,F. Aragon,R. Padovani,P. Pimenta
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1460833197001483817392682496584962601858769859955
#%11925687116899364979995827655327918288352939177
#%1236103591405615382934545717009417436492875023201

#*Role of monocyte chemotactic protein-1 and nuclear factor kappa B in the pathogenesis of proliferative diabetic retinopathy
#@Chikako Harada,Akinori Okumura,Kazuhiko Namekata,Kazuaki Nakamura,Yoshinori Mitamura,Hiroshi Ohguro,Takayuki Harada
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index354079766685554095206467943310118547115933640701
#%393825449274549075930785422234662008785916212687
#%904889427775832484962054135602791455645473700783
#%909622498978703430826677962682699662044814544045
#%909622498978703430826677962682699662044814544045
#%1271793508520952160930075233202982825404164279630
#%1271793508520952160930075233202982825404164279630
#%1322851889231484257992959414520149767352934916904

#*Macro and microvascular complications are determinants of increased infection-related mortality in Brazilian type 2 diabetes mellitus patients
#@R.L. Cardoso,F. Salles
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index726555606942043553477750003824134848844666942938
#%589669208480772912634875077950979204782436298576

#*Prevalence of the metabolic syndrome in Korean adolescents aged 1219 years from the Korean National Health and Nutrition Examination Survey 1998 and 2001
#@Man Kim,Jong Park,Ho-Seong Kim,Hee Kim
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1147173800783967659888297143886663796714935225541

#*Influence of diabetes mellitus on in-hospital mortality in patients with acute myocardial infarction in Japan: A report from TAMIS-II
#@Yoshihisa Hirakawa,Yuichiro Masuda,Masafumi Kuzuya,Akihisa Iguchi,Takaya Kimata,Kazumasa Uemura
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1257897076373101208219321263651643861855695544880
#%453128791512142692776523594621968549941195391048
#%627243805965254715160462953178837198564995168087
#%651239501622318882549966667500566263473247641584
#%1198362744857388403465790799005572271292801670222
#%873950309793086823316946873268430750485790879806

#*Short term efficacy of a lifestyle intervention programme on cardiovascular health outcome in overweight Indigenous Australians with and without type 2 diabetes mellitus
#@C.K. Chan,Robert Ware,Janine Kesting,Maureen Marczak,David Good,T.E. Shaw
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1178224139180322255902093233391293485844717947180
#%738272528135187873196878963152334505281871955416

#*Appropriate waist circumference cutoff points for central obesity in Korean adults
#@Yeoup Lee,Soon Park,Jung Kim,Hye Han,Mee Kim,Joo Cho,Young Kim,Sang Kwon,Rae Kim,Beom Lee,Joon Oh,Young Park,Joon Yoo
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index425359508911865790944680143974007765055061334363
#%377540217445836200324260906171352376060362824630

#*Carvedilol improved diabetic rat cardiac function depending on antioxidant ability
#@He Huang,Jiang Shan,Xiao-Hong Pan,Hui-Ping Wang,Ling-Bo Qian,Qiang Xia
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index995881013073609405077055193375079527458788019314
#%1018149709879746522485259009560627024873274102972
#%1253565636852887185579056881976754349402900854701
#%74531886051169131014219476596246356773709553977
#%1018149709879746522485259009560627024873274102972
#%991304417414644842545982731981173684378047631082
#%91598309945997309409676042036205879398664169216
#%569412012334448641823315576318265415168531548929

#*Leptin, triglycerides, and interleukin 6 are independently associated with C-reactive protein in Japanese type 2 diabetic patients
#@Takiko Yanagawa,Ataru Taniguchi,Mitsuo Fukushima,Yoshikatsu Nakai,Shoichiro Nagasaka,Minako Ohgushi,Kazunari Matsumoto,Akira Kuroe,Michihiro Ohya,Yutaka Seino
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index711853556618862593765346030074619536470805651991
#%777125853342177893815085839700628327237149358415
#%969524897769484743695608436852303125400079647950
#%381789821404060174922816252552020481648361864961
#%694212225212735594566443344533076511290373795657
#%1161900099806027881145100715982915036200442903531
#%957657531200932639566301030369316651939254947199

#*A case of diabetic amyotrophy with severe atrophy and weakness of shoulder girdle muscles showing good response to intravenous immune globulin
#@Yuko Wada,Chie Yanagihara,Yo Nishimura,Nobuyuki Oka
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1157174320605860006425666853779360794653613347391

#*Regulation of hormone-sensitive lipase in islets
#@Wen-Jun Shen,Yu Liang,Jenny Wang,Kenji Harada,Shailja Patel,A. Michie,Jun-Ichi Osuga,Shun Ishibashi,B. Kraemer
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1416379456281018812064193078241585292092221091091
#%775384400574347504494452101353160250939536972099
#%688008480056179726741214992717539647727004077003

#*A simple nurse-based prompt increases screening and prevention counseling for diabetes
#@M. Boltri,Ike Okosun,Monique Davis-Smith,Paul Seale,Phil Roman,W. Tobin
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index352020927889891277818177755838864346038334164052
#%254477139701029124901834120178830569842317799771

#*Effect of pioglitazone on insulin secretion in patients with both impaired fasting glucose and impaired glucose tolerance
#@Manuel Gonzlez-Ortiz,Eduardo Hernndez-Salazar,M. Kam-Ramos,Esperanza Martnez-Abundis
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index499604820798347531319677842308861073895950490901
#%370157455021203649697831131751341337346661081022

#*Racial and ethnic differences in diabetic patient-reported depression symptoms, diagnosis, and treatment
#@Julie Wagner,John Tsimikas,Gina Abbott,Mary Groot,Alicia Heapy
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index78318404885724385347140708162687682816350557850
#%702415529131163997942264680808577654853597070891

#*Under-utilization of capillary glucose monitoring by type 2 diabetic patients
#@Marie-Claude Brindisi,Jina Hahn,Jean-Louis Chiasson,Rmi Rabasa-Lhoret
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index509024290699231720004790279098420964865105707380
#%447432957791090693257412871396778845181448764791
#%342160771889902249778067326556199263702032340792

#*Efficacy of continuous glucose monitoring system (CGMS) to detect postprandial hyperglycemia and unrecognized hypoglycemia in type 1 diabetic patients
#@F.R. Maia,R. Arajo
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index325458707157478678810813466533106139849105269509

#*Effect-modifications by age and sex on the risks of coronary artery disease and revascularization procedures in relation to diabetes
#@Hua-Fen Chen,Chung-Yi Li
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index916760377022060406378523263059680953283886923187
#%572476713197424704356977848025221545357691239847
#%807442205568224217578169642011879736793099263408
#%566824459045093364203746399348920582462591644183
#%634404816320656328652605092371256474028586128376
#%816288063008886026562690004102967508680265408781

#*A patient with Werner syndrome and adiponectin gene mutation
#@Naotake Hashimoto,Sachiko Hatanaka,Koutaro Yokote,Hiroko Kurosawa,Tomohiko Yoshida,Rie Iwai,Hidenori Takahashi,Katsuya Yoshida,Atsuya Horie,Kenichi Sakurai,Kazuo Yagui,Yasushi Saito,Shouji Yoshida
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1193268842732130886632421548938268704151152242295
#%93505884654740132880746838689444380826855187165

#*Chronic renal failure in diabetic patients increases lipid risk factors for atherosclerosis
#@D. Brites,M. Fernndez,Julin Verona,C. Malusardi,Paula Ischoff,Hugo Beresan,Alicia Elbert,L. Wikinski
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index421833921535583989157200649460460139339020664037
#%1241167458510918954351084490385254806121424185361
#%544132076176932427815210727287005629580549001029
#%544132076176932427815210727287005629580549001029
#%84123547748320748971571108494960989702605993952
#%1403082537254502500681473823219253282700369302589

#*MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients
#@Nabil Mtiraoui,Intissar Ezzidi,Molka Chaieb,Hela Marmouche,Zied Aouni,Arbi Chaieb,Touhami Mahjoub,Martine Vaxillaire,Y. Almawi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1147399719177261367707374884406170369678117302840
#%1015395241229185734211981734500548499664385725278
#%1071015481378338030101143022720790835943326438182
#%1328705430566810656536091902350373780502041732120
#%197526230047636714132038670954651092322592618506
#%709516719222252572798127631945482499585171890650
#%412848702180542750611574154136705366148540674079
#%412848702180542750611574154136705366148540674079

#*Maternal third trimester hyperglycaemic excursions predict large-for-gestational-age infants in type 1 diabetic pregnancy
#@Lucrecia Herranz,F. Pallardo,Natalia Hillman,Pilar Martin-Vaquero,Africa Villarroel,Alberto Fernandez
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1080916951969298941249926190447599325049816405379
#%220210715379554085967752530350272448837508680255
#%102892353661692069193874475258023115878310765399
#%546749408723295842862649137231984647154563545978
#%15339542770279045065937640666745115698634453831
#%995667601117459839318734244072985101468674927065

#*Waist circumference estimation from BMI in Japanese children
#@Aya Morimoto,Rimei Nishimura,Akira Kanda,Hironari Sano,Toru Matsudaira,Yumi Miyashita,Takako Shirasawa,Eiko Takahashi,Takeshi Kawaguchi,Naoko Tajima
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index671322481838068678728570897420112930403180628033
#%576014543183933311782298797543626940218279865244
#%33134122640333840335717024352748233409831572114
#%959231419534254226753409696883367637222578877793

#*Methicillin-resistant Staphyloccocus aureus (MRSA) isolation from diabetic foot ulcers correlates with nasal MRSA carriage
#@Stephen Stanaway,Deborah Johnson,Probal Moulik,Geoffrey Gill
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index147381754638769235176456227815250115329800540862

#*A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting
#@Mustafa Cesur,Demet Corapcioglu,Alptekin Gursoy,Sait Gonen,Mine Ozduman,Rifat Emral,Riza Uysal,Vedia Tonyukuk,Ender Yilmaz,Fahri Bayram,Nuri Kamel
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1034672378593879948569666925827007624471930394577
#%918477653884555660933916819198909438471178353738

#*Cardiovascular risk factor control among diabetic patients attending community-based diabetic care clinics in Italy
#@Furio Colivicchi,Massimo Uguccioni,Mauro Ragonese,Claudio Nardozi,Stefania Angotti,Francesco Principe,Lo Pinto,Massimo Santini
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1047504863938193420097890596549470589506903909237
#%1281124986609559746717087056889716986399381719789

#*Improvement of diabetic foot care after the Implementation of the International Consensus on the Diabetic Foot (ICDF): Results of a 5-year prospective study
#@Roberto Anichini,Franco Zecchini,Ivano Cerretini,Giuseppe Meucci,Daniela Fusilli,Lorenzo Alviggi,Giuseppe Seghieri,Alessandra Bellis
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1293845879261375123727300341431216412190918873952
#%1438722055857034958941658233292115225811594968877
#%903495506477675560405026948366438471888641788078
#%1140118094001794487686590725984699699287200074159

#*Comparison of survival between diabetic and non-diabetic patients on maintenance hemodialysis: A single-centre experience
#@Sanjin Raki,Luka Zaputovi,Boidar Vujii,eljka Crnevi-Orli,tefica Dvornik,arko Mavri
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1279863117345243851655035290705798623956401106734
#%816726560438156018581047030519680671926270146254

#*Diabetes, hand and/or foot ulcers: A cross-sectional hospital-based study in Port Harcourt, Nigeria
#@Chioma Unachukwu,Seye Babatunde,E. Ihekwaba
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index787697127062446961587755580636254239932390656349
#%965623351764089213424175684108145815594666716422

#*Feasibility of a hospital-based, family-centered intervention to reduce weight gain in overweight children and adolescents
#@Daina Dreimane,David Safani,Marsha MacKenzie,Mary Halvorson,Sharon Braun,Barry Conrad,Francine Kaufman
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index598156861336273532194474384208074095153185468788

#*Disturbed hemodynamic cardiac exercise stress test response in non-smoking, normolipidemic, normotensive, diabetic subjects
#@R. Khoshdel,L. Carney,Saxon White
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index221131734211822758093226907569994515051048438506
#%42442849497884644578699717270259427671352394038
#%1410864531401214986209144788065230917468455806931

#*High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown
#@B. Lu,J. Wen,X.Y. Song,X.H. Dong,Y.H. Yang,Z.Y. Zhang,N.Q. Zhao,H.Y. Ye,B. Mou,F.L. Chen,Y. Liu,Y. Shen,X.C. Wang,L.N. Zhou,Y.M. Li,X.X. Zhu,R.M. Hu
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index125327012990841675178692992579721409047519483881
#%1002562548910179524322707506321412134649928611250
#%1002562548910179524322707506321412134649928611250
#%431412729600776668789272016853046241948029539427
#%625379390653114337313458010927232033139902873608
#%547358930512710623846589533522993293435984688757
#%1134316742908806820439970403555300672044123021553

#*Impaired activity of serum alpha-1-antitrypsin in diabetes mellitus
#@Mohammad Hashemi,Mohammad Naderi,Homaira Rashidi,Saeid Ghavami
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index789872968133132471550356123006768669217657382874
#%233226740103387169455394594816933880607114627534
#%883711132617102132654367651286952697931570316106
#%505984882770876466430043087160425577254451500863

#*An examination of the moderating effect of treatment with anti-depressants on the association of heart disease with depression in males with type 2 diabetes attending a Veterans Affairs Medical Center
#@S. Higgins,S. Ritchie,A. Stetson,D. Burke,W. Looney
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index570572365735223792083091336684122961273499062793
#%188053409008237580312275728622404887954353918751
#%478767215958640308781609923404279538052957414516
#%894518523972583786221820703161436522766076091372

#*A cohort analysis of type 1 diabetes mortality in Havana and Allegheny County, Pittsburgh, PA
#@A. Barcel,Z. Bosnyak,T. Orchard
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index802446274547783216142459205020612901207646841949

#*Angiographic coronary artery disease is associated with progressively higher levels of fasting plasma glucose
#@S. Quadros,Rogrio Sarmento-Leite,Marcello Bertoluci,Kau Duro,Alexandre Schmidt,Giuseppe Lucca,D. Schaan
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index460594606812758299438775441160380286022936988705
#%1187471108648378252552230481879859805920635609369
#%1333458994150592547232350382208722127866259745301
#%334086088158315884590501612538529111497996340535
#%1297291947215417171854140091346960256317243245685
#%1125212071862974339577295732754963990239899024482
#%387561852149429517736079527887087231780344111378
#%800298685537357312148184090428723492380055408802
#%564461314931590743749585083887418615279865055764
#%1377195598302819269159912532398686832925395255413

#*Relationship between metabolic syndrome components and vascular properties in Japanese type 2 diabetic patients without cardiovascular disease or nephropathy
#@H. Yokoyama,M. Kuramitsu,S. Kanno,J. Tada,Y. Yokota,F. Kamikawa
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index377198187541258719549792156627111699897170759335

#*Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome
#@K.M. Choi,O.H. Ryu,K.W. Lee,H.Y. Kim,J.A. Seo,S.G. Kim,N.H. Kim,D.S. Choi,S.H. Baik
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index638159089568308042428350569942632231112803672376
#%170530705379996803102866393793503564509299977100

#*Fasting cut-points in determining prevalence of diabetes in an Arab population of the Middle East
#@A. Al-Lawati,N. Barakat
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index369659830000826486367918602292367986708357356171
#%956404848503341552112419567476517275928482514411

#*Type 2 diabetes and hearing loss in personnel of the Self-Defense Forces
#@Hidenari Sakuta,Takashi Suzuki,Hiroko Yasuda,Teizo Ito
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1443182887329862055847298681319447472675897907203
#%442017959730381418817503164059371192832160982744
#%582080704732669869107275261708419963710685617414
#%788268565627361646409162384052912462064489821587
#%200680134204856454071840353579829422367069003554
#%53405846534012954927484392108196894498818963458

#*Effect of Mongolian plants on in vivo insulin action in diabetic rats
#@Oyun Khookhor,Qin Bolin,Yoshiharu Oshida,Yuzo Sato
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index466263068818761330646951719757885879130248392222
#%449597797847515610498423377602587454327212516132
#%670879487629859731322023173497833474534559403234
#%1128170775871095904594401564046532809512240873829
#%225420155770614823263551511452153053076411237843

#*The spontaneously diabetic Torii rat with gastroenteropathy
#@Kotaro Yamada,Masaya Hosokawa,Shimpei Fujimoto,Kazuaki Nagashima,Kazuhito Fukuda,Hideya Fujiwara,Eiichi Ogawa,Yoshihito Fujita,Naoya Ueda,Futoshi Matsuyama,Yuichiro Yamada,Yutaka Seino,Nobuya Inagaki
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index45093039583750091049673856147511063173870831239
#%1173073231577153117159583634687478874706840488048
#%309848276995424474883946717400258140533946398662
#%620424880944077041500135409512810656267038635691
#%1337048177594259291710705376737609857691332065976
#%1138459680960260044682170674904020368711866861658

#*An audit of standards of care at a Sri Lankan diabetic clinic
#@S. Jayawardena,C. Idampitiya,C. Jayawarna
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1037029326184775581669183275397511100203349090239
#%1087512083770181992473923924381068081778941989079

#*Corrigendum to Childhood type 1 diabetes mellitus in Newfoundland and Labrador, Canada [Diabetes Res. Clin. Pract. 74 (2006) 8289]
#@Reza Alaghehbandan,D. Collins,Anne Newhook,Don MacDonald
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1221399693901381185887417699091278915903354891543

#*Alternative indicators of metabolic control
#@P. Feo,C. Loreto,A. Ranchelli,C. Fatone,M. Miccio,G. Gambelunghe,P. Lucidi
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index804248359874934489103306465788989245931808973771
#%1268909390168335227593486183665601124657801203130
#%1187327544715966119112148168740050738569216724353

#*Ketone bodies monitoring
#@Orsini Federici,Massi Benedetti
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index382912070036745253777805692659525828771236999163
#%197357275010727299925980648780962430779703641736

#*Clinical development of continuous glucose monitoring systems: considerations for the optimal strategy
#@Lutz Heinemann
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1150266580581382716974284293903996290694504674281

#*Pendra goes Dutch; lessons for the CE mark in Europe
#@J.H. DeVries,I.M.E. Wentholt,A. Zwart,J.B. Hoekstra
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index248474721951331628355309139587100744658307340899
#%633753298679387905245133291847151810352387344229
#%83202099774287212191333356934766777550912961490
#%1193084577129007563814528502638606751724979591558
#%71680962397758111393636337200034302533306703649

#*Continuous glucose monitoring: key challenges to replacing episodic SMBG
#@J. Stout,R. Racchini,E. Hilgers,E. Noujaim
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1106234283056908842072753970266149927843119504766

#*Long-term use of continuous subcutaneous insulin infusion
#@C. Pickup
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index288950793853243731240341035463519665664750517834

#*Acute complications of insulin pump therapy
#@Bruno Guerci
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1194544275249028634793126703605978435937806642983

#*Counterregulatory responses in CSII
#@G. Fanelli,Paolo Rossetti
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index3686380666963017650678543326557923680629222477

#*Continuous subcutaneous insulin infusion (CSII) in children with type 1 diabetes
#@V. Tamborlane,A. Sikes,T. Steffen,A. Weinzimer
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index543790981750865119969036604312923807003468017817

#*CSII in type 2 diabetic patients
#@Jean-Raymond Attali
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1013749360558930311542891381660062397716475599264

#*Aspart and lispro insulin, is there any difference when used with an insulin pump treatment?
#@Paolo Bartolo,Francesca Pellicano,Antonio Scaramuzza,Tiziano Fabbri,Piero Melandri,Valerio Miselli,T. Casetti,Francesco Cannat
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index72357549777509485849016745802384549228328858267

#*CSII in Europe: where are we, where are we going? An analysis of articles published in Infusystems International
#@Louis Selam
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index300061640514485793134362343245670335845196689140

#*Continuous subcutaneous insulin infusion (CSII)  Danish experiences
#@Inger Bendtson
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1064997950407363649580009031905222981724770738974
#%429802228692657563062243939154007495156216515620
#%554804773359388555302608214374911474651578426092
#%554804773359388555302608214374911474651578426092

#*Continuous subcutaneous insulin infusion (CSII) in Italy
#@Daniela Bruttomesso,Silvana Costa,Dalia Crazzolara,Paolo Bartolo,Angela Girelli,Antonio Tiengo
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index224072044272259384810111635254905309299624471198

#*National Register of patients with insulin pump treatment in the Czech Republic
#@Z. Jankovec,D. Cechurova,M. Krcma,S. Lacigova,M. Zourek,Z. Rusavy
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index659953914021137047923558798679114686209697671752

#*A new look at patient selection criteria for continuous subcutaneous insulin infusion (CSII)
#@James Lenhard
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1089938223313833601025185890277507129952473265933

#*Comparison between multiple daily insulin injection therapy (MDI) and continuous subcutaneous insulin infusion therapy (CSII), results of the five nations study
#@P.L.M. Hoogma,B. Hoekstra,P. Michels,Marcel Levi
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index504463193386176966583411424091143026212171597220

#*Innovative solutions for diabetes therapy
#@Danilo Verge
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index375989574311346892450335434623503740974416985756
#%741472667357967036521698557437635045148869117616
#%1127791066915712805899765165110618051926404999916

#*GLP-1: a new approach for type 2 diabetes therapy
#@Francesco Giorgino,Luigi Laviola,Anna Leonardini,Annalisa Natalicchio
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index271500039186883570677299651437704906629961327071

#*Early clinical experience with an integrated continuous glucose sensor/insulin pump platform
#@J. Mastrototaro,Ken Cooper,Rajiv Shah
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index978635872409243974972759676592909938429126676678
#%603719682485610248618052660561160498633883620754

#*Continuous glucose monitoring and hypo/hyperglycaemia prediction
#@Giovanni Sparacino,Francesca Zanderigo,Alberto Maran,Claudio Cobelli
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1325918201843102898540686316592505972761980181210

#*The EVADIAC experience
#@V. Lassmann-Vague,P. Schaepelynck-Belicar
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index777220301233728422174350477657211279727611668326
#%1351051151386477668607237380063460268291425476235

#*Implantable insulin pumps: the Veterans Administration Study, a decade later
#@D. Saudek
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index271699039146711097984302743776489464606743676598

#*Closed loop insulin delivery using implanted insulin pumps and sensors in type 1 diabetic patients
#@Eric Renard,Guy Costalat,Hugues Chevassus,Jacques Bringer
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1340603726077135615791092076073079009527338985007
#%834012862072111313204872560837005999373482759269
#%358937401688216009798397380733068357504929449464

#*Roadmap to the artificial pancreas
#@Roman Hovorka,E. Wilinska,J. Chassin,B. Dunger
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index499539227354397917132101829971455212834797004742
#%409562326928813714152669972341134724417512641817
#%941263808650847804602086848607598242957006472984

#*Metabolic modelling and the closed-loop insulin delivery problem
#@Garry Steil,Kerstin Rebrin,J. Mastrototaro
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index477887085934789222187683568046892993090429423242

#*Virtual type 1 diabetic patient for feedback control systems
#@Valentina Canonico,Giorgio Fabietti,Massi Benedetti,Orsini Federici,Eugenio Sarti
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index933988426250629197147175604570042492942133213896

#*Glucose prediction, iatrogenic hypoglycemia and medical intervention: the role of the Diabetes Data Centre
#@A.M. Albisser
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index775797358781539909065399656351288845831353310781
#%157916391367133109435408592045242774662675592949
#%1153788916929766301069719482525031876079016612941

#*The Taysisde Diabetes Network
#@P. Leese,I.R. Boyle,D. Morris
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index831956344418011555746725081369850817248872213948

#*The Umbria Diabetes Register
#@Massi Benedetti,Fabrizio Carinci,Orsini Federici
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index579832797876823276869989941586007425240514446996

#*Ten years experience with the disease management programme PROSIT for diabetes
#@Wolfgang Piehlmeier,Rolf Renner,Johann Fahn,Rdiger Landgraf
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index1160245232811039201172921303604715394586763668045

#*Diabetes registers and prevention strategies: towards an active use of health information
#@Fabrizio Carinci,Orsini Federici,Massi Benedetti
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index358734339526799495912307902178269798466875284082

#*New models of population management for patients with diabetes  using informatics tools to support primary care
#@W. Grant,T. Lester,B. Meigs,C. Chueh
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index997122846012525213666904333374632481284117075703

#*Telematic support in intensive insulin treatment. Frequency of the data transfer
#@J.M. Wjcicki,P. adyyski
#year2006
#confDiabetes Research and Clinical Practice
#citation0
#index4834784153329064092486139822838484930087046007

#*Pharmacy diabetes care program: Analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy
#@I. Krass,B. Mitchell,P. Clarke,M. Brillant,R. Dienaar,J. Hughes,P. Lau,G. Peterson,K. Stewart,S. Taylor,J. Wilkinson,C. Armour
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1382325054511974860880899549663437530537362959031

#*Role of metformin in the initiation of pharmacotherapy for type 2 diabetes: An Asian-Pacific perspective
#@C.N. Chan,Chaicharn Deerochanawong,Samad Shera,Kun-Ho Yoon,M.F. Adam,Ta Binh,Siew-Pheng Chan,Elwyn Fernando,Chung Horn,Thy Khue,D. Litonjua,Sidartawan Soegondo,Paul Zimmet
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index458417324817236383945280467060416749387285463590
#%798718960466278114635366482410674321074698856592
#%990395100180544771348391857881357882639795795315
#%1108300226913907538342845896071024302890237985122
#%788108423739254076808481918656146240487066121208
#%352489060506322272404438858461007561658695427980
#%1203511358949430774227861761600995550181321170963
#%660342420449731712882921190002435185607903595712
#%1354780198605040795740381062858891748563172364582
#%939816543313503039404475280706549131639594916946
#%718348332414317334457995179639912998819340900158
#%268244054245578324897183826810548946850466728245
#%184014912306338904682540605143384871201736448566
#%919769993787866952693479348278031401226733313050
#%45707474880794918547813594830198406359532378659
#%1379095007894975315105285158148903855895362611896
#%758053223034199824525608826494772575285367692878
#%608027367961477215758757976231510100673358964715
#%933493311442604793092931333742851632435749340985
#%292956298936211462877445492947404072264456396172
#%605727947530726985829368436572590483737172395583

#*How well controlled are our type 2 diabetic patients in 2002?
#@Natalie Apparico,Natalie Clerk,Giana Henry,Jason Seale,Roger Sealy,Simone Ward,Kameel Mungrue
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index530203510961260024996229377004209444868879223791
#%741472667357967036521698557437635045148869117616

#*A community-based study of chronic kidney disease among type 2 diabetics in Kinmen, Taiwan
#@Ching-Heng Lin,Wu-Chang Yang,Shih-Tzer Tsai,Tao-Hsin Tung,Pesus Chou
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index515495825044951267414010680728299690971572258364
#%760313407974168020886295920339898890766890804995
#%481570781244869144784002259840012820397148090045
#%923230950899319989723698336167797582739997380458
#%481133592538376784635822885743437248166688763925

#*The significance of tumor necrosis factor- in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment
#@Haibing Chen,An Ren,Shilian Hu,Weilin Mo,Xuenong Xin,Weiping Jia
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index901332187140039275921556044127956218643190319555
#%11925687116899364979995827655327918288352939177
#%616659538927863456534247480045485025043915931769
#%20844193928941083639576449071603094602270144161

#*Metabolic syndrome and endothelial dyfunction and associated high proportions of erectile dysfunction in men: Innocent bystanders or accessories to the crime?
#@M.H. Ahmed
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1436504817614846900295096076466991211350924359206

#*Clinical effects of mechanical periodontal therapy in type 2 diabetic patients
#@Guglielmo Campus,Abeer Salem,Gianluca Sacco,Carmelo Maida
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index214585932404681129145083277325034518672165951538

#*A gas forming renal abscess in a person with diabetes mellitus and adult polycystic kidney disease
#@U.A.B. Medagama
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index528929012672752980611506075023083321076039489089
#%1371554822112846353984383146886073062699465170168
#%111504238942923087082426767523942004577090494483

#*Monocyte-derived macrophages from men and women with Type 2 diabetes mellitus differ in fatty acid composition compared with non-diabetic controls
#@Saranga Senanayake,M. Brownrigg,Vijay Panicker,D. Croft,A. Joyce,H. Steer,B. Puddey,B. Yeap
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1315358139764287068881485020667113423364096193571
#%429445204087131090811571066670064910401230055013
#%1043652171611627093804463490084495723088998616517
#%235842889736199738964485129544385719514828971518
#%948040983860084309920425963763483787712389018478
#%927176002056415081752533067205518423946938868302
#%380840557791850729327497652353123429400533893699
#%1061647548310847909655036157004881180781160654468
#%1029526689262328254011506306659974699176096277263
#%1200675641458314636115253669734630431214977751550
#%1290096246464146783157385826225218091388800230734
#%878198632068177381577731339950318863422021826103

#*Possible relevance of alpha lipoic acid contained in a health supplement in a case of insulin autoimmune syndrome
#@Noboru Furukawa,Nobuhiro Miyamura,Kenro Nishida,Hiroyuki Motoshima,Kayo Taketa,Eiichi Araki
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index383454418030874727055208732968022469589981528056

#*Severe insulin resistance associated with subcutaneous amyloid deposition
#@G. Albert
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index869329090519975231905298168776766068184518794466

#*Bilateral parietal lobe hemorrhage in a patient with diabetic ketoacidosis
#@Aman Sharma,Susheel Kumar,Navneet Sharma,Sanjay Jain,Subhash Varma
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index374405407008649329518459507436660735574264319596
#%1276510210913195828436178982867771232303762334351

#*Risk factors for long-term complications in patients with type 2 diabetes attending government institutions in the Western Province of Sri Lanka: A case control study
#@D.A.C.L. Amarasinghe,P. Fonseka,K.C.S. Dalpatadu,N.C. Unwin,D.J.S. Fernando
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index116975575314542622760314687180968425075678605534

#*Developing and validating a diabetes database in a large health system
#@C. Zgibor,J. Orchard,Melissa Saul,Gretchen Piatt,Kristine Ruppert,Andrew Stewart,M. Siminerio
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index609842363946676933575137474567546640111821755306

#*Hepatitis C, metabolic syndrome, and inflammatory markers: Results from the Third National Health and Nutrition Examination Survey [NHANES III]
#@Magda Shaheen,Diana Echeverry,Garcia Oblad,I. Montoya,Senait Teklehaimanot,J. Akhtar
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index59466552376101123466712750139105859332752384656
#%1152728991512452220184273341730650300692989111235
#%1171405405456372127761721301200063672961966004026
#%231142197255569191538021629732607720396255992037
#%243436552734739657963075245289481699762806756344

#*Population-based family casecontrol proband study on familial aggregation of metabolic syndrome: Finding from Taiwanese people involved in Keelung community-based integrated screening (KCIS no. 5)
#@Yueh-Hsia Chiu,Wen-Yuan Lin,Po-En Wang,Yao-Der Chen,Ting-Ting Wang,Jane Warwick,Hsiu-Hsi Chen
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1112848630328488844116834501220085509657354901960

#*Role of angiotensin II type-1 and type-2 receptors on vascular smooth muscle cell growth and glucose metabolism in diabetic rats
#@Masahiko Igarashi,Akihiko Hirata,Hisae Nozaki,Yuko Kadomoto-Antsuki,Makoto Tominaga
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index624382187513731157035099323170729392025057193077
#%78352572084905341639090636593345442635067376666
#%1438361308239152205343302480156715263383345379538

#*Prevalence of undiagnosed metabolic syndrome in a population of adult asymptomatic subjects
#@Simona Bo,Giovannino Ciccone,Neil Pearce,Franco Merletti,Luigi Gentile,Maurizio Cassader,Gianfranco Pagano
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1272690912146166118084062099239749379324741717481

#*Hemodynamic and oxidative stress profile after exercise in type 2 diabetes
#@L. Villa-Caballero,A.A. Nava-Ocampo,A.C. Frati-Munari,S.M. Len,A.R. BecerraPrez,R.M. Ceja,M.G. Campos-Lara,H.A. Ponce-Monter
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1095969356201111481469553121475187829565495027456
#%305759761218316749225853189869551868365721584961
#%1422381547893344449889088646521843609109726886777

#*Increased intima-media thickness of the carotid artery in Japanese female type 2 diabetic patients with midband lipoprotein
#@Shigetoshi Hosaka,Yoichi Okada,Kazutoshi Maruyama,Daiji Maruyama
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index112331775998471307724000023446575566131447366040
#%765903352368021036560232681768999708891000220492
#%965958021506001862694019761992393589987457501831
#%1217324643484238544161962369664163603562833343799
#%1073750733787861835193120701175487889797996648221

#*Acute onset of type 1 diabetes accompanied by acute hepatitis C: The potential role of proinflammatory cytokine in the pathogenesis of autoimmune diabetes
#@Hajime Masuda,Toshiya Atsumi,Atsushi Fujisaku,Chikara Shimizu,Narihito Yoshioka,Takao Koike
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index702966780197065369396456404879226834984413996332
#%1153088541844423692860462491765989994913986602590
#%1452521348857712489410329200559276878989565142521
#%303674096765353391781810577316476880117157180338

#*Factors associated with improvement of fasting plasma glucose level by mealtime dosing of a rapid-acting insulin analog in type 2 diabetes
#@Toshinari Takamura,Masaru Sakurai,Masumi Nakamura,Akiko Shimizu,Tsuguhito Ota,Hirofumi Misu,Yumie Takeshita,Naomi Tsuchiyama,Seiichiro Kurita,Hitoshi Ando,Shuichi Kaneko
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index56312148809108121445969222528220191720490620381
#%643597713477026494052956113893281067489438955422
#%541152725270332316165398297904481504638938841665

#*Evolution of OGTT in patients with -thalassaemia major in relation to chelation therapy
#@Athanasios Christoforidis,Vassilios Perifanis,Ioanna Tsatra,Efthimia Vlachaki,Miranda Athanassiou-Metaxa
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1190704988203253719908320252135445028656581069245
#%482275710937539756375802876743294360063830069306

#*Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes
#@Lee Hand,L. Hand,Yvonne Vasquez
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index588154705823780535200299912545062694532180886101
#%1424291025856093537393587968880011142501490517980
#%555659603761440447727764408500835060224308077506
#%166831407171061780197722074702759236116753167018
#%908924740845745682659022004624368706334424635201
#%837165429119456444766133608037138102991755580239
#%265210889447492060400593377074552011945409793328
#%265210889447492060400593377074552011945409793328
#%278177264217147959273751719190378742229794014804

#*C-reactive protein and the risk of developing type 2 diabetes in Aboriginal Australians
#@Zhiqiang Wang,E. Hoy
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index395124852668171361609544172895318046221398358906
#%916912534836989719743813239231023366100476579369
#%364316568884850669360849430684081854750735769973
#%1299132414953617378733412174120815819955689190808
#%1379380937627240551005834870823045538463336951517
#%1144440395865962874566645139422488848297376310567

#*Public awareness of the metabolic syndrome
#@Judit Ndas,Zsuzsanna Putz,Gyrgy Jermendy
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1419438291049671149000754894234055390894825759355

#*Acute anuric renal failure secondary to intravenous immunoglobulin in diabetic nephropathy
#@Moushmi Biswas,J. Evans
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1195796495594930391101973535224158165526366817814
#%514670793242642388052344464812551367304515534225
#%955095605930629818342049255577917000770427444788

#*Diabetes associated with a low serum uric acid level in a general Chinese population
#@Hairong Nan,Yanhu Dong,Weiguo Gao,Jaakko Tuomilehto,Qing Qiao
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index183931095659104338435490791040848706189007333546
#%757226343445582439787846162097850218161186064009
#%515175933959400134457121062359434051496881441040
#%1247557858711530969401306214176454575439595537560

#*Seasonal variation in the diagnosis of type 1 diabetes in south-east Sweden
#@U. Samuelsson,J. Carstensen,O. Lfman,S. Nordfeldt
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index937554555755904525544112952893310908216250819890
#%808613419146319421086621306633858093962833351233
#%549735961324624694207663439073808266980639729661
#%1069258339605769266138261601953478156252418815017

#*Diabetic ketoacidosis in Denmark
#@M. Henriksen,E. Rder,B. Prahl,Lander Svendsen
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1104751407897396071980020847186156986126281753663

#*Preconception care of women attending adult general diabetes clinicsAre we doing enough?
#@G.I. Varughese,S.R. Chowdhury,D.P. Warner,D.M. Barton
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index402067344313617286862356414197886354175697465998

#*Hyperhomocysteinemia induces insulin resistance in male SpragueDawley rats
#@Jamal Golbahar,Amin Aminzadeh,Eddin Kassab,Rangbar Omrani
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index32772434393931453557029787323399982850072242731
#%434872964733915351168126391905034617785082711168
#%177514801968040369097976486701164084734883445785
#%1164167211050928800536685107246018968245302544253
#%1293649025946426143645152922638968495852358820399

#*Clinical and electrophysiological correlations in type 2 diabetes mellitus at diagnosis
#@Eugenia Rota
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index205421425160791050331575307687702060783707337805
#%121356830126059455389186768712768588524338132372

#*Lactate and ventilatory thresholds in type 2 diabetic women
#@Tasa Belli,Aurlio Ackermann,Paulino Ribeiro,Rodrigo Langeani,Rozinaldo Silva,Vilmar Baldissera
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index827055783652404466024772297706134725301258566840
#%1241024828397013040003650749211335870916438966327
#%1155116291109847487987385886785360553272467714459
#%1264383480019066623021099127531452182627896227885
#%1363720464846402832122769678882944767658140378001
#%1499880760379459663764097664530945177463479377

#*Multi-country study on the prevalence and clinical features of peripheral arterial disease in asian type 2 diabetes patients at high risk of atherosclerosis
#@Youl Rhee,Heng Guan,Min Liu,Wing-Keung Cheng,Sarwono Waspadji,Patricio Palmes,Yuan Tai,Sompongse Suwanwalaikorn,Seol Kim
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index449257797695563277966023645265877616802934854444
#%29964716439974909353210375069696706303508787054
#%621930068743800434330787487750861690552494893092

#*Amylin S20G mutation in Mexican population
#@Lorena Garcia-Gonzalez,Hector Montoya-Fuentes,Miguel Padilla-Rosas,Jose Sanchez-Corona
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1394395177933058289399189905228315456285390892955
#%76654444815938717987669449843234176780699873119
#%1071328056227835228113762629413684923579777077924
#%218584859896011095291175935686988079798225911229

#*Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance
#@Teoman Dogru,Alper Sonmez,Ilker Tasci,Ergun Bozoglu,Ilker Yilmaz,Halil Genc,Gokhan Erdem,Mahmut Gok,Necati Bingol,Selim Kilic,Taner Ozgurtas,Sezin Bingol
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index420678721583814257978460366381870733954688828022
#%950935218462113895987553557600568515851854455100
#%1122876593430619089198321703881073477797148556416
#%1122876593430619089198321703881073477797148556416
#%41333059132371080759290349441294000742333963012
#%641348617866864373891920013059264305956382906137

#*GCK and HNF1 mutations and polymorphisms in Polish women with gestational diabetes
#@Magdalena urawek
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index143482985159481341642272339282876462264696479999

#*In addition to obesity and insulin resistance, microalbuminuria and diminished insulin secretion are linked with the metabolic syndrome in community-dwelling nondiabetic Taiwanese subjects
#@Yi-Ching Yang,Jin-Shang Wu,Feng-Hwa Lu,Wan-Chi Chang,Chih-Hsing Wu,Chih-Jen Chang
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index95226720892289830449980482753638918608198735304
#%1452587202457107023030152607790541450093887520015
#%1239678428901684734281216596067885398422176059035
#%1305372912053979810929894754461647293315149530446

#*Evaluation of the superiority of insulin glargine as basal insulin replacement by continuous glucose monitoring system
#@Ling Wang,Ming Lu,Yu Pan,Ming Mu,Tao Dou,Ming Ba,Xuemin Wang
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index406627268008390124287429037767430188735742044826
#%726078703346320276446947837110818731020028296553

#*Isoprostanes, a marker of lipid peroxidation, may not be involved in the development of glucose intolerance
#@S. Boyne,A. Sargeant,I. Bennett,J. Wilks,S. Cooper,E. Forrester
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1102109332824790148123815747199567641423640034139
#%253863016621495518347929025908534574014979336184

#*Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome
#@Atsuhito Saiki,Tomokazu Oyama,Kei Endo,Mariko Ebisuno,Masahiro Ohira,Nobukiyo Koide,Takeyoshi Murano,Yoh Miyashita,Kohji Shirai
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index650401748840294775086341715207434182242116041826
#%955988395618588331045131275253074690220070780608
#%475021722854895630328605339288305472827812370338
#%476775724491028809961008022418359275862456827717
#%1058441079563236832905811800951353762257647838949
#%218832808340256916950100344164183339077024015869
#%324021310492296151580502224049622609425325114099
#%531490826784110720723944549568344744553085896276
#%1347131148159653833870809454228854616978879559695
#%943445413929490291105051608164037760300465308310
#%1347904561940518950522538753247777747881134446726
#%1347904561940518950522538753247777747881134446726
#%1295548609264593970230494983262928490203266426610
#%1286454733799329683626275240252906987892290006361

#*Association between insulin resistance and endothelial dysfunction in type 2 diabetes and the effects of pioglitazone
#@Masaaki Suzuki,Itaru Takamisawa,Yasunao Yoshimasa,Yutaka Harano
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index346028554610520853144163546216631872513454152571
#%825488010840441768398216731757171449718059503067
#%1390767547099907495498470368123019264452888981682
#%1390767547099907495498470368123019264452888981682
#%1241887802608743499001325241141019977161726728683
#%1354780198605040795740381062858891748563172364582
#%1049920671025215600842272004345140481677671711189
#%485319647525669821858526441895456817388904311832

#*Cardiovascular risk factors in pre-pubertal Malays: Effects of diabetic parentage
#@Ee Choo,Bee Lau,A. Davis,Hong Chew,J. Jenkins,M.E. Davis
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index866170340326980640061980551362148546829251943398
#%1321753673430474893306416348909014044013283173558
#%564461314931590743749585083887418615279865055764
#%112961201443507899984279949518869071336994856713
#%1261513649812580967220912941370113789075733381767
#%318271292099999578666873709293163172693134132403
#%599581541095041910448473063345254841637136062044

#*Erratum to A single transplantation of the islets can produce glycemic stability and reduction of basal insulin requirement [Diabetes Res. Clin. Pract. 73 (2006) 235240]
#@Mariko Sassa,Kazuhito Fukuda,Shimpei Fujimoto,Kentaro Toyoda,Yoshihito Fujita,Shinichi Matsumoto,Teru Okitsu,Yasuhiro Iwanaga,Hirofumi Noguchi,Hideo Nagata,Yukihide Yonekawa,Takeshi Ohara,Masahiko Okamoto,Koichi Tanaka,Yutaka Seino,Nobuya Inagaki,Yuichiro Yamada
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1075109694711707817231387789683586107503686992277

#*Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
#@Chang-Yu Pan,Patrick Sinnassamy,Kab-Do Chung,Kwang-Won Kim
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1204210450054912597786899191343141949179439576611

#*The CD4 + regulatory T-cells is decreased in adults with latent autoimmune diabetes
#@Zhifang Yang,Zhiguang Zhou,Gan Huang,He Ling,Xiang Yan,Jian Peng,Xia Li
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1148946327256356161585652108647541910473596861331
#%1134918346280193030670224700659769331018105506429

#*Efficacy and tolerability of vildagliptin monotherapy in drug-nave patients with type 2 diabetes
#@Xavier Pi-Sunyer,Anja Schweizer,David Mills,Sylvie Dejager
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index696970312526267721009096536762753932140593136071
#%1218475962443845287931377302097210133611088923040

#*Taurine in women with a history of gestational diabetes
#@Giuseppe Seghieri,Federica Tesi,Loria Bianchi,Alberto Loizzo,Giuseppe Saccomanni,Giovanni Ghirlanda,Roberto Anichini,Flavia Franconi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index437996214586300121883065373237942343960423490352
#%157586833371456941523679511245816911292790745227
#%458976193958088492690555297656062264251303973794
#%670509391370259322650853875491086993748424758940

#*Metabolic syndrome does not increase the risk of conversion of impaired glucose tolerance to diabetes in Asian IndiansResult of Indian diabetes prevention programme
#@A. Ramachandran,C. Snehalatha,K. Satyavani,S. Sivasankari,V. Vijay
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1173561383081208421337958902184247881958638558675
#%377540217445836200324260906171352376060362824630
#%990967316702656331397821802252330140801664445874
#%591970307517695847210297464522381981181327346590

#*Bilateral isolated acute cataracts in three newly diagnosed insulin dependent diabetes mellitus young patients
#@Ciro Costagliola,Roberto DellOmo,Francesco Prisco,Dario Iafusco,Francesca Landolfo,Francesco Parmeggiani
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index281085861069547741693670743219397304424683693009
#%1257488253371992513728240674168110147777680077401

#*Prevalence of diabetes in Pakistan
#@A.S. Shera,F. Jawad,A Maqsood
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index479048755542080329004940903545377400614905151241
#%391645723309965161953094572468833504202217435651

#*Transforming growth factor-beta 1 levels in women with prior history of gestational diabetes mellitus
#@S. Yener,T. Demir,B. Akinci,F. Bayraktar,L. Kebapcilar,M.A. Ozcan,S. Biberoglu,S. Yesil
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index974111677960649164815448921469297172157093559253
#%372116311512599769990312320163145541497148155154
#%1041278663981828752782424159506391319890900220183
#%15087632596950242196111081193893955934845171263
#%704408864559252406050372540954769420307599288594

#*-Cell preservation with thiazolidinediones
#@W. Campbell,Segundo Mariz
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index696484680501625084830775205346768597604100171345
#%405358859455161293643593699516554537835781930299
#%99120042405552080602313304468932751792260662881
#%491475007289661386521175319863316192471790359027
#%289352202875674771407712270636896958614042387799
#%115352082134933519392282625871162677533913396815
#%198907950911951331418393303936334862721062167543
#%1353878295937440094315749124413900187213468734151
#%789198489702586542926219084517612861962341004780
#%1382418450614098050663389260378438796173418950574
#%530742815982948056355266956550925744819808900472

#*Increased prevalence of VNTR III of the insulin gene in women with gestational diabetes mellitus (GDM)
#@Hariklia Litou,Eleni Anastasiou,Louminitsa Thalassinou,Helen-Leda Sarika,George Philippou,Maria Alevizaki
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index599038583822579216937576112040617384216751078527
#%596475391364911159177803030476153955090427783809
#%1038339391720992584598173962085354070925059433277
#%424335754835209756378704210604148441463227864633
#%1034141004341622194916033325193941898808913139182

#*Characteristics of undiagnosed diabetes in community-dwelling French elderly: The 3C study
#@I. Bourdel-Marchasson,C. Helmer,P. Barberger-Gateau,E. Peuchant,B. Fvrier,K. Ritchie,J.-F. Dartigues
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1103444974893510808133990635071449913559201928584
#%20974908667366551872942389171008465367644595653

#*Averting iatrogenic hypoglycemia through glucose prediction in clinical practice: Progress towards a new procedure in diabetes
#@A.M. Albisser,C.E. Wright,S. Sakkal
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index229332749020052919338100388930804995696084417023
#%183329249999832243363488879288632559372146295956

#*Insulin glulisine imparts effective glycaemic control in patients with Type 2 diabetes
#@Gerrard Rayman,Velimir Profozic,Michelle Middle
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index799459498121064796655319828252241542533110110656
#%630507425983902650216713361073070198705231366169

#*Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients
#@Guang-da Xiang,Hui-ling Sun,Lin-shuang Zhao
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1338421880100598708642307800944431456889491895906
#%1019295311003677583817726196325719686806737641603
#%1096145954816657691066785398447680031567481890490
#%1094513585285326603783653267733514653414590597070
#%509594842920952678725508142429248068685566069190

#*No independent role of the 1123 G > C and + 2740 A > G variants in the association of PTPN22 with type 1 diabetes and juvenile idiopathic arthritis in two Caucasian populations
#@Ondrej Cinek,Ondrej Hradsky,Gunduz Ahmedov,Antonij Slavcev,Stanislava Kolouskova,Michal Kulich,Zdenek Sumnik
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index33236009791438333242631090006284535570385738017
#%870685262678074870775774842999399084651993699366

#*Thiazolidinediones and the risk of edema: A meta-analysis
#@D. Berlie,S. Kalus,A. Jaber
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1280788194876751118971376536177585926246580838139
#%1236897550330994677741615452877373786897442171239
#%747494549459929334439546805110245830284331121758
#%90411492023920119689076896271202359439068690282
#%1212541066311221910162609272290170181534929739253
#%270659814422014433735562862294382923401002109181
#%771838189793421032014531980540519755597781321453
#%1373381618968659012550067877021656395415076747936
#%697999729707112882035165415974075911916741613288
#%1376399892214428830294649454134536962368195315659
#%783476294531824817803023260393246693940829742338
#%1353878295937440094315749124413900187213468734151
#%1441270554715646561153452755379177844800857709698

#*Novel roles of the IGFIGFBP axis in etiopathophysiology of diabetic nephropathy
#@L. Vasylyeva,J. Ferry
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index461685251394485225258213489535858344005117913088
#%623481914425758596367568552061788055360124372288
#%1044342654748472350227275899541777186120382316760
#%305798974744093249619559778493259917585267581179

#*Coping strategies in immigrant men and women with type 2 diabetes
#@Catharina Gfvels,Eric Wndell
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index506721046307641348542188411663298260164526746403
#%177694896289598442042421938078290819012511099084
#%104486044209099923886224824913513881556843208519
#%257751131556989767583909033548113252250013932968

#*Hepatic safety profile and glycemic control of pioglitazone in more than 20,000 patients with type 2 diabetes mellitus: Postmarketing surveillance study in Japan
#@Ryuzo Kawamori,Takashi Kadowaki,Morikazu Onji,Yutaka Seino,Yasuo Akanuma
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index654163650717519780850144187956088575986019153560
#%60418076270815542099030675398758032587967847318
#%497374437417074855403068751823532698494740453003
#%856537884140432138093842042156523599248953399383
#%1222287489159964799902526025570129237619060768498
#%1222287489159964799902526025570129237619060768498

#*Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes?
#@Tomoko Nakagami,Makoto Tominaga,Rimei Nishimura,Nobuo Yoshiike,Makoto Daimon,Toshihide Oizumi,Naoko Tajima
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1132398465386585154738124150268332354623696726057
#%1265041975770594301123298845077467671671972445934

#*Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes
#@Hiroyuki Unoki,Hideaki Bujo,Sho-ichi Yamagishi,Masayoshi Takeuchi,Tsutomu Imaizumi,Yasushi Saito
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index480291026676578747628313583805344013170618836403
#%450764188286433994760981960954951405629425944639
#%738054254360179761879866714973106042967472318710
#%982785298701792548581033927181127443070175504341

#*Childhood obesity and its relation to serum adiponectin and leptin: A report from a population-based study
#@Rimei Nishimura,Hironari Sano,Toru Matsudaira,Yumi Miyashita,Aya Morimoto,Takako Shirasawa,Eiko Takahashi,Takeshi Kawaguchi,Naoko Tajima
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index386496997161184264935864191597417802455999302077
#%823688206939404144743129184678050060900791275090
#%33134122640333840335717024352748233409831572114
#%959231419534254226753409696883367637222578877793
#%1347131148159653833870809454228854616978879559695

#*Effectiveness of lifestyle counseling by certified expert nurse of Japan for non-insulin-treated diabetic outpatients: A 1-year randomized controlled trial
#@Taiga Shibayama,Koji Kobayashi,Akiko Takano,Takashi Kadowaki,Keiko Kazuma
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1257873910285722202300178079731360064907192209619
#%203504423004871745671925906962463231751896202636
#%597729893514837039160839267240659310256216106916
#%977911525924826229759472675780366549934446938471

#*Zero prevalence of diabetes in camel milk consuming Raica community of north-west Rajasthan, India
#@R.P. Agrawal,S. Budania,P. Sharma,Rajeev Gupta,D.K. Kochar,R.B. Panwar,M.S. Sahani
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index561736679891099272211540259247770937548270124725
#%19691795296066575247509290728062186066004815137

#*The effect of the optimal use of rapid-acting insulin analogues on insulin secretion in Type 2 diabetes
#@A. Gallagher,T.J. Butler,P.D. Home
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index400583693325704290887566961342452963436784379064
#%643597713477026494052956113893281067489438955422
#%998172976297612424093107715281322102698719104916

#*Work stress and low emotional support is associated with increased risk of future type 2 diabetes in women
#@M. Norberg,H. Stenlund,B. Lindahl,C. Andersson,J.W. Eriksson,L. Weinehall
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index427563458955728906761334766839218939333905623785
#%460199042841412278047330451604216026432362594838
#%324276051960055703327406022355298248376067324412
#%123792264483409467282786776783861190454684182257
#%1316035652934785351643106419861172336398556885788

#*Urinary PGDS levels are associated with vascular injury in type 2 diabetes patients
#@Ritsuko Yoshikawa,Jun Wada,Kousuke Seiki,Takashi Matsuoka,Satoshi Miyamoto,Kenji Takahashi,Sachiko Ota,Kazuhi Taniai,Kazuyuki Hida,Minoru Yamakado,Kenichi Shikata,Yoshio Uehara,Yoshihiro Urade,Hirofumi Makino
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index443582868839136054872666891067856303246882604720
#%190201338580778337585385694038689699634308819011
#%1401500081086010184066489492152889255893033642050
#%1143247054964945273405816221419647363121423316843
#%1378232309151013105142487145858927163597592381276
#%842036095489228881592283125012264011695324380963
#%667111737732720711066568264278287653347865381304
#%1200007092484345151257169059303676403517075743640

#*Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance
#@Eva Palik,Eva Baranyi,Zsolt Melczer,Maria Audikovszky,Albert Szcs,Gbor Winkler,Kroly Cseh
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index325915472837582132483494898601630656603058892300
#%21289436496846075670654955772691900449330503037
#%997813168373711276369796927049829448781053796308

#*Effect of a viscous fiber-containing nutrition bar on satiety of patients with type 2 diabetes
#@JoMay Chow,S. Choe,J. Noss,J. Robinson,E. Dugle,H. Acosta,A. Garleb
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1175311267590005556830813966355607894216637977630
#%227205600348725313393326952192190613324676840829

#*Carotid atherosclerosis associated to metabolic syndrome but not BMI in healthy menopausal women
#@Tiziana Montalcini,Gaetano Gorgone,Carmine Gazzaruso,Giorgio Sesti,Francesco Perticone,Arturo Pujia
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index656651804688849669423633123524055117684740422295

#*Patient education in type 2 diabetesA randomized controlled 1-year follow-up study
#@Thors Adolfsson,Marie-Louise Walker-Engstrm,Bibbi Smide,Karin Wikblad
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index360856265743213499282178218693954360501566927080
#%742649546860732510692646641827788060043608536853
#%140456867570021162146665298826090763856251962362
#%899675930818028268884650328082562365397791864167
#%5604387664633126198781777401849230653872495927
#%252073336749077700880668752094513082215620129541

#*Metabolic syndrome in connection with BMI in young Finnish male adults
#@Ilona Mikkola,Sirkka Keinnen-Kiukaanniemi,Mauri Laakso,Jari Jokelainen,Pirjo Hrknen,Benno Meyer-Rochow,Anna-Kaisa Juuti,Ari Peitso,Markku Timonen
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index928316802919591391657651706835287432914496115685
#%884049804894460243807248550417114824043532018892
#%965506810568305241756946125001974095536961573407
#%608027367961477215758757976231510100673358964715

#*Prevention of type 2 diabetes: A review
#@A. Hussain,B. Claussen,A. Ramachandran,R. Williams
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index175338537068949131109522161901533732814489247040
#%1347131148159653833870809454228854616978879559695
#%1419803114697950334165048919798682246654527469823
#%559230555486031655109138599697783983518388204319
#%1156966818236800600201200851607649111520077438894
#%1156966818236800600201200851607649111520077438894
#%1367193082161929986775763619898813748274685204973
#%1224074640070684510826799989009048076231558784418
#%530742815982948056355266956550925744819808900472
#%530742815982948056355266956550925744819808900472

#*Vascular phenotype and subclinical inflammation in diabetic Asian Indians without overt cardiovascular disease
#@A. Ray,E.D. Beishuizen,A. Misra,M.V. Huisman,J.T. Tamsma
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index161640902308495907154496515702656355081302722380
#%10707252567382812568302225801780250022167623403
#%975187157342990116121420845773982710901334565162

#*Insulin secretion and insulin resistance in newly diagnosed, drug naive prediabetes and type 2 diabetes patients with/without metabolic syndrome
#@Youl Rhee,Suk Chon,Seungjoon Oh,Woon Kim,Jin-Woo Kim,Seol Kim,Jeong-taek Woo
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index94577769714666607732098930324025695866280610384
#%347460200864815537375234089001588228352740272966
#%1401607269839429390408309751866937438263484975134
#%417766593200355128364595364000005086684040970422

#*Brazilian version of the Problem Areas in Diabetes Scale (B-PAID): Validation and identification of individuals at high risk for emotional distress
#@Campos Gross,Fiore Scain,Rafael Scheffel,Luiz Gross,Simon Hutz
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index280518669565011618273824391316832500053864126078

#*Hemosiderosis and diabetes mellitus in an untransfused patient with hemoglobin H disease and H63D homozygous hereditary hemochromatosis
#@Apostolos Tsapas
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index701326728717839222934047040706462844497831660126

#*Results of the pilot study of DIADEMA comprehensive disease management programme for type 2 diabetes
#@S. Luzio,W. Piehlmeier,C. Tovar,S. Eberl,G. Ltzsch,E. Fallbhmer,E. Rumpel,D.R. Owens,R. Landgraf
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index578170328374077541867712261007041473258478241378

#*Familial aggregation of metabolic syndrome among the Chinese: Report from the Chin-Shan community family study
#@K.L. Chien,H.C. Hsu,W.J. Chen,M.F. Chen,T.C. Su,Y.T. Lee
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index266718288438101340788845214219273187755721620443
#%860022615160432358769576638139277096798571837825
#%800017830610853549012273463136499867416919430384
#%1375767567589750328428177808060687550153794506441

#*Prevention of type 2 diabetes in a primary health care setting
#@Annamari Kilkkinen,Sami Heistaro,Tiina Laatikainen,Edward Janus,Anna Chapman,Pilvikki Absetz,James Dunbar
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index13894055135370535924759089826675421285186166123

#*Novel mutations found in mitochondrial diabetes in Chinese Han population
#@Song-Mei Liu,Xin Zhou,Fang Zheng,Xia Li,Fang Liu,Hong-Mei Zhang,Yan Xie
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index247196532452584723572772151400074784622650329783
#%1333522231951929369019932768679679049714245680061
#%1333522231951929369019932768679679049714245680061
#%23314735123526796315850181600730135794651142938
#%23314735123526796315850181600730135794651142938
#%812333368253828922660958353444173464381845358636
#%1210367909285069943471461880319733759633413980409
#%1210367909285069943471461880319733759633413980409
#%843203109197169972308987813034717901021817298235
#%25414593645105309674639289332488377891606457936
#%1448129527618604400261472296359389018739932129681
#%73584982353806137052187365847169591233602588254
#%1085138437808893489428991630598308607564140883464
#%650923347289780313935698746087581606375065334281
#%374192665312213335620224384894614078944482221472
#%598537727443552843684773394116208463023101690132

#*Cardiovascular disease risk in subjects with type 2 diabetes mellitus in a population in southern Spain
#@Blanca Lahoz-Rallo,Manuel Blanco-Gonzalez,Inmaculada Casas-Ciria,Alberto Marn-Andrade,Carlos Mendez-Segovia,Guillermo Moratalla-Rodriguez,Rafael Quintero-Dominguez,Manuel Ramirez-Raya,Jose Guerrero-Pinedo,Manuel Aguilar-Diosdado
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1084378929924489706655078349588648931467426543844
#%730984606219552461470784668072027288578470715443
#%1118924508192030884186352296070736173906329338410

#*Cardiovascular disease: Is C-reactive protein the bad guy?
#@H. Ahmed
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index962525544015625015446515570245563519934038156931
#%1209619963572228696814422880750378206665307046209

#*The prospective association of general and central obesity variables with incident type 2 diabetes in adults, Tehran lipid and glucose study
#@Farzad Hadaegh,Azadeh Zabetian,Hadi Harati,Fereidoun Azizi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index824243424153724777891234146247146709934481880562
#%340035279079324791840196450218319126054720600885
#%340035279079324791840196450218319126054720600885
#%928670943840683491319615474360322243537244463157
#%325040581011859195295908238935096747626280469467
#%290952418391219773409907227976179690740069149479

#*A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women
#@C. Anjalakshi,V. Balaji,S. Balaji,V. Seshiah
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index685413638253436830544231106165888851078431635871

#*Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome
#@Asuka Hino,Hisashi Adachi,Mika Enomoto,Kumiko Furuki,Yoshiyuki Shigetoh,Maki Ohtsuka,Shun-Ichi Kumagae,Yuji Hirai,Ali Jalaldin,Akira Satoh,Tsutomu Imaizumi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index66904303812641205288594004251532657094618659804
#%1364050431905476068412681359058331292889936640877
#%1450663128122814647133198450662123081742603482276
#%784363583192435917977362717223009080090048300462
#%483922109448467667764750626660968546866740208839
#%1318584245533501160272753248768312857762551173862

#*Hypovitaminosis D is frequent in Japanese subjects with type 2 diabetes
#@Hiroyuki Koshiyama
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1045104269905801820061997632023215672935869596210

#*Glycated Collagen I (GC) impairs angiogenesis in vitroA study using an innovative chamber for cell research
#@V. Brodsky,M.H. Merks,Natalia Mendelev,Cara Goo,Jun Chen
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1107513259255185044073285142263943852887238742110
#%1013163759010800308966830502676227879922310241513
#%872513331315349154291752961823268604495587509109

#*Prospects for angiotensin receptor blockers in diabetic retinopathy
#@Katrin Sjlie
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1194464662961911742047903030376774698133269781317
#%1004467331217795033394001466623905602592569826965
#%1296241669695170069911970423246426534713868410285
#%1202184390112890396865924333326748671567132385405

#*Angiotensin receptor blockade in diabetic renal diseaseFocus on candesartan
#@Garca Donaire,M. Ruilope
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index574255097115500258108110963080897715509978797627
#%278127858286973653161543618403114419263092873657
#%431412729600776668789272016853046241948029539427
#%762918842968601386815873334585375362738730334517
#%281413304012272914867592139413303053721321156036
#%1275807021431949257691019901457974996579306948804

#*Reninangiotensin-system blockade in the prevention of diabetes
#@Jan stergren
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index637113610907922217292354673082192147113367282306
#%806602564731002517047345188425611073634965329664
#%524310425574276645999642321889258866520560845428
#%78352572084905341639090636593345442635067376666
#%348093596653537113747220411812367639572459974780
#%851817410589523825178658772986072365885578143050

#*The burden of diabetes and its complications: Trends and implications for intervention
#@Nish Chaturvedi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1070905556764175439569011787851119957132976517450
#%1108285737248830368953346724399581105940096847396
#%1007415568986649201144596323391078967389976577414
#%530742815982948056355266956550925744819808900472
#%1115140191322679590365185151066158863916116409428

#*A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects
#@Munehide Matsuhisa,Yoshimitsu Yamasaki,Masanori Emoto,Michio Shimabukuro,Tohru Funahashi,Yuji Matsuzawa
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index478047793690143211436112980093248380065382684373
#%321281171723193944844056464460585958651900349327

#*Total and excess bed occupancy by age, specialty and insulin use for nearly one million diabetes patients discharged from all English Acute Hospitals
#@J. Sampson,Nicoletta Dozio,Brian Ferguson,Ketan Dhatariya
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1084449748323079658033075401412030051228839675457
#%599837043519258494668977948963356643112093680425
#%173430597232584187095923117536148243016064792635
#%871911564815836356408887282458637486167803148893

#*Oligomeric procyanidins of French maritime pine bark extract (Pycnogenol ) effectively inhibit -glucosidase
#@Angelika Schfer,Petra Hgger
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index427471151368312621396664663846960319708738334830
#%1019325616472464565108753516109054708512508051567
#%511008125131950743667638179120564860754237701335

#*Elevated fasting glucose levels predicts IGT and diabetes also in middle-age subjects
#@E.H. Schwarz,R. Bornstein,Markolf Hanefeld
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index116182041430242440860070030952201915335399022763
#%263564522004446620110117973110174444579083876482

#*Improving metabolic control in sub-optimally controlled subjects with Type 1 diabetes: Comparison of two treatment algorithms using insulin glargine
#@Ramon Gomis,Fred Storms,Ignacio Conget,Patrick Sinnassamy,Melanie Davies
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index484957543522881687677153675076600645788055185690

#*Monocytes from type 2 diabetic patients have a pro-inflammatory profile
#@Annapaula Giulietti,Evelyne Etten,Lut Overbergh,Katinka Stoffels,Roger Bouillon,Chantal Mathieu
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1293512144216879868817569771556560060208988527174
#%1299132414953617378733412174120815819955689190808
#%375833938308889525574530297755162301040919199581
#%869070465063547206247731288049700037047133932379
#%268900386861461341629084155348812095065086433526
#%578576681833365567649458027981236065660580662854
#%853050021613660693207190959191662986911750481430
#%408059917926705555937829541628510960145693982358
#%483764532353913006336206383763491192109364135918
#%1454099158839043683772738783994411369756713963807
#%950346808113313538746489663499927115215462530179
#%737577288454441167163625585745845969184998912567

#*Prevalence of the metabolic syndrome among Korean adults using the new International Diabetes Federation definition and the new abdominal obesity criteria for the Korean people
#@Man Kim,Jung Kim,Hyun Jung,Chanwang Park,Jong Park
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1280289314018846934604262562508608855099323385934
#%417766593200355128364595364000005086684040970422
#%425359508911865790944680143974007765055061334363

#*Ethnic differences in C-peptide secretion but not in non-esterified fatty acid metabolism in pre-menopausal women with and without abdominal obesity
#@Manja Reimann,E. Schutte,W. Huisman,Rudolph Schutte,M. Rooyen,Leon Malan,T. Malan,E.H. Schwarz
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index641366055889551089184463464096846695905252415163
#%941578172842352087395119157718545561317469634461
#%222556591676978590075481324571014886166443258643
#%716759959801103486568332130519705522017740536658
#%1454058237317953786769633225340767762824071145789
#%50352233540185571770431459348939486396378992332

#*Viral/self-mimicry and immunological cross-reactivity as a trigger of hepatic C virus associated autoimmune diabetes
#@Dimitrios-Petrou Bogdanos
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index692003313634041177216832571863301446681735410004
#%702966780197065369396456404879226834984413996332
#%242278849316829126396623217489161378549177042613
#%1000943229072033851076389851707342128239341990875
#%1000943229072033851076389851707342128239341990875

#*Treatment of diabetic ketoacidosis in adults in Denmark: A national survey
#@M. Henriksen,B. Prahl,E. Rder,Lander Svendsen
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index762361860583022930775347964880011148095535476306
#%663009190819276514230883037907508794817296812523
#%70627363835915865691145764175678919532222764490
#%71804196560319434248746455886613366042352995921
#%71804196560319434248746455886613366042352995921
#%1285420721670976127926497761439259346928436558907
#%1002100032041541885761141913614079755061833535420
#%397558376002807822637804318170193968757074876469

#*Differences in coronary heart disease prevalence and risk factors in African and White patients with type 2 diabetes
#@John Kalk,I. Joffe
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index60681705119617213577449226537555419240325086261
#%296230500029000779276135879038312054676120838670
#%701226865595645657133035320955597158247442795124

#*A review of human and analogue insulin trials
#@C.L. Gough
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index497708998244205723171236061580448431567300017522
#%643597713477026494052956113893281067489438955422
#%896821395246568402621506676574005174593636698413
#%707902077053608907834739575725305064393287645619
#%451245237813493871982158470456954646693566556120
#%1454173051140223056214004912298129667489991059702

#*Undertreatment of cardiovascular risk factors among persons with diabetes in the United States
#@Shaista Malik,Victor Lopez,Roland Chen,Wei Wu,D. Wong
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index469325929880231860904196685721175959400091183340
#%298948132451392872508877290061772889371096263221
#%741472667357967036521698557437635045148869117616
#%1014050429518595887361295856904183858259214252958

#*HbA1c is outcome predictor in diabetic patients with sepsis
#@Ivan Gornik,Olga Gornik,Vladimir Gaparovi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index965388380633944957266582245076480099338601475913
#%1064063100425375443904064099554448919054632380061
#%545213210983838201449606921355780497685595371190
#%863229336498071247912357223260237892853032310246
#%660134182187421808855332383965528837562407567349

#*VDR polymorphisms influence the immune response in type 1 diabetic children from Santiago, Chile
#@Diego Garca,Brbara Angel,Elena Carrasco,Cecilia Albala,Luis Santos,Francisco Prez-Bravo
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index944324777662011542473601214794521184477475496198
#%939952663207005295339727640009048814808313685417
#%231547377690906738905014440888385757738445552133
#%175126004237154548348489369693828871550502981615

#*Sustained beneficial metabolic effects 18 months after a 30-day very low calorie diet in severely obese, insulin-treated patients with type 2 diabetes
#@M. Jazet,J. Craen,M. Schie,Edo Meinders
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1384247444449122258278294715017029348846977940004
#%1276167838821349937052906713907484655642484722047
#%583136685607995677126304053148153695861661274149
#%642123718911654533837580083492293604217175075852
#%760350382067616006602023286108732917710119595307

#*The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients
#@Serpil Sava,Kale Krolu,Rifat Koyuncuolu,Erturul Uzar,Hakan elik,Mehmet Tamer
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1352076155794751714596759331296987408387141703869
#%1043191904236236246857071447048690900271880986427
#%630430192077266136860959545395793375038505236213
#%44310388651223277833980930530251669920175945346
#%498537922073096340968759416905741775517468068892
#%1317744759676684582290811006672630263108576225343

#*Association of sulfonylurea receptor 1 genotype with therapeutic response to gliclazide in type 2 diabetes
#@Huijuan Zhang,Xiaomin Liu,Hongyu Kuang,Ran Yi,Houxun Xing
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index413861684376385535469716492804005672642985870114
#%1395936297418711593669437622117178645425575186127
#%762874191291691206307969232525531146334489963613
#%1136344016781035463551567270092867896970718242028
#%1198764462080963912806584681375332536965632843163

#*Non-invasive glucose monitoring: Assessment of technologies and devices according to quantitative criteria
#@Andrea Tura,Alberto Maran,Giovanni Pacini
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1153619390435542522834121196549365845243878137030
#%365053623439856626151440837225816431641951651645
#%549643428088683430142107354303590296657170309283
#%983442222484577778004687022615468797669473533181
#%1193084577129007563814528502638606751724979591558
#%1183590016932079026803472970637675610291619863461
#%430303892502852035604195748058417967701809671523

#*Patients with aortic valve stenosis and Type 2 diabetes have similar coronary flow reserve and aortic distensibility compared with non-diabetic patients with aortic valve stenosis
#@Attila Nemes,Tams Forster,Mikls Csandy
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index451609450917656044162371101807044281849294379579

#*Predictors of glucose intolerance in HCV-infected patients with no family history of diabetes
#@Wassim Chehadeh,A. Sarkhouh,Widad Al-Nakib
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index759175421448544258498983634065591207636948837231
#%1219967129454705658394013377336870070714631371121
#%108598548046606644375010235561390999093560421575
#%231142197255569191538021629732607720396255992037
#%50329227852965444149470241338902408623226862307
#%59466552376101123466712750139105859332752384656
#%1152527586522501556777127034273779844981723229927

#*Sight-threatening retinopathy is associated with lower mortality in type 2 diabetic subjects: A 10-year observation study
#@Monica Lvestam-Adrian,Catarina Hansson-Lundblad,Ole Torffvit
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1427251650845547762766065630426572781671883485706
#%798924464429766493090680407512972429770812138621
#%999728022867127968642455493692432993118536523997
#%412859647928624522633347843309291966681444576865

#*Metabolic improvement of male prisoners with type 2 diabetes in Fukushima Prison, Japan
#@Masamitsu Hinata,Masami Ono,Sanae Midorikawa,Koji Nakanishi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index749404171594426706335101977064697697774458371494
#%936069583900768098272343450335544347261807063193
#%192656187719348078911838862482417258485619675070
#%518331109437668466376328215218057288544323553748
#%56213596177477615112274194847464951607717018266

#*Antepartum and intra-partum insulin management of type 1 and type 2 diabetic women: Impact on clinically significant neonatal hypoglycemia
#@A. Kline,Alun Edwards
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index545762341669845287855185850139529923102836359095

#*A group-based healthy lifestyle program for women with previous gestational diabetes
#@Wah Cheung,J. Smith,Helle Henriksen,C. Tapsell,Mark McLean,Adrian Bauman
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1438957507055878270154076805704797108912767471750

#*Superiority of the Modification of Diet in Renal Disease equation over the CockcroftGault equation in screening for impaired kidney function in Japanese Americans
#@Fernando Gerchman,Jenny Tong,M. Utzschneider,L. Hull,Sakeneh Zraika,Jayalakshmi Udayasankar,J. McNeely,L. Andress,L. Leonetti,J. Boyko,Y. Fujimoto,E. Kahn
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index824564462861087594625200314021799789661767657797
#%1102880864833037643035743539547463658107628255008
#%937131914790451353527035492147992876950719692795

#*Glargine versus NPH insulin: Efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetesThe glargine and aspart study (GLASS)
#@S. Chatterjee,J. Jarvis-Kay,T. Rengarajan,I.G. Lawrence,P.G. McNally,M.J. Davies
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index261605376126437589267023579096565562616629279080
#%726078703346320276446947837110818731020028296553
#%334699660748335939863538163124033888769630615793

#*Attendance at an Irish Diabetes Dietetic Outpatient Clinic
#@M. Finucane
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index697031945859682624646645930358501821258978236031

#*Rising prevalence of type 2 diabetes in rural Bangladesh: A population based study
#@M.A. Rahim,Akhtar Hussain,A.K. Khan,Abu Sayeed,S.M. Ali,S. Vaaler
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1414519649302587451084247101981431991774536803237
#%156490188097253052891307517611441322263179931480
#%1029904264331246377480361003230437275872526408763

#*Daily-life activities and in-shoe forefoot plantar pressure in patients with diabetes
#@A. Guldemond,Pieter Leffers,P. Sanders,C. Schaper,Fred Nieman,H.I.M. Walenkamp
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index81230316981598999554926922597959189080859224213
#%991189133790843914022537796324206112295137520238
#%1201956909260933008354135391487106567339247967983

#*Hypertension in people with diabetes in sub-Saharan Africa: Revealing the hidden face of the iceberg
#@Pierre Choukem,Pascal Kengne,Mesmin Dehayem,Leonie Simo,Claude Mbanya
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1039681447135391682259981440299378311415160619558
#%29964716439974909353210375069696706303508787054
#%283965586968701217430013085213462904388827271239
#%276157518944922492850924366818433851579250135450

#*Comparison of ventilatory threshold and exercise habits between Japanese men with and without metabolic syndrome
#@Nobuyuki Miyatake,Takeshi Saito,Jun Wada,Motohiko Miyachi,Izumi Tabata,Sumiko Matsumoto,Hidetaka Nishikawa,Hirofumi Makino,Takeyuki Numata
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index280111069398237047439513885025953718354045049525
#%363862356738881115350986881574917069347733798522
#%1420936798300482831678452425531394016045143671933
#%26826178630254663959920817119918589483953056396
#%295185880225514743548043715399679584844378783557

#*The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults
#@Ho Kang,Ki Min,Man Son,Ju Kim,Ki Kim
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1393240609779696108157096099965190967083200004506
#%830561113794342335339376911214975698828176141520

#*Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes
#@J. Woerle,Christoph Neumann,Silvia Zschau,Stephanie Tenner,Andrea Irsigler,Joerg Schirra,E. Gerich,Burkhard Gke
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1107077332916807107612234537146857924798176677820
#%481570781244869144784002259840012820397148090045
#%353715221701313857076643502336962388114740836244

#*Serum C-reactive protein levels correlates better to metabolic syndrome defined by International Diabetes Federation than by NCEP ATP III in men
#@Mao-Shin Lin,Shyang-Rong Shih,Hung-Yuan Li,Lee-Ming Chuang,Tien-Chun Chang,Jung-Nan Wei,Gow-Jen Shieh,Yu-Fen Chien,Cyue-Huei Hua,Juey-Jen Hwang
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1242396231290313386378803578210913433062426430884
#%379965717971066516478246333857787569759209257048
#%268608629525735653172987794890963286185301459861
#%1378232309151013105142487145858927163597592381276
#%153539551667742061273866354021610053900456615606
#%324021310492296151580502224049622609425325114099
#%608027367961477215758757976231510100673358964715
#%840212220830164465883215697216954870587410420358

#*Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions
#@Azadeh Zabetian,Farzad Hadaegh,Fereidoun Azizi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1374310210571094178812676785082365325858134197455
#%1324973972417001029253325432822342429893670319200
#%731951810301996354737974581221314481843404671356

#*Impact of the sulfonylurea receptor 1 (SUR1) exon 16-3c/t polymorphism on acute hyperglycaemia in type 2 diabetic patients
#@Marzena Dworacka,Hanna Winiarska,P. Jagodziski
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1063282333536180374172581270094244878980985474192

#*Glyceryl trinitrate spray in the management of painful diabetic neuropathy: A randomized double blind placebo controlled cross-over study
#@R.P. Agrawal,Ramdev Choudhary,Poornima Sharma,Srikant Sharma,R. Beniwal,K. Kaswan,D.K. Kochar
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index30565546244249540882574858631195829206134184921
#%374221946361013625086233631894782295029673335815
#%211754517450469810403999466848912351742893766523
#%771003142776402382501782957397790674480794363871
#%1431258448935863036299678115510843133370219571114
#%587738863469222904308391264900221771139529905716
#%188362846562337997799823750887524450504290764871

#*Outcomes of pregnancies affected by impaired glucose tolerance
#@M. Kwik,S.K.M. Seeho,C. Smith,A. McElduff,J.M. Morris
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index524380152099799022435627634673668615652372756005
#%1223247918430045996673746611021496790846445947301

#*High prevalence of glucose intolerance even among young adults in south India
#@Palany Raghupathy,Belavendra Antonisamy,H.D. Fall,S. Geethanjali,D. Leary,Julia Saperia,G. Priya,Abel Rajaratnam,Joseph Richard
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index175673282637710485932719241697136839548400631097
#%1290359002008954037878198402653239866747905973361
#%1290359002008954037878198402653239866747905973361

#*FABP2 Ala54Thr polymorphism and diabetes in Chilean elders
#@Cecilia Albala,Ana Villarroel,Luis Santos,Brbara Angel,Lydia Lera,Claudio Liberman,Hugo Sanchez,Francisco Prez-Bravo
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1063099915631932743442993828315626896995246522395
#%810107488954471304060275761946553057648506946819
#%819958761356179059528257977578755746400823234001
#%1253634491343653810975506172092637539079245176509

#*AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus
#@Agnieszka Piwowar,Maria Knapik-Kordecka,Maria Warwas
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index801366489234351413362817697578308976155450823242
#%1403763027417994643087616683344415689880782057917
#%508227104004016396550355242134076029369983032173
#%1261446058673288221610596657737298167397909849770
#%38690514645133385024906477061191661907261198819
#%214495172274237966003468790890801782305223628376
#%1272232993624934042588711298394207990014775799757

#*Determination of the antioxidant status of plasma from type 2 diabetic patients
#@O. Medina,A. Veloso,rica Borges,Armond Isoni,R. Calsolari,M. Chaves,A. Nogueira-Machado
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1396979071714212423122519283320861380931827585552
#%317796361451657207033566924801759200651488297630
#%806027081011361886635760766305321593406016779019

#*Prevalence of the metabolic syndrome in Caucasian obese children and adolescents: Comparison between three different definition criteria
#@Alessandro Sartorio
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index391816700710748662618855957497334548720847303757

#*Differential effects of rosiglitazone and insulin glargine on inflammatory markers, glycemic control, and lipids in type 2 diabetes
#@Raymond Reynolds,J. Kingsley,G. Karounos,R. Tannock
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1414548789419485913486382715084414933958144171684
#%804341135052087127742674922863505654769519761557
#%979330384717240711393328320729590600958563051846
#%1097230673122116155468480590685744445329070611472
#%894866533972400498965807938551824721232071474025
#%747494549459929334439546805110245830284331121758

#*Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus
#@K. Kestil,U. Ekblad,Tapani Rnnemaa
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index965360440100230411921704957881531351168220692352
#%911483419556458804652426778452562585126038278105
#%1330765628654106739568864800427784252962063340749
#%1448295967843193778486650025192007362809866177896

#*Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients
#@K. Chiu,C. Tsai,Rattan Juneja,James Stoever,Barbara Brooks-Worrell,Amit Goel,P. Palmer
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index415789436299534902247729529330715383950706408066
#%539055328712827785987904224516893633629567870073
#%287193272466959972754088047810121532132652488708
#%612996013956783174386016149695405911634332514289
#%1039946643923187151455269584999663670591740671001
#%1405639378185684952295359055729608957717762545860

#*Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients
#@Isao Usui,Shiho Fujisaka,Katsuya Yamazaki,Atsuko Takano,Shiho Murakami,Yu Yamazaki,Masaharu Urakaze,Haruo Hachiya,Michiyo Takata,Satoko Senda,Minoru Iwata,Akira Satoh,Toshiyasu Sasaoka,Dim AK,Rie Temaru,Masashi Kobayashi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index378378598939250245341756671112084696753349010634
#%149978724848984337500854377495070640170152393449
#%78352572084905341639090636593345442635067376666
#%125453740245132416618553776809341336819917349298
#%842498980017533687207488737127263878632351325165
#%1417470776692061999728212935155955339818386011391

#*High prevalence of glucose metabolism disturbance in patients with lichen planus
#@Muammer Seyhan,Hamdi zcan,Ibrahim Sahin,Nalan Bayram,Yelda Karincaolu
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1064928023040388217628737684049130464104158259834
#%1168344243588234407329200092312870501339306496557
#%1083761267421715889846545665593962648578138668870
#%469271326854164260006542443270656224179407294616

#*Hyperhomocysteinemia is associated with visceral adiposity in Japanese patients with type 2 diabetes mellitus
#@Takayuki Masaki,Futoshi Anan,Manabu Anai,Keiko Higuchi,Tetsuo Tsubone,Koro Gotoh,Seiichi Chiba,Isao Katsuragi,Katsuhiro Tanaka,Tetsuya Kakuma,Hironobu Yoshimatsu
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index428005768383268203936008128834655318378168449293
#%28473522500141627635670264798727946398700637558
#%285316938085478198761155047555012516117694981130
#%62502370273409718279596734020678468849737199774
#%1170735961639644429024175699167023736417577421947
#%177514801968040369097976486701164084734883445785
#%775406346647581929722452976148888800269632550504
#%1420936798300482831678452425531394016045143671933
#%1373938179062209385569422059451688067750590403973
#%649760285104154095895915048688433439738196636121
#%649760285104154095895915048688433439738196636121

#*Incidence of lipohypertrophy in diabetic patients and a study of influencing factors
#@Bahar Vardar,Sevgi Kzlc
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index377328669578125371483976519342002759835413661205
#%1237967305750547754940418100735385311154907973472

#*Aspirin inhibits the formation of pentosidine, a cross-linking advanced glycation end product, in collagen
#@P. Urios
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index439685945331709402092357854691445708886660476689
#%1308737538400170216433272275037331936916371614070

#*Impaired metabolismsecretion coupling in pancreatic -cells: Role of determinants of mitochondrial ATP production
#@Shimpei Fujimoto,Koichiro Nabe,Mihoko Takehiro,Makiko Shimodahira,Mariko Kajikawa,Tomomi Takeda,Eri Mukai,Nobuya Inagaki,Yutaka Seino
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index28003336490462022014279475110864435743284028544
#%169975748239322542778029434017258431304462443820
#%651872613766517365801873836487320885742261728293
#%1148700875388731650899427544887991630228491791988
#%532223215313051252671958585369803769348340789853
#%85101372191573518643187046729758488217693954947
#%896779027787898141378601374997664114967832649161
#%414716988019751264611108002657890580303501005181
#%1292285416273119008435963289576219116448030816377
#%1077439618906427229057874544573658826118889922642
#%561903558351791736159773088487891416914884109600

#*New evaluations of redox regulating system in adipose tissue of obesity
#@Jiyoung Park,Jun-Jae Chung,Bum Kim
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1268712974516972127109501025457955907541523776922
#%34090011534066248448035771136564561999544798148
#%205169039745300467496870712704008057169872861466
#%1365393296031390002748537034680903081503516722436

#*Role of adiponectin and adipocyte fatty acid binding protein in the metabolic syndrome
#@Kazuhisa Maeda
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index921345376409120128782902001079529289907394582514
#%983595616216243005869116938688063989690888163807
#%1347131148159653833870809454228854616978879559695
#%857242410680689497381988393770385841841071549629
#%1232501439374062361965134784980106293045174871350
#%1394055652255162434210799812258678576145528649893
#%92676474189339125975931902322124542819900614847

#*Cross-sectional association between BMI, glycemic control and energy intake in Japanese patients with type 2 diabetes
#@Hirohito Sone,Yukio Yoshimura,Sachiko Tanaka,Satoshi Iimuro,Yasuo Ohashi,Hideki Ito,Hiroaki Seino,Shun Ishibashi,Yasuo Akanuma,Nobuhiro Yamada
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1346924256388074356966639874881745484702764011716
#%387214988192954058198705784009966453553186294415
#%1366568076898090969905012930742914397583749264789

#*Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial cells
#@Yasuhiko Yamamoto,Hideto Yonekura,Takuo Watanabe,Shigeru Sakurai,Hui Li,Ai Harashima,Mar Myint,Mari Osawa,Akihiko Takeuchi,Masayoshi Takeuchi,Hiroshi Yamamoto
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index705856289231655874504800596639498283884405847533
#%455146157495938416671109713314053928741749796170
#%949115955900502927108086797128833622528529587760
#%666327856723659265309261198424206520171913034160

#*Impact of mitochondrial ROS production on diabetic vascular complications
#@Takeshi Nishikawa,Daisuke Kukidome,Kazuhiro Sonoda,Kazuo Fujisawa,Takako Matsuhisa,Hiroyuki Motoshima,Takeshi Matsumura,Eiichi Araki
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1276184297400336257751032277077807109148404577424
#%481570781244869144784002259840012820397148090045
#%136615243618364089170279399184929139973806344382

#*The modulating effects of the overexpression of uncoupling protein 2 on the formation of reactive oxygen species in vascular cells
#@Hye-Soon Kim,Keun-Gyu Park,Bon Koo,Seung Huh,In-Kyu Lee
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1363527213377320417427569353676380051631166285997
#%468419420771253672956937285040072858845231633125
#%1180144651645158119851324601257993938652977064289
#%497907889679487616420135674382308634537027512721

#*The role of GSK3 in glucose homeostasis and the development of insulin resistance
#@Jongsoon Lee,Myung-Sunny Kim
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index201728577943947602849648359913427869330056441581
#%811298333523360283386431159549640272388580978069
#%46472970973378968338572649636743302473676160763
#%267711179070210678255947206755006356692937114359
#%868933990388623207061821006010999794858067766070
#%307243509490747870073285061509971258680066939202
#%1429366612722518296537836996512430815270927436144
#%914610694626111096704151889990448279420909124243
#%359416862503854672273478931820403636435303851850
#%750418244019272597077930441957400282116489248771
#%882966885732066783986519299989681230167653123315
#%923677999978080934801546758725824499598705010100
#%263945316244845776437361295403772877055107613150
#%850591291213841910322423585190515693843977569902
#%287240510328655762758836585247589194495867354016

#*Glucose fluctuation on the progression of diabetic macroangiopathyNew findings from monocyte adhesion to endothelial cells
#@Hirotaka Watada,Kosuke Azuma,Ryuzo Kawamori
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index648003057019620018949679062742755453468631731322
#%483559785571578479349695764699463859240495738914

#*Novel role of erythropoietin in proliferative diabetic retinopathy
#@Hitoshi Takagi,Daisuke Watanabe,Kiyoshi Suzuma,Masafumi Kurimoto,Izumi Suzuma,Hirokazu Ohashi,Tomonari Ojima,Tomoaki Murakami
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1258050384326634605501899645580581875738446089611
#%1196568100140970470324782063841478186443019579626

#*Role of vascular reactive oxygen species in development of vascular abnormalities in diabetes
#@Man Son
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index491923147554360283708762012113214417783702230614
#%75448655685234757755086301179064344670715031828
#%825488010840441768398216731757171449718059503067
#%891470225367849775618824449963369433412189873147
#%301598472238600437238470668391335060040581376710
#%223486495510909793303109979215841576600672479479
#%558022538384860696911980026302020132541668904570

#*Current status of diabetes management in elderly Koreans with diabetes
#@Jung-Hyun Noh,Su-Kyung Kim,Young-Jung Cho,Hong-Uoo Nam,In-Ju Kim,In-Kyung Jeong,Moon-Gi Choi,Hyung-Joon Yoo,Yoo-Hun Ahn,Hak-Yun Bae,C. Jang
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index297503607547227275061467205168914549547737231641

#*Epidemiology of diabetes mellitus in old age in Japan
#@Tadasumi Nakano,Hideki Ito
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index713882284341591989778843478709502508031204592259

#*Present state of diabetes management in the elderly, Japan
#@Tomomi Fujisawa,Hiroshi Ikegami,Koji Nojima,Yumiko Kawabata,Shinsuke Noso,Katsuaki Asano,Yoshihisa Hiromine,Aya Fukai,Nobuyasu Shindo,Toshio Ogihara
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index518381825873321838768289122541241610729062021546
#%1367742372804159475110202842745898745234983117454

#*Clinical aspects of physical exercise for diabetes/metabolic syndrome
#@Yuzo Sato,Masaru Nagasaki,Masakazu Kubota,Tomoko Uno,Naoya Nakai
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index10631892067620642243943417605625516094773355112
#%562150060932838916786661865982619324770462029575
#%288097708770743419393073808430945307435332794847

#*Role of AMP-activated protein kinase in exercise capacity, whole body glucose homeostasis, and glucose transport in skeletal muscle
#@Nobuharu Fujii,M. Seifert,M. Kane,E. Peter,C. Ho,Schuyler Winstead,F. Hirshman,J. Goodyear
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1049580341060287580342512456148990254144162600868

#*Immunological aspects of fulminant type 1 diabetes
#@Masao Nagata,Hiroaki Moriyama,Reiko Kotani,Hisafumi Yasuda,Minoru Kishi,Midori Kurohara,Kenta Hara,Koichi Yokono
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index538877205531579866996305680456512821436336058375
#%1173073231577153117159583634687478874706840488048

#*Current aspects on the clinical immunology and genetics of autoimmune diabetes in Japan
#@Eiji Kawasaki,Katsumi Eguchi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1112820460041912410184798912120359062894051410648
#%1404401825097809215017684971991092855126766552358
#%106129192845100190994425469060920203237848506276
#%210510573789142386252114095784343801642877003292
#%307085351926955733886722551473612805956776260392

#*Functional evaluation of the type 1 diabetes (T1D) susceptibility candidate genes
#@Yongsoo Park
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1280945665969923841870927996552835608797318253272
#%939952663207005295339727640009048814808313685417
#%1197743928728669713238134661272957103348320968301

#*Genetics of type 1 diabetes in Asian and Caucasian populations
#@Hiroshi Ikegami,Yumiko Kawabata,Shinsuke Noso,Tomomi Fujisawa,Toshio Ogihara
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index912203533349026353147251418593097166535618593203

#*Functional association of the morphogenic factors with the clusterin for the pancreatic beta-cell differentiation
#@So-Yoon Kim,Song Lee,Bon-Hong Min,In-Sun Park
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index483537514783682319499973520738324756026640948931
#%397164069931639148962304598170407945946537894379
#%176217877597831789754298533710993185923492830827
#%207658922821732202939516345818740232903593921292

#*Role of PDX-1 and MafA as a potential therapeutic target for diabetes
#@Hideaki Kaneto,Takeshi Miyatsuka,Yoshio Fujitani,Hirofumi Noguchi,Ki-Ho Song,Kun-Ho Yoon,Taka-aki Matsuoka
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1144527340290780798547021009581098674971750501949
#%1086487247948018150004340816038063203735270213530
#%157789826903573207864436808943946059679937052617
#%777869369481148792073698301936702922915017252934
#%82524581165847084467227611682737443529708776083
#%552675794071570925192589527099542385151877525660
#%479386404185418996803920913775075180681513033343
#%550792833425664349495793583183598443305893684370
#%550792833425664349495793583183598443305893684370
#%776188835098405097439679052386069334563217936717

#*Both Pdx-1 and NeuroD1 genes are requisite for the maintenance of insulin gene expression in ES-derived differentiated cells
#@Koichi Saitoh,Eiji Yamato,Satsuki Miyazaki,Jun-Ichi Miyazaki
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1095760563855952821284138742681460394378768713760

#*Effect of aging on insulin secretory function and expression of beta cell function-related genes of islets
#@Sung-Hee Ihm,Ju Moon,Goo Kang,Young Park,Won Oh,Kyung Jeong,Yang-Seok Oh,Woo Park
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index322403232534030646009802363927196615412416671932
#%1270612852405498674831754035979211279061447508886
#%976068176192136882336057584258409215747801294710
#%351788550941394981498809867848626613231262266373

#*Insulin as a T cell antigen in type 1 diabetes supported by the evidence from the insulin knockout NOD mice
#@Hiroaki Moriyama,Masao Nagata,Takashi Arai,Yasuyo Okumachi,Katsumi Yamada,Reiko Kotani,Hisafumi Yasuda,Kenta Hara,Koich Yokono
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index394788470173482509051689300998295731473989796574
#%1318398826418307640501103436375405668008476975560
#%656297504206725722690336393817957288639069765989
#%734522658323183099191235193070267864682980213650

#*Impact of mitochondrial ROS production in the pathogenesis of insulin resistance
#@Takeshi Nishikawa,Daisuke Kukidome,Kazuhiro Sonoda,Kazuo Fujisawa,Takako Matsuhisa,Hiroyuki Motoshima,Takeshi Matsumura,Eiichi Araki
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index410503784008633614031143632203140492380895247519
#%281532077056456540458734078570662449814712362473

#*The depletion of cellular mitochondrial DNA causes insulin resistance through the alteration of insulin receptor substrate-1 in rat myocytes
#@Y. Park,Wan Lee
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index843398885423522473294039887211262786928397656380
#%1415153073861260342688797532374460909146710851989
#%1415153073861260342688797532374460909146710851989
#%1102725866507651866615686497111762649408459346013
#%769305863408275641156438501916262925078298814287
#%705612927513811702916054627133643624644909052345
#%779375242025999605816239383045649636789132789366

#*Genetic factors related to mitochondrial function and risk of diabetes mellitus
#@Min Cho,Soo Park,Kyu Lee
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index724544977252578074554708167809436943647922263727
#%828292118653387392827138341016926847601608395152
#%1415153073861260342688797532374460909146710851989
#%1415153073861260342688797532374460909146710851989
#%1241733702379598846314401879849948967700357516003
#%1241733702379598846314401879849948967700357516003
#%444788545308257266591867653658893710639906234604
#%23442536641819237181408492461757548819620048300
#%825745508895334987396537285937578187419349625845
#%1119801004925110225120598804937862992067453472631
#%873685488406986128405129721887278478584975444871

#*Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy
#@Hitoshi Yasuda,Mitsuru Sanada,Kanako Kitada,Tomoya Terashima,Hyoh Kim,Yoshio Sakaue,Masashi Fujitani,Hiromichi Kawai,Kengo Maeda,Atsunori Kashiwagi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index871095565394619334911915401178605577984989527055

#*Pathology and pathogenetic mechanisms of diabetic neuropathy: Correlation with clinical signs and symptoms
#@Soroku Yagihashi,Shin-Ichiro Yamagishi,Ryuichi Wada
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index350587444709900776762643105800405028413820914950
#%1324193400637151596032094877874779864828751032569

#*Advanced diagnostic methods of small fiber diabetic peripheral neuropathy
#@Sun Park,Sun Baek,Hyun Park
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index971537227836574603945209718803191668908109396733
#%860680440001058433092357904590396640424745082555

#*Educational program for diabetic patients in KoreaMultidisplinary intensive management
#@Suk Park,Woo Ahn
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1246572912458344904766789746563936135260639820399
#%700543556941930640882204839683510043582170238059

#*The present status of diabetes education and the role recognition as a diabetes educator of nurses in Korea
#@Jeong-Rim Lee,Soon-Ai Kim,Joo-Wha Yoo,Yang-Kyo Kang
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index182896074721781491299380601349920475167894301497

#*Certified diabetes expert nurse and nurse educators in Japan
#@Teruko Kawaguchi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index483714764570975491705199034909973614154889052669

#*Comparison of the alteration of the concentration of C-peptide in 24-h urine according to the combination patterns of hypoglycemic agents in type 2 diabetes patients
#@Chan-Hee Jung,Eun-Jung Rhee,Eun-Ran Kim,Se-Yeon Kim,Hun-Sub Shin,Won-Young Lee,Ki-Won Oh,Sung-Woo Park,Sun-Woo Kim
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1331506664415132131119738011671968122839382130994
#%129197594178879173581026860283166829779632608796
#%425828057905353603559942556467069859001913136443
#%491475007289661386521175319863316192471790359027
#%1353878295937440094315749124413900187213468734151

#*Factors responsible for the evolution of insulin resistance in Japanese type 2 diabetic patients: Association with atherosclerosis
#@Ataru Taniguchi,Mitsuo Fukushima,Yoshikatsu Nakai,Akira Kuroe,Michihiro Ohya,Minako Ohgushi,Yutaka Seino
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1407592854441407079224806526565219886869681022407
#%856537884140432138093842042156523599248953399383
#%1257587466316964849383643445711581818340645171001
#%211300411892540380311003802700905698950003682095
#%969524897769484743695608436852303125400079647950
#%711853556618862593765346030074619536470805651991
#%306104335156973371859748687530079124705626988473
#%1103512996948924459571281727227046823279474507536

#*Analysis of waist circumference in Japanese subjects with type 2 diabetes mellitus: Lack of propriety to define the current criteria of metabolic syndrome
#@Yukiko Kanda,Masafumi Matsuda,Sumiko Hamamoto,Fumiko Kawasaki,Ko Kotani,Michihiro Matsuki,Kohei Kaku
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1379183407291503808690255497917857730596483225976

#*Increase of visceral fat area in Indonesians and Japanese with normal BMI
#@Yoko Fuke,Shuichi Okabe,Naemi Kajiwara,Ketut Suastika,A.A.G. Budhiarta,Satoko Maehata,Hiroshi Taniguchi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index341865917330001682520192931905390937272783092172

#*Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients
#@Mi-Kwang Kwon,Youl Rhee,Suk Chon,Seungjoon Oh,Jeong-taek Woo,Sung-Woon Kim,Jin-Woo Kim,Seol Kim,Kyung-Hwan Jeong,Sang-Ho Lee,Tae-won Lee,Chun-Gyoo Ihm
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1057404291913662070394709595680718457828268233203
#%348230081727467246817117407930075527581185420427
#%1437206680708161502922633694646059397917765576225
#%856958288715892556604662099883820028817411925355
#%405197976008435173983818520862713058992932711379
#%1079443792446999460553112031980710707635786271266
#%123486495466674158660287294181899312387343710578

#*Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome
#@Ra Park,Youngju Choi,Hye-Jin Lee,Jee-Young Oh,Sun Hong,Yeon-Ah Sung
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index695706058975233497934361809338558870713837557026
#%1000082656771179692198007002470706183419305898998
#%938874772194679738327342714744121823200358061102

#*N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction
#@Ji-Youn Kim,Young Lee,Jae-Hwan Jee,Byung-Wan Lee,Hoon Chung,Suk Jeun,Yong-Ki Min,Myung-Shik Lee,Kwang-Won Kim,Moon-Kyu Lee
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1255297293536431227221476177180713235571476425385
#%219951068730247266634539337525842782639940543841
#%732593315601066099809664876324550327152824383172

#*The metabolic syndrome in young Korean women with polycystic ovary syndrome
#@Ra Park,Youngju Choi,Hye-Jin Lee,Jee-Young Oh,Sun Hong,Yeon-Ah Sung
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index959150442440309987980749979154111146524707875156
#%52439518098016693151505092801328252795372188739

#*Effect of pinitol on glucose metabolism and adipocytokines in uncontrolled type 2 diabetes
#@Jin Kim,Ha Yoo,Hoon Kim,Tak Seo,Wook Ha,Hyun Kho,Goo Shin,Hee Chung
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1158147647137912186423750508938081206953573557101
#%820850163893555247914992177750520969250724639548
#%192774302162940699986676572204058850835924938553

#*Clinical characteristics of Korean type 2 diabetic patients in 2005
#@Jung Kim,Eun Song,Ji-Won Park,Keun Cho,Kwan-Woo Lee,Bum Huh
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1372221882801798911676388375614667544068232097697
#%390371137728887586911880288885235639516434221172
#%390371137728887586911880288885235639516434221172
#%672923644847167173082080713137925210327799704657

#*Effect of insulin sensitivity on severity of heart failure
#@Hitoshi Adachi,Tomio Ohno,Masato Oguri,Shigeru Oshima,Koichi Taniguchi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index633746380315524619910624922347424915597587971058
#%716377092009299480259221683290533471879354536630
#%716377092009299480259221683290533471879354536630
#%883082590729858502639408528860902347881021156652
#%1022614393863146066222035922334418887345104611855
#%1336901763124372917368136122614935540245503065572
#%1122624300265500036596522483352875369180428071055

#*RETRACTED: A long-term effect of epalrestat on motor conduction velocity of diabetic patients: ARI-Diabetes Complications Trial (ADCT)
#@Kempei Matsuoka,Nobuo Sakamoto,Yasuo Akanuma,Nigishi Hotta,Motoaki Shichiri,Takayoshi Toyota,Yoshitomo Oka,Ryuzo Kawamori,Yukio Shigeta
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index335840373010803133567247653923759546136537234955

#*Negative and positive feedback regulation of insulin in glucose-stimulated Ca 2+ response in pancreatic beta cells
#@Sung Hee-Park,Bora Lim,Won-Ki Baek,Jae-Hoon Bae,Dae-Kyu Song
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1333749794882816091671571092854496662510504180230
#%165236662389920821273649377441619107410099053764
#%152995150126559920292976317523848718331273286010
#%152995150126559920292976317523848718331273286010
#%1257349581991308882482038627310256119895624490840
#%986264763171242423763815759594104738416471142198

#*Survey of dietary habits in obese patients with type 2 diabetes treated with either OHA or insulin injections in Japan
#@Yasuko Uchigata,Yasuhiko Iwamoto
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index438946965147566780927632716103932193394002799620

#*The effects of Danggui-Buxue-Tang on blood lipid and expression of genes related to foam cell formation in the early stage of atherosclerosis in diabetic GK rats
#@Hongmin Zhang,Shiwei Chen,Xifang Deng,Xuguang Yang,Xi Huang
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1377728298927261415305538593256521917036433139019
#%53717690190400100176353993379993722147259730321
#%1022535936393508785227822799082676531457185428903

#*Corrigendum to A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects [Diabetes Res. Clin. Pract. 77 (2007) 151154]
#@Munehide Matsuhisa,Yoshimitsu Yamasaki,Masanori Emoto,Michio Shimabukuro,Shinichiro Ueda,Tohru Funahashi,Yuji Matsuzawa
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index463144757795625909041428303312343871863114747024

#*Estimation of influence of gastric emptying on shape of glucose concentrationtime profile measured in oral glucose tolerance test
#@Ladislav Dedk,Mria uriov,Adela Penesov,Daniela Mikloviov,Martina Tvrdoov
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index957671159255481858477406145225414912209734861475
#%739978808208198986331523821875391168092446127161
#%348719254888406802700041555770080188286663972059

#*Haptoglobin polymorphism and diabetic retinopathy in Brazilian patients
#@P.A. Wobeto,T. Rosim,B. Melo,P Calliari,Ftima Sonati
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index945626711729087404540731305473486517213664106708
#%1150284805627011368930584849180530287370518470057

#*Early and late onset side effects of short-acting insulin analogue in seven Japanese diabetic patients
#@Akira Kuroe,Ataru Taniuguchi,Mitsuo Fukushima,Yoshikatsu Nakai,Minako Ohgushi,Michihiro Ohya,Yutaka Seino
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index853801911577853119655313276168408852357906196074

#*Comparison of different methods to assess body composition of weight loss in obese and diabetic patients
#@P. Ritz,A. Sall,M. Audran,V. Rohmer
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1300305714575751056862435049110616105308985043831
#%177643363650594658101491792962264404858188324488

#*Gestational diabetes mellitus manifests in all trimesters of pregnancy
#@V. Seshiah,V. Balaji,S. Balaji,A. Paneerselvam,T. Arthi,M. Thamizharasi,Manjula Datta
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1353240000207297255461923972303605558783872218691
#%951346678248064778510684062381229795620586493366
#%951346678248064778510684062381229795620586493366

#*Type 2 diabetic patients attending a nurse educator have improved metabolic control
#@F. Scain,L. Santos,Rogrio Friedman,L. Gross
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index827556674273760409977999482754550798774318570894

#*Awareness about diabetes and its complications in the general and diabetic population in a city in southern India
#@N. Murugesan,C. Snehalatha,R. Shobhana,G. Roglic,A. Ramachandran
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1127606418944726163441687181544380694207525777034

#*Incidence of critical limb ischemia and amputation outcome in contralateral limb in diabetic patients hospitalized for unilateral critical limb ischemia during 19992003 and followed-up until 2005
#@Ezio Faglia,Giacomo Clerici,Manuela Mantero,Maurizio Caminiti,Antonella Quarantiello,Vincenzo Curci,Alberto Morabito
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1137402035633338915049851488238812571410856544271
#%33342989994577321740211982935617401424807533831
#%1111984344881471904815608409635823147939715209575
#%903495506477675560405026948366438471888641788078
#%14811552405869803050601379820104133931869058457

#*Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice
#@Vivencio Barrios,Carlos Escobar
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index431752256122032695473796047490817132922494481159
#%765651525113461344560227359192055000876711516622
#%583136685607995677126304053148153695861661274149
#%87060303653826920792295124888285597661949196777

#*Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among U.S. adults aged 40 or older
#@W. Gregg,Qiuping Gu,Desmond Williams,Nathalie Rekeneire,J. Cheng,Linda Geiss,Michael Engelgau
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index957105689480149996380266088945947400615831292096
#%593042637009300427299012652370141156292339790676
#%121356830126059455389186768712768588524338132372

#*Association between high levels IL-8 and Staphylococcus aureus-specific IgA antibodies in subjects with type 1 diabetes mellitus from Argentina
#@S. Satorres,L. Alcaraz,S. Genaro
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index881579411669187340618592198212641683557783225181

#*Sulfonylurea and glinide reduce insulin content, functional expression of K ATP channels, and accelerate apoptotic -cell death in the chronic phase
#@Akira Takahashi,Kazuaki Nagashima,Akihiro Hamasaki,Naomitsu Kuwamura,Yukiko Kawasaki,Hiroki Ikeda,Yuichiro Yamada,Nobuya Inagaki,Yutaka Seino
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index439401970437257455988376806745012233668450287464
#%251685784886341145524095343901135008676799132624
#%172237707133229649359497821067130552893197434868
#%172237707133229649359497821067130552893197434868

#*Effect of pioglitazone on atherogenic outcomes in type 2 diabetic patients: A comparison of responders and non-responders
#@Masahiko Igarashi,Yumi Jimbu,Minako Kimura,Akihiko Hirata,Hiroshi Yamaguchi,Makoto Tominaga
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1024560845297934989925757260808245267760918764801
#%1438361308239152205343302480156715263383345379538
#%697999729707112882035165415974075911916741613288
#%534283620449794657856606017370357452206898077298
#%750039497862421493910878516312725479833565690205
#%254707813408690908515029585228958584717578537708
#%259225173713287506800010730665893143524608005266
#%1370197991314820389164480363831766230117168745644
#%699008661639445086996291908605820988049825700408

#*Correlations of urinary albumin excretion and atherosclerosis in Japanese type 2 diabetic patients
#@Futoshi Anan,Takayuki Masaki,Yoshikazu Umeno,Naoya Fukunaga,Yasushi Teshima,Tetsu Iwao,Koji Kaneda,Hidetoshi Yonemochi,Nobuoki Eshima,Tetsunori Saikawa,Hironobu Yoshimatsu
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index583201749174093039236684932786174879676467683593
#%635894664578588444100407649163603459372962459637
#%1310564006108690170254597413910550252616292304899
#%1438361308239152205343302480156715263383345379538
#%237769300452252787810824693246791056522161252264
#%851817410589523825178658772986072365885578143050
#%1457799931337899971143820000336406403623271496215
#%1124561780262374287465320601351379872096328102786
#%52547857183752011841764951056945089582186573981
#%635537591431592051149384823804851093432715879649

#*Effect of camel milk on residual -cell function in recent onset type 1 diabetes
#@P. Agrawal,Sanjay Saran,Poornima Sharma,P. Gupta,K. Kochar,S. Sahani
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1258795265841826073488401715723526029696104355079
#%904007014485140206678939047331532731708618456080
#%806676572955982944760341710132261852890570058371

#*Diabetes risk score in Oman: A tool to identify prevalent type 2 diabetes among Arabs of the Middle East
#@J.A. Al-Lawati,J. Tuomilehto
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index631612601811352992178146197004509176967429294554
#%530742815982948056355266956550925744819808900472
#%504715455000031665147760194551861597104499414188

#*Glutathione suppresses increase of serum creatine kinase in experimental hypoglycemia
#@Zhongli Jiang,Masahiro Kohzuki,Taku Harada,Tokutaro Sato
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index570465820724117672695680659765569794875610440887
#%934105973843859774778617741243586618558363482110
#%1266919267126710625116148075616142983336871737861

#*Oral pioglitazone administration increases food intake through ghrelin-independent pathway in Zucker fatty rat
#@Yukie Saitoh,Runhua Liu,Hiroaki Ueno,Masanari Mizuta,Masamitsu Nakazato
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index677893735989370953666818964240322382233305661724
#%1417977441475778283261429425636460795354448786062
#%1299720499938494054769130046250291217935018567732
#%1307001737455193541330742693248184110448912716119

#*Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes
#@Klaus-Dieter Kohnert,Petra Augstein,Peter Heinke,Eckhard Zander,Karolina Peterson,Ernst-Joachim Freyse,Eckhard Salzsieder
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index184345863281573025258448210771500662598817344714
#%1187471108648378252552230481879859805920635609369

#*Can plasma glucose and HbA1c predict fetal growth in mothers with different glucose tolerance levels?
#@A. Lapolla,M.G. Dalfr,M. Bonomo,M.T. Castiglioni,G. Cianni,M. Masin,E. Mion,R. Paleari,C. Schievano,M. Songini,G. Tocco,L. Volpe,A. Mosca
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1395844524419465877465635594972154437971560499999
#%214328230319322044322901641316379935090278975810
#%15339542770279045065937640666745115698634453831
#%920797495405598589342300880865607165533838458466
#%1355523126139526722897727659472809492088447184386

#*The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers
#@Kazuo Inoue,Masatoshi Matsumoto,Yasuki Kobayashi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index730072577305037262807955773466283663531940931443
#%974336857708287472466838010914690946810799194571
#%481570781244869144784002259840012820397148090045
#%956404848503341552112419567476517275928482514411

#*Erythrocyte susceptibility to oxidative stress and antioxidant status in patients with type 1 diabetes
#@Mohsen Firoozrai,Mitra Nourbakhsh,Maryam Razzaghy-Azar
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index141013111166932315228516814762552829783165232321
#%455872403806859641099069728046553628824642226785
#%1253505749329293583968028398067230838746690123084
#%1026818997121080994370492579573276348585469454487
#%1261446058673288221610596657737298167397909849770

#*The Metabolic Syndrome in Australia: Prevalence using four definitions
#@J. Cameron,J. Magliano,Z. Zimmet,Tim Welborn,E. Shaw
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index66865259309889545584907194121638472402515008997
#%608027367961477215758757976231510100673358964715
#%658041026980849672884350471099324117015220897750
#%1186501341515059391140442800919395799048423877293
#%345114337583328306212236429146494231285266012720

#*Study of iron metabolism disturbances in an animal model of insulin resistance
#@Guillaume Guenno,Emilie Chansaume,Marc Ruivard,Batrice Morio,Andrzej Mazur
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index700301870688818858430457870964505768752795461311
#%1378162553475414068835525540163659637429120745056
#%230958944574761805741002396395616824100530195037
#%122529425045731222859445308225058697669874461867
#%988927288424421807630185781856586469665604122556

#*Using common clinical data improves the prediction of abnormal glucose tolerance by the new criteria of impaired fasting glucose: Tehran lipid and glucose study
#@F. Hadaegh,H. Harati,A. Ghasemi,M. Tohidi,A. Zabetian,Y. Mehrabi,F. Azizi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index597094394382311199554111259596402199372598177702

#*Prevalence of GAD autoantibodies in Brazilian women with previous gestational diabetes
#@B. Ferraz,S. Motta,M. Capibaribe,Herbster Ferraz,R. Chacra,C. Forti,A. Dib
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1111528658046335328873851527929782532956602355124

#*Morphometric study of placental villi and vessels in women with mild hyperglycemia or gestational or overt diabetes
#@M.P. Calderon,C. Damasceno,L. Amorin,A.A. Costa,A.M. Brasil,V.C. Rudge
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1258887570847571715891709737392897207879171292342
#%483951525806017469350338287438668718002138286038
#%280815298819075638719074406710979237492684214522
#%856648946768878127180443888666084957264378026455
#%299298803679940823377264385414461903470485816240
#%181211210953412017111842230994487233508646720981
#%133546798629881004221294644162147293766708052289
#%206028774516969340525970384824688230428876052358

#*Stem cells therapy for type 1 diabetes
#@Ping L,Fang Liu,Lei Yan,Tao Peng,Tao Liu,Zhong Yao,Chun-You Wang
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index614683917261363569803991906877378936954982453642
#%18345574307640700433408202397994420413251061178
#%270586827792899706587642056092721189225660134546
#%493494582358506831205748482988814007784123126741
#%1186319214814339262566230011087577972029576232251

#*Individualized pharmacokinetic risk assessment for development of diabetes in high risk population
#@N. Gupta,N.H. Al-Huniti,P. Veng-Pedersen
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index288606747946738025930866085671100535988638164573
#%1298888924721350131033295591530302217923025041749
#%1088587051995613423685866763403957849463063264378

#*Emphysematous pyelonephritis in diabetes mellitusA series of five cases
#@A. Ganie,R. Masoodi,A. Laway,A. Misger,I. Wani,I. Bashir,H. Zargar
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index50160168579319311688003470112097231587232106230
#%1371554822112846353984383146886073062699465170168

#*Sildenafil citrate diminishes microalbuminuria and the percentage of A1c in male patients with type 2 diabetes
#@Fernando Grover-Pez,Geannyne Rivera,Ral Ortz
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index867120727841024074083834639793113055380635756343
#%983543244500727674769444515554309784558777343957

#*The effects of a patient-based risk assessment prompt on diabetes screening
#@M. Boltri,Paul Seale,S. Okosun,Andrew Ouzts,Monica Cornelius,Monique Davis-Smith
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1358659568164559479625739048682212648353351364958
#%352020927889891277818177755838864346038334164052

#*Relationship between smoking, white blood cell count and metabolic syndrome in Japanese women
#@Nobukazu Ishizaka,Yuko Ishizaka,Ei-Ichi Toda,Ryozo Nagai,Kazuhiko Koike,Hideki Hashimoto,Minoru Yamakado
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1101927679205946257681092212303909203392260733188
#%243436552734739657963075245289481699762806756344
#%671941576031416921482792938762135343658773472603
#%1172613238896852218626690456354931163675939775873
#%94747255325700946774407657765785844721935866914
#%94747255325700946774407657765785844721935866914
#%803567093376657037661469811399770135802291454729
#%803567093376657037661469811399770135802291454729
#%1012529261024223491089503166008299198465523718638
#%795307244131653661035270571012565318554678460458
#%795307244131653661035270571012565318554678460458

#*Prevalence of metabolic syndrome and optimal waist circumference cut-off values in Japan
#@Rimei Nishimura,Tomoko Nakagami,Makoto Tominaga,Nobuo Yoshiike,Naoko Tajima
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1326084201975187210229616475103365770080321128447
#%417766593200355128364595364000005086684040970422

#*The association between urodynamic findings and microvascular complications in patients with long-term type 2 diabetes but without voiding symptoms
#@Alireza Esteghamati,Armin Rashidi,Abolghasem Nikfallah,Amir Yousefizadeh
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index978618581696190521914461131408994856575302930650
#%415941819516885316874785117631868276076082490105
#%124928379554183979087199320229444027111549382663
#%1234664727078846597110161744424551553653651624525

#*A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients
#@L. Pala,E. Mannucci,I. Dicembrini,C.M. Rotella
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index984049842362139656266621984915673974009256256637
#%1130855455022599916486289947929244017018493585310
#%1278277632447244488281770435706842732643091016225

#*Fibrillogenic amylin evokes the apoptosis of human mesangial cells
#@Ai Peng,Zhi-Hong Liu,Hong Zhou,Mao-Yan Zhu,Lei-Shi Li
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index105811699276512598436116323067911972519106700082
#%1344780690794789586448404417661144737207045629275
#%1355243980956572609593818790318140985000211611801

#*Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients
#@Masahiro Ohira,Yoh Miyashita,Mariko Ebisuno,Atsuhito Saiki,Kei Endo,Nobukiyo Koide,Tomokazu Oyama,Takeyoshi Murano,Hitoshi Watanabe,Kohji Shirai
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index87702758402841997216139687649622788881513552258
#%268244054245578324897183826810548946850466728245
#%955988395618588331045131275253074690220070780608
#%943445413929490291105051608164037760300465308310
#%1058441079563236832905811800951353762257647838949
#%1286454733799329683626275240252906987892290006361
#%437122232503439444345823446866446773323197123004
#%1347131148159653833870809454228854616978879559695
#%233838377957685430048803818125205676416323623334
#%502869652952229164704057158439463852104591939936

#*Elevation of serum adiponectin and CD146 levels in diabetic nephropathy
#@Takako Saito,Osamu Saito,Takahisa Kawano,Hiroyuki Tamemoto,Eiji Kusano,Masanobu Kawakami,San-e Ishikawa
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index768558136642982657406714316850142372794894345564
#%1347131148159653833870809454228854616978879559695
#%1034916667461373835664848983124742256636116897206
#%528133368890541850301612499763181496041298437299
#%255712721746095296719931785283761993281941039691

#*Quality of diabetes care in Saudi Arabia
#@Mohsen Eledrisi,Buthina Alhaj,Rifat Rehmani,Munera Alotaibi,Mahmoud Mustafa,Daad Akbar,Shadia Matboli
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index851420050272931600514306778163463224696810205188

#*Co-morbidity, functionality and time since diagnosis as predictors of physical activity in individuals with type 1 or type 2 diabetes
#@C. Plotnikoff,Sonia Lippke,Nandini Karunamuni,Neil Eves,S. Courneya,Ronald Sigal,J. Birkett
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1226920500451588498022665897662306879715653851274

#*C-reactive protein and features of metabolic syndrome in Brazilian women with previous gestational diabetes
#@B. Ferraz,S. Motta,Lousada Ferraz,Moreira Capibaribe,C. Forti,R. Chacra
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index977992663128440885343113632307618624652664670234
#%97864553377708666547293183294096565990347374228
#%564461314931590743749585083887418615279865055764
#%1299132414953617378733412174120815819955689190808

#*Normal mortality in the elderly with diabetes under strict glycemic and blood pressure control: Outcome of 6-year prospective study
#@Masafumi Katakura,Motoji Naka,Teruki Kondo,Mitsuhisa Komatsu,Keishi Yamauchi,Kiyoshi Hashizume,Toru Aizawa
#year2007
#confDiabetes Research and Clinical Practice
#citation1
#index728377781294257035906633180871949308823755211429
#%481570781244869144784002259840012820397148090045
#%701226865595645657133035320955597158247442795124
#%848446097154446515550684321677004412865285362948
#%848446097154446515550684321677004412865285362948
#%728377781294257035906633180871949308823755211429

#*Increased fat absorption and impaired fat clearance cause postprandial hypertriglyceridemia in Spontaneously Diabetic Torii rat
#@Tomohiko Sasase,Hisayo Morinaga,Hiromi Yamamoto,Naoto Ogawa,Kenichi Matsui,Katsuhiro Miyajima,Takashi Kawai,Yasuko Mera,Taku Masuyama,Masami Shinohara,Takeshi Ohta,Mutsuyoshi Matsushita
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1376684341175744440905360949359884112536929668589
#%1291573163104079293177596234591617643328052147
#%1173073231577153117159583634687478874706840488048
#%45093039583750091049673856147511063173870831239
#%116218535061975858199340050720589851829439004892
#%885373117259177813753350503621357736771224216544
#%57195477506275087218375324629476907730888733297

#*Strengthduration properties in diabetic polyneuropathy
#@Deniz Yerdelen,Filiz Ko,Hilmi Uysal,Yakup Sarica
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1034799276558212326679987633255882587122979693764
#%928170898780260785018232161941660725422341425911
#%1282743469921103568851642271136609112567890139173
#%396970631896614524176750794598548259537132925179
#%1312681548493942945395646877819236120903977513225

#*The additional prognostic power of diabetes mellitus on coronary flow reserve in patients with suspected coronary artery disease
#@Attila Nemes,Tams Forster,L. Geleijnse,Valentina Kutyifa,Klra Neu,I.I. Soliman,J. Cate,Mikls Csandy
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index842011661470410161858543209775988601710490893945
#%169273890558470736756026120431986442128778382990
#%280985046597763502189391953610274036842032099020
#%589765595514293158147458685514226442155822752824
#%684738073059108836770205874236558372131544624784
#%498288739452911381326884147755931365799106302079
#%344247764826847621444569407512940300304523766402

#*Glycated albumin is low in obese, type 2 diabetic patients
#@Yumi Miyashita,Rimei Nishimura,Aya Morimoto,Toru Matsudaira,Hironari Sano,Naoko Tajima
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1096582618964600867120239590419758540307404945421
#%576014543183933311782298797543626940218279865244
#%516063374164972390407511519209867235309995594236

#*Diabetes and exercise-induced hemodynamic responses
#@Patrice Brassard,Paul Poirier
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index520886711721079327607249266298121452746145942134
#%221131734211822758093226907569994515051048438506
#%1156438429490184843085251751349565267004785937592
#%717160730038455869044635050073054352631913640118

#*Gender differences in the relationship between percent body fat (%BF) and body mass index (BMI) in Japanese children
#@Aya Morimoto,Rimei Nishimura,Hironari Sano,Toru Matsudaira,Yumi Miyashita,Takako Shirasawa,Shotaro Koide,Eiko Takahashi,Naoko Tajima
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index212722477460632743501358533569710573498957338966
#%576014543183933311782298797543626940218279865244
#%33134122640333840335717024352748233409831572114
#%671322481838068678728570897420112930403180628033
#%386496997161184264935864191597417802455999302077

#*Coefficient of variation of RR intervals in electrocardiogram is a sensitive marker of anemia induced by autonomic neuropathy in type 1 diabetes
#@Takatoshi Saito,Katsuyoshi Tojo,Rimei Nishimura,Shigeru Kageyama,Naoko Tajima
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index873233084253940735241513922594777901361689851472
#%1383618093254241189117602900585504378029570379337
#%1023537988430171942858711627888127549829337845409

#*Administration of miglitol until 30 min after the start of a meal is effective in type 2 diabetic patients
#@Kazutaka Aoki,Akinobu Nakamura,Satoshi Ito,Uru Nezu,Tomoyuki Iwasaki,Mayumi Takahashi,Mari Kimura,Yasuo Terauchi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index534679800657190500139226397851286356846557695629
#%530742815982948056355266956550925744819808900472
#%1235526062920225338923957537271161738236072578508
#%580633537887075702181559226369831613451120755151

#*Perturbation of erythrocyte antioxidant barrier, lipid peroxidation and protein carbonylation in non-diabetic first degree relatives of patients with type 2 diabetes
#@V. Sathiyapriya,N. Selvaraj,Zachariah Bobby,Aparna Agrawal
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1396955702489409750038964254210161675193823842451
#%632499296179317867733802994218554336538891686351
#%1337997533185622287259350041676653095829533144807
#%513610769457918019659886523590357143456036496309
#%508227104004016396550355242134076029369983032173

#*Relevance of casual undetected hyperglycemia among high-risk individuals for developing diabetes
#@Bernardo Costa,Jess Vizcano,Llus Piol,Josep Cabr,Mara Fuentes
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1353362385981631848214882760045911401878981819608

#*Diabetes team consultation: Impact on length of stay of diabetic patients admitted to a short-stay unit
#@J. Puig,A. Superva,M.A. Mrquez,J. Flores,J.F. Cano,J. Gutirrez
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index712800279964403685953818307179506427258283590973
#%173430597232584187095923117536148243016064792635
#%1376393917079779352645846909558464232972646638801
#%20974908667366551872942389171008465367644595653

#*Lifestyle factors and incident metabolic syndrome
#@Tom Wilsgaard,K. Jacobsen
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1187323880787148387984466964864025916395776633683
#%746326370605751462996893634183664272680540961713
#%1380784471642225322295358251208789382080299916988

#*Effect of age, degree and distribution of adiposity on the prevalence of the metabolic syndrome in a cohort of obese Italian women
#@Alessandro Sartorio,Fiorenza Agosti,Fulvio Adorni,Franca Pera,L. Lafortuna
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index930199817071385370027210499190831691939519741892
#%63727780791979031568253413858289357393887786201
#%62502370273409718279596734020678468849737199774
#%326985759915143411245311583153438781566095278008
#%1270612852405498674831754035979211279061447508886
#%989454431439055939634299683570688809345427654104
#%75443533392391994140659518095863259317092388412

#*Cardiovascular disease risk prediction in type 1 diabetes: Accounting for the differences
#@Kristine Ruppert,S. Roberts,J. Orchard,C. Zgibor
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index663501753131419940438149704679470670996059841598
#%862657679846278038580576167863191047286304090527

#*Carotid intima-media thickness in patients with liver cirrhosis associated with diabetes mellitus
#@Miho Tamura,Yasuyuki Kihara,Makoto Otsuki
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1198244044689844076180290951947251759156336914900
#%170530705379996803102866393793503564509299977100
#%562129837445800806418274866964614856830543215446
#%903548805523140709378225339757870072023912580987
#%1317480685467673913401496544048866222752567004179
#%1418969487390140330820473847720339390603904673362
#%1315083396092820207936662882722576577794146315244

#*Insulin glargine in enteric tube feeding
#@Gloria Marchetti,Manfredi Tesauro,Nicola Daniele,Rosa Bollea,Renato Lauro,Aldo Bertoli
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index391117046835282342652835371753318175448620335025

#*Low rate of screening for gestational diabetes mellitus in region Centre, France
#@Franois Maillot,Charles Couet
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1129169602398187702144236651422849822620477818044
#%311585495731536091503021021014570502314669531603

#*Relationship between proinsulin-to-insulin ratio and advanced glycation endproducts in Japanese type 2 diabetic subjects
#@Yoshifumi Saisho,Taro Maruyama,Hiroshi Hirose,Takao Saruta
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index742173805305240786412973320227273033176521415335
#%243918680168621269427377268322242782384698781382
#%1395630271754904249740095945737723130555340648689
#%660134182187421808855332383965528837562407567349
#%852884898843127552641428724668915286251709100892

#*Beer ethanol consumption and plasma homocysteine among patients with type 2 diabetes
#@Hidenari Sakuta,Takashi Suzuki,Teizo Ito,Hiroko Yasuda
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index533638400577051882751453953980602581097112393717
#%731879245835583146327200349484153149054454886557
#%1364799555434526253296485961534695455975854484743

#*Monocyte chemoattractant protein-1 promoter 2518 polymorphism is associated with post-challenge insulin and glucose levels in non-diabetic Japanese subjects
#@Noriko Maruyama-Furuta,Yutaka Yano,C. Gabazza,Mina Suematsu,Kazutaka Matsumoto,Hajime Akatsuka,E. Bruno,Rika Araki,Akira Katsuki,Yasuhiro Sumida
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index131605612568937257580463371550826011838397518356
#%889374908328622735820677564906740261594558117072

#*Relationship between Apolipoprotein E polymorphism and nephropathy in type-2 diabetic patients
#@Elba Leiva,Vernica Mujica,Isabel Elematore,Roxana Orrego,Gonzalo Daz,Mara Prieto,Miguel Arredondo
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1454735602406884850931279834348015944440268301890
#%348230081727467246817117407930075527581185420427
#%469260224567105733999936506787307516399426882738

#*Pregnancy outcome in gestational diabetes mellitus: Continued risk related to FBS levels
#@Jasbinder Kaur,Shivani Jaswal
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index769014396941835248052826361104763475123149574670

#*Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetes
#@Cristina Bianchi,Giuseppe Penno,Francesca Pancani,Alessia Civitelli,Alberto Piaggesi,Francesco Caricato,Giovanni Pellegrini,Stefano Prato,Roberto Miccoli
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1168746772146962965252726631191764586513764488938
#%640598302626297979896453158337577887599163958319
#%449257797695563277966023645265877616802934854444
#%1426243186614138028453684909556305521170974393188
#%690655494515084844752324213609763188112030774105
#%621930068743800434330787487750861690552494893092
#%1404519061143256576623647384998072816115756334437
#%1208406324434549231881422941018378844761906673502

#*Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: The Canadian INSIGHT Study
#@Robyn Houlden,Stuart Ross,Stewart Harris,Jean-Francois Yale,Luc Sauriol,C. Gerstein
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1223233905761656090765928906726754137677495278040
#%68914550848559778514845464711226135156998489072

#*Type 2 diabetes and impaired glucose tolerance in aboriginal populations: A global perspective
#@H.Y. Yu,Bernard Zinman
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index410461435904805580979497922458378530292878706418
#%1403115023187165812052239110518077933373535832410
#%63054821013796211110519383969823604828797582210
#%63054821013796211110519383969823604828797582210
#%545028829766022470157045363302735271464087167232
#%1322479360721928955152711358322662653878553360798
#%166650011619127948929247527987898898362991996350
#%291292171861063633240929376194774285827612884826
#%1435214536368794324485411259950707387470387748249
#%30913883272283493229541174558772341431003478239
#%478767215958640308781609923404279538052957414516

#*Insulin's 85th anniversaryAn enduring medical miracle
#@Simon Heller,Plamen Kozlovski,Peter Kurtzhals
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index44269635533991527565924215102363708675334520966
#%1169293796816107314381672818036363250941017341287
#%1421651075179194101300850237679188581600237478841
#%1254316073187794332842042293119941405435219375400
#%1254316073187794332842042293119941405435219375400
#%171724944647105793207246368384713453489278140657
#%377940409489454389203124258126310877493330981019
#%647207352993700572949540616003108104467853498106
#%409626656069243571600726781225249831553175469072
#%1123334957213657420038230434085859517859619424120
#%1146984969964178064341892068427764115581067166649
#%1340958318977983575319083360676197887238994092123

#*Ethnicity and young age influence the frequency of diabetic ketoacidosis at the onset of type 1 diabetes
#@Melanie Rodacki,Dantas Pereira,Nabuco Oliveira,Bianca Barone,Mac Dowell,Paula Perricelli,Telles Bravo,Miranda Oliveira,Dias Brum,Camara Belem,Guimares Ornellas,Szundy Berardo,Jorge Luescher,Ludmila Campos,Menezes Vangelotti,Rosane Kupfer,Lenita Zajdenverg,Adolpho Milech,Paulo Oliveira
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index816487304372354908435503100335461179187047511004
#%617376061506811043062097633370221910876366980939
#%1069258339605769266138261601953478156252418815017
#%889923740193043015076273459006991200299749370279

#*Glycemia and inflammatory markers in acute coronary syndrome: Association with late post-hospital outcomes
#@Tolledo Maciel,Campos Pellanda,Lucia Portal,DAgord Schaan
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1415076326082384937409391741580811559705573742052
#%1449005384960677540707614895751154616790243102417
#%257283614297475919200171781414552262782901127002
#%1049907657240994786236608100666786834383569129681
#%950346808113313538746489663499927115215462530179
#%1452024137376570560362789532478525241547705616797

#*Early manifestation of cardiovascular disease risk factors in offspring of mothers with previous history of gestational diabetes mellitus
#@Hoon Lee,C. Jang,K. Park,H. Cho
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1276766701594175737292104450415929619140843221481
#%1368465599411094239459691350067821036267419817712
#%993136193610658257971946210958427840193276957584
#%1021052704848185434531626359148721218984978292227
#%915727653060471346180239381537417559200085268162
#%61299554131210008080540929840920626788287584334

#*Nodular glomerular lesion: A later stage of diabetic nephropathy?
#@Du Hong,Tang Zheng,Shao Jia-qing,Wang Jian,Liu Zhi-hong,Li Lei-shi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1228964372265955158295793103406023801679233067230

#*Prevalence of the metabolic syndrome in Peruvian Andean hispanics: The PREVENCION study
#@Josefina Medina-Lezama,Humberto Zea-Diaz,L. Morey-Vargas,F. Bolaos-Salazar,Edgar Muoz-Atahualpa,Mauricio Postigo-MacDowall,Fernando Corrales-Medina,Zoila Valdivia-Ascua,Carolina Cuba-Bustinza,Sheyla Paredes-Daz,Paola Villalobos-Tapia,Julio Chirinos-Pacheco,B. Goldberg,A. Chirinos
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1050049596580543025857583962057159401138946356655
#%891813990457766803591266582999413549972302390684
#%77059618969538015066945507814829021652450048052
#%188694409365103620573165318012776860041271977326
#%1433791179649179945553475094057085830871790482413
#%779392786480892222893512964299053397734959670067
#%764097893005597638045140270986073704384133089105
#%1087590640195649014213209567220552157576623161488
#%417766593200355128364595364000005086684040970422
#%1324973972417001029253325432822342429893670319200
#%848611662715273749258735016164807571071057995027
#%848611662715273749258735016164807571071057995027
#%638268359587094248860009971178768574942589394982
#%215264660802406979525901944302558739451373218190

#*Diabetes prevalence and association with social statusWidening of a social gradient?
#@Andrea Icks,Susanne Moebus,Astrid Feuersenger,Burkhard Haastert,Karl-Heinz Jckel,Guido Giani
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1196931578634920937981286077472557307211264989008
#%88350791676726944068179233493973136322582949218
#%655245462528250842778496926566262975371200299264
#%664276404711043208126296192709017448137169916881

#*The relationship between post-prandial plasma glucose and post-challenge plasma glucose in Japanese population
#@Rie Oka,Senshu Hifumi,Junji Kobayashi,Hiroshi Mabuchi,Akimichi Asano,Kunimasa Yagi,Tomomi Hagishita,Hideji Tanii,Masakazu Yamagishi,Susumu Miyamoto
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1094713180038213684170237850377825381533176632292
#%166688693930316500097684870504955600225545042459

#*Corrigendum to Angiographic coronary artery disease is associated with progressively higher levels of fasting plasma glucose [Diabetes Res. Clin. Pract. 75 (2006) 207213]
#@S. Quadros,Rogrio Sarmento-Leite,Marcello Bertoluci,Kau Duro,Alexandre Schmidt,Lucca Jr,D. Schaan
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1101441856711832174971311365330861892412354895893

#*Triple oral therapy for type 2 diabetes
#@S.H. Bell
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index177878566934051453968859837513683193358945084161
#%270659814422014433735562862294382923401002109181
#%691613181236886225460280718339586075744450853278

#*Extent of satisfaction with tablets and food-timing in sulphonylurea-treated diabetes
#@A. Woodcock,S. Bain,M. Charlton,C. Bradley
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1003189617538897876962588825824704754828955524679

#*Predictors of type 2 diabetes and diabetes-related hospitalisation in an Australian Aboriginal cohort
#@Valerie Burke,Yun Zhao,H. Lee,Ernest Hunter,M. Spargo,Michael Gracey,M. Smith,J. Beilin,B. Puddey
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index466877795307037031415850434260482199828655989993
#%545028829766022470157045363302735271464087167232
#%934323770308663076343212884613211725921137771190
#%620594658419178370021938699937140805042428423107

#*Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates
#@Hussein Saadi,George Carruthers,Nicolaas Nagelkerke,Fatima Al-Maskari,Bachar Afandi,Richard Reed,Miodrag Lukic,Gary Nicholls,Elsadig Kazam,Kais Algawi,Jumaa Al-Kaabi,Charles Leduc,Sufyan Sabri,Mohamed El-Sadig,Seham Elkhumaidi,Mukesh Agarwal,Sheela Benedict
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index488030466161149701832258981262032499462602487110
#%447570740366864965035300359436596789956610868106
#%1134316742908806820439970403555300672044123021553
#%620407339253680498443142197918299545654843116677

#*Bone metabolism is linked to disease duration and metabolic control in type 1 diabetes mellitus
#@R. Brandao,J. Vicente,H. Daltro,Marisa Sacramento,Agnaluce Moreira,Luis Adan
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index354437354113036279438520260863840403280525092613
#%494810375177743367900507436536185144485059194155
#%624421167659437885946529554618188051471240703137
#%1088095359393851777895238261727284328143259432955
#%300707196625396303536710879553294923193642504269
#%518908021403814567722381133545761500873899443222

#*Genome-wide search for susceptibility genes to type 2 diabetes in West Africans: Potential role of C-peptide
#@Guanjie Chen,Adebowale Adeyemo,Jie Zhou,Yuanxiu Chen,Hanxia Huang,Ayo Doumatey,Kerrie Lashley,Kofi Agyenim-Boateng,A. Eghan,Joseph Acheampong,Olufemi Fasanmade,Thomas Johnson,Godfrey Okafor,Johnnie Oli,Albert Amoah,Charles Rotimi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index489953928268316921880671104245750576689756475151
#%645459786005255142247306245367912381455470742968

#*Change in prevalence and 6-year incidence of diabetes and impaired fasting glucose in Korean subjects living in a rural area
#@K.-H. Song,I.S. Nam-Goomg,S.-M. Han,M.-S. Kim,E.-J. Lee,Y.S. Lee,M.S. Lee,S. Yoon,K.-U. Lee,J.-Y. Park
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index843802554003403561334879612977918897033815175493
#%608599557601443201658711010464765932553998229738
#%608599557601443201658711010464765932553998229738
#%997540535011446998871193915546101863446383772292
#%543392940072172135993561210410679410705969340567
#%543392940072172135993561210410679410705969340567

#*Glycemic control over 3 years in a young adult clinic for patients with type 1 diabetes
#@T. Lane,Agnes Ferguson,Joyce Hall,Maxine McElligott,Marilyn Miller,H. Lane,Elizabeth Pfeffer
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1040414381661929386084123696124727537455093133371

#*Fibrinolytic dysfunction after gestation is associated to components of insulin resistance and early type 2 diabetes in latino women with previous gestational diabetes
#@K. Morimitsu,S. Fusaro,H. Sanchez,C.F. Hagemann,Maria Bertini,A. Dib
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index730635263883807963254206964561132164957901679511
#%269422036370717556703052986143291205732976290391

#*Effect of pioglitazone therapy in lean type1 diabetes mellitus
#@R. Bhat,A. Bhansali,S. Bhadada,R. Sialy
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index206861176660584858981234332110140183133354532427
#%1382927638437060116556788686875955260182714516603

#*Does diabetes mellitus facilitate aortic stiffening in acromegaly?
#@Attila Nemes,Henriette Gavallr
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index788623589605621161991466098540769150323285319799
#%1104384690490769940341605440970966230916129920846

#*Effects of yoga and meditation on clinical and biochemical parameters of metabolic syndrome
#@Deepali Khatri,K.C. Mathur,S. Gahlot
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index742621578174520756981623555705549314532204932537

#*Clinical outcomes associated with the use of subcutaneous insulin-by-glucose sliding scales to manage hyperglycemia in hospitalized patients with pneumonia
#@Taryn Becker,Andrei Moldoveanu,Tali Cukierman,C. Gerstein
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index484322180623858409768225232114183770311585259894

#*Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies
#@C. Gerstein,Pasqualina Santaguida,Parminder Raina,M. Morrison,Cynthia Balion,Dereck Hunt,Hossein Yazdi,Lynda Booker
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index817256778313934031949420523017093154160834658706
#%216775968562943297201480925354428045409728052408
#%1003768245955088897442006657725408272593891570418
#%530742815982948056355266956550925744819808900472

#*High insulin levels impair intracellular receptor trafficking in human cultured myoblasts
#@Anna Bertacca,Annamaria Ciccarone,Paolo Cecchetti,Barbara Vianello,Incoronata Laurenza,Stefano Prato,Luca Benzi
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index199099065268176401232115071494222089108019545963
#%1212311013457709001118448104521933984928330506428
#%1086576819707577088030119514283527123796963160405

#*Gestational diabetes and the incidence of diabetes in the 5 years following the index pregnancy in South Indian women
#@V. Krishnaveni,C. Hill,R. Veena,Suguna Geetha,N. Jayakumar,L.S. Karat,H.D. Fall
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index6329755326426557311815463798436682222367765413
#%557126726522211095257620777694329919879631546225
#%157586833371456941523679511245816911292790745227

#*Recombinant human epidermal growth factor (REGEN-D 150): Effect on healing of diabetic foot ulcers
#@Krishna Mohan
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1292136664507399387229260128721809910155290873543
#%318266557990548568472177777276711432617830441817
#%181553532527211095191855922754549318047794709842

#*Use of continuous subcutaneous insulin infusion since the first weeks of pregnancy in five women with type 1 diabetes mellitus
#@Giuseppe dAnnunzio,Nicola Minuto,Valentina Emmanuele,Sara Mangini,Vera Morsellino,Renata Lorini
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1409249611533287856497642910352999151151462906817

#*The relationship of the peroxisome proliferator-activated receptor-gamma 2 exon 2 and exon 6 gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy
#@M. Erdogan,M. Karadeniz,Z. Eroglu,B. Tezcanl,N. Selvi,C. Yilmaz
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index573895132593036923808609785237406829342303386072

#*Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes: The Fremantle Diabetes Study
#@M.E. Davis,G. Bruce,A. Davis
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index510342119826177583119557928189730182651742411576
#%608027367961477215758757976231510100673358964715

#*Waist circumference, BMI and the prevalence of self-reported diabetes among the elderly of the United States and six cities of Latin America and the Caribbean
#@A. Barcel,E.W. Gregg,M. Pastor-Valero,S.C. Robles
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1356728970567717920562576691177339626498680397681
#%1198393057108484586427270116939021492656425134787

#*The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy
#@Byung-Wan Lee,Sung-Hee Ihm,Moon-Gi Choi,Hyung-Joon Yoo
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index359770401966893519236488759273803162131118028341
#%266392361051386075876210298131949848099456522365
#%415718921369716071186479817791551497296872631411
#%1351192608191730866553213569850914177740806777675

#*Effects of thiazolidinediones on the triad of type 2 diabetes mellitus, insulin resistance and cardiovascular disease
#@Y.C. Chan,Liza Ilag,H. Tan
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1136203580237627175887139439647190888627729808058
#%1143247054964945273405816221419647363121423316843
#%1162046703957847572843451792892755136499630628698
#%52547857183752011841764951056945089582186573981
#%771838189793421032014531980540519755597781321453
#%223158277128339612096086241672659345262669897807

#*Treatment of dyslipidemia in patients with type 2 diabetes: Overview and meta-analysis of randomized trials
#@Ivan Tk
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1422093060066799658560297506548538444088070649965
#%555753851563517960315948655836509271542027312160
#%1455038516438212923317581939252494070676638244194
#%298948132451392872508877290061772889371096263221
#%624886694475913690494041907691774480704551536521
#%806999650028062183539294847549091501669413301243
#%291417959754538038238909331244275920203826479160

#*PPAR agonistsAntidiabetic drugs with a potential role in the treatment of diseases other than diabetes
#@Gyrgy Jermendy
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index558709703924604565612437714373051079442984283938
#%674173775395992141055394194318685946159116000748
#%1373938179062209385569422059451688067750590403973
#%1288960549546065981944084860739712150098346355234

#*Achieving normoglycemia in hospitalized patients
#@Aleksandra Szymborska-Kajanek,Krystyn Sosada,Krzysztof Strojek
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index451953372778278469516175152254001357378947854877
#%780767992282311300397751487115174289832078260375
#%1452024137376570560362789532478525241547705616797
#%155215534855769944192370700315035155028694547615
#%278902297087246250714577509819263279364879683793

#*The eyes in diabetes and diabetes through the eyes
#@Ilana Harman-Boehm,Tomas Sosna,Henrik Lund-Andersen,Massimo Porta
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index107883265918674142141977662042667774462122108935
#%198945367099796850834249980062741985892022707500
#%198945367099796850834249980062741985892022707500
#%150400762070141937008560986304246142360477678630
#%150400762070141937008560986304246142360477678630
#%870651381524712065084403491855958404044803635696

#*Exploiting the pleiotropic actions of GLP-1 for the management of type 2 diabetes mellitus and its complications
#@Francesco Giorgino,Annalisa Natalicchio,Anna Leonardini,Luigi Laviola
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index138992236040849687773894393310955765637940701455
#%880218638519402573953108891077870310822937090960
#%455811398526908874408389737481224335556722286997
#%741485235067323050940871952719393611419069014326
#%1384402130285014631429461175565130367736150572893

#*Impaired glucose balance and subtypes of diabetes mellitus revealed in intravenous glucose tolerance test
#@V. Dreval,Alexander Ametov
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1263250483074123759032636501130396379326276452921

#*Role of adipose tissue in the development of vascular complications in type 2 diabetes mellitus
#@Irina Kowalska
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1238681938952244368719236642797178407759437359337
#%1021002299222599989778245421123926371941613289901
#%876716803728294273393557807229839935633055159742
#%676263457990465202690768553397016483572989849828
#%408196804256812449180218906334977276263366120186
#%810834590851489859820322576312585775976837598411
#%272056019394042470500330251058306794963949745821
#%861266548754435870989625842530194364413113720105
#%1347131148159653833870809454228854616978879559695
#%857242410680689497381988393770385841841071549629
#%378137051288437957603692429171019388217589401034

#*Targeting acute hyperglycaemia in clinical practice
#@Simon Heller
#year2007
#confDiabetes Research and Clinical Practice
#citation0
#index1433404762259245719808114618358061282311537494111
#%278966046865434804766829784723847340836077054517
#%187221847497790455506763007275325464488250067450
#%1405289936925555641146330394603561340891040062201

#*Coeliac disease and its relation to glycaemic control in adults with type 1 diabetes mellitus
#@Barbara Depczynski
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index444809255679374556015172759725198147734893641389

#*Avoidance of ACE inhibitors or angiotensin receptor blockers among women of childbearing potential with diabetes
#@B. Guirguis
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index78516745361894066496466235599175062002916116801
#%402067344313617286862356414197886354175697465998

#*Intracytoplasmic cytokine levels and neutrophil functions in early clinical stage of type 1 diabetes
#@S. Bilgic,E. Aktas,F. Salman,G. Ersahin,G. Erten,M.T. Yilmaz,G. Deniz
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1305891501612168309667114101576221301222146868936
#%462502728559625831626817027614275625969763875003
#%295059041457588987276494463203444011793498843482
#%1038982401130630343743440346164014693019850451479
#%1133738357030914739827182361516405327918518936125
#%856592721510261674739201201075716160547857574734
#%45699288886487542747195357542077817414158888892
#%106129192845100190994425469060920203237848506276
#%247136787809082430509313755767520902935743184980
#%1435611447627895875066240718781787072194051572125
#%307198642262059065615140829413046717323046233221

#*The impact of apathy on glycemic control in diabetes: A cross-sectional study
#@R. Padala,V. Desouza,Stephanie Almeida,Vijay Shivaswamy,Krishan Ariyarathna,Lance Rouse,J. Burke,Frederick Petty
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index293352128833507955470442318758715366156165332440
#%741472667357967036521698557437635045148869117616
#%413969288818594281986496418401371744698467022441
#%866290582300251172737595129515120551148467917224

#*Epidemiology and genetic risk of type 1 diabetes among children in Aragon community, Spain
#@Jess Soria,M. Garagorri,Mercedes Rodrguez,Gerardo Rodrguez,Luis Larrad,Mercedes Elizalde
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index239907546755876748871056243051632879657483169152

#*Hepatic fat content-independent association of the serum level of gamma-glutamyltransferase with visceral adiposity, but not subcutaneous adiposity
#@Tomoyuki Iwasaki
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index586166765161940257096383759979825075010533481882
#%1393240609779696108157096099965190967083200004506

#*Safety and efficacy of repaglinide in combination with metformin and bedtime NPH insulin as an insulin treatment regimen in type 2 diabetes
#@Miguel Civera,Angel Merchante,Mara Salvador,Javier Sanz,Isidoro Martnez
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index718106568300449711411955532417604626251034997948
#%183424769552238276633692043850860692005720188534

#*Relationship between plasma levels of soluble CD40L and insulin sensitivity and insulin secretion status in non-diabetic dyslipidemic patients
#@Claudia Filozof,Dulcenombre Gmez-Garre,Leonardo Reinares,Luisa Gonzlez-Rubio,Paloma Muoz-Pacheco,Antonio Rueda,Arntzazu lvarez-Arcaya,L. Calle-Pascual,Arturo Fernndez-Cruz
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index199544398427050808465451978896903744366504143736
#%569872898419240337533603439305371360724688701645
#%1157160877266848204755264282556285503407370669641
#%641348617866864373891920013059264305956382906137
#%530897721991195769129500441639456639697391525420

#*Assessment of health-related quality of life (HRQoL) of patients with type 2 diabetes in Turkey
#@Fevzi Akinci,Aysegul Yildirim,Hulya Gz,Haluk Sargn,Ekrem Orbay,Mehmet Sargn
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index316722550284194274106979159548116372382088191393
#%813613033718314463591081892438927993910490133091
#%27096163423311949041485650293775586390756129282
#%961470346641606853593713724199540319023282068699
#%120164318105580360079948316181739986058637616391

#*Stroke presentation in Type 2 diabetes and the metabolic syndrome
#@M. Shah,K. Ghosh,Andrew Collier
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index926757244467707855509001040339579674312278656847
#%79462056394886565094462057591847987886345893087
#%1406111222439269119684482003551910010533257194464
#%349199090565112099463445957088141832135831115470
#%1297291947215417171854140091346960256317243245685

#*Prevalence of celiac disease in type 1 diabetes mellitus in North West Rajasthan, India
#@P. Agrawal,Ashok Rathore,Ashish Joshi,Harish Changal,D.K. Kochar
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index562996450938620257386063069493966504228948746011

#*Depression and diabetes in a rural community in Pakistan
#@Naeem Zahid,Shaheen Asghar,Bjrgulf Claussen,Akhtar Hussain
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index260838592768493440239480242607601174509266821607
#%1232315247709413748640036935234975415615890804506
#%149126751242630835380740392034687408159048401959

#*Skin autofluorescence in type 2 diabetes: Beyond blood glucose
#@Matteo Monami,Caterina Lamanna,Francesca Gori,Francesca Bartalucci,Niccol Marchionni,Edoardo Mannucci
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index642391665239488056374229008292274226894353675387
#%944886406524318949953418278030907136171968074713
#%608027367961477215758757976231510100673358964715

#*Weight gain in type 2 diabetes mellitusNot all uphill
#@Ohad Cohen,Clara Norymberg,Eylon Neumann,Hilla Dekel
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index435631859711940708471608263466431024626293268123

#*Decreased obestatin in plasma in metabolically obese, normal-weight men with normal glucose tolerance
#@Xin-Yuan Gao,Hong-Yu Kuang,Xiao-Min Liu,Xue-Yan Wang,Yan-Hui Pan,Xiao-Xia Ma
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1284269852125351245837481889109194495967622437382

#*Type of antidepressant therapy and risk of type 2 diabetes in people with depression
#@C. Brown,R. Majumdar,A. Johnson
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index906305443196127112875120519663629624183674035805
#%754655368429522879212521520098694443280339636973
#%968653877427965325858573933914831791920517433674
#%1434165271717369141066280999306082895931256194862
#%57411669094118332488580246767243126650008445508

#*Probable NAFLD, by ALT levels, and diabetes among Filipino-American Women
#@A. Wong,G. Araneta,Elizabeth Barrett-Connor,John Alcaraz,Donna Castaeda,Carol Macera
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index488048582581895885461765782166971526517955964236
#%1113546003439604590706208013297333441609459960380
#%1289593039928421999121087397285163376230265349018
#%1174189470100465013856707682375599398349923689721
#%910345422030065901441482359827793789187402813939
#%441767412132051941843102880384187622551974045495
#%679905319709773893941449697290738371753700134758
#%785404378387908356642228240554375299519988120224

#*The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy
#@Magorzata Myliwiec,Anna Balcerska,Katarzyna Zorena,Jolanta Myliwska,Pawe Lipowski,Krystyna Raczyska
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1398183549888763937791709779711088494990442938935
#%1150284805627011368930584849180530287370518470057
#%1013780793124572153681660679688096980707236893482
#%361549276987961122347604593330024641337356380546
#%1402170612181716984786922235305497503357012703284
#%1157276154722988112795280442592721460456070819207
#%4730816146776692061865152361796102703595402153

#*Severe hypoglycemia after gastric bypass surgery for morbid obesity
#@Pablo Abelln,Rosa Cmara,Francisco Merino-Torres,Antonia Prez-Lazaro,Isabel Olmo,Luis Ponce,Miguel Rayn,Francisco Pin
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index968198450968510003145473034135082173089554485858

#*Clinical and electrophysiological differences in male and female patients with diabetic foot
#@Erdemir Kiziltan,Gulcin Benbir
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index810882184677829966725422307307110336999355534951
#%497381553439262794668365157285564049196706882375
#%497381553439262794668365157285564049196706882375
#%552027984265951934574392479088553549713399410339
#%639013761770883357607736383896754121555108292740

#*Circulating cholesterol as a modulator of risk for renal injury in patients with type 2 diabetes
#@A. Earle,Diane Harry,Karima Zitouni
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index296823772054853815319300344600061599966859743625
#%1150912071872299803044372636027576802198239270312
#%1101187582082405183269474842613756217921864602656

#*Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance
#@D.A. Luis,R. Aller,O. Izaola,M. Sagrado,R. Conde,J.M. Gonzalez
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index983780420079922449209741159201695566823325759782
#%1133609069549119980928474196454768694341982948715
#%1133938240078490757464937841929328487682146649491
#%102457087601577207232734684441176623725172445149
#%1133938240078490757464937841929328487682146649491
#%1062102914805636190528624029436745766855225529621
#%1247584568640917432378988189365557209831242849121
#%910345422030065901441482359827793789187402813939
#%1078651783297654481136500476561490743420607855133
#%192903608927002475737420712591355996166491379477

#*Diabetes screening in Basrah, Iraq: A population-based cross-sectional study
#@Ali Mansour,Laftah Wanoose,Ibrahem Hani,Akeal Abed-Alzahrea,Laftah Wanoose
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index922952118269926778690188181842860451559943496241

#*The likelihood of diabetes based on the proposed definitions for impaired fasting glucose
#@Weiguo Gao,Yanhu Dong,Hairong Nan,Jaakko Tuomilehto,Qing Qiao
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index765427292262096626625080162256023805214090750248
#%119856418065636278349091420094885937772742281106

#*The influence of obesity on the oxidative stress status and the concentration of leptin in type 2 diabetes mellitus patients
#@Aleksandra Stefanovi,Jelena Kotur-Stevuljevi,Slavica Spasi,Natasa Bogavac-Stanojevi,Nada Bujisi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1449170784111953584771864189778158645151816805914
#%806999650028062183539294847549091501669413301243
#%1098144179829421639042084536125523179231106568885
#%465851402249112232575646891625001968763318852403
#%1122876593430619089198321703881073477797148556416
#%1122876593430619089198321703881073477797148556416
#%1059128011133246495028315560091798038373879561174
#%253288732454437674317052801723889899386414484856

#*Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects
#@M. McKillop,A. Duffy,R. Lindsay,P.M. OHarte,M. Bell,R. Flatt
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index755609667264321705050403463018155814280098923170
#%803848525000947047142811211530847668906096038709
#%1382380505919333060693006536586680810760282054098
#%323465782413825067018943021285194719797517186506
#%1274798045467274166661795624804665572218084295307

#*A renoprotective effect of low dose losartan in patients with type 2 diabetes
#@Hideaki Sawaki,Jungo Terasaki,Atsushi Fujita,Seiko Nakagawa,Norio Kanatsuna,Katsuhiko Sadahiro,Haruhiko Isotani,Akihisa Imagawa,Toshiaki Hanafusa
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index473095937305845845621015019760078676816094820333
#%431412729600776668789272016853046241948029539427
#%1156704978130691139103990205335633435258417393308
#%1424949121179476886336986044310875526481785515833

#*A promoter polymorphism of the 2-HS glycoprotein gene is associated with its transcriptional activity
#@Mari Inoue,Hiroshi Takata,Yukio Ikeda,Tadashi Suehiro,Shojiro Inada,Fumiaki Osaki,Kaoru Arii,Yoshitaka Kumon,Kozo Hashimoto
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index222777296934820176117685485639678657972644486442
#%1221861025877427093400174194466980345876514575329
#%884552067292499264616553894900618106177736612120
#%697046812835895351834748099469298392631383467314
#%1262388556395650870705028114739055863170638034773

#*Ferulic acid prevents pathological and functional abnormalities of the kidney in Otsuka Long-Evans Tokushima Fatty diabetic rats
#@Atsuyo Fujita,Hideyuki Sasaki,Asako Doi,Kunihisa Okamoto,Shohei Matsuno,Hiroto Furuta,Masahiro Nishi,Taisei Nakao,Takuo Tsuno,Hisaji Taniguchi,Kishio Nanjo
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index191562262015146158144902964977445773215901326893
#%596349194082927128319581436195583907320420882836
#%1390198437486992998952717875840791378016919722305
#%1406481612951019558979966277764579451029581836688
#%295049822057237005815063055113781827319344360003

#*Left ventricular diastolic dysfunction in normotensive diabetic patients in various age strata
#@Hisashi Masugata,Shoichi Senda,Fuminori Goda,Yumiko Yoshihara,Kay Yoshikawa,Norihiro Fujita,Hiroyuki Daikuhara,Hiroyuki Okuyama,Teruhisa Taoka,Masakazu Kohno
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index321456632906540419493651914171399794615711781533
#%1144401261676822534734071372037533472505965155022
#%340102460101869163573117365919377666143574075586
#%483303417387462728086320956747073437418411656349
#%296335473722858457419373720677246593838379508437
#%125048424519925041054126587156271474031138347754
#%1396147718788239353483834063096629060283060057701
#%429602726035478494674800228422557832578753100302
#%96972034248234847494623766715602791247893889056
#%370932592469225865292638725259041175743489334241
#%679015987606612188819748628798267344799291072548
#%231547554223326799964410428015950013851704926141
#%332545002498888395371104250185766201291358130787

#*Efficacy of insulin glargine and glimepiride in controlling blood glucose of ethnic Japanese patients with type 2 diabetes mellitus
#@Ryuzo Kawamori,G. Eliaschewitz,Hideichi Takayama,Y. Hayashida
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1382003585910044735993912779812136468645734336144

#*Six-month multicentric, open-label, randomized trial of twice-daily injections of biphasic insulin aspart 30 versus multiple daily injections of insulin aspart in Japanese type 2 diabetic patients (JDDM 11)
#@Koichi Hirao,Keiko Arai,Mikio Yamauchi,Hirofumi Takagi,Masashi Kobayashi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index956803042954471985366406152496359639505557671256
#%481570781244869144784002259840012820397148090045
#%74108759385361979204156615352365733346388426847
#%701787196052191727984636046236679810905159195013

#*Age-dependent difference in factors affecting choice of system for self-monitoring of blood glucose
#@Tomomi Fujisawa,Hiroshi Ikegami,Soji Kasayama,Munehide Matsuhisa,Yoshimitsu Yamasaki,Jun-Ichiro Miyagawa,Tohru Funahashi,Iichiro Shimomura
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index922725690256395123817847228888282863257651406228
#%970102488476482110549139414214111260215840803200
#%848854482254986863536987364474472545743487522597
#%57060469004969453483512417920889895531867132442
#%1335287205972834184323898412618318724738141698837
#%1104887923826044000599122491144282133731730369749
#%992526920318358556758474114167285252592690879698
#%1094430867125625912798195691588619445409891792254

#*Regulation of gut-derived resistin-like molecule  expression by nutrients
#@Junko Fujio,Akifumi Kushiyama,Hideyuki Sakoda,Midori Fujishiro,Takehide Ogihara,Yasushi Fukushima,Motonobu Anai,Nanao Horike,Hideaki Kamata,Yasunobu Uchijima,Hiroki Kurihara,Tomoichiro Asano
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index477372967442214450358878591934857203117422319650
#%1031361844897704253165587523703474772652686339141
#%272056019394042470500330251058306794963949745821

#*New insulin sensitivity index from the oral glucose tolerance test
#@Youichiro Kazama,Toshinari Takamura,Masaru Sakurai,Hisakazu Shindo,Eizho Ohkubo,Kaoru Aida,Norikazu Harii,Katsumi Taki,Masahiro Kaneshige,Shoichiro Tanaka,Hiroki Shimura,Toyoshi Endo,Tetsuro Kobayashi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index120149851462123300204270388513273718623698278847

#*Plasma visfatin levels are positively associated with circulating interleukin-6 in apparently healthy Korean women
#@A Seo,Suk Jang,Gil Kim,Hyun Ryu,Young Kim,Won Lee,Gon Kim,Mook Choi,Hyun Baik,Seop Choi,Hee Kim
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index507617326142177579075846203347295166635327917448
#%982771805899213301359700692166756396511858716536

#*Impaired flow-mediated vasodilatation and insulin resistance in type 2 diabetic patients with albuminuria
#@Hisashi Makino,Kentaro Doi,Aki Hiuge,Ayako Nagumo,Sadanori Okada,Yoshihiro Miyamoto,Masaaki Suzuki,Yasunao Yoshimasa
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index309763107791291819995036699850419828679426949345
#%1390767547099907495498470368123019264452888981682
#%1390767547099907495498470368123019264452888981682
#%901359864765299262641577783931321979801441463060
#%116946116299964777866131895583497451680709896200
#%751432988523129975893247835252145457097126847599

#*Hyperplastic islets observed in reversed NOD mice treated without hematopoietic cells
#@Yoshiaki Okubo,Akira Shimada,Yasuhiko Kanazawa,Toshikatsu Shigihara,Yoichi Oikawa,Takatoshi Imai,Junichi Miyazaki,Hiroshi Itoh
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index350660525767012246267987478794731562563860221787

#*Educational interventions aiming at improving adherence to treatment recommendations in type 2 diabetes
#@Johan Wens,Etienne Vermeire,Hilary Hearnshaw,Antje Lindenmeyer,Yves Biot,Paul Royen
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1043027946067117633581182695413028065787632604828
#%1441636290916066261218739043327731391659340221120
#%990752621164712896064935861434007825154841031584
#%790257977266919026600258544309505004315090114540
#%629111992633395030878793956584841191677761072326

#*Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus
#@C. Limbert,G. Pth,F. Jakob,J. Seufert
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index127571014554405642574081639115799620537701725785
#%278436152178358553934388123028748657194225677186
#%34828515604314904507426612985369715861478966651
#%549430851661567202712672855364203389029525782828
#%1318398826418307640501103436375405668008476975560
#%175169274472138663341217914811871524082520108725
#%104752332120842593956237539998402442900347098995
#%793688193477096924829646072302772265397500162487
#%1219289549375443867471921189177797948953164760197
#%416492768544264725639698562075745915217188674505
#%1409962978338814005796539920749781015810704146050
#%823768374354455539164072572343668847823444780563
#%748256164372701069186112525796260292540491985942
#%776188835098405097439679052386069334563217936717
#%897082657268421146384980946319316582128110714497

#*Cardiovascular risk management of different ethnic groups with type 2 diabetes in primary care in New Zealand
#@Raina Elley,Tim Kenealy,Elizabeth Robinson,Dale Bramley,Vanessa Selak,L. Drury,Ngaire Kerse,Janet Pearson,Roy Lay-Yee,Bruce Arroll
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index476571631254768597653519160533539362073376184513
#%446072257212842976018065577347557613862706180556
#%1186501341515059391140442800919395799048423877293

#*Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol
#@Hua Jin,Boren Jiang,Jinfeng Tang,Wenli Lu,Wei Wang,Libin Zhou,Wenbin Shang,Fengying Li,Qingyun Ma,Ying Yang,Mingdao Chen
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1219282700056370978334347413976089859241929716567
#%123250729326228105743627021275612517257878127520
#%420678721583814257978460366381870733954688828022

#*Technical and clinical evaluation of a glucose meter employing amperometric biosensor technology
#@Suleyman Demir,Can Yilmazturk,Diler Aslan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1097235320687136902487585886993567274629985883204
#%1037450130696770265691302738197130976966260002683
#%5926716052516631870402014173079425143989729664
#%916136218042452031032878962844924069504203976519
#%841721864707626681278781973810818237676700523049

#*Improved endothelial function following a 14-month resistance exercise training program in adults with type 2 diabetes
#@N.D. Cohen,D.W. Dunstan,C. Robinson,E. Vulikh,P.Z. Zimmet,J.E. Shaw
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index866674109624188754095168152680804918491048659887
#%1437529675305796619126368714718022068202422432218
#%403274341781259345600624900725420543562981544658
#%1171048371391695283514569370576627916337089259728
#%1354780198605040795740381062858891748563172364582
#%201023164091737315235781613592739923486990734764
#%328236535557163505890536831789297189847311355064
#%426453962391262006378391622803429911923441799893
#%849983282422384407771576961629705349125539168017
#%929029884490907212573462058961611503564327644350

#*A nonlinear relation between glucose and A1c
#@George Trevio
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index122277959297203607988136331151485504087661595159

#*Clinical significance of the metabolic syndrome in the absence of established hypertension and diabetes: A community-based study
#@Pai-Feng Hsu,Shao-Yuan Chuang,Hao-Min Cheng,Shih-Tzer Tsai,Pesus Chou,Chen-Huan Chen
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index793228445659010661060277849081181658912748317992
#%482859254794527483970388691938667449037267918907
#%988365858853113189517601457577966508186949091619
#%1239678428901684734281216596067885398422176059035
#%435732111316475520310010960123937676548019230325
#%381667046375903297905485204690591349919689047750
#%808918416448774985305066619063124257506047829588

#*High total-to-HDL cholesterol ratio predicting deterioration of ankle brachial index in Asian type 2 diabetic subjects
#@I-Te Lee,Chien-Ning Huang,Wen-Jane Lee,Hong-Shen Lee,Huey-Herng Sheu
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index785361059737178392453119066058496063771480724438
#%1418519123182179658507677860277160619133074594235
#%1321753673430474893306416348909014044013283173558
#%68382385423782876958103979980627236815583205387
#%68382385423782876958103979980627236815583205387
#%68382385423782876958103979980627236815583205387
#%1286111263500713427545647999537065916050617017389
#%1052340632632182686047819515057168077028906114910
#%1426243186614138028453684909556305521170974393188
#%242833913998710503761977940199976434709269517950
#%639869836967781555716474353988492051007345812338
#%639869836967781555716474353988492051007345812338
#%590661735065560083944691042617146463597088750015
#%420697900222532142084610685365457259075860093517
#%1185314561784871927709365776757592540096512866116

#*Impaired early insulin secretion in Japanese type 2 diabetes with metabolic syndrome
#@Etsuko Fukuda-Akita,Kohei Okita,Yukiyoshi Okauchi,Miwa Ryo,Tadashi Nakamura,Tohru Funahashi,Hiromi Iwahashi,Iichiro Shimomura,Junichiro Miyagawa,Kazuya Yamagata
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index312339132346176004710391741463198300802190579037

#*Age and gender differences in the impact of diabetes on the prevalence of ischemic heart disease: a population-based register study
#@E. Wirhn,Johan stgren,M. Carstensen
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index53147088967972963649999553320786045774507725483
#%1369169977251681221353458117930773079143906684696
#%1449005384960677540707614895751154616790243102417

#*Likelihood of having isolated postchallenge hyperglycemia in an Iranian urban population
#@Farhad Hosseinpanah,Mehdi Rambod,Fereidoun Azizi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index354748413357366449254755840592007774264807831467
#%1394040760563690837429646130926542816065113868265
#%956404848503341552112419567476517275928482514411

#*A lack of increase in high molecular weight-adiponectin in macroalbuminuric subjects with metabolic syndrome may exert renal and atherosclerotic risks
#@Shin-ichi Tsuda,Shigeru Nakano,Kazunori Konishi,Daisuke Koya
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1400025059372877587465311030592802166435595897413
#%1129051833275975075094412679271974103559970391996
#%176150433092309855792472228519962213704579196368
#%1347131148159653833870809454228854616978879559695
#%322114998298676065841034270150936214982578885641
#%414786460177622927831882659605271039360136356448
#%528133368890541850301612499763181496041298437299

#*Prevalence of metabolic syndrome compared between native Japanese and Japanese-Americans
#@Masayasu Yoneda,Kiminori Yamane,Kuniaki Jitsuiki,Shuhei Nakanishi,Nozomu Kamei,Hiroshi Watanabe,Nobuoki Kohno
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1340115210635843606169338026654386636222088337895
#%612996013956783174386016149695405911634332514289
#%608027367961477215758757976231510100673358964715
#%1410374207007295930028655162443067647706268079337
#%1074008517642227463449750245282918182404216805617
#%1087590640195649014213209567220552157576623161488

#*Coverage and predictors of influenza vaccination among adults with diabetes in Spain
#@Rodrigo Jimnez-Garca,Isabel Jimenez,Carrasco Garrido,Valentn Hernndez-Barrera,Lopez Andres,Luis Barrio,Gil Miguel
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1332914498594670803127408949046173025976399745836
#%607855564640269277755098640906591996181132923164
#%484303832692378591461986677759291213426168886815
#%820201920530531336905567598302478431644209357301
#%541811638485209409748943714289764196228993436933
#%827701850869884493658578378100875081352266912837
#%1443493615316585040037381348522324555153446902994
#%1354681859179470476379519137973397116751190387140
#%20974908667366551872942389171008465367644595653
#%773696032816897185723725260439037518812608951868
#%781130656076650223370967159857127370229737456538

#*Association of psychosocial factors with anxiety and depressive symptoms in Chinese patients with type 2 diabetes
#@Cai-Xia Zhang,Yu-Ming Chen,Wei-Qing Chen
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index406518602306813972721683740308922791593655979062
#%812948565761603187663394367739041502228222946961
#%812948565761603187663394367739041502228222946961
#%629748287668039163394617541263991970859353504877

#*Prevalence of the impaired glucose metabolism and its association with risk factors for coronary artery disease in women with gestational diabetes
#@Katia Rivero,Lcia Portal,Matias Vieira,Ivo Behle
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index877725727530304123486948934410108828022194907567
#%1290794634586429745536555557796346018683703347347
#%298800650402824987447050946154775496969633499851
#%1299132414953617378733412174120815819955689190808
#%17674881215790657806859292270109383287563123475
#%1213668463160996165507558060176774001145788124651

#*Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome
#@Rie Oka,Junji Kobayashi,Kunimasa Yagi,Hideji Tanii,Susumu Miyamoto,Akimichi Asano,Tomomi Hagishita,Mika Mori,Tadashi Moriuchi,Makoto Kobayashi,Shouji Katsuda,Masa-aki Kawashiri,Atsushi Nohara,Yoshiyu Takeda,Hiroshi Mabuchi,Masakazu Yamagishi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index485552785234323115571115524400782929431561797146
#%377540217445836200324260906171352376060362824630
#%425359508911865790944680143974007765055061334363

#*Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy
#@Akihiro Kakehashi,Shigeru Inoda,Chiho Mameuda,Masatoshi Kuroki,Tadashi Jono,Ryuji Nagai,Seikoh Horiuchi,Masanobu Kawakami,Yasunori Kanazawa
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index21459439016859310106531516661389554601903176389
#%1341971400198420472171157471571326564473764055601
#%560255666677914370575650153880625739156287397433
#%755588704257674440456245658118301619954929087341
#%1421025633532097180112060465616560128048373905562
#%1421025633532097180112060465616560128048373905562

#*Plasma relaxin concentration is related to beta-cell function and insulin sensitivity in women with type 2 diabetes mellitus
#@Barbara Szepietowska,Maria Gorska,Malgorzata Szelachowska
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1233154649112869256375529938252949618850327886094
#%1093720841052017767824479764353254532813824772555

#*Leu54Phe and Val762Ala polymorphisms in the poly(ADP-ribose)polymerase-1 gene are associated with diabetic polyneuropathy in Russian type 1 diabetic patients
#@G. Nikitin,A. Chudakova,A. Strokov,R. Bursa,A. Chistiakov,Valery.V. Nosikov
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index816681872348399393485209451472164710929613022206
#%686551077869585333037948397680421879535379202333
#%1055290228100529110951535085868359026535104821174
#%1055290228100529110951535085868359026535104821174
#%378655512390676003721780033294114522774749805587
#%450609503557736606923972960149555318426215806122
#%1292614989302838342741552343006259508044182798268
#%73837643684163911375066396850440034740480173776

#*Erythromelalgia in a diabetic patient managed with gabapentin
#@Chrisoula Pipili,Evangelos Cholongitas
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index100599415899913732217228508231326307742450425883

#*Personality characteristics in adolescence predict long-term changes in body fatness
#@L.J. Koppes,R. Boer,David Samoocha,M.T. Kreuk,Frans Pouwer,W.R. Twisk,Willem Mechelen
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index923777533251053470203505796605429304409537854227
#%1214233565326348349263228890424521972363237689549

#*A case of fulminant type 1 diabetes mellitus after influenza B infection
#@Hiroyuki Sano,Jungo Terasaki,Chiharu Tsutsumi,Akihisa Imagawa,Toshiaki Hanafusa
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index633448444578164014956544238120143608504154826060

#*Elevated liver enzymes in women with a family history of diabetes
#@Kazuo Inoue,Masatoshi Matsumoto,Yuji Miyoshi,Yasuki Kobayashi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index128025462304855195367717164710681402353801849856
#%1298888924721350131033295591530302217923025041749

#*2-Year effects of pioglitazone add-on to sulfonylurea or metformin on oral glucose tolerance in patients with Type 2 diabetes
#@Jochen Seufert,Richard Urquhart
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1380649750762894317422131002348448960892056433262
#%515343432303513953337039661862346907083717620645
#%697999729707112882035165415974075911916741613288
#%1373381618968659012550067877021656395415076747936
#%129197594178879173581026860283166829779632608796
#%997540535011446998871193915546101863446383772292

#*Neither the presence of metabolic syndrome as defined by the IDF guideline nor an increased waist circumference increased the risk of microvascular or macrovascular complications in Japanese patients with type 2 diabetes
#@Tomoyuki Iwasaki,Yu Togashi,Kenji Ohshige,Masato Yoneda,Koji Fujita,Atsushi Nakajima,Yasuo Terauchi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1150060562286891124518990243240476461458127169241
#%1280289314018846934604262562508608855099323385934
#%1280289314018846934604262562508608855099323385934
#%377198187541258719549792156627111699897170759335
#%600729171836014079433319300461533078223380139900

#*Determination of serum 7-ketocholesterol concentrations and their relationships with coronary multiple risks in diabetes mellitus
#@Kei Endo,Tomokazu Oyama,Atsuhito Saiki,Noriko Ban,Masahiro Ohira,Nobukiyo Koide,Takeyoshi Murano,Hitoshi Watanabe,Manabu Nishii,Minoru Miura,Kyoichi Sekine,Yoh Miyashita,Koji Shirai
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index97917556321098690052979138798770076229428737499
#%597676105884538501726502645859443601337291313012
#%1249012202004253039445995466626986897567312357033
#%133740543217274239325395505741332754212741581571
#%285316938085478198761155047555012516117694981130

#*Incidence and trends of childhood Type 1 diabetes in Croatia from 1995 to 2003
#@G. Stipancic,L. Sabolic,M. Malenica,A. Radica,V. Skrabic,Kujundzic Tiljak
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1358605884571760435847016539236820639303743857344

#*A simple clinical score for type 2 diabetes mellitus screening in the Canary Islands
#@Antonio Len,Domnguez Coello,Cristo Prez,Batista Medina,Delia Gonzlez,Brito Daz,Muros Fuentes,Armando Aguirre-Jaime
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index642539456836390384281364791507496018292838021571
#%580973138377794928834204511558657714396331358321

#*The assessment and management of albuminuria in primary care
#@C. Thomas
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index468311302715917323137697602590403846766728183216
#%81213820779628439997771728246816137838544651559

#*Gender modulates the relationship between body weight and plasma glucose in overweight or obese subjects
#@Giuseppe Seghieri,Federica Tesi,Roberto Anichini,Alessandra Bellis,Gianna Fabbri,Raffaella Malagoli,Flavia Franconi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1275369281751458783254349499894787180250188123210

#*Long-term use of a diabetes-specific oral nutritional supplement results in a low-postprandial glucose response in diabetes patients
#@Daniel Magnoni,H.F.C. Rouws,Mirian Lansink,M.J. Laere,C. Campos
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index100559463776079310200646757243194464284781954056
#%379111772490452979403780348357245337124785192988
#%398966926411729416063166796594408977831586910264
#%643892280851792942294522486675583311401819463484

#*Glycemic levels with glucose loading test during pregnancy and its association with maternal and perinatal outcomes
#@Umit Korucuoglu,Aydan Biri,Esengul Turkyilmaz,F. Yildirim,Mustafa Ilhan,M. Hirfanoglu,Yildiz Atalay
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index502624163117150179234204243774968538953677856424
#%1223247918430045996673746611021496790846445947301
#%1253935414126736185811236390950252169677798286103
#%436220921492092668613091285053289536753115517955

#*Controlling the ABCs of diabetes in clinical practice: A community-based endocrinology practice experience
#@Swarna Varma,L. Boyle,R. Varma,A. Piatt
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index276535657305851626650864198797223094843350806525
#%741472667357967036521698557437635045148869117616
#%431412729600776668789272016853046241948029539427
#%1411987010450786263247625633644665645353121599481
#%18669916695505403943504004103395582638831699446

#*Comparison of serum uric acid levels between Japanese with and without metabolic syndrome
#@Takeyuki Numata,Nobuyuki Miyatake,Jun Wada,Hirofumi Makino
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index533146293015046255865944863975329896634284513146
#%205762002233378755214312397134121714831989070480
#%806870819209680144188259582945761366779943870553
#%1247557858711530969401306214176454575439595537560
#%901773852231245468559388091758809333105699636183

#*All-cause mortality in insulin-treated diabetic patients: A 20-year follow-up
#@I. Dawson,Jinny Willis,M. Florkowski,S. Scott
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index298794029168782677604839581850498133391517384847
#%1156418508487027509741777892469887392816925600442
#%957496190651851255763179508437313766178512621143

#*Cause-specific mortality in insulin-treated diabetic patients: A 20-year follow-up
#@I. Dawson,Jinny Willis,M. Florkowski,S. Scott
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1224542754601651304283494061895764357387871567557
#%1156418508487027509741777892469887392816925600442

#*Alanine variant of the Pro12Ala polymorphism of the PPAR gene might be associated with decreased risk of diabetic retinopathy in type 2 diabetes
#@T. Malecki,Katarzyna Cyganek,Barbara Mirkiewicz-Sieradzka,P. Wolkow,Krzysztof Wanic,Jan Skupien,Bogdan Solnica,Jacek Sieradzki
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index245656206888817567717574866315664737547405393693

#*Short-term reproducibility of impaired fasting glycaemia, impaired glucose tolerance and diabetes
#@S.S. Rasmussen,C. Glmer,A. Sandbaek,T. Lauritzen,B. Carstensen,K. Borch-Johnsen
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index149930875115356164020246715607606683108801906425
#%1394040760563690837429646130926542816065113868265
#%530742815982948056355266956550925744819808900472

#*High glucose increases phosphocofilin via phosphorylation of LIM kinase due to Rho/Rho kinase activation in cultured pig proximal tubular epithelial cells
#@Fukashi Ishibashi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index272013387132069690155980607960551267273903627034
#%779375242025999605816239383045649636789132789366
#%1256815453697237586531955583387723530782331503993
#%515233084800289805792163034575597160289609353988
#%480589178049781033572565708647875202354011799084

#*The economic burden of nephropathy in diabetic patients in Germany in 2002
#@M. Happich,R. Landgraf,W. Piehlmeier,Petra Falkenstein,Sabine Stamenitis
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1140804828608036507931364806099494213121650518657

#*Psychometric evaluation of the Satisfaction with Oral Anti-Diabetic Agent Scale (SOADAS)
#@Christina Donatti,Diane Wild,Ruslan Horblyuk,M. Beusterien,T. Anderson,Bhakti Arondekar,Britt DiBenedetti
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1074369249772284876577784550752701632837490072523
#%1183249298378249590869114072152797670776932184697
#%219749103130416572843730063712051372118085291651
#%960602569768989208474174462026983082201104910421

#*Variability in creatinine excretion in adult diabetic, overweight men and women: Consequences on creatinine-based classification of renal disease
#@David Jacobi,Christian Lavigne,Jean-Michel Halimi,Hlne Fierrard,Christian Andres,Charles Couet,Franois Maillot
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index388907700657925507843131911994299409946298311779
#%994475607095600051713800635381025975997042111883

#*Low discomfort and pain associated with intensified insulin therapy in children and adolescents
#@B. Karges,R. Muche,M. Moritz,I. Riegger,K.-M. Debatin,E. Heinze,M. Wabitsch,W. Karges
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index782256921917578585755217554847808632045270796268
#%524058293979636223849246697946658268114675212136
#%667833048576749923896013401528005017909549567069
#%1354320655749871550623061380061542132826208359052

#*Association of elevated alanine aminotransferase with BMI and diabetes in older veteran outpatients
#@A. Hermos,A. Cohen,Robert Hall,R. Gagnon,T. Brophy,D. Fiore
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index699163001919814292116945222612673688258758154073
#%1289593039928421999121087397285163376230265349018
#%667850417950253695273468839982230542853468421792
#%731462202590481614299903390079244584398975843207
#%282631434623269146018353748493294384952338699016
#%1084533543497321484722217680169950402426606001289
#%925680157019748441177826312900513644906214306500
#%1327711365720790117535336334257743906560514072654

#*Pregnancy complicated by type 2 diabetes: An emerging problem
#@Annunziata Lapolla,Grazia Dalfr,Domenico Fedele
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index557502760685593264371640706687128397307596588305

#*Effect of corosolic acid on gluconeogenesis in rat liver
#@Kotaro Yamada,Masaya Hosokawa,Shimpei Fujimoto,Hideya Fujiwara,Yoshihito Fujita,Norio Harada,Chizumi Yamada,Mitsuo Fukushima,Naoya Ueda,Tetsuo Kaneko,Futoshi Matsuyama,Yuichiro Yamada,Yutaka Seino,Nobuya Inagaki
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index926550498268797383595095055218886821429506755573
#%607099293851372963650140063757795555815673860134
#%780700083042812890776462530858193343826627849507

#*Renal segmental hypoplasia, Ask-Upmark kidney, in a patient with microalbuminuric hypertensive type 2 diabetes mellitus
#@Tomoya Fuke,Toshiro Sugimoto,Satoshi Ugi,Yasushi Omura,Yoshihiko Nishio,Hiroshi Maegawa,Atsunori Kashiwagi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1388190009499858743703668755803532621045212770274
#%1372008271274784947443115881421823550741327559588
#%932534173818479229217545879822252369997920690552

#*Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease?
#@J. Hickman,J. Russell,B. Prins,A. Macdonald
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index5192139820816186230562750376580367542846710051
#%61003256100308584211205322537742770026045382331
#%102703727586433472694240895928992735120353712183
#%785404378387908356642228240554375299519988120224
#%1266571986266933073709876804876245567159025588246
#%679905319709773893941449697290738371753700134758
#%133548043580818015226759811152512175407052147970

#*Plasma retinol-binding protein is unlikely to be a useful marker of insulin resistance
#@G. Lewis,I. Shand,A. Elder,S. Scott
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index58176312509085642757941276329816360783856253547
#%1412296228679507819686353718055045505430575749843
#%1412296228679507819686353718055045505430575749843
#%834294040834063780548150223032531293737344324970

#*Keishibukuryogan ameliorates glucose intolerance and hyperlipidemia in Otsuka Long-Evans Tokushima Fatty (OLETF) rats
#@Takako Nakagawa,Hirozo Goto,Ghazi Hussein,Hiroaki Hikiami,Naotoshi Shibahara,Yutaka Shimada
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index535574679031035349276990767324088051725796230054
#%131960404965145236196923479747249896405067258015
#%921005169630008256170860871296288543711908288572
#%920971825692726615286336402796881903506516030428
#%1138160824780186745637090459036223397982442699965
#%200507423008692080811027997432437260403169002711
#%712227286747981153831184659748079072021354925305
#%1021002299222599989778245421123926371941613289901

#*Urban rural differences in prevalence of self-reported diabetes in IndiaThe WHOICMR Indian NCD risk factor surveillance
#@Viswanathan Mohan,Prashant Mathur,Raj Deepa,Mohan Deepa,D.K. Shukla,R. Menon,Krishnan Anand,G. Desai,P. Joshi,J. Mahanta,K.R. Thankappan,Bela Shah
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1209260377311547759050501928523960951966357392143
#%730389061745123827854102800773141565268893687811

#*Adipokines and insulin resistance during pregnancy
#@Bertha Zavalza-Gmez,Roberto Anaya-Prado,Rosa Rincn-Snchez,Miguel Mora-Martnez
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index481965859436245325047640750745133722369346931509
#%915824825273085506018614623398318901812135390394
#%1024370063696090162543612804446199148803852559326
#%40064874082184541916108175904698998446959394243
#%97864553377708666547293183294096565990347374228
#%276049964365407590455522870512045612572433084312
#%799005943719481675371819620011320520430605958054
#%666618596030129488520200466192214154998325784915
#%789789363536552479311304939067609100970395113400
#%789789363536552479311304939067609100970395113400
#%272056019394042470500330251058306794963949745821
#%785113000099014877279282692385203242224976358010

#*Short-term intensive glycemic control improves vibratory sensation in type 2 diabetes
#@Yoshihito Fujita,Mitsuo Fukushima,Haruhiko Suzuki,Ataru Taniguchi,Yoshikatsu Nakai,Akira Kuroe,Koichiro Yasuda,Masaya Hosokawa,Yuichiro Yamada,Nobuya Inagaki,Yutaka Seino
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1142685893668929037115770933096380725237133914119
#%481570781244869144784002259840012820397148090045
#%856537884140432138093842042156523599248953399383

#*Social support, self-efficacy and psychological stress responses among outpatients with diabetes in Yogyakarta, Indonesia
#@Sakiko Kanbara,Hiroshi Taniguchi,Motoyoshi Sakaue,Da-Hong Wang,Jiro Takaki,Yuki Yajima,Fumihiro Naruse,Shinji Kojima,Rani Sauriasari,Keiki Ogino
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index502297251171935110173512947625420583815927558737
#%148405005998127907419507843628168174947195770175

#*A case of lipoatrophy with insulin detemir
#@I. Olmo,Vicente Campos,Pablo Abelln,Francisco Merino-Torres,Francisco Pin
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1097900355115351292606916688392656458698219579685

#*Improving the quality of diabetes care in a Sri Lankan diabetes clinic through a diabetes nurse educator
#@C. Idampitiya
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index959141680592499676364478257422215784382897034838
#%1037029326184775581669183275397511100203349090239

#*Comparison of coronary flow velocity reserve and aortic distensibility in diabetic versus non-diabetic patients with and without aortic atherosclerosis
#@Attila Nemes,Mikls Csandy,Tams Forster
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index854902853894908649842349011650804405748642580440
#%601701254539151027394794842575003745696572220511
#%451609450917656044162371101807044281849294379579
#%842011661470410161858543209775988601710490893945
#%1046740043772410847570750735511836857964401395333

#*Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)A 5-year follow-up of the Ehime study
#@Satoshi Murao,Shiori Kondo,Jun Ohashi,Yasuhisa Fujii,Ikki Shimizu,Masao Fujiyama,Keizo Ohno,Yasuharu Takada,Kazuaki Nakai,Yukio Yamane,Haruhiko Osawa,Hideichi Makino
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index603280360248547623943245686675220415156143474713
#%889923740193043015076273459006991200299749370279
#%307085351926955733886722551473612805956776260392
#%1290100661173209927699374087704693760410673113855
#%818554156228999800006951698202714620509325965626
#%471510529695899069413637119763314520122636405187
#%6555031686858691040449285321292487676393599711
#%1002074174875775658268654665077028407319781207731

#*A polymorphism (D20S32e) close to the human melanocortin receptor 3 is associated with insulin resistance but not the metabolic syndrome
#@Jencia Wong,L. Nock,Zhiying Xu,Cam Kyle,Andre Daniels,Marie White,K. Yue,C. Elston,G. Mountjoy
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index180676180382030003955549327722220145174143857134
#%345437676891594129800868258885798029001719631112
#%648376267096817316500506349113998857281377332144

#*Poor metabolic and blood pressure control in patients with diabetic retinopathy attending a tertiary ophthalmic hospital in Australia
#@Gabriella Tikellis,Shiqi Wang,Nathan Wong,Jin Wang,C. Harper,Y. Wong
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index304074286127432368880228685644974350587297374402
#%1070905556764175439569011787851119957132976517450
#%1372609963945178549484299047750695024766901201297
#%741472667357967036521698557437635045148869117616
#%823105217572764320707023930727387118574940651578

#*Mutations in the 1 adrenergic receptor gene and massive obesity in Japanese
#@Yuzuru Ohshiro,Mina Hayashi,Koichi Yabiku,Kazuya Ueda,Hisao Wakasaki,Masayuki Ishigame,Hiroto Furuta,Masahiro Nishi,Hideyuki Sasaki,Nobuyuki Takasu,Kishio Nanjo
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index776938030005583886349901303646595317829250175892
#%645459786005255142247306245367912381455470742968
#%737687190586332816538662130161051974671127697928

#*Necrotizing fasciitis: A life-threatening clinical disorder in uncontrolled type 2 diabetic patients
#@O. Oncul,C. Erenoglu,C. Top,Y. Kkardal,O. Karabudak,Y. Kurt,M.L. Akin,S. Cavuslu,T. Celenk
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index348679102692997438215192405563246473174728697752
#%1235358437294096841689689980880890426711792704749
#%423713425527444359782977008464518069220536048427
#%759123388389088249126055101177323776164814488476
#%316873554968497280734346406850259888519839411423

#*Diabetes during the Russian transition
#@Francesca Perlman,Martin McKee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index612823267756017887849255603691642195571491657227

#*Islet autoimmunity status in Asians with young-onset diabetes (1240 years): Association with clinical characteristics, beta cell function and cardio-metabolic risk factors
#@A.C. Thai,V. Mohan,B.A.K. Khalid,C.S. Cockram,C.Y. Pan,P. Zimmet,J.P. Yeo
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index204658161477875982609246646955105533718450130650
#%1404401825097809215017684971991092855126766552358
#%1153252314837653026549133983716329939105140812748
#%1238085165068360819081516777234685275855993984639
#%735009024663998479048138862737818215104111252409

#*Curcumin inhibits glucose production in isolated mice hepatocytes
#@Hideya Fujiwara,Masaya Hosokawa,Xiaorong Zhou,Shimpei Fujimoto,Kazuhito Fukuda,Kentaro Toyoda,Yuichi Nishi,Yoshihito Fujita,Kotaro Yamada,Yuichiro Yamada,Yutaka Seino,Nobuya Inagaki
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1053619412775890015973609733642766297399402781848
#%368032038131481103621627205383584572714295175600

#*Small particle size of a solid meal increases gastric emptying and late postprandial glycaemic response in diabetic subjects with gastroparesis
#@A. Olausson,Magne Alpsten,Annhild Larsson,Hkan Mattsson,Henrik Andersson,Stig Attvall
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1085178703972940325918258700025613541625397448114
#%1424952004074248149821755565781303674053341385620
#%317469109434448049826556960925721043281753780579
#%121462279815335128982480862336095048423822129414
#%375362792107943614923013276608327663170207999875

#*Immediate insulin treatment prevents gut motility alterations and loss of nitrergic neurons in the ileum and colon of rats with streptozotocin-induced diabetes
#@Ferenc Izbki,Tibor Wittman,Andrs Rosztczy,Nikolett Linke,Nikolett Bdi,va Fekete,Mria Bagynszki
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index3881767830529692998960890528601788912100452745
#%370879302526699497243173189511052607749013079910
#%620424880944077041500135409512810656267038635691
#%1337048177594259291710705376737609857691332065976
#%1339212787982414014018784237316651293438140652695
#%859586508234752932944411712697058397519727817659
#%45093039583750091049673856147511063173870831239
#%1286339101951672875681298350984243820531998805810

#*Screening of diabetes, thyroid, and celiac diseases-related autoantibodies in a sample of Turkish children with type 1 diabetes and their siblings
#@Glay Karagzel,Suzan imek,Orhan Deer,Ayenur kten
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index707635543188375787483189417011265504277988665874
#%1357041002072585866646519810265756503364086660332
#%1033910262124879170401677569925317402070295247809
#%495115585231789036613398331792426352035725530605
#%641988125876210780166381462478866338075558700446

#*Risk factors for hospitalization due to diabetes complications
#@M. Tomlin,M. Dovey,W. Tilyard
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index517042959828939937273266876186753704179010092191
#%599837043519258494668977948963356643112093680425
#%35918773438102490407235411685987031588980286580
#%784142748632893177986606977259374919644987189014
#%388265915305538131258113760487077870312106959751

#*Detection and care of women with gestational diabetes mellitus from early weeks of pregnancy results in birth weight of newborn babies appropriate for gestational age
#@V. Seshiah,Alexander Cynthia,V. Balaji,S. Balaji,S. Ashalata,Rajan Sheela,M. Thamizharasi,T. Arthi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1040700354068325260064097697326114896066955079693
#%951346678248064778510684062381229795620586493366
#%951346678248064778510684062381229795620586493366
#%1353240000207297255461923972303605558783872218691
#%905848932633090410910309312642153155415002826334

#*Early manifestation of macrovasculopathy in newly diagnosed never treated type II diabetic patients with no traditional CVD risk factors
#@Sayeeda Rahman,Al-Safi Ismail,Bahari Ismail,Nyi Naing,Abdul Rahman
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index270804871058413796524218420823488540511496603211
#%1177203212721309603149948679946620019075650242158
#%480499976849348146895692527103401019882968657055
#%1160028118325946375947600876657428420942003101655
#%708364942755841818604510871280195435549934471513

#*High levels of saturated very long-chain fatty acid (hexacosanoic acid; C26:0) in whole blood are associated with metabolic syndrome in Japanese men
#@Atsumi Kume,Tetsuro Miyazaki,Yohei Kitamura,Kyoichi Oshida,Naotake Yanagisawab,Hirotaka Takizawa,Kiyotaka Fujii,Takashi Kiyanagi,Katsuhiko Sumiyoshi,Hirotoshi Ohmura,Hiroshi Mokuno,Kazunori Shimada,Hiroyuki Daida
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index263908540915974064356759203530979144093141043746
#%337873948128180642351799481693096839986031209457
#%1198364753574001826074478481552826208862577615764
#%543370779181503705022577374303399954377659193188
#%824313343934521951016568289326666846156225931673
#%608027367961477215758757976231510100673358964715

#*Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure
#@Junko Ibata,Hideyuki Sasaki,Tetsuhiro Kakimoto,Shohei Matsuno,Muneki Nakatani,Masato Kobayashi,Kunihiro Tatsumi,Yoshio Nakano,Hisao Wakasaki,Hiroto Furuta,Masahiro Nishi,Kishio Nanjo
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1352866179330232980705047798833446654614156817772
#%1431850914911976184220292177659474161129556420992
#%739579494330595434198759060611437401770919379429
#%1061687353785634625658755869401681549327230637642
#%229677516950680097706748199669342825814378520129

#*Low prevalence of retinopathy, but high prevalence of nephropathy among Maori with newly diagnosed diabetesTe Wai o Rona: Diabetes Prevention Strategy
#@Sarina Lim,Chandrasakaran Chellumuthi,Nic Crook,Elaine Rush,David Simmons
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index598483388973701930670381122217528860457609990821

#*Association of the Glu298Asp polymorphism of the eNOS Gene with ischemic heart disease in Japanese diabetic subjects
#@Hiroyuki Tamemoto,San-e Ishikawa,Masanobu Kawakami
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index367198389156980536137460394974375711319173872496
#%945068904226924073927284713999996111233063530960
#%509100549857255444303466717109539348577619500824

#*Disease-specific health-related quality of life instruments among adults diabetic: A systematic review
#@Youness Achhab,Chakib Nejjari,Mohamed Chikri,Badiaa Lyoussi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index888077609588786977732268351109905122742887149246
#%219749103130416572843730063712051372118085291651
#%291724664109600163139732877479275814349167494784
#%923108486065747268458346522172437746936735187283

#*Evaluation of status of toxic metals in biological samples of diabetes mellitus patients
#@Imran Afridi,Gul Kazi,Naveed Kazi,Khan Jamali,Balal Arain,Nusrat Jalbani,Ahmed Baig,Adil Sarfraz
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1045761964238156541886677355045671445186904603712
#%180401832339733592390604173828597789504107249924
#%521165178415879636028513922054355579875779987140
#%1344156169760092084974836597555135814116241025821
#%1344156169760092084974836597555135814116241025821
#%1203911560647305891134205670960759267400292142690
#%390177401085336254505759499512321814718886856110
#%390177401085336254505759499512321814718886856110
#%12471495782792156186096482439469729231062863240
#%526738044104655894401127396043337444925026802787

#*Evaluation of the relationship between gestational diabetes and a history of polycystic ovarian syndrome
#@Maryam Kashanian,Zohreh Fazy,Arezoo Pirak
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index770460845452934329276579376905321431659116752549
#%876326550454550650334479541286453146301556718144
#%51042211408950319792441155767019339408282104269
#%876326550454550650334479541286453146301556718144
#%979479311084893283970172907951823736629432051541

#*Optimal dose and timing of insulin Aspart to mimic first phase insulin response in patients with recently onset type 2 diabetes
#@C. Gredal,A. Rosenfalck,A. Dejgaard,J. Hilsted
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index696837075182257783109021934800698930235378753832
#%56312148809108121445969222528220191720490620381
#%186090774584366707901148348993429435523173147315
#%872924448658529980515315639773360860090470414348
#%599385221501797898130757631190744628937750086593
#%405358859455161293643593699516554537835781930299

#*Endothelin-1 levels and albuminuria in patients with type 2 diabetes mellitus
#@M. Zanatta,Fernando Gerchman,Lucas Burttet,Gustavo Nabinger,C. Jacques-Silva,H. Canani,L. Gross
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index726567222497149829971108002393884234249371970429
#%923230950899319989723698336167797582739997380458
#%757122613439380016522903808626346075180245768313
#%1401196771419821112553934958794551429671642659672
#%1302597743635085078432400438930864772548918304964
#%1259928900117647391992898558087400045303488742086

#*The gap between guidelines and practice in the treatment of type 2 diabetes
#@G. Jenssen,Serena Tonstad,Tor Claudi,Kristian Midthjell,John Cooper
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index6521251268725018138967016988436468682468832052
#%481570781244869144784002259840012820397148090045
#%741472667357967036521698557437635045148869117616

#*Serum uric acid and incident diabetes in Mauritian Indian and Creole populations
#@Hairong Nan,Qing Qiao,Stefan Sderberg,Janne Pitkniemi,Paul Zimmet,Jonathan Shaw,George Alberti,Ulla Uusitalo,Vassen Pauvaday,Pierrot Chitson,Jaakko Tuomilehto
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index284595754957701055302456575651961245174778448799
#%81743634789223207001998240527274064794783811672
#%183931095659104338435490791040848706189007333546
#%901773852231245468559388091758809333105699636183
#%409001227677130449419683368277559244849410936446
#%1070883523767485142822001724615502002990203247416

#*The metabolic syndrome and incident diabetes: Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population
#@Farzad Hadaegh,Asghar Ghasemi,Mojgan Padyab,Maryam Tohidi,Fereidoun Azizi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index760812979363879832759947905176414869989442315105
#%608027367961477215758757976231510100673358964715
#%1374310210571094178812676785082365325858134197455
#%1173561383081208421337958902184247881958638558675
#%597094394382311199554111259596402199372598177702

#*Glutathionyl haemoglobin is not increased in diabetes nor related to glycaemia, complications, dyslipidaemia, inflammation or other measures of oxidative stress
#@Peter Hoffmann,Jade Woon,G. Rowley,Connie Karschimkus,L. Nelson,George Dragicevic,David ONeal,Andrew Wilson,D. Croft,A. Mori,E. Kemp,D. Best,J. Jenkins
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index692543923614168444032613772627708918167336941701
#%1187827638752902079140280386684183941068537808240
#%1394559404431086381390546026339141716118288663949

#*Effectiveness of the novel anti-diabetes medication exenatide in everyday practice: Comparison with clinical trials
#@Sirisha Donekal,E. Shomali
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index732511240557697719957015050982127663733564693042

#*Heparin-induced hyperkalemia
#@C.M. Thomas,J. Thomas,F. Smeeton,B.A. Leatherdale
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index233188322031792815837883476880974777863355678373
#%1369077377197611585577932661530152050478129645427

#*Rapid overgrowth of a fetus after interruption of insulin therapy in a diabetic woman
#@Takashi Sugiyama,Nao Murabayashi,Takashi Umekawa,Kenji Nagao,Yuki Kamimoto,Taku Sugihara,Norimasa Sagawa
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1229139485491974236029910229295291911058304708457

#*The Effect of pioglitazone on circulating adiponectin is highly predictable based on its basal level
#@Yukio Ikeda,Fumiaki Osaki,Hiroshi Maruyama,Shojiro Inada,Masayuki Shinahara,Kosuke Inoue,Hiroshi Takata,Tadashi Suehiro,Kozo Hashimoto
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1257587191976168366509653854318949535120401023702
#%747494549459929334439546805110245830284331121758

#*Does diabetes increase levels of depression and anxiety after lower limb amputation?
#@Rajiv Singh,David Ripley,John Hunter
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index204957373429046219191450970427867577357529281084

#*Diabetes research and clinical practice: Developing a leading medium for diabetes care, prevention and cure
#@Stephen Colagiuri
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index745008543262192679292687314695767907130033942520

#*The impact of the chronic disease assistance plan (CDAP) on the control of type 2 diabetes in Trinidad
#@Astral Bobb,Danielle Gale,Sherisse Manmohan,Amanda Mohammed,Francia Seetahal,Penny Small,Kameel Mungrue
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index854858709066069231434870763125046022040895068599

#*In vivo and in vitro studies of GAD-antibody positive subjects with Type 2 diabetes: A distinct sub-phenotype
#@J. OGorman,Obada Yousif,Gordon Dixon,Siobhan McQuaid,Elaine Murphy,Yousif Rahman,Declan Gasparro,Giovanni Pacini,Philip Newsholme,J. Nolan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index726710455597918623770524664213475304120891576060
#%307085351926955733886722551473612805956776260392

#*Glycated haemoglobin or mean blood glucose as indicators of metabolic control in Type 2 diabetes?
#@Mario Pupillo,Giorgia Berardis,Daniela Antenucci,Anita Minnucci,Antonio Nicolucci
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index418554160504212035297162254476016035594092478307
#%152921597117318923953135929087727254859154485221
#%283046737808688700694678633234820676155743752225

#*Predictors of mortality in hospitalized diabetic patients: A 7-year prospective study
#@Mei-Chun Wu,Wen-Jane Lee,Scheng-Ming Tschen,Shih-Yi Lin,I-Te Lee,Chii-Yuan Jeng,Li-Nien Tseng,Ying-Mei Liu,Been-Yuan Chen,H-H Sheu
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index675685202535854623824109789067956851435485119937
#%1309348636333508695254546525574021509910462819191
#%323876508437449031803477107896245801843817062170

#*Effect of rosuvastatin on capillary filtration of albumin and blood pressure in rats with streptozotocin-induced diabetes
#@Karima Tarhzaoui,Paul Valensi,Cohen Boulakia,Roger Lestrade,Jean-Paul Albertini,Abraham Behar
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index468144971278698358032055637771165077791313283815
#%1363895625008847887032986614263690476731332992617
#%1298124677177655638936891334236511834401117403487
#%398138266858475906032933354728700610481222119155
#%1115227175644657362459252953863431873550158518371

#*Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial
#@A. Allen,A. Fain,Barry Braun,R. Chipkin
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1422589891361637313245105428246272758753297283059
#%824935615518824590915096861765420703227863707281
#%38100726301510870572045252922772327121234231288
#%564202107756324781375156314527007183180465810957
#%1118160987892974174054013178145146232884235353577

#*Postprandial lipaemia in patients with impaired fasting glucose, impaired glucose tolerance and diabetes mellitus
#@S.V. Madhu,S. Kant,S. Srivastava,R. Kant,S.B. Sharma,D.P. Bhadoria
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index261960736799853829721574208006495995852588545707
#%1074059765057976800649630756757955502926827062881
#%115520083568819070806731875473078127812242210954
#%386400172575725435475848536955949543864334715608
#%925638939137232237061108387676139671786679473881
#%1031188938861165138676392097749047372739725025134
#%184583850823910715096388613909298101146174820430

#*Circadian blood pressure variation in normotensive type 2 diabetes patients and angiotensin converting enzyme polymorphism
#@Leszek Czupryniak,Wojciech Mynarski,Maciej Pawowski,Magorzata Saryusz-Wolska,Anna Borkowska,Izabela Klich,Jerzy Bodalski,Jerzy Loba
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1457405499569435586968580148636197187003670797568
#%1010808359737819455372775178022479651170014284991
#%1451376670701415788781880453344104794454110939292
#%30050286391869560740813621937638614200535075674
#%414887502850956926378921935359350155999319222108

#*Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects
#@Hussein Saadi,Nicolaas Nagelkerke,George Carruthers,Sheela Benedict,Samar Abdulkhalek,Richard Reed,Miodrag Lukic,Gary Nicholls
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index709253991975809948830603784064472306905320698173
#%447570740366864965035300359436596789956610868106
#%488030466161149701832258981262032499462602487110

#*Factors associated with treatment failure in patients with diabetic foot infections: An analysis of data from randomized controlled trials
#@Z. Vardakas,Maria Horianopoulou,E. Falagas
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index999499840275990100852308610818302941480570065702
#%1438722055857034958941658233292115225811594968877
#%14811552405869803050601379820104133931869058457
#%242100088374053588581671592183846224365418032251
#%705250653385405566685865478675720010666562451190
#%246662386060241155917511578285745305481994749434
#%544838229555657885967335985372296034261791990127

#*Glucose variability, blood pressure and arterial stiffness in type 1 diabetes
#@D. Gordin,M. Rnnback,C. Forsblom,V. Mkinen,M. Saraheimo,P.-H. Groop
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index877109510198641184793984526188350798710116569740
#%409562326928813714152669972341134724417512641817

#*Complications of diabetes in urban Indigenous Australians: The DRUID study
#@Louise Maple-Brown,Joan Cunningham,Karin Dunne,Cherie Whitbread,Diane Howard,Tarun Weeramanthri,Shaun Tatipata,Terry Dunbar,A. Harper,R. Taylor,Paul Zimmet,Kerin ODea,E. Shaw
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index537920194951062880307747015093041517342137533670
#%1212428627131952568682822305088197810628207000294
#%658041026980849672884350471099324117015220897750
#%249264471260886693526616202004894322898933466062
#%859483543257039096916354482271890551675225194070
#%178496724751886047816230394674959056938107279728

#*Metabolic risk factors, insulin-resistance and lifestyle in children of type 2 diabetes patients in Karachi, Pakistan
#@A. Rashid,A. Jabbar,R.P.J. Michels,J.H. DeVries
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index997700391360834213167861990166274317885275355994
#%479048755542080329004940903545377400614905151241
#%1117496322653766759827720816971106811218622281682

#*Factors influencing risk of macrosomia in women with gestational diabetes mellitus undergoing intensive diabetic care
#@Jarosaw Ogonowski,Tomasz Miazgowski,B. Czeszyska,Brygida Jaskot,Magdalena Kuczyska,Zbigniew Celewicz
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index668786824472449662161174639113172092628985191282
#%636047894914985950363613443307437036189992522131
#%829537043807608568939045101826706724249071161035
#%254372055880903665663663794090781902064810777219
#%1140161764695031003090754387596571494440068092310
#%308332029178327338430345595053119872385356964187
#%562418483107796242217670065188120466615470276366
#%674527045262548111472146874022721734868025405026

#*What glucose target should we aim for in myocardial infarction?
#@N.W. Cheung,V.W. Wong,M. McLean
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index623202213413257467014955804045573225969915727324

#*A report on the diagnosis of intermediate hyperglycemia in Korea: A pooled analysis of four community-based cohort studies
#@Jee-Young Oh,Soo Lim,Jung Kim,Hee Kim,Jun Kim,Dae Moon,Chul Jang,Min Cho,Kee-Ho Song,Woo Ahn,Yeon-Ah Sung,Joong-Yeol Park,Chol Shin,Kyu Lee,Soo Park
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1097222719677870316553611417202972914973666288290
#%997540535011446998871193915546101863446383772292
#%956404848503341552112419567476517275928482514411
#%735009024663998479048138862737818215104111252409
#%672923644847167173082080713137925210327799704657
#%238833678911521896659698772768141671766599116145
#%238833678911521896659698772768141671766599116145
#%390371137728887586911880288885235639516434221172
#%390371137728887586911880288885235639516434221172
#%956911174466392205815650756117722862763483349301

#*Impaired peripheral circulation in lower-leg arteries caused by higher arterial stiffness and greater vascular resistance associates with nephropathy in type 2 diabetic patients with normal anklebrachial indices
#@Toru Yoshimura,Eiji Suzuki,Isamu Ito,Masayoshi Sakaguchi,Takashi Uzu,Yoshihiko Nishio,Hiroshi Maegawa,Shigehiro Morikawa,Toshiro Inubushi,Akitaka Hisatomi,Kazuma Fujimoto,Jun Takeda,Atsunori Kashiwagi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index606013566177946618683239582939183482005217261881
#%431412729600776668789272016853046241948029539427
#%1062419277271444057737754023953305346019300989991

#*Relationship between response of -glutamyltransferase to alcohol consumption and levels of fasting plasma glucose
#@Yoshiaki Hashimoto,Azusa Futamura
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index349809191651514030046050945730243802332193346320

#*Detailed glomerular ultrastructure in Japanese type 2 diabetic patients by the quick-freezing and deep-etching method
#@Tatsumi Moriya,Shinichi Ohno,Yoko Hirasawa,Keiji Tanaka,Yoshikuni Fujita
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index185275404080285720806576830785553343091212138945

#*Efficacy of pioglitazone on type 2 diabetic patients with hemodialysis
#@Masanori Abe,Fumito Kikuchi,Kazuyoshi Okada,Kazo Kaizu,Koichi Matsumoto
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index855181563151833371525206736342250105762837336876
#%1404115445931446577346986320255582647451089005933
#%1243514339120405778577791220642128280313200138463
#%945205506516588029931968841866627190840522024498
#%265038060581318214311281953757448642256123215841
#%265038060581318214311281953757448642256123215841
#%240991863988326953660188855527451955137103471170
#%327821286675085613509521487445833601825051368118
#%600729171836014079433319300461533078223380139900

#*Incidence of children with slowly progressive form of type 1 diabetes detected by the urine glucose screening at schools in the Tokyo Metropolitan Area
#@Tatsuhiko Urakami,Junichi Suzuki,Ayako Yoshida,Hiroshi Saito,Hideo Mugishima
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index665566680386317683250615717928706315883492469436
#%391642221958875625469995052339771156517198762242

#*Prevention of recurrent but not spontaneous autoimmune diabetes by transplanted NOD islets adenovirally transduced with immunomodulating molecules
#@Muneaki Sakata,Hisafumi Yasuda,Hiroaki Moriyama,Katsumi Yamada,Reiko Kotani,Midori Kurohara,Yasuyo Okumachi,Minoru Kishi,Takashi Arai,Kenta Hara,Hirofumi Hamada,Koichi Yokono,Masao Nagata
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1273602569184757426523115279864800060871933991459
#%541163765274635337817821845229903630261410596068
#%983408866755250251286193611844157957254698946250
#%700375949755639840172542068829530182705833564520

#*Association of abnormal glucose tolerance with self-reported sleep apnea among a 57-year-old urban population in Northern Finland
#@Anna-Kaisa Juuti,Liisa Hiltunen,Ulla Rajala,Mauri Laakso,Pirjo Hrknen,Pirjo Hedberg,Aimo Ruokonen,Sirkka Keinnen-Kiukaanniemi,Esa Lr
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index711291557072649659636143359094515052146284230924
#%649508808427951353540968768834727069745995907789
#%649508808427951353540968768834727069745995907789
#%1095766769092697973278302050542363983789810146473
#%1414387362830283031727216959593362836977819441127
#%118578533337694185778176174373956726377702928161
#%665216621030591815039872009752220483007370719415
#%284912115945890587852662759393968385460351281480

#*Flexible eating and flexible insulin dosing in patients with diabetes: Results of an intensive self-management course
#@J. Lowe,S. Linjawi,M. Mensch,K. James,J. Attia
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1100851425852609610925765389288422433432017348775
#%115369490912729955754828440217572936758387839824

#*Is insulin lispro safe in pregnant women: Does it cause any adverse outcomes on infants or mothers?
#@Yusuf Aydn,Dilek Berker,Nafiye Direktr,hsan Ustn,Ate Ttnc,Serhat Ik,Tuncay Deliba,Serdar Guler
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index841988093812744477362474859898569670300403954948
#%493413416089351901283722531885157459727079033410

#*Lanreotide Autogel  for persistent diabetic macular edema
#@C. Hernaez-Ortega,Enrique Soto-Pedre,A. Pinis
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index555590112782824591916383555671458620314971725007
#%1219038715073461980088014149211269561779992345439

#*Diabetes and cardiovascular risk factors in urban Indigenous adults: Results from the DRUID study
#@Kerin ODea,Joan Cunningham,Louise Maple-Brown,Tarun Weeramanthri,Jonathan Shaw,Terry Dunbar,Paul Zimmet
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index768222784442117804079138066962007247901691761454
#%658041026980849672884350471099324117015220897750
#%856408957004379910100842067020466105339915845464

#*Adsorption of insulin onto infusion sets used in adult intensive care unit and neonatal care settings
#@Najam Zahid,M.G. Taylor,Hardyal Gill,Fiona Maguire,Rob Shulman
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1176011331211949414326404128156483347497681893072

#*Diagnostic strategy to improve the efficiency of screening diabetesROC analysis for fasting plasma glucose
#@Junxi Lu,Weiping Jia,Lei Chen
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index808319531267194949279742209685170048750270057609

#*HbA1c negatively correlates with LCAT activity in type 2 diabetes
#@Manouchehr Nakhjavani,Alireza Esteghamati,Fatemeh Esfahanian,Azam Ghanei,Armin Rashidi,Saeideh Hashemi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index226736910950666377178748420097732262719459327968
#%1451356232670346808246136459808162269673069763674
#%1079606014114273381640081091035693674171220594445
#%392216421721611817012426222752870155331643841752
#%251553310998999768026861222982472725810184647368
#%1280709538127030171759598259510933870743254681054
#%157503036357487989286314399569663411909826223467
#%1185566761484746050249663929636116122765099762186
#%271206851939036404097614112760391262355524847727

#*Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus
#@Jin Kim,Kyung Kim,Sub Shim,Hyuk Lee,Yeon Hur,Seok Kang,Woo Ahn,Kil Lim,Chul Lee,Soo Cha
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index651908137543050453485444087898353793843624560796
#%442247854339600553246765371580326339007947570594
#%674086373334239605065167411559918365548418780031
#%377549868103987761897521817157472032619117176238
#%377549868103987761897521817157472032619117176238
#%377549868103987761897521817157472032619117176238

#*Improvements in HbA1c remain after 5 years  a follow up of an educational intervention focusing on patients personal understandings of type 2 diabetes
#@sa Hrnsten,Hans Stenlund,Berit Lundman,Herbert Sandstrm
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index752178116110440107867727498763106081407358465651
#%1441636290916066261218739043327731391659340221120

#*The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients
#@Canan Ersoy,Sinem Kiyici,Ferah Budak,Barbaros Oral,Metin Guclu,Cevdet Duran,Hadi Selimoglu,Erdinc Erturk,Ercan Tuncel,Sazi Imamoglu
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index226031019630481747458327496527114344770585642650
#%13345210828126281387702086792858456439440660572
#%126302732128882379734486270326585281230401329817
#%1059343512257278227070980703174691001016454598081
#%1354780198605040795740381062858891748563172364582
#%753387087908177370482395907720349893592962694367
#%547474015344809544181661456726476740592028811388
#%469684864063605785628610744327956910904139715332
#%1079265775177256081610661474833715240359021608686
#%1351118445457018318103512302714958757263603256512

#*Knowledge after five-day teaching program in intensive insulin therapy performed at the onset of type 1 diabetes influence the development of late diabetic complications
#@Aleksandra Araszkiewicz,Dorota Zozulinska-Ziolkiewicz,Magdalena Trepinska,Bogna Wierusz-Wysocka
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1229767122966318758437134786425358037360765126343

#*Cardiovascular events and insulin therapy: A retrospective cohort analysis
#@M. Engel-Nitz,Sherry Martin,Peter Sun,Don Buesching,Vivian Fonseca
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index275699047400324501874521819000006887330019115571

#*High-normal blood pressure, impaired glucose regulation and metabolic syndrome have variable impact on central artery stiffness
#@Kunihiko Aizawa,Kevin Shoemaker,J. Overend,J. Petrella
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index979666132106914015693832157098175140763111233600
#%645065595204707760807697954435677983266288018909
#%975594269446797166881458381619456774486226570374
#%834437147182693067781976395733060264840207051895
#%1403105501787433953476810635247990541158850246732

#*The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in Type I diabetic patients: A systematic review
#@V.T. Chetty,A. Almulla,A. Odueyungbo,L. Thabane
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index95422658731389676026262542332856728815215801174
#%545626493949273196867672440351619089259974614830
#%524058293979636223849246697946658268114675212136
#%582837888036975073134038422433561035225731180840
#%1292110379918747549018322929657578770938902971112
#%603719682485610248618052660561160498633883620754
#%768247779115369498662625639438801948530949825098

#*The accuracy of population health data for monitoring trends and outcomes among women with diabetes in pregnancy
#@C. Bell,B. Ford,A. Cameron,L. Roberts
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index687945407402549849910896926810000019568438345702
#%354029231281981279886337045378105864042653539876
#%1175607117154184461108000723669038286528888691547
#%435775113390405825055487808420269959548414496184
#%1219815014671946993305412158750340360303754072059
#%405859285318037340811671366012378426845973781039

#*Analysis of muscle microcirculation in advanced diabetes mellitus by contrast enhanced ultrasound
#@D. Duerschmied,P. Maletzki,G. Freund,M. Olschewski,J. Seufert,C. Bode,C. Hehrlein
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index101843703121519245966948086703984285253689186833
#%449257797695563277966023645265877616802934854444

#*Gestational diabetes has no additional effect on plasma thrombin-activatable fibrinolysis inhibitor antigen levels beyond pregnancy
#@Baris Akinci,Tevfik Demir,Saba Saygili,Serkan Yener,Inci Alacacioglu,Fatih Saygili,Firat Bayraktar,Sena Yesil
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index922200335994758574304468071781530149863991743453
#%150924820793988661376722861938585999280518503164
#%1244668844683705780038299568062271647490345448040
#%963884426449497680513177040449874465869287486145
#%1289400065468162438832347210328194493574768915126
#%1191441783441467555024182935660296169725662816288

#*Effects of sulfonylurea drugs on adiponectin production from 3T3-L1 adipocytes: Implication of different mechanism from pioglitazone
#@Yukiko Kanda,Masafumi Matsuda,Kazuhito Tawaramoto,Fumiko Kawasaki,Mitsuru Hashiramoto,Michihiro Matsuki,Kohei Kaku
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index322206245203435533470845042947428142131495796616
#%1347131148159653833870809454228854616978879559695
#%1127956677808160097945284298980041188937972710753
#%555064556135246892516443731839580883083981771471

#*A case of new mutation in maturity-onset diabetes of the young type 3 (MODY 3) responsive to a low dose of sulphonylurea
#@D. Jei,Silvija Saji,M. Jei,Monika Maringa,Dragan Mici,Svetislav Neci
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1174278504282448814970590998742982046421771081841
#%1166309812586244514028711015268732481655515668500

#*Leisure time physical activity in individuals with screen-detected type 2 diabetes compared to those with known type 2 diabetes
#@Jaana Karjalainen,Markku Peltonen,Mauno Vanhala,Eeva Korpi-Hyvlti,Hannu Puolijoki,Juha Saltevo,Heikki Oksa,Timo Saaristo,Jaakko Tuomilehto,M. Kujala
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index624350732633222777022514821396120698325063467379
#%1172677228348686885501689655071745393817660190684
#%1391678818424462780198257900960799566460938816007
#%610933636802206784054441052388249503323609875906
#%869664808450158640683311382198703984992622889083

#*Characteristics and blood pressure management in patients with and without diabetes in primary care in rural Victoria
#@David Simmons
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index185842208358110372544764652719286279117531275667
#%764312753565349303891027853166470931288928689145

#*The activation of NF-B and AP-1 in peripheral blood mononuclear cells isolated from patients with diabetic nephropathy
#@Sun Nam,Ho Cho,Taek Lee,Suk Park,Woo Ahn,Soo Cha,Kil Lim,Rae Kim,Joo Ha,Chul Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index736478200008805716625616604407437990207689906009
#%548015544124711038045290869046536090178197294647
#%1134815585017459209171883409728029001654701057989
#%13509464718125359004323242949801417035726347069
#%1124697681869862203068419861343619000073406708805

#*Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome
#@Shi-Jun Liu,Zhi-Rong Guo,Xiao-Shu Hu,Ming Wu,Feng-Mei Chen,Guo-Dong Kang,Hui Zhou,Lu Guo
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index302611068002930886170945082619010899891934294892
#%729011491030204087305000494930908873556615854408
#%173068796121104773673572854557285518544821230679
#%608027367961477215758757976231510100673358964715
#%944940952388715148989370803828489774517505362952

#*The haplotype identified in LEPR gene is associated with type 2 diabetes mellitus in Northern Chinese
#@Yanchun Qu,Ze Yang,Feng Jin,Liang Sun,Jie Feng,Lei Tang,Chuanfang Zhang,Xiaoquan Zhu,Xiaohong Shi,Hong Sun,Binyou Wang,Li Wang
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index190749317667130621221913120941354193540463485108
#%1159167972526680595035531327467316909885049610756

#*Increased serum pigment epithelium-derived factor levels in type 1 diabetic patients with diabetic retinopathy
#@Naoto Katakami,Hideaki Kaneto,Yoshimitsu Yamasaki,Munehide Matsuhisa
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index812572350152832764608958825442764247230426728208
#%63876128836752088636546773298870987134385353369
#%1414975792207601331989675115728940263877242316454
#%361549276987961122347604593330024641337356380546

#*Prevalence of type 2 diabetes among women with a previous history of gestational diabetes mellitus
#@Hoon Lee,C. Jang,K. Park,E. Metzger,H. Cho
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index410764867058528300571252344229691934388488139958
#%735009024663998479048138862737818215104111252409
#%340035279079324791840196450218319126054720600885
#%340035279079324791840196450218319126054720600885
#%425359508911865790944680143974007765055061334363
#%1017838868978988002083081478663843828244283907057
#%1066063158367629299004027611797224278059141513348
#%1298888924721350131033295591530302217923025041749
#%97864553377708666547293183294096565990347374228
#%1133012900983942807876756904025993086730161253436

#*Beneficial effects of severe sleep apnea therapy on nocturnal glucose control in persons with type 2 diabetes mellitus
#@Maria Pallayova,Viliam Donic,Zoltan Tomori
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1147599069371876638735352154933233256970060837231

#*The angiotensin converting enzyme insertion/deletion polymorphism and differences in fasting plasma glucose in Hindustani Surinamese, African Surinamese and ethnic Dutch: The population-based SUNSET-study
#@G.M. Valkengoed,Karien Stronks,N. Hahntow,B.L. Hoekstra,Frits Holleman
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index654643440805838066610557726553890182590583506631
#%359789505531557513541833183653039718289774604036
#%359789505531557513541833183653039718289774604036

#*Lack of knowledge of glycosylated hemoglobin in patients with diabetic retinopathy
#@Shiqi Wang,Gabriella Tikellis,Nathan Wong,Yin Wong,Jin Wang
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index93966116379789061876913919621753069883620326482
#%335349567956742759346127749159388950731422420282
#%741472667357967036521698557437635045148869117616

#*Enterococcus gallinarum endocarditis in a diabetic patient
#@Massimiliano Ortu,Eugenia Gabrielli,Ilaria Caramma,Roberto Rossotti,Maria Gambirasio,Cristina Gervasoni
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1362734930336409315031530175517952669958206894341
#%164627696311884878628131839804054668866360365845

#*Sleep-disordered breathing and type 2 diabetes
#@E. Shaw,M. Punjabi,P. Wilding,M.M. Alberti,Z. Zimmet
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index287078960129649520982773373663433657960019787796
#%1425236715197593267448916569848699529358635903187
#%1425236715197593267448916569848699529358635903187
#%1425236715197593267448916569848699529358635903187
#%713540244543656635640617293931540976177290391992
#%753007754582794310624158109308785210175254190808
#%330879168352785446751999505618325857990083022183
#%721460529748626091946607489529998862479438602526
#%1231834185904462089820442380765976457153826802076
#%72294007444217036698437581704992125692996235178

#*Obstructive sleep apnoeaAnother important diabetes-associated problem
#@Stephen Colagiuri
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index919374596855771987762892652686978931452795265740

#*Preoperative risk evaluation in diabetic patients without angina
#@Jingming Bai,Jun Hashimoto,Tadaki Nakahara,Naoto Kitamura,Takayuki Suzuki,Atsushi Kubo
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index760989287510567409751913112805367363284448058300
#%330084171126046009669358567913170215505209509970
#%328769875745177909569342371814587463993802751543
#%257383024524948935812914496238041971057831708598
#%985064865108386973087840781228144655977078391804

#*Comparison of coronary plaque characteristics between diabetic and non-diabetic subjects: An in vivo optical coherence tomography study
#@Stanley Chia,Christopher Raffel,Masamichi Takano,J. Tearney,E. Bouma,Ik-Kyung Jang
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index520025747105284160472049023195497375317817919483
#%473145865442996896430004132135207880992572597433
#%1444741601684317290348245239166398347312501231135
#%1187507756824401385952460935004980686773448030367
#%1105244180022601647475668485583187762695124727957
#%1249736044297014338481852405781370253373707072305
#%1215078023042785338844737183579126811346502093875
#%384549260654037835372096522424822072615521978124

#*The quality of life and economic burden of neuropathy in diabetic patients in Germany in 2002Results from the diabetic microvascular complications (DIMICO) study
#@Michael Happich,Jrgen John,Sabine Stamenitis,Johannes Clouth,Dorit Polnau
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index353512652985242774076074366240762877462260917001

#*Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia or weight gain: A double-blind, randomized, controlled trial in Japanese patients with type 2 diabetes
#@Y. Seino,M.F. Rasmussen,M. Zdravkovic,K. Kaku
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1125883236968947230792865653325336291251909538587
#%484915302048216297982043338261390071563821490864

#*Absence of evidence for an association between resistin gene variants and insulin resistance in an Asian population with low and high blood pressure
#@L. Kimbell,A. Koropatnick,S. Grove,Yung-Hsiang Huang,Fu-Tien Chiang,Thomas Quertermous,Randi Chen,A. Donlon,L. Rodriguez,David Curb
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1144581247276204641322098582582160578678474998810
#%550806660826579196240334882143442528068465218911

#*Improvement of glycemic control and quality-of-life by insulin lispro therapy: Assessing benefits by ITR-QOL questionnaires
#@Hitoshi Ishii,H. Anderson,Ayuko Yamamura,Masakazu Takeuchi,Ichiro Ikeda
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1111619129422686229936081788557512223965395589827
#%481570781244869144784002259840012820397148090045
#%124347794970516082571193490069354646775323679555

#*Effects of changes in basal/total daily insulin ratio in type 2 diabetes patients on intensive insulin therapy including insulin glargine (JUN-LAN Study 6)
#@Motoyuki Tamaki,Tomoaki Shimizu,Akio Kanazawa,Yoshio Fujitani,Hirotaka Watada,Ryuzo Kawamori,Takahisa Hirose
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1008343575815585326261625594283331934790171954358
#%974805200289707624657149319035097252347654280267

#*Prevalence of diabetes mellitus and metabolic syndrome in Slovakia
#@Marin Mok,Peter Galajda,Dana Prdavkov,Viera Tomkov,udovt utark,udmila Kruinsk,Andrea Bukovsk,Gabriela Rusnkov
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index922986831108587469864109157469462914048656934590
#%393865339362114710523463128999850163711520687076
#%393865339362114710523463128999850163711520687076
#%326985759915143411245311583153438781566095278008
#%1120175854143875344688243148653684930546921391784

#*High prevalence of type 2 diabetes mellitus in affluent urban Indians
#@R. Boddula,S. Yadav,V. Bhatia,G. Genitta,D. Pandey,A. Kumar,H.K. Singh,V. Ramesh,S. Julka,B. Bansal,K. Srikant,E. Bhatia
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index983807498380577437236757040102448188647613079358
#%83601227522677886787379561658857657895968763595
#%83601227522677886787379561658857657895968763595
#%83601227522677886787379561658857657895968763595

#*Coated-platelet levels in patients with Type 1 and with Type 2 diabetes mellitus
#@J. Jenkins,K. Gosmanova,J. Lyons,D. May,Azar Dashti,Z. Baker,Leann Olansky,E. Aston,L. Dale
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1396310800260138983359333405238961408752234261513

#*Low-grade chronic inflammation is not accompanied by structural arterial injury in polycystic ovary syndrome
#@Fernandes Costa,dos Santos,Mnica Oliveira,Aline Viana
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index267803899684443392918339320221558895348546752457
#%1226237053771352385803555690166012985923168579886
#%1273588792531722431509182872225825942447716641331
#%934119508939528377120556677347512265698227889229

#*Relation between age and coronary heart disease (CHD) risk in Asian Indian patients with diabetes: A cross-sectional and prospective cohort study
#@I. Idris,R. Deepa,D.J. Fernando,V. Mohan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index118398129095519927609985175202679430195884338318
#%213692516551383425882431509383289064378112777048
#%837921765406650140104122394303026034238297271485

#*Long-acting insulin analogues versus NPH human insulin in type 2 diabetes
#@Matteo Monami,Niccol Marchionni,Edoardo Mannucci
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1459075944012268933010478197203568438895622444456
#%1189029430276948011704907806569661416793802370013
#%1204210450054912597786899191343141949179439576611
#%331125870934479234182160053302514815224859038971
#%406627268008390124287429037767430188735742044826
#%545626493949273196867672440351619089259974614830
#%974805200289707624657149319035097252347654280267
#%1071600986827864669940529472070420702990062425008
#%707902077053608907834739575725305064393287645619

#*Increasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults: The InterASIA study
#@Dongsheng Hu,Pengyu Fu,Jing Xie,Chung-Shiuan Chen,Dahai Yu,K. Whelton,Jiang He,Dongfeng Gu
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index631533597668917216550139443186317980325934730010
#%1329324488888932526555071966269634652929007615719
#%63054821013796211110519383969823604828797582210
#%63054821013796211110519383969823604828797582210

#*A common polymorphism is associated with body mass index in Uyghur population
#@Jun Zhang,Rong Lin,Fen Wang,Ming Lu,Ren-yong Lin,Shi-zhen Wang,Hao Wen,Li Jin,Xiao-feng Wang
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index811191820048712732446267533717544633798709500934

#*Glycemic instability in type 1 diabetic patients: Possible role of ketosis or ketoacidosis at onset of diabetes
#@Mariko Sassa,Yuichiro Yamada,Masaya Hosokawa,Kazuhito Fukuda,Shimpei Fujimoto,Kentaro Toyoda,Katsushi Tsukiyama,Yutaka Seino,Nobuya Inagaki
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index821582914828023021827089721368654924898119076371
#%1162080773818429787095011864650506175914730572736
#%1248526042107158614524985385571988431710319516601

#*Acute progression of severe insulin edema accompanied by pericardial and pleural effusion in a patient with type 2 diabetes
#@Satoshi Kawashima,Hideaki Kaneto,Kenya Sakamoto,Tetsuyuki Yasuda,Akio Kuroda,Toshihiko Shiraiwa,Kaoru Yamamoto,Ryuichi Kasami,Taka-aki Matsuoka,Yoshimitsu Yamasaki,Munehide Matsuhisa
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index188249735947279228890760909421740439640776594996
#%1186701914830674285619733022610993059018584220163

#*CLD (chronic liver diseases)-HbA 1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases
#@Masafumi Koga,Soji Kasayama,Hideo Kanehara,Yukihiro Bando
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index51555828765853766762089151397231602077145999209
#%1219967129454705658394013377336870070714631371121

#*Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function
#@Tomohito Gohda,Mitsuo Tanimoto,Ju-Young Moon,Hiromichi Gotoh,Tatsuya Aoki,Masakazu Matsumoto,Terumi Shibata,Isao Ohsawa,Kazuhiko Funabiki,Yasuhiko Tomino
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1069574211461964889153248760598250174842077085761
#%742749049217386605104451746167000406557938816827
#%660134182187421808855332383965528837562407567349
#%123222428576100622517757303164683030264104968188
#%821610308975083232404896204086646136680337153655
#%501339625268403939664151454813959361250072627810

#*Fatty liver and chronic inflammation in Chinese adults
#@Pei-Wen Wang,Ching-Jung Hsieh,Leung-Chit Psang,Yu-Fan Cheng,Chia-Wei Liou,Shao-Wen Weng,Jung-Fu Chen,I-Ya Chen,Rong-Hwai Li,Hock-Liew Eng
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1327917229193807665436691998775007118837368286232
#%1438361308239152205343302480156715263383345379538
#%1247584568640917432378988189365557209831242849121
#%745141609985269016498344671854280977424073433512
#%187388253333999103074330157445826953701325522093
#%1232501439374062361965134784980106293045174871350
#%639985632551033912980344163437115694946281369965
#%1378232309151013105142487145858927163597592381276

#*The effect of rosiglitazone on oxidative stress and insulin resistance in overweight individuals
#@J. Manning,H.F. Sutherland,J. Walker,M. Williams,A. Jong,A. Berry
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index828743149241457957704969117937635952244646276469
#%1036209666691324726752807572529996476922599048965
#%197625299189262077057065658615739135766289904184

#*Prevalence of diabetes mellitus in Croatia
#@eljko Metelko,Ivana Pavli-Renar,Tamara Poljianin,Lajos Szirovitza,Stjepan Turek
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index233977983668887543759705082774969369950628037536
#%433513365266439636606227846414073596900410825731
#%83601227522677886787379561658857657895968763595
#%83601227522677886787379561658857657895968763595
#%433513365266439636606227846414073596900410825731

#*Experimental diabetes enhances Ca 2+ mobilization and glutamate exocytosis in cerebral synaptosomes from mice
#@Eiki Satoh,Ayako Takahashi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index60981655032326882944789480607208176282701122538
#%632457331482755377099061846451061723056736874514
#%712135674891721976020841536816246512611453552002
#%779076760556236727684996805329598648634165147830
#%1265687049668488475498756736131840021292054902392
#%1281194679080930721053910820568149849060833833457
#%732183215256985575885332690164069465650217012229

#*Hypotensive effects of exercise performed around anaerobic threshold in type 2 diabetic patients
#@C.J. Lima,V. Assis,Wolysson Hiyane,S. Almeida,Gisela Arsa,Vilmar Baldissera,S.G. Campbell,G. Simes
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index960941862665017555429991041855753439792498817860
#%756116858949913941145674086739005445396079697887
#%837921765406650140104122394303026034238297271485
#%1095969356201111481469553121475187829565495027456
#%1363720464846402832122769678882944767658140378001
#%827055783652404466024772297706134725301258566840
#%453423001805215130705005176928310782135176402268
#%1279299249110661671145917267229885204209668656837

#*Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet
#@Chun-Ching Shih,Cheng-Hsiu Lin,Wei-Li Lin
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1419376855103913978266591104191421315042828107346
#%1304669527920201327967786879501994652570664260783
#%33204819115154763686533976200787746424945045817
#%337873948128180642351799481693096839986031209457

#*Subjects with coronary artery disease are at high risk for glucometabolic abnormality
#@Min-Huang Hsieh,Kuei-Mei Yeh
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index769277079870144135061892223043790557374293455098

#*Effect of fasting on PPAR and AMPK activity in adipocytes
#@Kazuo Kajita,Tomoatsu Mune,Takahide Ikeda,Masami Matsumoto,Yoshihiro Uno,Chiyo Sugiyama,Kenji Matsubara,Hiroyuki Morita,Masao Takemura,Mitsuru Seishima,Jun Takeda,Tatsuo Ishizuka
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index738718642459049616291762088340293049640557981265
#%1056194466796169749275556848018398761343434953432

#*Diabetes research and clinical practice Junior Research Prize: Conference report, 2008
#@Jenny Collins
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1002135954705897946752421058010901325449986224747

#*Back to the futureDo IGT and IFG have value as clinical entities?
#@Stephen Colagiuri
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index451925438153163712209066516609077465690618431997
#%1186501341515059391140442800919395799048423877293

#*The PRESENT study: Helping to put clinical trials into clinical practice
#@Andreas Liebl
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1272087360206611719122043223437611127308590753079
#%1263172573414075701050399464616766099375123734074

#*Glycaemic control and hypoglycaemia in the PRESENT study
#@Majeed Almustafa,Ping Yeo,Duma Khutsoane
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index234464256120390197898967525223976092756457719098
#%1454173051140223056214004912298129667489991059702
#%331184958784217527171867215943072764217041741741
#%1070905556764175439569011787851119957132976517450
#%484915302048216297982043338261390071563821490864
#%833841521118113305003858268559800305509253683185

#*Study design and baseline characteristics of patients in the PRESENT study
#@Marina Shestakova,Molskov Bech,S. Momani
#year2008
#confDiabetes Research and Clinical Practice
#citation1
#index331184958784217527171867215943072764217041741741
#%1186346468612348943346164264824208867847496851823
#%1263172573414075701050399464616766099375123734074

#*Lessons in initiating insulin in clinical practice
#@K. Sharma,Ping Yeo,Alan Garber
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index789170383261450988427816261633300301626789881616
#%481570781244869144784002259840012820397148090045
#%398966926411729416063166796594408977831586910264
#%166688693930316500097684870504955600225545042459
#%497708998244205723171236061580448431567300017522
#%657463036024543305612674721533784506688334612312
#%647207352993700572949540616003108104467853498106
#%1026519972908381670571085199203635894850310149009

#*Intensification lessons with modern premixes: From clinical trial to clinical practice
#@Serdar Guler,A. Vaz,Robert Ligthelm
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index555302514651412625461968853320232058523709271818

#*Factors responsible for elevation of 1-h postchallenge plasma glucose levels in Japanese men
#@Norio Harada,Mitsuo Fukushima,Kentaro Toyoda,Rie Mitsui,Tomoyo Izuka,Ataru Taniguchi,Yoshikatsu Nakai,Yuichiro Yamada,Yutaka Seino,Nobuya Inagaki
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index105060508844412450869318906866582904287733299042
#%1288034188437030632047517680099362354857761085656
#%856537884140432138093842042156523599248953399383
#%626712650228435264764882127709525971901608379480

#*Risk of exercise-induced hypoglycaemia in patients with type 2 diabetes on intensive insulin therapy: Comparison of insulin glargine with NPH insulin as basal insulin supplement
#@Ursula Plckinger,Mendaha Topuz,Brigitte Riese,Thomas Reuter
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index436304552043296113360790296923734376341593628748
#%529366882350508612727658276200339461925564986772
#%756009885664760336098503993733188164515304275826

#*Efficacy and safety of modified Yale insulin infusion protocol in Japanese diabetic patients after open-heart surgery
#@Motoyuki Tamaki,Tomoaki Shimizu,Akio Kanazawa,Yoshifumi Tamura,Ayame Hanzawa,Chie Ebato,Chiharu Itou,Eisuke Yasunari,Haruna Sanke,Hiroko Abe,Junko Kawai,Kaede Okayama,Kazuhisa Matsumoto,Koji Komiya,Minako Kawaguchi,Noriko Inagaki,Takahiro Watanabe,Yoshie Kanazawa,Takahisa Hirose,Ryuzo Kawamori,Hirotaka Watada
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index605766126101627951190546752923262727561235998643
#%1034321277798709317650980772778247555971880193626

#*The relationship between angiotensin-converting enzyme insertion/deletion polymorphism and proliferative retinopathy in type 2 diabetes
#@Mostafa Feghhi,Abdolrahim Nikzamir,Alireza Esteghamati,Fereidoon Farahi,Manouchehr Nakhjavani,Armin Rashidi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1253127561181008942086513762112441092885416185962
#%1150284805627011368930584849180530287370518470057
#%1418150235500447176775269595970903286247099776540
#%236262254060566686291807186916313762363200787503

#*Abnormal glucose regulation in an Australian acute coronary syndrome population: A prospective study
#@Sharon Chih,M. McQuillan,Joey Kaye,P. Beilby,Joseph Hung
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index708108495160869570028343027163724616475860810976
#%2359573307378163113432573808006141772788557681
#%1449005384960677540707614895751154616790243102417
#%1045667635544603054168279070204550387926893754641
#%840662038395219205566876331832688090954680326580
#%409562326928813714152669972341134724417512641817

#*Prevalence of diabetes in a large, nationally representative population sample in Hungary
#@P. Vamos,S. Kopp,Andras Keszei,Marta Novak,Istvan Mucsi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index939895407046009785194847051457979111530054991836
#%593278508426615700564096658807807234883906851846
#%889063070304519765810295239969477366652303092963

#*AST-120 (Kremezin ) initiated in early stage chronic kidney disease stunts the progression of renal dysfunction in type 2 diabetic subjects
#@Kazunori Konishi,Shigeru Nakano,Shin-ichi Tsuda,Atsushi Nakagawa,Toshikazu Kigoshi,Daisuke Koya
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1306207435124534316810832863329206642813846027962
#%1243304313265350891572344831214816095320359655458
#%284603134208025813911662973167731051111523189851

#*Declining prevalence of diabetes mellitus in hereditary haemochromatosisThe result of earlier diagnosis
#@E.P. O'Sullivan,J.H. McDermott,M.S. Murphy,S. Sen,C.H. Walsh
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index169130835246900024778579267299059157017080989255
#%319657253745714969456272448684828180234208640649
#%500493838711269930508020703656412215685024212412
#%351727926955698968275244922361274735423434792002

#*Low leptin but high insulin resistance of smokers in Japanese men
#@Yo Hotta,Hiroshi Yatsuya,Hideaki Toyoshima,Kunihiro Matsushita,Hirotsugu Mitsuhashi,Seiko Takefuji,Yutaka Oiso,Koji Tamakoshi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index405262652787453437874715528832493110646940784118
#%1185822330885153882248453441319871316163743673924
#%728690757794925989388501786153819871968641722413
#%955435111464423087923374189605876501370734891449
#%563659808671810155975533953041700588228799213548
#%1335884736395878218637423559975729723050007140797
#%509268860753399877151495208572998318119530328893
#%1243430945935015428181091628768074367802618795923
#%356723084956678048310110746609000713474666274552
#%531473786077327165531326699746837659838828620619
#%74637082101529573808716474389778357243266217642
#%1136625705937828558021491787293276689216868391381
#%1032381218985703418853288054740093610156351724694
#%1122876593430619089198321703881073477797148556416
#%1122876593430619089198321703881073477797148556416
#%523412714197320871699125144518028382632377841121

#*Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children
#@JangSuk Yoo,SeonYeong Lee,KyuNam Kim,SunMi Yoo,EunJu Sung,JungEun Yim
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index41380166191379274296251247133691563454062375120
#%1062102914805636190528624029436745766855225529621
#%459982748413977877749978568933015547217590155878
#%1363017471832830800135128921364796578717023392165
#%81032631974576528930237266593192330879453386993
#%860383968360121006040401671505877822238696803430
#%1068785571614799542485697940007968607685337100273

#*Characteristics of signalling properties mediated by long-acting insulin analogue glargine and detemir in target cells of insulin
#@Tsutomu Wada,Mari Azegami,Maine Sugiyama,Hiroshi Tsuneki,Toshiyasu Sasaoka
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index922973486202645269642962712011008123844451192482
#%451245237813493871982158470456954646693566556120
#%1086576819707577088030119514283527123796963160405

#*The association of the PAX4 gene with type 1 diabetes in Han Chinese
#@Yun Zhang,Xinhua Xiao,Ying Liu,Xilin Zhu,Li Wenhui,Naishi Li,Tao Yuan,Heng Wang
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1456916085316104332259330760841446453615384516726

#*Pioglitazone treatment stimulates circulating CD34-positive cells in type 2 diabetes patients
#@Hisashi Makino,Sadanori Okada,Ayako Nagumo,Takako Sugisawa,Yoshihiro Miyamoto,Ichiro Kishimoto,K. Akie,Toshihiro Soma,Akihiko Taguchi,Yasunao Yoshimasa
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1363087087699811569299082075761127804358369508046
#%747494549459929334439546805110245830284331121758
#%1397386051841054713391250951143590837334441651715

#*Analysis of traditional and nontraditional risk factors for peripheral arterial disease in elderly type 2 diabetic patients in Taiwan
#@Chen-Kai Chou,Shao-Wen Weng,Hsueh-Wen Chang,Chih-Yin Chen,Sheng-Chi Su,Rue-Tsuan Liu
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index847224943865023729654779381669259967214956650818
#%1426243186614138028453684909556305521170974393188
#%1145189355739812945296988213990513043337198008888
#%635894664578588444100407649163603459372962459637
#%1304600205965406857477137708284533702758346961207
#%933563310632915580361227053629726344380042025991

#*Association of serum apolipoprotein B48 level with the presence of carotid plaque in type 2 diabetes mellitus
#@Kyoko Tanimura,Yasushi Nakajima,Mototugu Nagao,Akira Ishizaki,Toshiko Kano,Taro Harada,Fumitaka Okajima,Mariko Sudo,Hideki Tamura,Shinya Ishii,Hitoshi Sugihara,Shizuya Yamashita,Akira Asai,Shinichi Oikawa
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1452652065358613082741592867467614223774817820783
#%40526043267571496711631112709714191362915455380
#%402407522854826856923064074396242169303085016102
#%522467179575744634495993427265264656699473904671
#%1284235843331088085009668923368145027015789188117

#*Ethnic difference in patients with type 2 diabetes mellitus in inter-East Asian populations: A systematic review and meta-analysis focusing on fasting serum insulin
#@Masakazu Takeuchi,Kousuke Okamoto,Tatsuya Takagi,Hitoshi Ishii
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index50936492226713450662042994889032552805109411595
#%1102880864833037643035743539547463658107628255008
#%936069583900768098272343450335544347261807063193
#%260080633231581146552350026072317121059362168506
#%255967406113212341099994501119475161367196511428
#%837198783763783816831346456434338031298081739614
#%322307483286430839010186166883415500876394233111
#%1073677347102714921712200538365033731607436880856
#%1073677347102714921712200538365033731607436880856
#%1073677347102714921712200538365033731607436880856
#%856537884140432138093842042156523599248953399383
#%1035630632353132825605501487092498371038941011798

#*Aggravation of albuminuria by metabolic syndrome in type 2 diabetic Asian subjects
#@I-Te Lee,Chien-Ning Huang,Wen-Jane Lee,Hong-Shen Lee,H.-H. Sheu
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1176679363504979192741724592897669570669204757000
#%587117318111945668005794222336266644709775824331
#%587117318111945668005794222336266644709775824331
#%988365858853113189517601457577966508186949091619
#%1087590640195649014213209567220552157576623161488
#%700543556941930640882204839683510043582170238059
#%639869836967781555716474353988492051007345812338
#%639869836967781555716474353988492051007345812338
#%1269803042723723184929316905283302123850009768834
#%263039633651466198655291183318166647289499066025
#%614975234728911821292090308283346969514606343135
#%279999983877944761980039202936569032539827604549
#%765427292262096626625080162256023805214090750248

#*The metabolic syndrome identifies a heterogeneous group of metabolic component combinations in the Asia-Pacific region
#@Ying Lee,R. Huxley,Mark Woodward,Paul Zimmet,Jonathan Shaw,H. Cho,Rae Kim,Satu Viali,Makoto Tominaga,Dorte Vistisen,Knut Borch-Johnsen,Stephen Colagiuri
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index60132564672801738696820977742853925209897213203
#%988365858853113189517601457577966508186949091619
#%1101387924464804961309612687235002104295226827515

#*Effect of high glucose levels in human platelet NTPDase and 5-nucleotidase activities
#@Incio Lunkes,Sausen Lunkes,Daniela Leal,Carmo Arajo,Masa Corra,Lara Becker,da Rosa,Maria Morsch,Chitolina Schetinger
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index762529318575887089637225543537263431690079651527
#%443875079895641006866306167028263676272451109020
#%1117825262200461906570912064647890430043234099044
#%1117825262200461906570912064647890430043234099044
#%206723789855891112625685827679807346487675755332
#%481212674554644240378160884040399290398566600949
#%258508657169645356629191056802794400890268455687
#%258508657169645356629191056802794400890268455687
#%329043287041878308046367501048599817230671267170

#*Influence of Lys656Asn polymorphism of leptin receptor gene on insulin resistance in patients with diabetes mellitus type 2
#@D.A. Luis,M. Sagrado,R. Aller,O. Izaola,R. Conde
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index751986062464305221904059004876729721164714002368

#*Manganese superoxide dismutase Ala16Val polymorphism is associated with the development of type 2 diabetes in Japanese-Americans
#@S. Nakanishi,K. Yamane,W. Ohishi,R. Nakashima,M. Yoneda,H. Nojima,H. Watanabe,N. Kohno
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1278798932960262088671524496324193871959573369530
#%1379587318085462290336032320947366837959019057895
#%682410669387160455296661059966704512591264633290
#%642615619415039293906110121331280491675460273127
#%1398020159207202926660166837072050936127521028875
#%936069583900768098272343450335544347261807063193
#%1410374207007295930028655162443067647706268079337
#%1111950832010893696363679068857828004541809951493
#%231422036311550398724051550833968651849741585271

#*Effect of ENPP1/ PC-1-K121Q and PPAR-Pro12Ala polymorphisms on the genetic susceptibility to T2D in the Tunisian population
#@R. Bouhaha,D. Meyre,Abid Kamoun,H. Ennafaa,E. Vaillant,R. Sassi,T. Baroudi,V. Vatin,P. Froguel,A. Elgaaied,M. Vaxillaire
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1126591555464427151021435292052195826490531319986
#%387512923503036270563403183727073205448867318114
#%612739277073018874759551392855182335898105596239
#%678495465948430688959215408518871512799521768043

#*Low prevalence of MODY2 and MODY3 mutations in Brazilian individuals with clinical MODY phenotype
#@K. Furuzawa,M.A. Giuffrida,S.V. Oliveira,R. Chacra,A. Dib,F. Reis
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1141044102209217234044884353213035104714523918566

#*A case of hypoglycemic brittle diabetes with peripheral edema successfully managed by conversion from insulin lispro to insulin aspart
#@Atsuhito Tone,Kenichi Shikata
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index445676439637413532551683042667252449072915661752

#*Family history of type 2 diabetes is increased in patients with type 1 diabetes
#@B. Barone,M. Rodacki,L. Zajdenverg,M.H. Almeida,C.A. Cabizuca,D. Barreto,L.F. Arajo,R. Kupfer,A. Milech,J.E.P. Oliveira
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index426847896525448625818412985412530638861626278312
#%816487304372354908435503100335461179187047511004

#*Attenuation of aldose reductase gene suppresses high-glucose-induced apoptosis and oxidative stress in rat lens epithelial cells
#@Hirotaka Nambu,Eri Kubo,Yoshihiro Takamura,Shosai Tsuzuki,Miyuki Tamura,Yoshio Akagi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index54875454592657621185211573320081473955168044117
#%1429311916746719064228918837552224079256243581378
#%531490826784110720723944549568344744553085896276
#%447659034928183796072497759312661619532689150320
#%1224027125517144076179795135875111967649581636347
#%353497817937336743688915675067013356658156825974
#%505905691463615117465981311745524901519104382650
#%305116874197264592653777914537829825867260227134

#*Coronary artery calcification, arterial stiffness and renal insufficiency associate with serum levels of tumor necrosis factor-alpha in Japanese type 2 diabetic patients
#@Takuo Hirota,Eiji Suzuki,Isamu Ito,Masami Ishiyama,Shinobu Goto,Yukio Horikawa,Takahiko Asano,Masayuki Kanematsu,Hiroaki Hoshi,Jun Takeda
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index720688878333566945531664108430295250866165041701
#%580424105227444047322517750075203734778802489729
#%431412729600776668789272016853046241948029539427
#%1081584571011326619701528955852525737754528613286
#%633461680371896292474213356432768461383201339245
#%433767329639828187796978675019726710810980835560
#%707417043582795422549619522903969448372828210373
#%1344651659112630226132501585767625769535223822976

#*Attenuated metabolic effect of waist measurement in Japanese female patients with type 2 diabetes mellitus
#@Yuji Tajiri,Ryoko Takei,Kazuo Mimura,Fumio Umeda
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index846818530925701101489361624808016540522034783520

#*Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients
#@Alicia Jenkins,X. Zhang,Albina Gosmanova,Christopher Aston,Azar Dashti,Zoe Baker,Timothy Lyons,Jian-Xing Ma
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index338960899960690286628728536864199937967762277789

#*Eupatilin, isolated from Artemisia princeps Pampanini, enhances hepatic glucose metabolism and pancreatic -cell function in type 2 diabetic mice
#@Young-Jin Kang,Ju Jung,Mi-Kyung Lee,Hye-Jin Kim,Seon-Min Jeon,Bok Park,Hae-Gon Chung,Nam-In Baek,Tae Lee,Tae-Sook Jeong,Myung-Sook Choi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index870608177237303303681192888511980372538702864579
#%313381157982914819423214736601312812296163262929
#%1024788916465766166452251793251622865339840643160
#%1155487893682404249450868868643950528125397719318
#%282389367629227024634700380535533468872173893381
#%1401607269839429390408309751866937438263484975134
#%1272049666406328988258651037587617131791180388803
#%1112190330540780806896454211006751109264615101777

#*Transgenic expression of a mutated cyclin-dependent kinase 4 (CDK4/R24C) in pancreatic -cells prevents progression of diabetes in db/ db mice
#@Katsuyuki Miyawaki,Hiroshi Inoue,Parvaneh Keshavarz,Kuniko Mizuta,Aya Sato,Yukiko Sakamoto,Maki Moritani,Kiyoshi Kunika,Toshihito Tanahashi,Mitsuo Itakura
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1313599060526480802966937681164775938935521474500
#%1265525615863369768090491169709796199182433003361
#%177372180636382551572092905638986311498153909385

#*Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes
#@H.J. Yoo,H.G. An,S.Y. Park,O.H. Ryu,H.Y. Kim,J.A. Seo,E.G. Hong,D.H. Shin,Y.H. Kim,S.G. Kim,K.M. Choi,I.B. Park,J.M. Yu,S.H. Baik
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1106921582623277064047141258671572585603616848308
#%992526920318358556758474114167285252592690879698
#%535238639678866610875149050951920890753126373192

#*Time-course changes in clinical features of early-onset Japanese type 1 and type 2 diabetes: TWMU hospital-based study
#@Yasuko Uchigata,Toshika Otani,Hiroko Takaike,Junnosuke Miura,Mari Osawa,Sachie Tukahara,Tadasu Kasahara,Yasuhiko Iwamoto
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1051067420262169225862624087363340684993785284891
#%1404401825097809215017684971991092855126766552358

#*Association of WBC count and glucose metabolism among Chinese population aged 40 years and over
#@Jing-Yan Tian,Yan Yang,Qi Cheng,Hong-Er Huang,Rui Li,Guo-Xin Jiang,Shi-You Liu,Xiao-Ying Li,Guang Ning
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index394969422014275643443569731872274095917954137545
#%1299132414953617378733412174120815819955689190808
#%375623229780459483981696039314209608567749246668
#%1258487226959525013183485369172395268229992240270
#%811166379074150767080212587139158548814874134329
#%811166379074150767080212587139158548814874134329
#%950935218462113895987553557600568515851854455100
#%184193389417794393390836778199067282189248828725
#%912341887569825270782283285535626813898546078241
#%537877660680788043286025982623338411259323676746

#*A cardiac magnetic resonance imaging study of electrocardiographic Q waves in type 2 diabetes: The Fremantle Diabetes Study
#@Sanjana Kondola,A. Davis,G. Dembo,M.E. Davis
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index820113830159557985956952458245011506306421636491
#%1146644747750725185045323927293390664360719587081
#%608898863379681791271918692548186913097891340959
#%463418886688982882503450453262978215026280022216
#%918131595457219388123704192180892531187517149112
#%548952662529513753881269651250628898762789582569
#%1287451453174574725668899730735597038548526864002
#%354199810846967717614784030199125773303735065214
#%770306436348456646114755801713995920923927860635
#%373256072724465017773934119274468027785482111615
#%582509662697766296961472436126107659257325925976

#*Association of sterol regulatory element-binding protein-1c gene polymorphism with type 2 diabetes mellitus, insulin resistance and blood lipid levels in Chinese population
#@Ju-xiang Liu,Jing Liu,Pei-qiang Li,Xiao-dong Xie,Qian Guo,Li-min Tian,Xiao-qin Ma,Ji-ping Zhang,Jia Liu,Jing-yuan Gao
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index906615493530996357155651860818463946268584459234
#%1456073321630558235461997307305974691552630685867
#%1454926431617171350148404551312091050572521249521

#*Apolipoprotein B and insulin resistance are good markers of carotid atherosclerosis in patients with type 2 diabetes mellitus
#@Kazunari Matsumoto,Naruhiro Fujita,Kan Nakamura,Takemasa Senoo,Tan Tominaga,Yukitaka Ueki
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index180043611945115044982508924187782642920461941813
#%1185546321683881257310762300287846554605070866566
#%1126708038596492840536232840700080341312773394329
#%1438361308239152205343302480156715263383345379538
#%777125853342177893815085839700628327237149358415
#%660969766081954457097649987988995924460317287553
#%727978340336125488899334526171458645223834462551

#*Effects of reduced coronary flow reserve on left ventricular function in type 2 diabetes
#@Osamu Yonaha,Tatsuaki Matsubara,Keiko Naruse,Hideki Ishii,Toyoaki Murohara,Jiro Nakamura,Tetsuya Amano,Nigishi Hotta
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1224828984163330484497429800984525589918656925335
#%1297205751964095496372122310576322921624454778442
#%679660399745383962075972687807056508819047463321
#%1177240727943245705718757386639738764754199619370
#%842011661470410161858543209775988601710490893945
#%595182228387611198232118705437322115824615352239
#%759463480221710549215187968486753502626836342466
#%408285140036790783402691218849888721929233628618
#%1144966761277187719243374464806604345073974363561
#%778701404330971618381980274036830987950892623866
#%866068935798950519639850843910125881153764357825

#*Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults
#@Alireza Esteghamati,Haleh Ashraf,Armin Rashidi,Alipasha Meysamie
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index598873247439966584370087365624629334415723560410
#%1374310210571094178812676785082365325858134197455
#%1022718423096294409237416126786752421988035435418
#%485552785234323115571115524400782929431561797146
#%425359508911865790944680143974007765055061334363

#*Interleukin 6 174(G>C) gene polymorphism is related to celiac disease and autoimmune thyroiditis coincidence in diabetes type 1 children
#@Magorzata Myliwiec,Jolanta Myliwska,Katarzyna Zorena,Anna Balcerska,Ewa Malinowska,Piotr Winiewski
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index109747395557816324656696374240632029767861236704
#%736609086422251298547264322633861159794255565811
#%912204996083565342129143691247301809584350860663

#*Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on weight loss and insulin levels secondary to two hypocaloric diets: A randomized clinical trial
#@D.A. Luis,R. Aller,O. Izaola,Gonzalez Sagrado,R. Conde
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1050313793818678153422850347114505502413159192148

#*Increased bone resorption may play a crucial role in the occurrence of osteopenia in patients with type 2 diabetes: Possible involvement of accelerated polyol pathway in its pathogenesis
#@Makoto Takizawa,Kiyoshi Suzuki,Tadashi Matsubayashi,Munetsugu Kikuyama,Haruhiko Suzuki,Kazuto Takahashi,Hidenori Katsuta,Junko Mitsuhashi,Susumu Nishida,Shinya Yamaguchi,Katsuhiko Yoshimoto,Eiji Itagaki,Hitoshi Ishida
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index339773088786127592074046343076010905791013626802
#%1057565586127574062283982655461052368324384699192
#%738668646727277163539874322594161046487950322111
#%1377433418961411235744739243921303535136257147449
#%33923589118593984622782457158300895635847171086
#%412223734555900491044515579761921111067121118876
#%318428798475413936022076647276626063752693346264

#*The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes
#@Mykola Khalangot,Mykola Tronko,Victor Kravchenko,Jaroslava Kulchinska,Gang Hu
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index515979776088216495630450523859805409563518083469
#%1209915928043767877988071234305244160407052781159
#%1239276410722069842796823616864936666166804852056
#%170989270154568200679810849881246319663239996818
#%460282340370140985558862648681614439173071881340
#%923760739051123571119412390195306003161145403880
#%1418789145615841437525403716371066884628701554242
#%1068827015025077371091713296021472427550088881725

#*The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control
#@Akiko Yamana,Mikio Arita,Machi Furuta,Yoshinori Shimajiri,Tokio Sanke
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1258237802209131358730035413340920171161399615114
#%842498980017533687207488737127263878632351325165
#%1302237423387309659268743447384714660323552609272
#%851817410589523825178658772986072365885578143050

#*Comparison of short insulin tolerance test with HOMA
#@Rajeev Sharma,K. Vikram,Anoop Misra
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index633644396119555353626463016103330892943439673388
#%1434901688770539268636741683208718720462549030533
#%1084433649769807227007811327230310097304143654138
#%102711124862906286494213977515077410199003405411

#*First study of aryl hydrocarbon nuclear translocator gene in Indians: Correlation with resistance to diabetes in Raika community
#@Ashok Jhanjaria
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index460773079012320313436141518681750892481490897357
#%641234301888971404096741759568886130204974229146

#*The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality
#@Pou Tsai,Pang Wen,Ting Chan,Huang Chiang,Kuang Tsai,David Cheng
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1242272848521728750754143686530430854028719664525
#%303972967056662443548712452420849406184164352577
#%897686059490449168575386655937871114503501503419

#*Global complication rates of type 2 diabetes in Indigenous peoples: A comprehensive review
#@Mariam Naqshbandi,B. Harris,G. Esler,Fred Antwi-Nsiah
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index44441246935218975207111770844916144593024963307
#%319050216113529553197733551096001261711701911996
#%410461435904805580979497922458378530292878706418
#%1282138175656850298309754466986886272141717189539
#%1420936005234852038171676429696444486016578353484
#%758487732966734268279340077024249464441562503841
#%1259862702185788608723776279797942275339806589920
#%918665607716177391023619111337190668348582337950
#%476571631254768597653519160533539362073376184513
#%408939166431599714884883154981722721458711763350
#%158966345581643345999894858029161273550416433907
#%923742721466384196700516522243887187787112658388

#*A large observational study of cardiovascular outcomes associated with atorvastatin or simvastatin therapy in diabetic patients without prior cardiovascular disease
#@M. Foody,T. Joyce,W. Jeffers,Z. Liu,S. Benner
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index567048567198365185868611843381179087059931426599
#%266876744690917100965205025497383174744798095549
#%813451924666496587937350118644372765282611287394

#*Plasma insulin and C-peptide concentrations in diabetic patients undergoing hemodialysis: Comparison with five types of high-flux dialyzer membranes
#@Masanori Abe,Kazuyoshi Okada,Koichi Matsumoto
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index138106531865819073758181063771848228008000493972

#*Does HbA1c represent a valid index for tight control of glucose in type 1 diabetes?
#@Rimei Nishimura,Daisuke Tsujino,Kentaro Taki,Aya Morimoto,Naoko Tajima
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1381643602590731219864493108847098438477832108971

#*Winners and losers at the rosiglitazone gamble
#@Matteo Monami,Niccol Marchionni,Edoardo Mannucci
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index718447800496372966094218590754692186985971193248
#%791437010500835684446913673495202924917937619815
#%1439215861811557233869403989219471406481712382879
#%791437010500835684446913673495202924917937619815
#%920241321889669665287705793802399032889517257662
#%217426656728435012484085093460287903122538345995
#%1353878295937440094315749124413900187213468734151
#%1170935556263502936112704740333334068148811730616
#%1279871689382672313749855925500972798164053196964
#%546299017168065274420384267331911522531369644771
#%869315436784359004849578343805357573288605055617
#%39528781403275155164378591902302269616276889717
#%1414548789419485913486382715084414933958144171684
#%377549868103987761897521817157472032619117176238
#%377549868103987761897521817157472032619117176238
#%945205506516588029931968841866627190840522024498
#%93341555077175330307605321565496046930391561843

#*Association between future events of brain infarction and soluble levels of intercellular adhesion molecule-1 and C-reactive protein in patients with type 2 diabetes mellitus
#@Akio Kanai,Takahiko Kawamura,Tositaka Umemura,Masahito Nagashima,Nobuhisa Nakamura,Mikihiro Nakayama,Takahisa Sano,Eitaro Nakashima,Yoji Hamada,Jiro Nakamura,Nigishi Hotta
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index946726468856961399552266923536606260152522954441
#%923073157682947837438564691325393079177143857483
#%613065984029021449932333028668018272440807313860
#%234748103336222356273100612464937600968496886385
#%602804929517068982596762282449154663795196508569

#*Eleven cases of mucormycosis with atypical clinical manifestations in diabetic patients
#@Tuba Turunc,Ziya Demiroglu,Hikmet Aliskan,Sule Colakoglu,Hande Arslan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index8187981636379359089189889485288279055812803869

#*Plasma FGF-21 levels in type 2 diabetic patients with ketosis
#@Ling Li,Gangyi Yang,Heu Ning,Mengliu Yang,Hua Liu,Wenwen Chen
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index600781343197795612359986754408804490880578503558
#%1069924729209497270039841289173918994713992939513
#%687325752172912583604253931416762651924963851442

#*Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes
#@Baris Akinci,Tevfik Demir,Aygul Celtik,Mustafa Baris,Serkan Yener,Ali Ozcan,Faize Yuksel,Mustafa Secil,Sena Yesil
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index142467793937568304750362101029326417925193921935
#%1025354367948717115340769238565082122856803711627
#%1019295311003677583817726196325719686806737641603
#%1015587128813019761458750476130780663939083049366
#%188884052767810721775018399085832414433002268712
#%509594842920952678725508142429248068685566069190
#%322296598116194872643981245597609138135926560008
#%626892193771348417797748458354939912610020669417
#%74868594550777105752547503110105327187574736197
#%730635263883807963254206964561132164957901679511

#*Glucose peak and glucose spike: Impact on endothelial function and oxidative stress
#@Antonio Ceriello,Katherine Esposito,Ludovica Piconi,Michael Ihnat,Jessica Thorpe,Roberto Testa,Rita Bonfigli,Dario Giugliano
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index563696794164908787560407568047130171775763957658
#%398966926411729416063166796594408977831586910264
#%591433551729391668817260598795907936390788474863
#%1430895783313583148950733621358984655123077880356

#*Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden
#@M. Thunander,C. Petersson,K. Jonzon,J. Fornander,B. Ossiansson,C. Torn,S. Edvardsson,M. Landin-Olsson
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index623110777046670777425061404435882301771549022439
#%1026145126511100520909455506395851667098311432771

#*The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus
#@Gokhan Erdem,Teoman Dogru,Ilker Tasci,Ergun Bozoglu,Ozlem Muhsiroglu,Serkan Tapan,Nuri Ercin,Alper Sonmez
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index72564030768950231381587272374727032883680206259
#%420678721583814257978460366381870733954688828022
#%359704911589716698767639707562984061012562867961
#%1402175163986719238281133049175038933677435899096
#%1219282700056370978334347413976089859241929716567
#%1339118030089354802237220255046308357942963267493
#%813259255672563583360682975338321159614633351569
#%1257587191976168366509653854318949535120401023702

#*High molecular weight adiponectin correlates positively with myeloperoxidase in patients with type 2 diabetes mellitus
#@P. Bobbert,U. Rauch,B. Stratmann,P. Goldin-Lang,S. Antoniak,T. Bobbert,H.P. Schultheiss,D. Tschoepe
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index83758992950921579438523300856525792564149247848
#%129815950086526015512399741673161951042363797140
#%445374770742253487940235028708472135793319973477
#%1238681938952244368719236642797178407759437359337
#%1021002299222599989778245421123926371941613289901
#%901471954651976992354403050357627140160318739953
#%145290544300892797038499315140594567980386018414
#%322114998298676065841034270150936214982578885641
#%352538351643347235972388203314494558902346388976
#%244696392641623696734400889970827933224591102167

#*Is fasting glucose level during oral glucose tolerance test an indicator of the insulin need in gestational diabetes?
#@Baris Akinci,Aygul Celtik,Serkan Yener,Sena Yesil
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index765079649313895269605970315627918013194826601100
#%1111911381265382572303518945336865303046821233274
#%711965504757612764465329121545013778004363297969
#%970102488476482110549139414214111260215840803200
#%482827904355072306722426246810197858192315285031
#%1324179177452186169161830405362579201612581184946
#%108193723749067602232388641076366190877788878432
#%829537043807608568939045101826706724249071161035
#%493413416089351901283722531885157459727079033410
#%810560745429551868060277383219819081967137880891
#%442037807839377701030969689904777190475103130512

#*Inverse association between serum resistin and insulin resistance in humans
#@S. Coello,A. Len,D. Gonzlez,A. Hernndez,M.C. Prez,N. Ramos,B. Daz,R. Fuentes,A. Jaime
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index341888059529436488883140051631333486928612385085
#%1359255155272485105349265223836683244782826650739

#*A case of fulminant type 1 diabetes mellitus with exocrine pancreatic insufficiency and enhanced glucagon response to meal ingestion
#@Daisuke Yabe,Akira Kuroe,Michihiro Ohya,Koin Watanabe,Naomi Kitatani,Masayuki Oku,Takeshi Kurose,Yutaka Seino
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1400278725276759029300317331579967813532955592460
#%633448444578164014956544238120143608504154826060

#*Foot ulcer risk and location in relation to prospective clinical assessment of foot shape and mobility among persons with diabetes
#@S. Cowley,J. Boyko,B. Shofer,H. Ahroni,R. Ledoux
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1187546712791481917532260089411328948916173386303
#%816448208546113430841389493232416215086450685756
#%1015275505138329497918800333562808466369420651491
#%102649228045763953116272663574927828487888442556
#%600249701827195082311009821017684464520018575690
#%420067165815560661461515373938445871047003256843
#%1193554288174952050302009508736758736956443108061

#*Uniformity in clinical and HLA-DR status regardless of age and gender within fulminant type 1 diabetes
#@Akihisa Imagawa,Toshiaki Hanafusa,Hiromi Iwahashi,Yasuko Uchigata,Azuma Kanatsuka,Eiji Kawasaki,Tetsuro Kobayashi,Akira Shimada,Ikki Shimizu,Taro Maruyama,Hideichi Makino
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1182141162399594967943479975220484250581510658995
#%843309576215834727975480175244162080477645031405

#*A family history of type 2 diabetes is associated with glucose intolerance and obesity-related traits with evidence of excess maternal transmission for obesity-related traits in a South East Asian population
#@T. Tan,M. Tan,Seng Chia,Kai Chew,Shyong Tai
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1237540161171694378309872280797294565019085470586
#%866170340326980640061980551362148546829251943398
#%333611612229705608996038762681695341109296328113
#%751226182156713312072066138627209038898450000644

#*Prevalence of diabetes mellitus and other abnormalities of glucose tolerance in young adults aged 2040 years in North India (Kashmir Valley)
#@Hamid Zargar,Ahad Wani,Ahmad Laway,Rashid Masoodi,Iqbal Wani,Iftikhar Bashir,Ahmad Dar
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1456685161226442277839440551194153729845734828992
#%534974709789726405082546109764776427452383853314
#%175673282637710485932719241697136839548400631097

#*Type 2 diabetes but not coronary atherosclerosis is an independent determinant of impaired mobility in angiographied coronary patients
#@H. Saely,Thomas Dyballa,Alexander Vonbank,Magdalena Woess,Philipp Rein,Stefan Beer,Vlado Jankovic,Christian Boehnel,Stefan Aczel,Heinz Drexel
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1035913665763843377933754155554660700635793354404
#%267467002890041343378077719597506946738213840727
#%335138268383393151602301345052902863577390051628

#*Safety and efficacy of inhaled human insulin (Exubera ) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial
#@S. Skyler,A. Hollander,Lois Jovanovic,Sol Klioze,Alan Krasner,J. Riese,Joann Reis,Pamela Schwartz,William Duggan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index191120627885994755083268788155063663294917261112

#*Additive effect of diabetes mellitus and hypertension on coronary flow velocity reserve and aortic distensibility in patients with negative coronary angiograms
#@Attila Nemes
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1084411760652626681342814174688234768129345184967
#%601701254539151027394794842575003745696572220511
#%854902853894908649842349011650804405748642580440
#%451609450917656044162371101807044281849294379579
#%842011661470410161858543209775988601710490893945

#*An alternative exercise and its beneficial effects on glycaemic control and oxidative stress in subjects with type 2 diabetes
#@Naruemon Leelayuwat,Orathai Tunkumnerdthai,Montana Donsom,Nichanun Punyaek,Apiwan Manimanakorn,Upa Kukongviriyapan,Veerapol Kukongviriyapan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index174094889988504414806885913937656341927130607575
#%62812888087792783134653393529326806305646492170
#%1208102424931003645758340696147497725222459466308
#%380475141427421437752072310113759898980641735768
#%230955830864368081479176503496947511092131290569
#%397000423955846655522615239326246138003241551430

#*Enhanced short-term improvement of insulin response to a low-caloric diet in obese carriers the Gly482Ser variant of the PGC-1 gene
#@Estibaliz Goyenechea,B. Crujeiras,Itziar Abete,Dolores Parra,Alfredo Martnez
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1008041121718195827203424184421592197077189749756
#%546170465330916521067214091415919351772616876243
#%1002222101828721165009430265968447749420103212716
#%906255481852617273690561049009729084734055510725
#%187593763336323095146882731262285451838348112926
#%1118586007290838308928621554432637694791230419982

#*Cardiovascular autonomic neuropathy, autonomic symptoms and diabetic complications in 674 type 2 diabetes
#@Hung-Ta Chen,Hong-Da Lin,G.S. Won,Chen-Hsen Lee,Shiao-Chi Wu,Jiun-Dian Lin,Li-Ying Juan,Low-Tone Ho,Kam-Tsun Tang
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index250494692704200073433355556195403553660795632128
#%597761627742999597991988943212963147527768637034
#%658881202364191644241587865392034394572899459669
#%13356787239835423974516098715380410150585075193
#%712348600190381265099774014588426648867953859508
#%11073431182846884692421177624846173386969044728
#%836113851035164637648146200744284345488819242206
#%651647500955189779690675699018962180518625513426

#*Can diabetes medication be reduced in elderly patients?
#@Peter Sjblom,Ulla-Britt Lfgren,Christina Lannering,Niklas Anderberg,Ulf Rosenqvist,Sigvard Mlstad,J. stgren
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index317804104057925648251596071916162068245877259950

#*Twelve shifting paradigms in diabetic renal disease and hypertension
#@Erik Mogensen
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index87320657708402008634759656096568162259462901762
#%867161079374275151889269821849240372320873625819
#%59160455152802449237693998205848575018161798659

#*Changing course of diabetic nephropathy in the Pima Indians
#@G. Nelson,E. Pavkov,L. Hanson,C. Knowler
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index659127334835038988090373910055413370687460001105
#%431412729600776668789272016853046241948029539427

#*Diabetic nephropathyWhat are the unmet needs?
#@Andrea Luk,C.N. Chan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index391581798811758558385717708252425621745942965148
#%1438361308239152205343302480156715263383345379538
#%1143247054964945273405816221419647363121423316843
#%1414977085277382553976440960585211198215976821419
#%431412729600776668789272016853046241948029539427
#%984280687888332369076232528485611615362925696794

#*The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy
#@Toshio Doi,Akira Mima,Takeshi Matsubara,Tatsuya Tominaga,Hidenori Arai,Hideharu Abe
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index126817712613825770438033849367463098592614223502
#%923230950899319989723698336167797582739997380458

#*Inhibition of advanced glycation end products (AGEs): An implicit goal in clinical medicine for the treatment of diabetic nephropathy?
#@Toshio Miyata,Takashi Dan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index281327885256802255801330783184915823654654465826
#%178309686007686998211868781094357515337037212741
#%808345067986169451351061573967746732585821622424

#*New and old markers of progression of diabetic nephropathy
#@G. Jerums,E. Premaratne,S. Panagiotopoulos,S. Clarke,D.A. Power,R.J. MacIsaac
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index593878529855798006658620726247592985675096162011
#%923230950899319989723698336167797582739997380458
#%51460289052687309837575091107808726122404061698
#%1022303831200441806073628802674630762487734647538
#%473064159115522356092324859828405817271664016139
#%431412729600776668789272016853046241948029539427

#*Different roles for TGF- and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy
#@N. Ziyadeh
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1047004463905509489441304828147215633833156113199
#%1257877028164299500310386536546782771806189958293

#*Role of reactive oxygen species in the pathogenesis of diabetic nephropathy
#@Hunjoo Ha,In-A Hwang,Hee Park,Bahl Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1419166167713681457542461018157926274493194145648
#%92805081706595045165158577125395358163717942239
#%1403763027417994643087616683344415689880782057917
#%1410573940030787056012367634770998695068424850236

#*Between hyperfiltration and impairment: Demystifying early renal functional changes in diabetic nephropathy
#@T. Rosolowsky,A. Niewczas,H. Ficociello,A. Perkins,H. Warram,S. Krolewski
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index493501537255114106560528546059152499356795271548
#%862228661064377672452578872794073417237132988610
#%923230950899319989723698336167797582739997380458
#%429802228692657563062243939154007495156216515620
#%1335539453124806771647332574446801105713261569146

#*Clinical impact of reducing microalbuminuria in patients with type 2 diabetes mellitus
#@Shin-ichi Araki,Masakazu Haneda,Daisuke Koya,Atsunori Kashiwagi,Takashi Uzu,Ryuichi Kikkawa
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1439031598732807590659462079350980540290307265970
#%867161079374275151889269821849240372320873625819
#%12839681436988383514990027141321404610110753482
#%815698400384303336784517046020894911684280453276

#*Role of TSCmTOR pathway in diabetic nephropathy
#@Ken Inoki
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1459139169997279044279447135941502707993497024735
#%443094506575889027049268351872714217313464050733
#%1438945443475222288308686573323354217832001758372
#%640406411434090358150710335284233596782969904159
#%920527273871011346229073500671588389792645789343
#%33876756160336628229475884927750565323988518335
#%116221488460735284049097175356691101968511131823
#%1327399071412045807715995451428085049001313978783
#%378592824191488941873337089412131523644313620029

#*Activated prorenin as a therapeutic target for diabetic nephropathy
#@Atsuhiro Ichihara,Mariyo Sakoda,Asako Mito-Kurauchi,Hiroshi Itoh
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index760862821434060206819782724093584117278220082610
#%693479414487968708175643648907861651565507492300

#*Uncoupling of VEGF with NO as a mechanism for diabetic nephropathy
#@Takahiko Nakagawa
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index579458084146734957958432215412546541779707502079
#%1092674411973523375584653096214114832932019663905
#%756678894408772542248086698867397574680766962461
#%867054783330037305994938672183255016631893223090
#%661544744106008604400732458667022045736443910959

#*Protein kinase C- inhibition for diabetic kidney disease
#@R. Tuttle
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index117768619167813470672101318639576164053817118492
#%481570781244869144784002259840012820397148090045
#%431412729600776668789272016853046241948029539427

#*Diabetic nephropathy: Important pathophysiologic mechanisms
#@G. Soldatos,M.E. Cooper
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index318969296395222389962906774195833477355901686537

#*Effects of low intensity exercise therapy on early phase insulin secretion in overweight subjects with impaired glucose tolerance and type 2 diabetes mellitus
#@Ryoma Michishita,Naoko Shono,Takaki Kasahara,Toshiyuki Tsuruta
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index398679386725496201364519058236608840830809968637
#%789198489702586542926219084517612861962341004780

#*Renal structure as an indicator for development of albuminuria in normo- and microalbuminuric type 2 diabetic patients
#@Tatsumi Moriya,Keiji Tanaka,Tatsuki Hosaka,Yoko Hirasawa,Yoshikuni Fujita
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index670242960982713715967850114979151009019187890050

#*Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment
#@S.A. Ebady,M.A. Arami,M.H. Shafigh
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index5148757091253187396657894467064054031854689856
#%1180779078635497149696960565518979841178695522518

#*Temporal change in glucose tolerance in non-ST-elevation myocardial infarction
#@U. Srinivas-Shankar,J.D. Somauroo,A.-M. Delduca,T.S. Jordan,S.A. Bowles,M.K. Rutter
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1227490351596124064367707344359026263061102425146
#%1449005384960677540707614895751154616790243102417
#%684635403428804423797694605207550460631520619245
#%409562326928813714152669972341134724417512641817
#%853933485861833442499417434581928900747598495651

#*Type 2 diabetes does not predict incident thyroid dysfunction in the elderly
#@Bamini Gopinath,Jin Wang,Annette Kifley,R. Wall,R. Leeder,Paul Mitchell
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index711448387370276405376831621254872289905457201599
#%1413234556151811585006924582128152788048267630475

#*Blood lipid levels in relation to glucose status in European men and women without a prior history of diabetes: The DECODE Study
#@L. Zhang,Q. Qiao,J. Tuomilehto,N. Hammar,K.G.M.M. Alberti,M. Eliasson,R.J. Heine,C.D.A. Stehouwer,G. Ruotolo
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1432144291413142848311220109848646110278424827889
#%472499580955037818725224544913306628194144220563
#%648312258609535159195075381150443973447763412912
#%608027367961477215758757976231510100673358964715
#%1092188121641455288891147688004469839427158894354
#%1092188121641455288891147688004469839427158894354
#%158966345581643345999894858029161273550416433907
#%1178031689441182033075896556959435397593748564893
#%1188836717728393088633365861210074157027728067607
#%932862286689261514386152577763809351808483508277
#%497154820998809335539084658697723802665880515807

#*The association of plasma fibrinogen concentration with diabetic microvascular complications in young adults with early-onset of type 2 diabetes
#@N.T. Le,Rachelle Miles,J. Savage,Elaine Cornell,P. Tracy,C. Knowler,Jonathan Krakoff
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index616231211587203326494387963036316913196824935695
#%78572623705147618013316014912079859020926925392
#%78572623705147618013316014912079859020926925392
#%842941261248292302842089982894061809243529393739
#%1401334446619427753297931536606293897611776488362
#%341102207018851532267909214310696541281477116289

#*Cataract and type 1 diabetes mellitus
#@Freitas Esteves,Dal Pizzol,Augusto Sccoco,Felix Roggia,Blessmann Milano,Amaral Guarienti,C. Rodrigues,Henrique Canani
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index618193761530602187512560339198685679413681650914
#%519889446910011558881533122774786538823371435240
#%896701112415449950244885008542481189798573886990
#%1185225966287652549753426220449725450184787122156
#%1134316742908806820439970403555300672044123021553
#%1021947458944657444555959701758554832301303157631

#*High prevalence of peripheral arterial disease diagnosed by low anklebrachial index in Japanese patients with diabetes: The Kyushu Prevention Study for Atherosclerosis
#@Yasutaka Maeda,Toyoshi Inoguchi,Hirotaka Tsubouchi,Fumi Sawada,Shuji Sasaki,Masakazu Fujii,Ryoko Saito,Toshihiko Yanase,Michio Shimabukuro,Hajime Nawata,Ryoichi Takayanagi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index857020523314606912288454847868791825710693834744
#%895503432277428590861458013082548281179736006237
#%1418519123182179658507677860277160619133074594235
#%631741602333420002516786224472802044926060894433
#%1426243186614138028453684909556305521170974393188

#*Effect of the glycemic control on intracellular cytokine production from peripheral blood mononuclear cells of type 1 and type 2 diabetic patients
#@M.C. Foss-Freitas,N.T. Foss,E.A. Donadi,M.C. Foss
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index331524604288364253179439977664091762988999604513
#%1273741304179662300531241917318867963711693206555

#*Ethnic difference in inter-East Asian subjects with normal glucose tolerance and impaired glucose regulation: A systematic review and meta-analysis focusing on fasting serum insulin
#@Masakazu Takeuchi,Kousuke Okamoto,Tatsuya Takagi,Hitoshi Ishii
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index171011354295735042441981541899716917083265426315
#%936069583900768098272343450335544347261807063193
#%260080633231581146552350026072317121059362168506
#%255967406113212341099994501119475161367196511428
#%50936492226713450662042994889032552805109411595
#%856537884140432138093842042156523599248953399383
#%1186363517425204535500756036856179103041729943296
#%322307483286430839010186166883415500876394233111
#%390371137728887586911880288885235639516434221172
#%390371137728887586911880288885235639516434221172
#%1315172993889994444632081429054893961774220444558
#%1073677347102714921712200538365033731607436880856
#%1073677347102714921712200538365033731607436880856
#%1073677347102714921712200538365033731607436880856
#%843802554003403561334879612977918897033815175493
#%1092188121641455288891147688004469839427158894354
#%1092188121641455288891147688004469839427158894354

#*Nateglinide may increase high-molecular weight adiponectin in type 2 diabetic patients with hypoadiponectinemia
#@Masanori Iwase,Kenzo Iino,Yasufumi Doi,Tamotsu Asano,Mitsuo Iida
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index386703563437119835316066722638771346769064781578
#%405202322424178852135201041449605125199774873196
#%974127081707539555018643475737391229484375439916

#*Relationship between skin resistance level and static balance in type II diabetic subjects
#@Eyyup Gulbandilar,Ali Cimbiz,Murat Sari,Hilmi Ozden
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index166545277644205199215297534927158150188463877818
#%1317744759676684582290811006672630263108576225343
#%1042109537994201486496185634695535716202020456327
#%587374137545429830660791757185198022427962609956
#%666015867242769587310326742094635684701154895363
#%672653029473561399077333517687690876431926422924
#%384945538359662023692879776567348946928467370998
#%448885635675379747767242403851968153768976296400
#%1324193400637151596032094877874779864828751032569
#%196552434367077126058163088536819678912716620596

#*Differences in effects of insulin glargine or pioglitazone added to oral anti-diabetic therapy in patients with type 2 diabetes
#@Mozhgan Dorkhan,Anders Frid,Leif Groop
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index481443786221685435166760123030856077350962647785
#%771838189793421032014531980540519755597781321453

#*Use of anti-diabetic drugs and glycaemic control in type 2 diabetesThe Hong Kong Diabetes Registry
#@C.Y. Tong,T.C. Ko,Wing-Yee So,Sau-Chu Chiang,Xilin Yang,P.S. Kong,Risa Ozaki,C.W. Ma,S. Cockram,Chun-Chung Chow,C.N. Chan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index774590153242381037961819719432930379128538999434
#%807309505482295288577904931711318609777471426945
#%758053223034199824525608826494772575285367692878

#*Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: A matched casecontrol study
#@M. Sadikot,E. Mogensen
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index718289353968476167391866294445231533724167694397
#%313189615321675500328317455222672075115434297023

#*Analysis of factors influencing pancreatic -cell function in Japanese patients with type 2 diabetes: Association with body mass index and duration of diabetic exposure
#@Shogo Funakoshi,Shimpei Fujimoto,Akihiro Hamasaki,Hideya Fujiwara,Yoshihito Fujita,Kaori Ikeda,Yoshiyuki Hamamoto,Masaya Hosokawa,Yutaka Seino,Nobuya Inagaki
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index481206385586385395391530030955951534251324687444
#%1257587466316964849383643445711581818340645171001

#*Association between circadian rhythm of blood pressure and glucose tolerance status in normotensive, non-diabetic subjects
#@Lina Li,Supamai Soonthornpun,Virasakdi Chongsuvivatwong
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1047652784998366356805527894189203075739068992024
#%1355429664352569722526527885949424453590064258601
#%15819328587996568382823435861902696081577718567
#%15819328587996568382823435861902696081577718567
#%754334342536441965237071762934800331172184100282

#*Characteristics and cardiovascular risk of new cases of type 2 diabetes in Otago, New Zealand, 19982004
#@Kirsten Coppell,Sheila Williams,Karen Anderson,Claire Lamb,Jim Mann
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index7263019362724660802946580583035996622555395205
#%741472667357967036521698557437635045148869117616
#%1186501341515059391140442800919395799048423877293
#%886722609364707890981034347155270656978507328635

#*Effects of trans10 cis12CLA-induced insulin resistance on retinol-binding protein 4 concentrations in abdominally obese men
#@Erik Ingelsson,Ulf Risrus
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1026923791006381343265315120236954457476609325326
#%692246672517245920408980075498288200906587304082

#*Corrigendum to Low leptin but high insulin resistance of smokers in Japanese men [Diabetes Res. Clin. Pract. 81 (2008) 358364]
#@Yo Hotta,Hiroshi Yatsuya,Hideaki Toyoshima,Kunihiro Matsushita,Hirotsugu Mitsuhashi,Seiko Takefuji,Yutaka Oiso,Koji Tamakoshi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index747377383039565364336917334346973936596522386689

#*Psychosocial barriers to starting insulin therapy in type 2 diabetes mellitus
#@Jana Hummel,Christine Khner,Daniel Kopf,Bertram Krumm,Michael Deuschle,Florian Lederbogen
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index532022157983620738667470533151439604943283649065
#%232643773041123133324036904338875012345869565126

#*Can geneticists help clinicians to understand and treat non-autoimmune diabetes?
#@T. Malecki,Wojciech Mlynarski,Jan Skupien
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1080902716855706170199920664443543347860255366900
#%867951046186989685288421043790599318254896985149
#%25515074698262633189976737782063133251182112476
#%1211684242362578270689067887487535595085573192746
#%816849584605071334222474931820727367106388132148
#%749022501170938039881805487791450120764064967887

#*Endothelial dysfunction: Causes and consequences in patients with diabetes mellitus
#@Angelo Avogaro,de Kreutzenberg,GianPaolo Fadini
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1105174649043134246601884829585975780196949048658
#%595911912011796185103746660058613030140194591378
#%1295548609264593970230494983262928490203266426610
#%717351817527655326027544146620870529274046047703
#%1174917309969245425941195993022511511480205660513
#%34740109249804927392631962582086124067076942573
#%102982250299729214080413045904307887976130018336
#%1410635503098675861527614967570782743386460127555
#%1303984591773708358981383725423693610918752730882
#%1081511581826213331731330476912637234387154264232
#%72833656560387651703284570831923587085268130240
#%40216691288403827239939983986072668845683153922
#%182955674157213209053426843439611583136033895246
#%1354780198605040795740381062858891748563172364582
#%916103342167280588209738023862203960133136044706
#%437001211021874840386849596640548332632257508431
#%791437010500835684446913673495202924917937619815

#*Hypoglycaemia in Type 2 diabetes
#@R. Heller
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index281730779163764564688878367775030465742564175905
#%1337486150122567906167930597816442037332635693553

#*Can blood glucose self-monitoring improve treatment outcomes in type 2 diabetes?
#@Egle Varanauskiene
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1355206882772817520571418288972885295112125288221
#%643892280851792942294522486675583311401819463484
#%530742815982948056355266956550925744819808900472
#%992526920318358556758474114167285252592690879698

#*ADMA, cardiovascular disease and diabetes
#@Katarzyna Krzyzanowska,Friedrich Mittermayer,Michael Wolzt,Guntram Schernthaner
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index252693832016811599531590643562981977967939243334
#%901359864765299262641577783931321979801441463060
#%661635023342714106921266409199711184231311687987
#%1077802980483834556901755793162348834581807564316
#%119356918372456762527503925200433191748730193522
#%811337376684370645483166285967756543412025566317
#%852280684631525154091810376461671198164367603354
#%794294887510497058517758882084898847320575346803
#%103792902099967046968633297886358843546928450625
#%625137246255378419968844320274954019132033981568
#%1009595708924925669736594706540957763015868983034
#%323148143563684041420918061715310722487849403576
#%1395085470393926262434718397221945233794801429400
#%378365866920278626611694630534198297122760979224
#%528244420919577901006889373216029119557083704060

#*Fatty acid binding proteins in adipose tissue: A promising link between metabolic syndrome and atherosclerosis?
#@Eva Kruinov,Terezie Peliknov
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index853021103758365987391746008775612759922301299410
#%205482879605682714091152743885205940042589099135
#%115049113773817179550348707163435079937449566684
#%92676474189339125975931902322124542819900614847
#%190185134414838089871812441023155524019544957213
#%565560691145436843127239055142065421172169817648
#%658960945815607245348502689044894946838078476351
#%40335034682783922162359918157158572824314693810

#*Adipose tissue 11-beta-Hydroxysteroid Dehydrogenase Type 1 and Hexose-6-Phosphate Dehydrogenase gene expressions are increased in patients with type 2 diabetes mellitus
#@Gkhan kaya,Nuri Karadurmu,Onur Kutlu,Ahmet orak,Sefa Kzlda,Uur Ural,Davut Gl,Mustafa Kutlu
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1278809104384495741672647451846460862759995626853
#%108097515109847019531033761203884717497240231169

#*Continuous glucose monitoring in type 2 diabetes
#@Ilana Harman-Boehm
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index659747482923001447145723189272207453356506546096
#%603719682485610248618052660561160498633883620754
#%776041351016806482922214553970983890990927743638

#*Incretin-based therapies in type 2 diabetes: A review of clinical results
#@Emanuele Bosi,Pietro Lucotti,Emanuela Setola,Lucilla Monti,Marco Piatti
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index620180177313644076971168449399576644506130983165
#%1405289936925555641146330394603561340891040062201
#%331463535884605394994706450224403767834343688312

#*Progression of diabetic nephropathy in type 1 diabetic patients
#@Behzad Najafian,Michael Mauer
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index825186419627595879556207192145866103703831013870

#*Serum phosphate levels and the risk of cardiovascular disease and metabolic syndrome: A double-edged sword
#@Wan Park,Soo Kim,Eun Lee,Kwon Huh,Jin Kim,Chul Sung,Ho Kang,Ho Lee,Roe Park,Jung Rhee,Won Oh,Young Lee,Young Park,Woo Park,Woo Kim
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index22140213313484284045231876825755988898613405149
#%1022533565641243785552725655750911091651141204077
#%476008411006972074098083722774054870233198392305

#*Mortality of first-time amputees in diabetics: A 10-year observation
#@Yuki Izumi,Kathleen Satterfield,Shuko Lee,B. Harkless,A. Lavery
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index910970575432279197700507533984085340371905823564
#%123465382389976944504957231696460822170099976837
#%80355669645989079063776476601951455380129723401

#*Influence of cardiovascular autonomic neuropathy on atherogenesis and heart function in patients with Type 1 diabetes
#@Silvie Lacigova,Lubos Bartunek,Daniela Cechurova,Jakub Visek,Jitka Gruberova,Michal Krcma,Zdenek Jankovec,Zdenek Rusavy,Michal Zourek
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index778095922608117078981282671663838166809703835292
#%597761627742999597991988943212963147527768637034
#%560292057180898182531722857513326078017464922676
#%1105006767126622339366750948258796291374163504691
#%751082204483388651332644017611517628990762648005
#%1333909560846470004928144175156407464073696509794

#*Rosiglitazone preserves islet -cell function of adult-onset latent autoimmune diabetes in 3 years follow-up study
#@Zhifang Yang,Zhiguang Zhou,Xia Li,Gan Huang,Jian Lin
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index64400630621247126325635346703260198840393138868
#%415789436299534902247729529330715383950706408066
#%200768133755342755100757781446810223914267941100

#*Fine-tuning of prediction of isolated impaired glucose tolerance: A quantitative clinical prediction model
#@Mehdi Rambod,Farhad Hosseinpanah,M. Ardakani,Mojgan Padyab,Fereidoun Azizi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index320622891955548322063890358841029560692699753399
#%1094955879540622866161065291596800629687725405450
#%1381073059794766404269586648905202726599740137174
#%792755149168693384455440658528468452189336763063
#%817256778313934031949420523017093154160834658706
#%354748413357366449254755840592007774264807831467

#*Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylurea
#@Yan Gao,Ho Yoon,Lee-Ming Chuang,Viswanathan Mohan,Guang Ning,Sanjiv Shah,Chul Jang,Ta-Jen Wu,Don Johns,Justin Northrup,Robert Brodows
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index232716842385303890843266041490745678673729571240
#%735009024663998479048138862737818215104111252409
#%856537884140432138093842042156523599248953399383
#%626712650228435264764882127709525971901608379480
#%390371137728887586911880288885235639516434221172
#%390371137728887586911880288885235639516434221172

#*The impact of diabetes and age on pulmonary function: Data from the National Health and Nutrition Examination Survey
#@Pierre-Yves Berclaz,Haitao Gao,A. Tobian,L. Swanson,M. Webb,O. Crapo,L. Jensen
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1411868640328789716444940943939188781638862960525
#%706654872523593411376268368958704809755146114055

#*Derivation of a new equation for estimating creatinine clearance by using fat-free mass and serum creatinine concentration in Korean patients with type 2 diabetes mellitus
#@Kyung Lee,Min Cho,Taek Kim,Kyung Koo,Young Cho,Hyi Ku,Soo Park,Chul Jang,Yeon Kim,Kyu Lee
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index239550115007920263756548179655946207452909109391
#%40485559703048338631754987737879450055994059131

#*Relation of adipose tissue to metabolic flexibility
#@M. Sparks,Barbara Ukropcova,Jana Smith,Magdalena Pasarica,David Hymel,Hui Xie,A. Bray,M. Miles,R. Smith
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1001131015384679702407106419136269896137750355298
#%68540167150651371495485724947673820764584070691
#%379779926298601900092569959112573742940628030766
#%783656410178030155486506678919977842787145649839
#%1363026245756019247738631871564916152985072734215
#%1256383836500178818840398051061753274354220267084
#%89613364162753599749812197418448927861463897269
#%185627636499921548248282475379655145671200936395

#*Effect of insulin-unstimulated diabetic therapy with miglitol on serum cystatin C level and its clinical significance
#@Hiroki Yokoyama,Teruo Inoue,Koichi Node
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1152166111369963965962888704776029860836634554882
#%957817593582752271746411555564639376636149547611
#%1091535995862485780009582623302014687270559434472
#%1147968020078546218888407972075753704124491088978

#*Prevalence and pattern of cardiac autonomic dysfunction in newly detected type 2 diabetes mellitus
#@P. Jyotsna,Abhay Sahoo,V. Sreenivas,K.K. Deepak
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index91554233075046003730115208026121429802977433051

#*A case of nesidioblastosis causing hypoglycaemia after delivery
#@Jihyun Ahn,Eun Lee,Sil Lee,Jae Chung,Sahng Oh,Hyun Shinn,Jaetaek Kim
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index688345995858483211273795601374388370471021203299
#%625614484591562256567217676977673511437121813896
#%233804900779809434843724930554491688345730930458
#%87170067514474324596539695840126993955354678361
#%89060743779871531769301948724788838100955693713

#*Web-based management of diabetes through glucose uploads: Has the time come for telemedicine?
#@Madona Azar,Robert Gabbay
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index275188013907453750606722365298902989571162545009
#%631452335653332630177163862882721604441323457304
#%539416993328611371973842048292657002324106512311

#*Differences in prevalence of antibodies to GAD and IA-2 and their titers at diagnosis in children with slowly and rapidly progressive forms of type 1 diabetes
#@Tatsuhiko Urakami,Ayako Yoshida,Junichi Suzuki,Hiroshi Saito,Mika Wada,Shouri Takahashi,Hideo Mugishima
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index349942069295490134537553577017175398270705890803
#%106129192845100190994425469060920203237848506276
#%450516500390122113858702261199893243776092071319

#*Peripheral blood mitochondrial DNA content and dysregulation of glucose metabolism
#@Shao-Wen Weng,Tsu-Kung Lin,Chia-Wei Liou,Shang-Der Chen,Yau-Huei Wei,Hsin-Chen Lee,I-Ya Chen,Ching-Jung Hsieh,Pei-Wen Wang
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index271823286840743651112033455714390003252086554522
#%372168455702403549218459743598003157826412836643
#%335110775885894429563543153296527735104899426780
#%1138706179720810147066714459447862291796102851443
#%1415153073861260342688797532374460909146710851989
#%1415153073861260342688797532374460909146710851989
#%174627494513607313361536889680540544378902631038

#*Comparison of waist circumference with body mass index for predicting abdominal adipose tissue
#@Rie Oka,Katsuyuki Miura,Masaru Sakurai,Koshi Nakamura,Kunimasa Yagi,Susumu Miyamoto,Tadashi Moriuchi,Hiroshi Mabuchi,Masakazu Yamagishi,Yoshiyu Takeda,Senshu Hifumi,Akihiro Inazu,Atsushi Nohara,Masa-aki Kawashiri,Junji Kobayashi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1457871129674784636971787357351421116735164726319
#%739302984889691781913641581576441657209822219271
#%460201746967010262218251128170937693109578574784

#*Prevalence of macro- and microvascular complications among patients with type 2 diabetes in Iran: A systematic review
#@Masoud Amini,Ehsan Parvaresh
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1208216720455027239028458710720836007334618238882
#%274310322855768393636631788521320070872108074908

#*Lifetime prevalence of suicidal ideation in a representative sample of Canadians with Type 1 diabetes
#@Esme Fuller-Thomson,Jami-Leigh Sawyer
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1261070373763631771254248621408489522518758035139
#%562909166773803151441868084619891485253831281264
#%1430019288116083639257625443670192454520720752394
#%1298510560107857319806546197158961646635115368141

#*Which is the better option: recombinant human PDGF-BB 0.01% gel or standard wound care, in diabetic neuropathic large plantar ulcers off-loaded by a customized contact cast?
#@Anil Bhansali,S. Venkatesh,Pinaki Dutta,M.S. Dhillon,Sambit Das,Aditya Agrawal
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index44913324662416888355162852508595468133468312806
#%929444386295169668559258744306929368153210702344

#*Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea
#@Viswanathan Mohan,Wenying Yang,Ho-Young Son,Lei Xu,Liliane Noble,B. Langdon,M. Amatruda,P. Stein,D. Kaufman
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index647596432671004489065923668493460363068966497462
#%11294555597995160451427388033719509315863908238
#%1322857741911097270872650933679466413785282969918
#%1405289936925555641146330394603561340891040062201
#%735009024663998479048138862737818215104111252409
#%390371137728887586911880288885235639516434221172
#%390371137728887586911880288885235639516434221172
#%51675834967510788842701379014025640086766967269

#*Prevalence of metabolic syndrome among Asian Indian subjects with elevated intermediate glucose response during OGTT
#@Vijay Viswanathan,Satyavani Kumpatla,Clementina Michael,Priyanka Tilak
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index842312262341014498775217383255624414598976720555

#*Comparison of effects of amlodipine and angiotensin receptor blockers on the intimamedia thickness of carotid arterial wall (AAA study: Amlodipine vs. ARB in atherosclerosis study)
#@Hiroki Ikeda,Jun Minamikawa,Yoshio Nakamura,Sachiko Honjo,Yoshiyuki Hamamoto,Yoshiharu Wada,Kouichiro Nabe,Hiroyuki Koshiyama
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index609212543819183718655209151402793826551561390987
#%974522687939221527267486788083855437335765839753
#%420900084547299943533684819168197655057338742505

#*Olmesartan reduced microalbuminuria in Japanese subjects with type 2 diabetes
#@Hiroki Ikeda,Yoshiyuki Hamamoto,Sachiko Honjo,Koichiro Nabe,Yoshiharu Wada,Hiroyuki Koshiyama
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index159941267657890188346984687619319785818710799553

#*Drug-induced insulin autoimmune syndrome
#@Yasuko Uchigata,Yukimasa Hirata,Yasuhiko Iwamoto
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index63637450059237176837639244310149171734006179091
#%663078030755769960277546577862684546941080054732

#*Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs
#@M.A. Mollar-Puchades,Lafuente Villanueva
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index853435393371042091344859700159707638226023243979

#*NMR-determined lipoprotein subclass profile predicts type 2 diabetes
#@M. Hodge,J. Jenkins,R. English,Kerin ODea,G. Giles
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index883754098317188994055082630062462396182968750129
#%1183042760225377970486923217794255309550600028881
#%638755936925091480268248956031285272009009856063
#%381398457301481442611404395790748904718893092831

#*Immediate impact of a diabetes training programme for primary care physiciansAn endeavour for national capacity building for diabetes management in India
#@N. Murugesan,R. Shobana,C. Snehalatha,Anil Kapur,A. Ramachandran
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index686019541181824064961760395964267084181968333549

#*Long-term projections for diabetes-related work loss and limitations among U.S. adults
#@Kaan Tunceli,Huiwen Zeng,A. Habib,Keoki Williams
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index668813605446979488105081042964906202643137355098

#*Enhanced expressions of sodiumglucose cotransporters in the kidneys of diabetic Zucker rats
#@M. Tabatabai,Mukut Sharma,S. Blumenthal,H. Petering
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index86194329439739221561309144375049552432629585663
#%186396103254927355935455458071989750751964032890
#%499146168228766013389852798232441290335248851069

#*Novel phenotypic markers and screening score for the metabolic syndrome in adult Asian Indians
#@Anoop Misra,Abhishek Jaiswal,Divya Shakti,Jasjeet Wasir,Kishor Vikram,Mohan Pandey,Dimple Kondal,Bharat Bhushan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1248933789114311984477410663876283628340439387172
#%1447361853434363988291233158284447693785612743316

#*Increased insulin resistance and hyperinsulinemia in patients with type 2 diabetes and chronic hepatitis C
#@R. Oliveira
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index744679885255166710995098882357032438206083224142

#*The short-term effect of alcoholic beverage-intake on blood glucose levels in type 2 diabetic patients
#@Shigetoshi Hosaka,Manabi Miyashita,Junichi Inoue,Kazutoshi Maruyama
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1054939645402043670952952766517966811869167176926
#%1339706301868235269491771258646082420783807232970

#*Seasonal variation in the diagnosis of type 1 diabetes
#@J.P. Wouwe,G. Jacobusse,S. Buuren
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1142696396961153105591605013156425170461612117061
#%937554555755904525544112952893310908216250819890

#*Symptoms of gastroesophageal reflux in diabetes patients
#@H. Kase,Y. Hattori,N. Sato,N. Banba,K. Kasai
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index815462623076851217916578635078210798442835579096
#%50773770923779432487843351041822445935157612954
#%1449295111743092054345832452463460725396977560894

#*Pdx-1-independent differentiation of mouse embryonic stem cells into insulin-expressing cells
#@I. Takayama,S. Miyazaki,F. Tashiro,J. Fujikura,J. Miyazaki,E. Yamato
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index852231888827912178465699224859938984127892445767

#*Effectiveness of comprehensive diabetes care program in Taiwanese with type 2 diabetes
#@Kai-Jen Tien,Hsin-Chia Hung,Jeng-Yueh Hsiao,Shih-Chieh Hsu,Shih-Chieh Hsin,Shyi-Jang Shin,Ming-Chia Hsieh
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index343089324401105405765603908594910434876808386297
#%497895520119729909807330237049682253425785855183
#%856726371899221746472697803898542052582298609823
#%1198838675164825412735668110496905879476128256129
#%806999650028062183539294847549091501669413301243
#%860567054760069186006567692440502580452632394293

#*Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
#@Haiya Wu,Weiping Jia,Yuqian Bao,Junxi Lu,Jiehua Zhu,Ren Wang,Yaqing Chen,Kunsan Xiang
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1162802027208184720239599200167042969624541491799
#%1062102914805636190528624029436745766855225529621
#%803976172016604876493853198784913373402034376133
#%679905319709773893941449697290738371753700134758
#%165406441060206632744837119550123100680351041522
#%381689272994856571347453085485408282000075332068
#%763310641992881043323814677225387438014794291562

#*Association of polymorphisms in the insulin-degrading enzyme gene with type 2 diabetes in the Korean population
#@S.H. Kwak,Y.M. Cho,M.K. Moon,J.H. Kim,B.L. Park,H.S. Cheong,H.D. Shin,H.C. Jang,S.Y. Kim,H.K. Lee,K.S. Park
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1040016964104095059523192166469885532422356133126
#%584743777366757136242004614515791186212891762336
#%424024650834269067694567800909474464480537868364
#%178636823132885834441049153805314518954807889464
#%1145764240608947092912941121044405389148298181265
#%170735591682675268372312657237451207027508125485

#*Reducing waist circumference by at least 3 cm is recommended for improving metabolic syndrome in obese Japanese men
#@Nobuyuki Miyatake,Sumiko Matsumoto,Masafumi Fujii,Takeyuki Numata
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index929253247027917597095189718109418674523425861151

#*Altered degradation of circulating nucleic acids and oligonucleotides in diabetic patients
#@G. Kocic,G. Bjelakovic,Lj. Saranac,R. Kocic,T. Jevtovic,D. Sokolovic,G. Nikolic,D. Pavlovic,S. Stojanovic
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index975403806893195341921223959119368409285312809352
#%149986069166587284280662250581754754149835892360
#%1167642749316510454787509709153903481053050506894

#*Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes
#@Kenji Nonaka,Taro Kakikawa,Asako Sato,Kotoba Okuyama,Go Fujimoto,Naoki Kato,Hideyo Suzuki,Yukio Hirayama,Tuli Ahmed,J. Davies,P. Stein
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index502852898379658605503186822050482231521866642376
#%1458222360592100598637088753112949440534668462919
#%74108759385361979204156615352365733346388426847
#%331463535884605394994706450224403767834343688312

#*Diabetes processes of care in the Australian veteran population
#@E. Roughead,John Barratt,L. Gilbert,Robert Peck,Graeme Killer
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index318397531143316431933231439726198611203925462786

#*Glycohemoglobin screening in adolescents attending to the Department of Paediatrics at a tertiary hospital in Turkey
#@Dilek Dilli,lknur Bostanci,Yldz Dallar,Sabahat Gck
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1395787394460284816653808967501159115426020533553
#%1073267313995146264942724652451459045814092608728

#*Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: A meta-analysis
#@Matteo Monami,Caterina Lamanna,Niccol Marchionni,Edoardo Mannucci
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index94974346805613503925571111135837363562683657686
#%166576389047544215813299143790789865338775050554
#%22768127177035593066166586487100748940089137719
#%1235420491799837320412470041252513283731552126657
#%920241321889669665287705793802399032889517257662
#%546299017168065274420384267331911522531369644771
#%590519479996946842743768242972094160904989024468
#%657463036024543305612674721533784506688334612312
#%1186346468612348943346164264824208867847496851823

#*Genetic polymorphisms in the reninangiotensin system (RAS) genes and their association analysis with type 2 diabetes and related traits in Mexican Americans
#@Farook Thameem
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1105427418919230658437457089621201699087244951715
#%921459685602224058918452438980088613053750427621

#*Prevalence of metabolic syndrome in Japanese type 2 diabetic patients and its significance for chronic vascular complications
#@Yoshinori Shimajiri,Keiko Tsunoda,Machi Furuta,Yoshiki Kadoya,Shyoichi Yamada,Kishio Nanjo,Tokio Sanke
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1354939770678129543318148302783087654618197880317
#%1302237423387309659268743447384714660323552609272
#%1153170919038339118492404517796345357552341554654
#%857242410680689497381988393770385841841071549629

#*Expression of TNF- protein in omental and subcutaneous adipose tissue in obesity
#@Li Cao,Zhu Hu,Xin Meng,Fei Wang,Jin Zhang
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index990218927881483700342409880170816168049790763876
#%890167369757373157171388310791226442133215067993
#%1273227955255920727136262085956718856586715137137

#*Doppler ultrasonography imaging of hemodynamic alteration of retrobulbar circulation in type 1 diabetic children and adolescents without retinopathy
#@Gulgun Ovali,Betul Ersoy,Ozum Tuncyurek,Vildan Urk,Mine Ozkol,Bayram Ozhan,Esin Baser,Yuksel Pabuscu
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index255808682327883252192920913967791770942107654789
#%1445921729900440144035499776935093554628224804877
#%759868548393417533385392274947811351575514383888

#*Insulin administration may trigger pancreatic -cell destruction in patients with type 2 diabetes
#@Mai Nakamura,Wataru Nishida,Yuya Yamada,Daisuke Chujo,Yuji Watanabe,Akihisa Imagawa,Toshiaki Hanafusa,Eiji Kawasaki,Hiroshi Onuma,Haruhiko Osawa,Hideichi Makino
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1249613185847293345996339298084797677249563274015
#%889923740193043015076273459006991200299749370279
#%471510529695899069413637119763314520122636405187
#%211228355808160809362420011863655819952822895465

#*Does home-based exercise improve body mass index in patients with type 2 diabetes?
#@M.A. Krousel-Wood,L. Berger,X. Jiang,L. Blonde,L. Myers,L. Webber
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index821140737860624414196919650868333099887557553795
#%577097174543141068287490200902923883813087227511
#%1439714437861239782508143988402569945446049955673
#%390493129040455511441737158793780029656529327475
#%1382307818717359847098689020680822989597357260494
#%173830048293099155172095652794495262154420708580

#*Rising prevalence of diabetes among Greek adults: Findings from two consecutive surveys in the same target population
#@Aristofanis Gikas,Alexios Sotiropoulos,Demosthenes Panagiotakos,Vasilios Pastromas,Eystathia Paraskevopoulou,Eystathios Skliros,Stavros Pappas
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index755327367651590607530114271112304535289754219685
#%1238493761444858885847069673758032080571422578589
#%593278508426615700564096658807807234883906851846
#%387214988192954058198705784009966453553186294415
#%580973138377794928834204511558657714396331358321
#%1070905556764175439569011787851119957132976517450

#*Quality of diabetes care in Arab Americans
#@D. Berlie,H. Herman,B. Brown,Adnan Hammad,A. Jaber
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index174426494473077574177840038269154494694599685404
#%113454208461780523955596984728070507237981257872

#*Cerebral arterial pulsatility and insulin resistance in type 2 diabetic patients
#@Suk Park,Ho Cho,Yul Lee,Sik Kim,Jin Kim,Sun Nam,Woo Ahn,Soo Cha,Jig Lee,Kil Lim,Rae Kim,Chul Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index963838889407927417868202513976140515100584696782
#%332968721107833343901708353326096386907260430030
#%1390734918921973267807700778239356838529638184167
#%796797912017616824947611636190003897612723227902

#*Waist circumference is the main determinant of elevated C-reactive protein in metabolic syndrome
#@Hirofumi Nakamura,Hiroyuki Ito,Yuhko Egami,Yoshikazu Kaji,Toru Maruyama,George Koike,Sumie Jingu,Mine Harada
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1235975334813099191538518125295671496023178020041
#%34090011534066248448035771136564561999544798148
#%1336402988692050551821045229208352602305104466964
#%932301565720820102694488250049515867043402496271
#%339328639233513575928833623391958818390963603608
#%448711195734048503457867917305157803313343271474
#%365694544983775472972544607940382674382323855807

#*Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications
#@Giancarlo Mattia,Cristina Bravi,Oriana Laurenti,Arianna Moretti,Rosalba Cipriani,Alessandra Gatti,Elisabetta Mandosi,Susanna Morano
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index176754665503464054777757230849577802367625225860
#%586245700430724216836030812856627545964565103579
#%268707430809312644232367752956121776345109867915
#%292385803284376221171346865253571167138778881615
#%553385401060354711559473521753457200578062425782
#%1401196771419821112553934958794551429671642659672

#*A short message service by cellular phone in type 2 diabetic patients for 12 months
#@Kun-Ho Yoon,Hee-Seung Kim
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index345467241203650626188278535863277109853064878366
#%777447096479871111821562674586249026306562826781

#*Aortic distensibility is reduced, but coronary flow velocity reserve is similar in diabetic versus non-diabetic patients with coronary artery disease
#@Attila Nemes,I.I. Soliman,Mikls Csandy,Tams Forster
#year2008
#confDiabetes Research and Clinical Practice
#citation2
#index601701254539151027394794842575003745696572220511
#%661205540339300515685859727236145321809222396185
#%788623589605621161991466098540769150323285319799
#%451609450917656044162371101807044281849294379579
#%842011661470410161858543209775988601710490893945
#%1046740043772410847570750735511836857964401395333

#*Incidence and predictors of abnormal fasting plasma glucose among the university hospital employees in Thailand
#@Wiroj Jiamjarasrangsi,Vitool Lohsoonthorn,Somrat Lertmaharit,Somkiat Sangwatanaroj
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index998412985255024738686475222368294253158880713235
#%608599557601443201658711010464765932553998229738
#%608599557601443201658711010464765932553998229738

#*Renal manifestations of metabolic syndrome in type 2 diabetes
#@Ko Hanai,Tetsuya Babazono,Yasuhiko Iwamoto
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1160768522739076028937885021803051186694269897848
#%117575207847639272847917823303429775324738129810
#%1305372912053979810929894754461647293315149530446
#%716377092009299480259221683290533471879354536630
#%716377092009299480259221683290533471879354536630

#*Long-term effects of a diet loosely restricting carbohydrates on HbA1c levels, BMI and tapering of sulfonylureas in type 2 diabetes: A 2-year follow-up study
#@Hajime Haimoto,Mitsunaga Iwata,Kenji Wakai,Hiroyuki Umegaki
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index79975017337134443886350592736358265955027260239
#%228387717993145986263721026876393218448658027082
#%775406346647581929722452976148888800269632550504

#*Genetic variation and plasma level of the basic fibroblast growth factor in proliferative diabetic retinopathy
#@Michal Beranek,Petr Kolar,Svatava Tschoplova,Katerina Kankova,Anna Vasku
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index766717430027695160081667633063794602236815678963
#%778051332107473035773063306702379386508643717963
#%1114570573388949850345430609272582811504508628635
#%151780104450708179631197106738251407351217969387
#%1005939945746621579408885267535872309027041049591
#%1119857191024881707166891454659137567952276927063
#%1145764240608947092912941121044405389148298181265
#%855066336801553355069209241558867902162902335453
#%663104726486811311512348315329123891058650859154

#*Insulin glargine-based therapy improves glycemic control in patients with type 2 diabetes sub-optimally controlled on premixed insulin therapies
#@Melanie Davies,Patrick Sinnassamy,Fred Storms,Ramon Gomis
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index470798047979679412763008702873930998104065697174
#%657463036024543305612674721533784506688334612312

#*Uncomplicated type 1 diabetes and preclinical left ventricular myocardial dysfunction: Insights from echocardiography and exercise cardiac performance evaluation
#@Vittorio Palmieri,Brunella Capaldo,Cesare Russo,Michele Iaccarino,Salvatore Pezzullo,Gabriele Quintavalle,Giovanni Minno,Gabriele Riccardi,Aldo Celentano
#year2008
#confDiabetes Research and Clinical Practice
#citation1
#index560292057180898182531722857513326078017464922676
#%50166337834779859415531144983888673269509790234
#%219951068730247266634539337525842782639940543841
#%1408264080972582597178609033969816459042718189875
#%1156091094882975625367797525060005465136254473351
#%1156091094882975625367797525060005465136254473351
#%195051570121175792956109858792606035363054016206
#%1341533034536896944397862138186466570584322372243
#%176034451997426173658192697576872394442468158861
#%791803557976382721086651924030820280049240066145
#%598573126354447544915823462922076094802600489947
#%1269090094772578874325289360134281465407946161522
#%747600546507596567219894470300261985469489099206
#%679660399745383962075972687807056508819047463321
#%500356743507867593178891598748232580224521363114
#%217058214252503843117780158030195017610512883577

#*Letter to the Editor in response to the article The impact of apathy on glycemic control in diabetes: A cross-sectional study
#@S. Kilpatrick
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index963501738489840388424896674939181879326242793691
#%293352128833507955470442318758715366156165332440

#*Serum cystatin C in diabetic patients
#@Yoshiji Ogawa,Takashi Goto,Naoki Tamasawa,Jun Matsui,Yusuke Tando,Kazuhiro Sugimoto,Ken Tomotsune,Masahiko Kimura,Minoru Yasujima,Toshihiro Suda
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index157346108512825839714442576234735783462428157983

#*A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period
#@Stephen Luzio,Rajesh Peter,J. Dunseath,Laila Mustafa,R. Owens
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1248637160286621269658792121102898638848195535849
#%1169293796816107314381672818036363250941017341287
#%481570781244869144784002259840012820397148090045
#%1213970065150152242748918451103807760520145980868
#%1014833456607916740444189501448270852549747095631

#*Plenary 1 Global strategies for prevention of obesity and diabetes
#@Shiriki Kumanyika
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index618781501529523566321347543737591414679958134926

#*Plenary 2 The kidney, renin-angiotensin system and cardiovascular disease
#@E. Cooper
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1224679883609850667826125887808436661873638778812

#*Plenary 3 Role of inflammation in the etiology of obesity induced insulin resistance and Type 2 diabetes
#@A. Febbraio
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index488165015479071304618496252327582349853233496064

#*Plenary 4 Developmental origins of Type 2 diabetes
#@Susan Ozanne
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1311446967114667495311065336888148925745013317401

#*Plenary 5 Eye care delivery using telemedicine for reduction or prevention of diabetic retinopathy complications
#@Sven-Erik Bursell
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index158880042506387411829021876774469699274372023864

#*Open public forum A1 Beta-casein, Type 1 diabetes and links to other new world illnesses
#@Keith Woodford
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index670533933196585581425507963321716683513934027916

#*BS1-A Islet neogenesis
#@Susan Bonner-Weir
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index381711042521549472933348356957999814174585244200

#*BS1-B Xenotransplantation update
#@R.B. Elliott
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index635272777030915787377863510111540912617370292889

#*BS2-A Relevance of incretins in the treatment of Asian patients with Type 2 diabetes
#@Yutaka Seino
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index924626472811350503664303606189155312378865989858

#*BS2-B Beta cell lipotoxicity in Type 2 diabetes
#@J. Biden
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index951356071070339999675045520884296959962994148799

#*BS4-A Applications of proteomics in diabetes: route to new and improved understanding of disease mechanisms and the generation of new therapeutic approaches
#@J.S. Cooper
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1145141353762999956189775501129231999956935538936

#*BS4-B Translating gene discoveries into clinical practice for Type 2 diabetes
#@Mark McCarthy
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index540803759455358044054398645852852802729445771387

#*BS6-B Molecular aspects of diabetic complications
#@E. Cooper,Chris Tikellis,Phillip Kantharidis
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index949082092583125119603880969458803642128577886606

#*DWP1-A Diabetes in the Pacific Nations
#@Satu Viali
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index116207201938826403266122610775941181190402218704

#*DWP1-B Prediabetes (IGT) is the optimal time for intervention of diabetes and CVD prevention
#@Chang-Yu Pan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1269276563322926673991532300927028327613376938782

#*DWP2-A Diabetes, CVD and ethnicity; diverse patterns across the Western Pacific Region
#@Jonathan Shaw
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index453050448470611860742514617448113773133073397845

#*DWP3-A Determinants of diabetes mellitus and cardiovascular diseases in the Asia Pacific region
#@Anushka Patel
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index503074403476037569207965543011589109637252481890

#*DWP4-A Obesity and cardiometabolic risk factors in diabetes: role of novel adipokines
#@S.L Lam
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index842868666866555942501735923120901681277109519964

#*DWP5-A Ethnicity, diabetes and complications
#@E. Tai
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index584365021420156471654042830610808222512433319172

#*DWP6-A Is diabetes risk determined before mid-childhood?
#@E Harding
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index363519332861997685930385217120483216964157439143

#*DWP6-B Genetic factors and Type 2 diabetes: An Asia-Pacific perspective
#@Lee-Ming Chuang
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index208290709837879453211673165768350762426177772299

#*CD2-B Emerging treatment for the unmet needs In Type 2 diabetes
#@C.N Chan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1354638662285093888390901838472162355540212709098

#*CD4-A -cell function and volume in the development of Type 2 diabetes
#@Steven Kahn
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index917312207004499070338301577991319397184565499022

#*CD5-A Early retinal complications and vascular disease
#@Tien Wong
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1174665362530631340200813828453974846577652752290

#*CD6-A What lifestyle intervention trials are needed to lower cardiovascular risk in diabetes patients?
#@Harn Pan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index781622018774374616710130403211458444188542580793

#*CD6-B Foot care in diabetes
#@Vijay Viswanathan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1435588297172902583064808466981746924343294917974

#*PNO1-B The surgical management of Type 2 diabetes
#@John Dixon
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index28401006438827176181211079594356615814236116625

#*PNO1-C What have we learned about Type 2 diabetes from bariatric surgery and what of the future?
#@S. Stubbs
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index40124678452253468324726368739716219887615321962

#*PNO2-A Nutrition controversies
#@Jim Mann
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index500880269072532269470144963755044476159962059165

#*PNO4-A The food industry and diabetes
#@Boyd Swinburn
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1325332688961592074523427849726700851958554800160

#*PNO6-A Preserving B cell function in the Asian population
#@Kun-Ho Yoon
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index904403364568274920829026678066167127228033487100

#*PNO6-B You want fries with that?  the challenges of diabetes prevention and treatment among Pacific Peoples in New Zealand
#@Colin Tukuitonga
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index288608438099481335714010015810908594271310796553

#*HD2-A Patient empowerment: from compliance to collaboration
#@M. Funnell
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index511221671544334742972995544338658943293672627902

#*HD4-B Telemedicine facilitated diabetes health care delivery
#@Sven-Erik Bursell
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index894205959617093766915408052597519639129500689509

#*HD4-C Information technology based ubiquitous diabetes care system
#@Jae-Hyoung Cho,Kun-Ho Yoon
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index228077122709576405741521270741910389309216328342

#*HD5-A How to deliver better care by enhancing diabetes team care education?
#@H.-H Sheu
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1164326802722243776761932265291936780228440444828

#*BS2-1 Sterol regulatory element-binding protein-1c activation is implicated in pancreatic -cell lipotoxicity
#@Hao-ming Tian,Jian-wei Li,Jing-qiu Cheng,Xiao-jing Liu
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1431636925411037703249818503057121321953269464268

#*BS2-2 Intracelluar mechanism of ER stress related cytoprotective effect of rosiglitazone in cyclosporine A-induced pancreatic beta-cell dysfunction
#@Ji-Won Kim,Jae-Hyung Cho,Chenglin Sun,Jin-Hee Lee,Yu-Bae Ahn,Mi-Ja Kang,Yoon-Hee Choi,Bong-Yun Cha,Kun-Ho Yoon,Ho-Young Son
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index106811750001018807759431162391452906028687952075

#*BS2-3 Role of insulin secretary capacity in the development of Type 2 diabetes
#@Takeshi Kurose
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index158658981008605842769944194438745293343905325163

#*BS3-1 Regulation of de novo lipogenesis by palmitic acid in human adipocytes
#@M. Collins,J. Neville,N. Frayn
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index535421388000264567722494865599235451872498926565

#*BS3-2 Inhibition of lipid absorption and lipoprotein secretion in an intestinal absorptive cell model
#@Takanari Nakano
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index248800050954207703519493429248602190819083739671

#*BS3-3 The effect of meals rich in different types of fat and carbohydrate on plasma inflammatory cytokine concentrations in obese and lean women
#@J Manning,H.F Sutherland,Michelle McGrath,A Jong,J Walker,J.A Williams
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1438636386336392843507143350351001773313511067586

#*BS3-4 Comparison of metabolic syndrome markers to predict changes in fasting glucose concentration in overweight, non-diabetic subjects
#@Brett Shand
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index25994954880422391829932980597147797816864322590

#*BS3-5 Plasma adiponectin level is decreased in eNOS knockout mice
#@Hee Koh,Hee Cho,Min-Seon Kim,Joong-Yeol Park,Soo Ko,Je Lee,Ki-Up Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1417531086691799982818096374738983929856764596680

#*BS4-1 Angiotensin type 1 receptor blockers exhibit peroxisome proliferator- activated receptor alpha agonistic activity
#@Shi-nan Yin,Dan-qing Jing,Yi-ming Mu
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index205764250438916435539360671966158773758505802352

#*BS4-2 LPIN1 polymorphism is associated with the response to rosiglitazone in patients with Type 2 diabetes
#@Seok Kang,Eun Park,Hun Kim,Jin Han,Moonsuk Nam,Soo Cha,Chul Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index791557094724771076401142109219391704589877174463

#*BS4-3 Can mitochondrial mutations help explain the high incidence of young onset Type 2 diabetes mellitus in Northland New Zealand Maori? A study of maternally inherited diabetes and deafness in a very large extended whanau (family)
#@Nicole McGrath,Amy Savage,Liz Allen,Arlene Baldwin
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index770201801244719873397116317660565486267148934829

#*BS4-4 Study of rs7903146 polymorphism in the transcription factor 7-like 2 gene in Type 2 diabetes mellitus of Chinese in the Chengdu area
#@Qing-cui Zeng,Hao-ming Tian,Yan Ren,Yang Long
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index835762412316024487406221186750689455202795574071

#*BS5-1 Thiazolidinediones stimulate GLUT-2, glucokinase and BETA2/NeuroD expression and regulate insulin secretion and synthesis
#@Hyo-Sup Kim,Jung-Hyun Noh,Seung-Hyun Hong,You-Cheol Hwang,Myung-Shik Lee,Kwang-Won Kim,Moon-Kyu Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index652183902297192134865509600042216427153930128410

#*BS5-2 Incretin secretion is independent of glucokinase function
#@Rinki Murphy,P.M. Clark,J.J. Holst,A.T Hattersley
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index822773786342430063374259977667816649042285439548

#*BS5-3 Dexamethasone inhibits insulin stimulated glucose uptake by reducing akt substrate of 160 kDa (AS160) phosphorylation in human adipocytes
#@Sherry Ngo,Janelle Barry,John Prins,Jon Whitehead
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index82289712106504081612704457345700560150622939917

#*BS5-5 Black seed (Nigella sativa) regulates glucose, insulin level and lipid profile in patients with Type 2 diabetes
#@Ahmad Bilal,Tariq Masud,Mahmood Uppal
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index180001246441446136381071567554140835263959317376

#*DWP1-1 Surveillance of Type 2 diabetes in China: a subgroup analysis of diabetes duration in the DIABCARE 2006 study
#@Changyu Pan,Wenying Yang,Weiping Jia,Jianping Weng,Hui Tian
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index350106630624845443009293932623896469948936377158

#*DWP1-2 The individual and societal cost of Type 2 diabetes in Vanuatu
#@George Falconer,Christopher Tarianga,John Tasserei,Alexandra Buckley,Ruth Colagiuri
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1257459293050635466504952889806686906841773052045

#*DWP1-3 Prevalence of diabetes mellitus in Malaysia in 2006  results of the 3rd National Health and Morbidity Survey (NHMS III)
#@H Zanariah,L.R Chandran,W.B. Mohamad,W.M. Nazaimoon,G.R Letchuman,H Jamaiyah,I Fatanah,M.N Nurain,G.H Tee,I Rodi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index906226623786386936525844654777672608938018116011

#*DWP1-4 Trends in the prevalence and management status of diabetes in Korea: Korean National Health and Nutrition Examination Survey
#@Jung Kim,Man Kim,Won Park,Chang Kim,Il Suh,Jin Kim,Woo Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index264288432922399090973889401883829688470461946334

#*DWP1-5 Diabetes prevalence, hospitalisations and deaths in different population groups of Australia
#@Mardi Templeton,Claire Ryan,Indrani Pieris-Caldwell
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1014140245354277581878294475685412844577301853328

#*DWP2-1 Cardio-metabolic-inflammatory risk predictors for heart failure in Type 2 diabetes  the Hong Kong Diabetes Registry
#@C.W Ma,Xilin Yang,Wing-Ye So,P.S Kong,T.C Ko,Chung-Shun Ho,W.K Lam,S. Cockram,C.Y. Tong,C.N. Chan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index492932968559990943495200414380227648859411732107

#*DWP2-2 Control and complications in people with Type 2 diabetes from three countries starting premixed analogue insulin: comparing data from the IMPROVE  study in China, Japan and Poland
#@Yang Wenying,Vito Borzi,B. Hansen,Paul Valensi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index829237256722185044579005407860247765577754707398

#*DWP2-3 Complications of diabetes and its effect on people with diabetes in Australia
#@Indrani Pieris-Caldwell,Lynelle Moon,Mardi Templeton
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index330143720552982856072367008456844523708255716847

#*DWP2-4 The burden of diabetes complications in Vanuatu
#@Alexandra Buckley,Vernon Naidu,Christopher Tarianga,John Tasserei,Kirsty Boltong,Ruth Colagiuri
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1358621188875820229437379616864289895050025567741

#*DWP3-1 The effect of lowering the threshold for diagnosis of impaired fasting glucose
#@So Kim,Yong Kim,Wan Shim,Hun-Jae Lee,Seong Hong,Moonsuk Nam,Shin GooPark,Jong Lim
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index88857343056342861923550723348813962039088126717

#*DWP3-2 Insulin resistance and beta-cell dysfunction using HOMA in Asian patients with Type 2 diabetes mellitus (T2DM) treated with oral anti-hyperglycemic agents (OHA)
#@Ji Linong,Baik Hyun,Nitiyanant Wannee,Sheu Huey-Herng,Sheu Huey-Herng,Siew Pheng
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index415838992695916065957876018878622418640481282487

#*DWP3-3 Fatness and fitness are associated with metabolic syndrome risk factors in Maori
#@Elaine Rush,David Simmons,Nic Crook
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index487160839784115196389737503000913031508563246782

#*DWP3-4 Obesity and Type 2 diabetes in Chinese children
#@A.O.L. Fok,L.L. Cheng,H.C. Yau,G.W.K. Wong
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1271926383070514551576813944035788567831726182941

#*DWP4-1 The effect of glucose ingestion on inflammation and oxidative stress in obesity
#@J. Manning,H.F. Sutherland,J. Walker,A. Jong,A. Berry
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index756558954541432105353464613900528973309561407042

#*DWP4-2 Epicardial fat thickness and coronary artery disease in Type 2 diabetes mellitus
#@Byoung Park,Ha-Young Kim,Cho Cho
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index778914022348716797237453177486562474656474595820

#*DWP4-3 Effect of pioglitazone treatment on insulin secretion, insulin resistance and progression of atherosclerosis in renal transplant recipients without a history of diabetes
#@Seung Han,Kyu Hur,Eun Kang,Chul Ahn,Bong Cha,Kap Huh,Hyun Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index105931508268981353667404192355463911827770783239

#*DWP4-4 Reduction in blood pressure and lipids with increased uptake of ACE inhibitors and statins over 5 years of diabetes annual reviews: analysis of Get Checked cohort from primary care in the Wellington region
#@Bob Smith,Michael Hullah,Jeremy Krebs,Michael Shapleski
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index44529741230074768738834368797586441641722780666

#*DWP5-1 A profile of native Hawaiians and other Pacific Islanders in the USA
#@Fahina Pasi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index962543025021189639197655570420984488488870371252

#*DWP5-2 High incidence of diabetes in Australian indigenous communities in north Queensland
#@Robyn McDermott,Sandy Campbell,Brad McCulloch
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1412303985420497155572726797916044326534514176462

#*DWP5-3 High prevalence of diabetes and abnormal glucose tolerance in an Iranian urban population: Tehran Lipid and Glucose Study
#@Farzad Hadaegh,Mohammad Bozorgmanesh,Asghar Ghasemi,Hadi Harati,Navid Saadat,Fereidoun Azizi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index955284249910827135445762345841657557248461299027

#*DWP5-4 Progression of renal disease among diabetes patients in Waikato: an ethnic perspective
#@Grace Joshy,Peter Dunn,A. Lawrenson
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1230647614288136478333360139377240554319835263399

#*DWP6-1 Identifying a genomic signature for diabetes risk
#@Donia Macartney,David Hall,Lisa McCallum,Jeremy Krebs,Richard Stubbs,Rod Lea
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index112286555349761552567160269260893245626209783849

#*DWP6-2 Association between R325W zinc transporter-8 gene polymorphism (SLC30A8)and Type 2 diabetes
#@Yong Lee,Eun Kang,So Kim,Seung JinHan,Kyu Hur,Chul Kim,Chul Ahn,Bong Cha,Moonsuk Nam,Hyun Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index37689970916176439892936224001705079655914723085

#*DWP6-3 Meta-analysis of the association of TCF7L2 with Type 2 diabetes in the Asian population
#@Linong Ji,Yingying Luo,Hongyuan Wang,Qian Ren,Xueyao Han
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index727472197342377829970738309557039408751519178646

#*DWP6-4 Novel hepatocyte nuclear factor 4-alpha (HNF4A) promoter mutation in a New Zealand family
#@Rinki Murphy,Tim Cundy,Sian Ellard
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index907740393513959925322147219718461711371002279267

#*CD1-1 Glycemic index, glycemic load and diabetes risk: a meta-analysis
#@Alan Barclay,Peter Petocz,Joanna McMillan-Price,Victoria Flood,Tania Prvan,Paul Mitchell,Jennie Brand-Miller
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index85645003021700252318325101818590096096626450341

#*CD1-2 Acute changes in insulin sensitivity with very low calorie diet (VLCD) and gastric bypass
#@J. Krebs,Y. Tychinskaya,T. Croft,D. Bell,D. Macartney,M. Hayes,H. Rajekar,R. Stubbs
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1058221616819991676451453593463848580713661863129

#*CD1-3 The Women's Lifestyle Study: A 2-year randomised controlled trial of physical activity counselling in primary health care
#@Beverley Lawton,SallyB. Rose,Raina Elley,Tony Dowell,Anna Fenton,Selina Brown
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1180100406665470971331490906682361460066750481158

#*CD1-4 Increasing fruit and vegetable consumption  a multi- pronged intervention (Fresh for Less campaign)
#@Amanda Dunlop,Rob McNeill,Sarah Appleton,Brandon Orr-Walker
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1201319662919691780852656001711406724835884582553

#*CD2-1 Efficacy and safety of sitagliptin or rosiglitazone when added to ongoing metformin therapy in patients with Type 2diabetes
#@Russell Scott,Tom Loeys,J. Davies,S. Engel
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index846316238913925117084871057020437999684884482360

#*CD2-2 Efficacy and safety of repaglinide in combination with metformin in Type 2 diabetes inadequately controlled with oral anti-diabetic drugs
#@Guang-wei Li,Wei-ping Jia,Chang-yu Pan,Xiao-hui Guo,Da-jin Zou
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index128464324279586771590388700348461038845505683352

#*CD2-3 Pilot findings of N-acetylcysteine in Type 2 diabetes
#@Ryan Bradley,Heather Buckle,Paola Costa-Mallen,Sayed Sadrzadeh
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index747166732149619963140435842622566772174102855774

#*CD2-4 An observational study on the efficacy and safety of biphasic insulin aspart 30 among Korean patients with Type 2diabetes
#@Jang Chul,Choi Hee,Yoo Myung,Kim Han,Kim Man,Kim Jung
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index68752052893515433454610561317623975008230267984

#*CD3-1 NAFLD independently of either overall or central obesity is associated with various metabolic disorders and increased calculated risk of coronary heart disease
#@Hee Kim,Seop Choi,Sin Kim,Soo Park,Yun Lee,Hyun Jung,Tai Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index954952341371722185462306966429249077172240881632

#*CD3-2 Alanine aminotransferase (ALT) levels  a marker of cardiovascular risk factors clustering in adolescents
#@P.S. Kong,C.W. Ma,W.Y. So,PeterC.Y. Tong,T.C. Ko,C.C. Chow,C.N. Chan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index46943289289928629934887613180560640446708690454

#*CD3-3 Difference in power spectral analysis of heart rate variability between people with diabetes and healthy subjects in Korea
#@Chong Kim,T.S. Park,J.O. Mok,K.Y. Lee,Y.S. Kim,S.R. Kim,K.S. Kwon,J.H. Kim,S.O. Park,S.K. Song
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index116449395046573880751212607740291607477963854030

#*CD3-4 A contemporary model for cardiovascular risk prediction for different ethnic groups with Type 2 diabetes in New Zealand primary health care
#@C. Elley,T. Kenealy,E. Robinson,P. Drury,D. Bramley,N. Kerse,B. Arroll
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1106282418228085842299204420669488059780696242048

#*CD3-5 The cause of death in Type 2 diabetes mellitus during the past 10 years
#@Su Park,Ja Kim,Ying Han,Mi-Kyoung Park,Hye-Jeong Lee,Duk Kim
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index195176684979612410529569050918015003634649659712

#*CD4-1 Increasing incidence of Type 1 diabetes in Canterbury children and adolescents and spatial-temporal clustering
#@J.A. Willis,L.J. Miller,R.S. Scott,B.A. Darlow,J. Pearce,R. Barnett
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1456375884797918346180570352022527484491202221448

#*CD4-2 Population mixing and Type 1 diabetes in Canterbury, New Zealand
#@J. Miller,Jamie Pearce,A. Willis,Ross Barnett,S. Scott,A. Darlow
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1237209467801669149580237399027494124046043014922

#*CD4-3 Vitamin D deficiency in the young population with Type 1 diabetes: a case-control study
#@Abdulbari Bener,Amer Alsaied,Maryam Al-Ali,Marcellini Mian,Gerardo Guiter,Amit Abraham,Aisha Al-Kubaisi,Basma Basha,S. Hassan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index858079925995715199471758726283105523427473618806

#*CD4-4 Exendin-4 treatment expands graft  cell mass in diabetic recipients with a marginal number of fresh islets
#@Jyuhn-Huarng Juang,Chien-Hung Kuo,Chun-Hsing Wu,Charity Juang
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index529092577732658445299447011715146501289048198603

#*CD5-1 Serum extra domain B containing fibronectin (EDB FN)  a biomarker for proliferative diabetic retinopathy
#@Biju George,Shali Chen,Varun Chaudhary,John Gonder,Subrata Chakrabarti
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index17690220114899580220232957356143996330579497887

#*CD5-2 Autonomic neuropathy and hypertension in Type 1 and Type 2 diabetes mellitus: is there a relationship?
#@I. Istenes,K. Keresztes,. Sipos,Z.S. Putz,P. Vargha,P. Kempler
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1296946413137845864511042294158173404847043703179

#*CD5-3 Pro198Leu missense polymorphism of glutathione peroxidase 1 gene is associated with impaired vibratory perception in toe and the painful leg cramp in Japanese patients with Type 2 diabetes
#@Hideyuki Sasaki,Hiroshi Yamasaki,Kenichi Ogawa,Muneki Nakatani,Hiroto Furuta,Masahiro Nishi,Kishio Nanjo
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index56608768748690161803205463176291793801846768495

#*CD5-4 Associations of renal vascular resistance with microalbuminuria and other macroangiopathy in patients with Type 2 diabetes
#@Kumiko Hamano,Ai Nitta,Masami Seto,Shuzo Kobayashi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1285625969312537315422427047982825088553709210808

#*CD5-5 Delayed progression in left ventricular hypertrophy with intensive blood pressure control in Maori and Pacific patients with chronic diabetic kidney disease
#@C. Hotu,G.A. Whalley,R.N. Doughty,W. Bagg,J.F. Collins,H.J. Walsh,L. Harwood,G.D. Gamble,G.D. Braatvedt
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1447679994474239321729846393982395844341944564352

#*CD6-1 Step by step foot care project for people with diabetes, Dares Salaam, Tanzania
#@Z.G. Abbas,K. Bakker,S. Pendsey,L.K. Archibald
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index448493742846964563841607153675900016291902548174

#*CD6-2 A root cause analysis of diabetes-related amputations in Vanuatu
#@Ruth Colagiuri,Alexandra Buckley,Christopher Tarianga,John Tasserei
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1206503475130430689897579608616537964050523123225

#*CD6-3 Development and implementation of an evidence-based podiatric screening tool for diabetes-related foot complications among M aori
#@A. Bayley,B. Ihaka,K. Rome,D. Poratt,L. Penney,S. Rapana,E. McNeill,L. Marsden,L. Hetaraka-Stevens,N. Garrett
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1422221199189459539855503045610346836181124172349

#*CD6-4 Charcot neuroarthropathy of the lower limb in patients with diabetes in the South Auckland population  a case series of 58 patients
#@May Soh,Greg Gamble,Ajith Dissanayake,Brandon Orr-Walker
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index241450027543012743504186967696871945718046324430

#*PNO3-1 Effects of quinapril add-on treatment on aldosterone escape in hypertensive patients with Type 2 diabetes receiving valsartan
#@G. Yasuda,D. Ando,M. Kobayashi,S. Saka,K. Yatsu,Y. Yamamoto,N. Hirawa,S. Umemura
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1290348095017763877008009678168765443440398242443

#*PNO3-2 Relationship between sleep duration and the metabolic syndrome
#@K.M. Choi,J.S. Lee,T.N. Kim,H.J. Yoo,K.W. Lee,H.S. Park,S.H. Baik,D.S. Choi,S.M. Kim
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1381660921418489291480262682444300810044305871752

#*PNO3-3 Clinical inertia: reluctance to start insulin treatment in patients with poorly controlled Type 2 diabetes on oral agents
#@S. Choe,G. Cutfield,Karen Pickering
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index8442759536625095810267839925340305918838808500

#*PNO3-4 The concept of minimal mathematical modelling to understand and improve glycemic control in critical care
#@E. Hann,J. Chase,M. Shaw,Jason Wong,Jessica Lin,Thomas Lotz,Aaron LeCompte,Timothy Lonergan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index193255456664067712576860197831132708898929139126

#*PNO3-5 Prediction of resolution of Type 2 diabetes after gastric bypass surgery
#@R.S. Stubbs,M. Hayes,T. Croft,Y. Tychinskaya,L. Hunt
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1435703546592145297120856775346232699276547384960

#*PNO5-1 Ethnic differences in body composition of 2 year old children
#@Elaine Rush,Janet Rowan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index114865852297180828371262573836638641850092801123

#*PNO5-2 Understanding how we get from genotype to phenotype  time for geneticists and public health physicians to join forces
#@Robyn Toomath
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index228551156123577749554532383392167919103781582888

#*HD2-1 Recognition of HBA1 among Japanese patients with diabetes and effect of education using brochures
#@Noriko Nakayama,Hiroki Ikeda,Sachiko Honjo,Koichiro Nabe,Kazuhiro Nomura,Tetsuya Kimura,Tomohisa Aoyama,Yoshiharu Wada,Hiroyuki Koshiyama
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1051123238440382789263849295666848521985309429891

#*HD2-2 A multi-center study measuring the outcome of the China Diabetes Education Program
#@Xudong Wang,Linong Ji,Haoming Tian,Hongli Shi,Rongwen Bian,Benzhang Zhu,H. Ginsberg
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1421363156867338450837300404632691290227364697185

#*HD2-3 Motivational interviewing compared to patient education provided by Nurse Educators: A promising intervention for indigenous peoples
#@E.F. Britt,P.M. Moore
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index7393210848801573889857934576386708703300331106

#*HD2-4 It's more than the HBA1C: exploring the psychosocial dimensions of good diabetes control
#@Charles Greenfield,Marisa Gilles,Peter Shaw,Cynthia Porter,Kathy Willis
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index663905035506719997157694484658447980844397179713

#*HD3-1 GDM estimates: what is the current picture in Australia?
#@Mardi Templeton,Louise Catanzariti,Lynelle Moon,Indrani Pieris-Caldwell,Claire Ryan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index402526628896908920922157403727757709602507024566

#*HD3-2 Screening and follow-up for gestational diabetes in the Torres strait Islands
#@Ashim Sinha,Henrik Falhammar,Bronwyn Davis,Dianne Bond,Deirdre Frost,Marissa Arnot,Edna Sambo,Alexandra Raulli
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index579551189616387736237764267059435652060726521860

#*HD3-3 Microalbuminuria and hypertension in pregnancy in women with Type 1 and Type 2 diabetes
#@Matthew Farrant,Greg Gamble,Tim Cundy
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index731982808027971371060046035818770745750689321504

#*HD3-4 Maternal and fetal predictors of neo-natal hypoglycaemia, an audit related to diabetes in pregnancy
#@Mohammad Mohiuddin,Carl Eagleton
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index942284864217283361214357111301161430638632713153

#*HD4-1 Joint Asia Diabetes Evaluation (JADE) Program  a prototype for a electronic health record (EHR) for chronic diseases
#@Wing Son,T.C. Ko,C.Y. Tong,C.N. Chan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index798987306100358082968265826474760591975442298007

#*HD4-2 Community delivery of a web-based diabetes self-management project for Native Hawaiians
#@Donna-Marie Palakiko,Andrea Siu,Haunani Chai
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index30454861158604550161261682837587279581623406018

#*HD4-3 Shop for Your Life: healthy shopping was never so much fun
#@Kate Smallman
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index55519782445931892355886939645498140296046226980

#*HD4-4 Program to support Type 2 diabetes self-management
#@S. James,G. Biviano,K. Alexander,B. Penny,K. Hazelwood,L. Jackson
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1148602422588633925567018488173864782254887569053

#*HD5-1 Pacific diabetes self management group education programme in Pacific churches
#@Taouma Fatupaito,Rachael Lilomaiava
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1273629271585358612080396167766491084960021220365

#*HD5-2 The cultural and clinical effectiveness of a national community-based point-of-care testing program for improved diabetes management in indigenous Australia
#@Mark Shephard
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1340610502912794329614108577954675014815706660200

#*HD5-3 Do community led diabetes prevention interventions make a difference after 2 years?
#@David Tipene-Leach,Helen Pahau,Kirsten Coppell,Sheila Williams,Jim Mann,Sally Abel,Mark Iles,Jennie Hindmarsh
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index429576407620297315830451581566541031543198977690

#*HD5-4 Development of a diabetes self management education package to assist facilitators in their delivery
#@R. Milne,L. Ferguson
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index215676321596852111370351870314366836388311361645

#*HD5-5 Fostering co-operation between diabetes nurse specialist and general nurses through shared care
#@Kan Yee,Eva Chi,Tsang Chi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1160657028293183257653870533418765931733429384728

#*LWD4-1 An interactive online personal planner for healthy food choices and exercise
#@Patrick McKewen,Bronwyn Bannister,Paul Hansen,Mike Hodges,Franz Ombler
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1026921895319987613295868220434809384055604111803

#*LWD6-1 A community-based health care model for people with diabetes: a lesson learned from Thailand
#@Saowapa Pornsiripongse
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index472237186066881737479571469864706184184532622123

#*LWD6-2 Back to school to learn nutrition and activity: a pilot for Maori/Pacific Island parents
#@Donna Frost
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index738227428072999570669287455141803011707953140591

#*LWD6-3 Improvement of glycaemic control and diabetes awareness in the Pacific island community by intensive community management
#@Sam Chandler,Sera Tapu-Ta'ala
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index896270788746055076599979187783792879455990446587

#*P-1 NAD(P)H oxidase inhibitor improves endothelial dysfunction and prevents the development of hypertension in fructose fed rats
#@S. Unger,M. Patil
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index14355641215121113084138387503376877732248774389

#*P-2 NAD(P)H oxidase inhibitor improves endothelial dysfunction in streptozotocin induced diabetes in rats
#@M. Patil,S. Unger
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index51903602902167539938811072438551850938812805090

#*P-3 Peroxisome proliferator-activated receptor  coactivator-1  prevents endothelial apoptosis and dysfunction by increasing adenine nucleotide translocase-1 activity
#@Jong Won,Cheol Park,Woo Lee,Eun Koh,Min-Seon Kim,Ki-Up Lee,Joong-Yeol Park
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index823112116168336923523928739339721340172998795414

#*P-4 Cilostazol inhibits plasminogen activator inhibitor type 1 expression and prevents neointimal hyperplasia
#@Kyeong-Min Lee,Keun-Gyu Park,Hye-Soon Kim,Ho-Chan Cho,Mi-kyung Kim,Young-Yun Jang,Yong Kim,Jung-Guk Kim,Bo-wan Kim,Ju-Young Lee,Min-Ho Song,Hueng-Sik Choi,In-kyu Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index883283713291183466784110915364680243671378016712

#*P-5 A novel gastric inhibitory polypeptide (GIP) receptor splice variant influences GIP sensitivity of pancreatic  -cells in obesity
#@Norio Harada,Yuichiro Yamada,Katsushi Tsukiyama,Chizumi Yamada,Yasuhiko Nakamura,Eri Mukai,Yutaka Seino,Nobuya Inagaki
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index400011356993912953917804523092844606147090193822

#*P-6 Sequencing and association analysis of transcription factor 7-like 2 (TCF7L2) polymorphisms in the Chinese Type 2 diabetes population
#@Linong Ji,Qian Ren,Fang Wang,Xueyao Han
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1377430825978769750493257180500593682200428230944

#*P-7 The replication of association of four known risk loci for Type 2 diabetes in the Chinese Han population
#@Linong Ji,Xueyao Han,Qian Ren,Fang Wang,Xiuying Zhang,Lingchuan Han,Yingying Luo,Xianghai Zhou
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1195444101122098655519319191830636200799642698374

#*P-8 The associations of  -glutamyl transferase with visceral fat, adipokines, and insulin resistance in non-diabetic subjects
#@Jang Shin,Soo Nam,Mi Lee,Jang Koh,Young Shin,Choon Chung
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index803036796736695273057621614935862334754448880553

#*P-9 Serum resistin levels among Asian Indians: Relationship to inflammatory marker CRP and adipocytokine, leptin
#@Sujata Mahadik,Sudha Deo,S.D. Mehtalia
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1379451406033754378047844217768409730154258776864

#*P-10 Rosiglitazone inhibits the inflammation through MAPK signal transduction in rat skeletal muscle cells
#@Eun Kim,I.L. Nam-Goong,I.L. Choi,Hyo Chung,I.L. Kim
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1418653837957740908671619924940320817547830020308

#*P-11 2-Deoxy-d-ribose produces oxidative damage through mechanisms of protein glycation in pancreatic -cells
#@Gwanpyo Koh,Jeong-taekL Woo
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index600146283216330879753574042118383785052607859267

#*P-13 Effects of bacterial liypopolysaccharides and the iNOS blocker, S-methylisothyourea (SMTU, 10 mg/kg), on glucose control in non-diabetic and streptozotocin-diabetic Wistar rats
#@Orlovsky Alexandrovich,Skibo Grigorievna
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index954083608481084500291077788075457896240016368382

#*P-14 Localization of gamma-aminobutyric acid and glutamic acid decarboxylase in the endocrine pancreas of Type 1 and Type 2 animal models of diabetes
#@Ernest Adeghate,Rasheed Hameed,Mohammed Shafiullah,Amna Kuwaiti,Azza Qassimi,Fatema Shehhi,Nejoud Sayeri
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index562781028408550068888286706859268393657125760586

#*P-15 The effect of homocysteine on the proliferation of rat vascular smooth muscle cells via the MAP kinase pathway
#@Hyung Yoo,Young Cho,Hong Nam,Byung Lee,Min Chae
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1364435654089126287619245270221037090906156032210

#*P-16 Introduction of a new hyperinsulinemic-euglycemic clamp technique without isotope in mice
#@Fei Ye,Rongya Tao,Weina Cong,Yuewen Chen,Dahai Zhu,Jinying Tian,Qian Liu
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index552457092205363049545898971091805094986267684931

#*P-17 Novel insulin formulations for oral administration: system characterization and in vivo studies in diabetic mice
#@Dekel Yaron,Margalit Rimona
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index878572103299537110141613854592691098097555038724

#*P-18 Glucose induced oxidative stress may cause ERCC1-XPF upregulation via an epigenetic mechanism
#@Biju George,Shali Chen,Biao Feng,Subrata Chakrabarti
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index608207395211638411229944890719844307259026237202

#*P-19 Does the ratio of the A and B isoforms of the insulin receptor of the liver change with diabetic status?
#@T. Hayes,Y.S. Kwan,Daniel Hutchings,S. Stubbs
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index662093379300539645637737469135568688872449854060

#*P-20 Promoter polymorphism of insulin-like growth factor binding protein-3 (IGFBP-3) in patients with Type 2 diabetes
#@Ji Nam,Jung Han,Jeong Yoo,Han Jung,Min Cho,Jong Park,Chul Ahn,Bong Cha,Kyung Kim,Hyun Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index551999125702117148140234305784144575770719043882

#*P-21 Are insulin-like growth factor-1 levels affected by the presence of Type 2 diabetes mellitus?
#@Victoria Stott,Patrick Manning,Dion Astwood,Stephanie Farrand
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index798006850715339307441085432068739175939323788163

#*P-22 Intensive anolog therapy in children younger than 6 years
#@Sanjay Kalra,Bharti Kalra,Amit Sharma
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index412240896722926347286616965695181605716715097252

#*P-23 A randomised trial in search of effectively treating hypoglycaemia in children with Type 1 diabetes mellitus
#@Lindsay McTavish
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1321587424487607806362902837851321998100490288938

#*P-24 MidCentral Health is 'Pumping'
#@M. Yiannoutsos,P. Giles,L. Nikolajenko,R. Knowles,H. Snell,P. Dixon,N. Pereira,D. Smith,W. Hunter
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index161321862109678577841105416285837015972956626510

#*P-25 Collaborative clinics for university students with Type 1 diabetes
#@Kirsty Newton,Catherine Nelson
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index842100277170550773416987424712883156831613536835

#*P-26 Acute liver dysfunction due to therapy for diabetic ketoacidosis in a patient with fulminant Type 1 diabetes
#@Kaoru Iso
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index822852999999271298631704069632566618725901268020

#*P-27 Treatment with biphasic insulin aspart 30 improves glycaemic control in patients with Type 2 diabetes inadequately controlled with oral antidiabetic drugs: results from China cohort in the PRESENT study
#@Yan Gao
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index862271107392411112722003789258055589348504145119

#*P-28 Switching patients from human premix insulin to biphasic insulin aspart 30 leads to improved glycaemic control: a subgroup analysis of Korean patients with Type 2 diabetes in the PRESENT study
#@Seung Oh,Jong Kim,SukO. Park,Suk ManSon,Sun Song,So Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1373807535163977149642207377052028805181214106959

#*P-29 Comparison of biphasic insulin aspart and human insulin premix in patients with Type 2 diabetes
#@Hiroshi Itoh,Akizuki Morikawa,Mahito Asai,Hideo Nishimura,Keita Atoh,Eiji Mutou,Eiji Oshima,Yasunori Iwashima,Takanori Miura,Masatomo Sekiguchi,Mitsunori Tani,Masakazu Haneda
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index33159673338060711941974456705227589026163859823

#*P-30 Clinical profile of patients considered for biphasic insulin aspart 30: baseline characteristics of insulin nave patients from the IMPROVE study
#@Ryuzo Kawamori,Paul Valensi,Cathrine rskov,J. Ligthelm
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1386837990957287373431097923636492040272494232138

#*P-31 Clinical profile of patients starting on biphasic insulin aspart 30: baseline characteristics from China, Japan, Poland and Italy from the IMPROVE study
#@Yang Wenying,Ryuzo Kawamori,B. Hansen,Robert Ligthelm
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index57788357742710809721627622941851086180260547727

#*P-32 Clinical profile of patients moving from human premix to premix analogue insulin: baseline characteristics of an IMPROVEstudy sub-group
#@Yang Wenying,Joseph Shaban,Janusz Gumprecht,Cathrine rskov,Paul Valensi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index671582533931195648266962754381450378537241488577

#*P-33 Thrice daily biphasic insulin aspart 30 regimen: another therapeutic option for Chinese patients with Type 2 diabetes
#@Wenying Yang,Qiuhe Ji,Dalong Zhu,Jinkui Yang,Lulu Chen,Zhimin Liu,Demin Yu,Li Yan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1380310638256916247354075783264380503169042033096

#*P-34 Comparison of 2-h postprandial blood glucose excursion (PPBG) in response to a standard test meal in insulin-requiring patients with diabetes treated twice daily with insulin Lispro Mix 50 or human insulin Mix 50
#@Yan Gao,Guangwei Li,Yan Li,Xiaohui Guo,Geheng Yuan,Qiuhong Gong,Li Yan,Yiman Zheng,Jia Zhang
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index805150971426662386858274732235228834836355597756

#*P-35 Study of metabolic control, body weight, body mass index and blood pressure in patients with Type 2 diabetes with insulin resistance with intensified insulin therapy
#@Anil Kumar,Reddy Iska
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index503635183933274418189177352280061397887719940269

#*P-36 The effect of morning intermediate insulin and night-time long acting insulin therapy in patients with Type 2 diabetes
#@Yonghyun Kim,Donghyun Shin
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index919196901326220605668903820849314709711016531428

#*P-37 Usefulness of C-peptide value for estimating pancreatic -cell function: Application to the assessment of insulin therapy for Type 2 diabetes
#@Akihiro Hamasaki,Takao Taniguchi,Yo Aramaki,Motozumi Okamoto,Shunsuke Yamane,Shimpei Fujimoto,Masaya Hosokawa,Yutaka Seino,Nobuya Inagaki
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1248268353025328806365531301582240686114064618040

#*P-38 Effect of insulin on endothelial lipase in Type 2 diabetes mellitus
#@C.B. Tan,W.M. Shiu,Ying Huang,Ying Wong
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index908810874139925334407674928629506247636735533777

#*P-39 Critical insulin treatment to diabetes patients prevents their risk of cardiovascular events
#@Shingo Kaneko
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index335108223194580497215888134244550011596638408380

#*P-40 Patterns of oral antihyperglycemic therapy and level of glycemic control among patients with Type 2 diabetes mellitus (T2DM) in Malaysia
#@Siew Chan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1156231261496056877938106332626646400140443989982

#*P-41 Level of glycemic control and patterns of oral antihyperglycemic therapy among patients with Type 2 diabetes mellitus (T2DM) in Thailand
#@Wannee Nitiyanant,Pongamorn Bunnag,Sompongse Suwanwalaikorn,Yupin Benjasuratwong
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1218130544651890015744066339670556745313937490563

#*P-42 Patterns of oral antihyperglycemic therapy and level of glycemic control among patients with Type 2 diabetes mellitus (T2DM) in Taiwan
#@Wayne Sheu
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index846541079252400045222667578669704100931773665519

#*P-43 Patterns of oral antihyperglycemic therapy and status level of glycemic control among patients with Type 2 diabetes mellitus (T2DM) managed at general hospitals in Korea
#@Sei Baik
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index354696549162285382552078693237189086905117004834

#*P-44 Patient reported hypoglycemic symptoms among Asian patients with Type 2 diabetes receiving oral anti- hyperglycemic agents
#@Sei Baik,Wannee Nitiyanant,Wayne Sheu,Linong Ji,Siew Chan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1156366025553539526506963297954820642405666946897

#*P-45 Hypoglycemic experience is associated with lower quality of life (QoL) in Asian patients with Type 2 diabetes mellitus (T2DM) treated with oral anti-hyperglycemic agents (OHA)
#@Wayne Sheu,Linong Ji,Sei Baik,Siew Chan,Wannee Nitiyanant
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1081094783773988567898284551219867036947923921656

#*P-46 Frequency and severity of patient-reported hypoglycemic symptoms are associated with increased worry of hypoglycemia among Asian patients with Type 2 diabetes mellitus (T2DM) treated with oral anti-hyperglycemic agents (OHA)
#@Siew Chan,Wannee Nitiyanant,Sei Baik,Linong Ji,Wayne Sheu
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index269608797124172170784949949348003806799740534426

#*P-48 Longitudinal change of HbA1c depending on initial antidiabetic therapy in Type 2 diabetes
#@Mi-kwang Kwon,Sang Rhee,Suk Chon,In-Kyung Jeong,Seungjoon Oh,Kuy Ahn,Ho Chung,Jeong-taek Woo,Sung-Woon Kim,Jin-Woo Kim,Young Kim,Young Choi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index81096380325188937602051912837940926167032821859

#*P-47 Medication adherence amongst people with less than ideal glycaemic control  the lifestyle over and above drugs in diabetes (LOADD) study
#@Kirsten Coppell,Jim Mann,Alex Chisholm,Sheila Williams,Sue Vorgers,Minako Kataoka
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index651996859323027266727870067531384023825955283458

#*P-50 The effect of nateglinide on postprandial hyperglycemia and oxidative stress in Type 2 diabetes mellitus
#@Jeong Yoo,Ji Nam,Han Jung,Jung Han,Min Cho,Jong Park,Chul Ahn,Bong Cha,Kyung Kim,Hyun Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index473745079393424850857527271134930861543536537518

#*P-49 A retrospective case note audit of patients treated with pioglitazone in the Counties Manukau District Health Board
#@S.G. Adikari,J.R. Baker,A.M. Dissanayake,B. Orr-Walker
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index352175144143756003320660911783950618276261673271

#*P-51 The determinants of maintenance of body weight reduction from 12 weeks diet restriction after one year in Korean woman with Type 2 diabetes
#@Hee-Jung Ahn,Bo-Kyung Koo,Ji-Yeon Jung,Hee-Geum Seok,Hyun-Jin Kim,Hyo-Jeong Kim,Kang-Seo Park,Kyung-Ah Han,Kyung-Wan Min,Eung-Jin Kim
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1133757996617374550491315145454467247900553609067

#*P-52 Type 2 diabetes patient and treatment characteristics from a multidisciplinary CAM clinic
#@Ryan Bradley,Eva Shen,Heather Buckle,Jennifer Kaltunas,Setareh Tais
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1387300074137485042517031764523523803204977515536

#*P-54 Lifestyles, dietary macronutrient compositions and glycemic control in Type 2 diabetes mellitus with community primary care  based on the Diabetes Case Management Program 2001, Taiwan
#@M.-T Fuh,H.-Y. Su,H.-Y. Chang,C.-T. Chang,R.-H. Chen,C.-C. Chen,C.-C. Lee,C.-C. Lin
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index857828496043145924799085869020247876822987512041

#*P-55 Testing the effect of serum from diabetic and non-diabetic patients pre and post gastric bypass surgery on insulin stimulated glucose uptake using an in vitro hepatocyte model
#@Daniel Hutchins,T. Hayes,Y.S. Kwan,S. Stubbs
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1078357815694401912224088620484654841914587125192

#*P-56 Does the pre and post gastric bypass serum environment influence insulin receptor binding?
#@Y.S. Kwan,T. Hayes,Daniel Hutchings,Richard Stubbs
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1425545841733545709971116798394536920594932668926

#*P-58 Effects of olmesartan on blood pressure, glucose metabolism and BNP in patients with Type2 Diabetes
#@Izumi Takei,Toshihide Kawai,Yoshiko Odanaka,Takeo Ogawa,Hiroshi Itoh
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index930470741033522328155860942880233693536518831229

#*P-59 Pitavastatin reduces lipid profile, especially various oxidized-LDL parameters, and does not change diabetic control and adiponectin levels in diabetic patients with hyperlipidemia
#@Yoshihisa Nakatani,Toyoko Fukushima,Rieko Ishibashi,Tetsuyuki Yasuda,Takao Watarai,Eiichi Imano
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index683148068757025297203275146999167594521864768736

#*P-60 Pitavastatin improves lipid profiles and reduces high-sensitivity CRP in Japanese diabetic subjects with hypercholesterolemia (KISHIMEN multi-center prospective study)-subanalysis of diabetic subjects
#@H. Koshiyama,A. Taniguchi,Y. Fujioka,K. Tanaka,S. Kagimoto,K. Hirata,Y. Nakamura,A. Iwakura,K. Hara,T. Yamamoto,A. Kuroe,M. Ohya,S. Fujimoto,Y. Hamamoto,S. Honjo,H. Ikeda,K. Nabe,K. Tsuda,N. Inagaki,Y. Seino,N. Kume
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index535522691753645127042064474686746678041146731995

#*P-61 Association of diabetes mellitus in Japanese subjects, especially the effect of atypical antipsychotic agents
#@Koichiro Nabe,Kazuhiro Nomura,Hiroki Ikeda,Sachiko Honjo,Yoshiharu Wada,Tetsuya Kimura,Tomohisa Aoyama,Yoshiyuki Hamamoto,Hiroyuki Koshiyama
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1018401929038886301916261603013088170470692725702

#*P-62 The South Asian variant of Type 1.5 diabetes: a series of 48 cases
#@Sanjay Kalra
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1157529193362780615988286510251045189097243121339

#*P-63 The clinical characteristics of Korean diabetic patients under 40 years of age
#@Dong-Lim Kim,Kee-Ho Song,Suk Kim
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1157204163736483884404521519289520307658179923656

#*P-64 Effect of obesity and glucose tolerance status on incidence of Type 2 diabetes: Tehran Lipid and Glucose study
#@Hadi Harati,Farzad Hadaegh,Navid Saadat,Fereidoun Azizi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1169637285129618026627505627207639763575531205144

#*P-65 Population-based incidence rate of Type 2 diabetes and its associated risk factors: The Tehran Lipid and Glucose study
#@Hadi Harati,Farzad Hadaegh,Fereidoun Azizi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index510127027276101101854684621699835832388557223669

#*P-67 The association between the level of carbohydrate intolerance and adverse maternal and neonatal outcomes in pregnancy
#@Ma Shan,Cheung Keung,Ho Yan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index786386905830316660343186845048756973832040961085

#*P-66 Maternal and fetal outcomes of pregnancy complicated by diabetes: Pregestational diabetes mellitus versus gestational diabetes mellitus
#@Seok-Won Park,Yong-Hun Kim,Won-Hee Kim,Soo-Kyung Kim,Yu-Lee Kim,Won-Keun Park,Young-Kil Choi,Sang-Jong Lee,Yong-Wook Cho
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index420921154310190727859193853158606705389089233768

#*P-68 Late onset gestational diabetes mellitus (LO-GDM): distinct cohort
#@Sanjay Kaira
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index540728440985206499784441645914267675653680605310

#*P-69 Congenital malformations in pregnancies complicated by diabetes
#@Sanjay Kaira,Bharti Kalra,Poonam Kapoor,Sarita Chatley
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index863907362358313156338078957857328202926529033879

#*P-70 Effect of oral antidiabetic agents on the fetus during the embryogenesis period
#@Chang Lee,Seung Kim,Chong Kim,Cheol Park
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index538550588606983112020863974769314289483561577739

#*P-71 Amniotic fluid adipokines in diabetic pregnancy: a snap-shot of the fetal environment
#@Stojkovic Mirjana,Maria Rosario,Snezana Brankovic,Christina Buchanan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index559824219096041403575771734890629965623534998637

#*P-72 Foot care intervention by nail drilling with topical antifungal application improves onycomycosis and self-care behaviour in diabetic patients
#@Masuko Sumikawa,Yasuyuki Sumikawa,Takako Egawa,Minoru Kubota
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index893800299597961106670528727879379579045267531753

#*P-73 Podiatry training on the diabetic foot for nursing and medical staff in the Central East Division of Fiji
#@Katie Hjorth
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index773327628668844624909230898134835110728572507773

#*P-75 Quantitative sensory test for early detection of diabetic neuropathy
#@Byoung Kim,Minky Kim,Manho Kim,Dong Yun
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index706064403420234255946148790498549960415025167548

#*P-76 Complete restoration of sensory nerve dysfunction in newly diagnosed Type 1 diabetic patients following long term benfotiamine treatment (two cases)
#@P. Kempler,K. Keresztes,I. Istenes,Zs. Hermnyi,P. Vargha,. Kdr,M. Kempler,Zs. Putz
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index412612310870526133582336665715843653572302313568

#*P-77 Higher fasting glucose levels within the normal range are associated with sensory nerve dysfunction in patients with essential hypertension
#@P. Kempler,K. Keresztes,I. Istenes,P. Vargha,. Kempler,Zs. Putz,N. Tth
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1046304597040958605050274615705625691116409249975

#*P-78 The case of severe distal symmetric diabetic neuropathy-diagnosed after the third toe amputation
#@N. Tth,Zs. Putz,I. Istenes,Zs. Hermnyi,K. Keresztes,P. Kempler
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index137180979902252119017616994665088007922307905723

#*P-79 Small fiber neuropathy including widespread impairment of autonomic function represents the key clinical characteristic of nerve dysfunction among patients with IGT
#@Zs Putz,Gy Tabk,N. Tth,I. Istenes,R. Gandhi,C. Emery,Zs. Hermnyi,V. Csiki,K. Keresztes,S. Tesfaye,P. Kempler
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index428065897207076027707875264130313743399417972581

#*P-81 The morphological observation of gastric nerve fibers in experimental animals and people with diabetes
#@Heung Jin,Ming Piao,So Kim,Seon Kang,Chong Kim,Dong Kim,Ji Park,Hong Baek,Tae Park
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index732535581721726267692111659259924790239095960060

#*P-80 Severe burn injury induced by unusual self-treatment in a patient with diabetic neuropathy (case report)
#@Zs. Putz,N. Tth,I. Istenes,Zs. Hermnyi,K. Keresztes,P. P,Gy. Jermendy
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index331383086106478556116285078997361447970975207796

#*P-83 Relationship between inflammatory markers and outcome in patients with diabetic nephropathy
#@Ana Silva,Alexandre Baptista,Ana Cabrita,Marlia Fasca,Pedro Neves
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1154278833506147136692633303360028420465831938005

#*P-82 Inflammatory markers and progression of end-stage renal and cardiovascular disease in patients with diabetic nephropathy
#@Ana Silva,Alexandre Baptista,Marlia Fasca,Ana Cabrita,Pedro Neves
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index321758822026376970873751361486791910376590347773

#*P-84 Anemia management in diabetic patients with chronic renal disease
#@Ana Silva,Alexandre Baptista,Ana Cabrita,Pedro Neves
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1351002125541673594232468710066975329713667876808

#*P-86 High prevalence of diabetes as the cause of chronic kidney disease in Thai adults: a cross sectional health survey in a community-based population
#@Kriengsak Vareesangthip,Leena Ongajyooth,Wichai Aekplakorn,Panrasri Khonputsa,Mayura Kusoom
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index176617073044411272346965960901547855283765212856

#*P-85 Metabolic syndrome identifies chronic kidney disease in Chinese patients with Type 2 diabetes  a prospective study
#@A. Luk,R.C.W. Ma,W.Y. So,A.P.S. Kong,X. Yang,C.C. Chow,J.C.N. Chan,P.C.Y. Tong
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index78211208761034922181657905711286641435806059385

#*P-87 Poor glycaemic control and chronic kidney disease  independent predictors of prolonged postoperative hospital stay in patients with diabetes
#@Mitsuyoshi Takahara,Hideaki Kaneto,Shin-ichi Gorogawa,Masahiko Ikeda,Munehide Matsuhisa,Takao Watarai,Minoru Kubota
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1088194123479794070564353079333501459832441718209

#*P-88 The effect of strong statins in diabetic nephropathy  comparison of atorvastatin and pitavastatin
#@Hirotsugu Iwatani,Yoshihisa Nakatani,Kenji Yokoyama,Eiichi Imano
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index840505008171262087499123038127821545670602767569

#*P-89 Relationship between carotid ultrasonography and silent cerebral infarction in Japanese subjects with Type 2 diabetes
#@Kazuhiro Nomura,Shiho Takahara,Osamu Kikuchi,Yoshiyuki Hamamoto,Sachiko Honjo,Hiroki Ikeda,Koichiro Nabe,Yoshiharu Wada,Hiroyuki Koshiyama
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index76146583056206312225194194063073494989178970465

#*P-90 Cerebrovascular risk in diabetic patients with acute coronary syndrome
#@Zampi Giordano,Fabiola Fini,Giulio Illuminati,Concetta Torromeo,Francesco Barill,Vincenzo Paravati
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1143959337647880828832881539582473803083095491838

#*P-91 Comparative risk factors for early development of macrovascular complications in Korean patients with Type 2diabetes
#@E.G. Hong,J.M. Yu,H.R. Lee,O.H. Ryu,J.K. Kang,C.S. Kim,S.J. Lee,B.W. Lee,H.K. Kim,D.M. Kim,S.H. Ihm,M.G. Choi,H.J. Yoo
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index261094187355356504546735876711923786919169565437

#*P-92 UKPDS coronary heart disease risk score might be more explanatory for carotid atherosclerosis in newly diagnosed Korean patients with Type 2 diabetes without the metabolic syndrome
#@Bo Koo,Kyung Han,Hyo-Jeong Kim,Eung Kim,Hyun-Jin Kim,Kang Pak,Kyung Min
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1079617729119034134757574597064729129630094263494

#*P-94 Study of left ventricular function in women on insulin with dependent diabetes mellitus during pregnancy
#@Rajitha Chichili
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index631196414069906998168053250431872105884381614538

#*P-93 Diabetes and cardiovascular disease survey
#@Carl Eagleton,Gill Aspin,Sally Morgan,Theresa Busler,Belinda Gordge,Shameem Husain
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1311386789399903327227444852137972692015796215631

#*P-95 Relationship between cardio-ankle vascular index (CAVI) and intima-media thickness of the carotid artery (IMT) in Type 2 diabetic patients
#@Yasuyo Tsuchida,Natsumi Asaka,Takatoshi Otaka,Syuki Usui,Hiromi Ouchi,Naoki Hiroi,Gen Yoshino,Mariko Higa
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1170267758651924535127820057756552191924688580134

#*P-96 Cardio-ankle vascular index, a novel method for measuring arterial wall stiffness, is less influenced by changes in blood pressure in diabetic and non-diabetic subjects
#@Junko Ibata,Hideyuki Sasaki,Tetsuhiro Kakimoto,Shohei Matsuno,Yoshio Nakano,Hisao Wakasaki,Masato Kobayashi,Kunihiro Tatsumi,Hiroto Huruta,Masahiro Nishi,Kishio Nanjo
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index581860327553041715170547979314485314340431517286

#*P-97 Sources of variation of arterial pulse wave velocity measured by Sphygmocor in normal and diabetes subjects
#@D. Fung,D Smyth,M Weatherall,J Delahunt,S Mann
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index855644643441471087311317349805706962089098230117

#*P-98 A single albumin:creatinine predicts left ventricular hypertrophy better than ECG in primary care patients with Type 2 diabetes mellitus
#@Warwick Bagg,B. Somaratne,K. Poppe,Christina Morunga,J. Walsh,M. Bals,M. Wadams,Ann Pearl,Clare Ward,A. Whalley,N. Doughty
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index96687908684684888452634679796339721998715970153

#*P-99 The impact of homocysteine and folic acid as risk factors of coronary artery disease in asymptomatic patients with Type 2diabetes
#@Jun Moon,Woo Chang,Chan Lee,Ji Lee,Kyung Chun,Ihn Cho,Ji Lee,Ho Shon,Ji Yoon,Kyu Won,Hyoung Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1104912284167219686507687125839560193670800342640

#*P-100 Relationship between serum bilirubin levels and subclinical coronary atherosclerosis in patients with Type 2 diabetes
#@Jun Moon,Woo Chang,Chan Lee,Ji Lee,A. Chun,Ihn Cho,Ji Lee,Ho Shon,Ji Yoon,Kyu Won,Hyoung Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index848856727806448671176234489392532380347805326230

#*P-101 Prevalence, associated factors and the use of a claudication questionnaire for peripheral arterial disease (PAD) in diabetic patients in the community  results from a primary health care survey
#@Raj Narayanan,Koh Puay,Tavintharan Subramaniam,Jonathan Phang
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index477432106537411722780359940782976699432221998328

#*P-102 Risk factors of PAD in asymptomatic Type 2 diabetes patients in the north Indian population
#@Rohit Kapoor,Atul Kapoor
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index450301589127577481605604508470751157805083648058

#*P-103 Prevention of Diabetic Gangrene, when should we start?
#@M.W. Ashrafi,C.S.H. Shaheed,R. Santos,A.N. Ashrafi,P.M. Lamont
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index758634686714047586298497236312412589771355532826

#*P-104 Sleep disturbance is associated with cardiovascular risk factors in Type 2 diabetes
#@Hye Lee,Jee-Young Oh,Young Hong,Yeon-Ah Sung
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1362468362738087494131080280214564952294667940614

#*P-105 Four cases of hyperglycemic chorea in diabetic patients
#@Hiromi Ohuchi,Natsumi Asaka,Takatoshi Ootani,Shuki Usui,Yasuyo Tsuchida,Naoki Hiroi,Mariko Higa
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1145826455080588010600605125873672667050999731900

#*P-106 The prevalence of metabolic syndrome: difference between criteria
#@Husaini Umar,M.S. Adam,Himawan Sanusi,M.F. Adam
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index270293873137304110390878588140569765007310282711

#*P-107 Discrepancy of the prevalence of metabolic syndrome between the ATP III and IDF criteria in Korean subjects with Type 2 diabetes mellitus
#@Sang Rhee,Seungjoon Oh,Jae Yu,Jae Jee,Moon Lee,Kyong Park,Hong Lee,Kyung Lim,EunSeok Kang,Hyun Lee,Yong Kim,Jae Kim,Soon Shinn,Woong Choi,Young Choi,Young Kim
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index95343828863153837646986635700842937729614256324

#*P-108 The metabolic syndrome and incident diabetes: assessment of alternative definitions of the metabolic syndrome in an Iranian urban population
#@Asghar Ghasemi,Farzad Hadaegh,Mojgan Padyab,Maryam Tohidi,Fereidoun Azizi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index461590696850461850534157403763709842823449442595

#*P-109 The association between health behaviour and the prevalence of the metabolic syndrome
#@Yun Kim
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1366037092470585788289386297819608771620269996919

#*P-110 To determine which obesity index is a better predictor of Type 2 diabetes mellitus in Iranian women
#@Farzad Hadaegh
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1133222711045124703503044441921516928572397156382

#*P-111 Metabolic syndrome is more prevalent in sarcopenic obesity than in non-sarcopenic obesity in patients with abnormal glucose tolerance in the Korean population
#@Ji Jung,Hee Ahn,Hee Seok,Bo Koo,Hyun Kim,Hyo Kim,Kang Park,Kyung Han,Kyung Min,Eung-Jin Kim
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index499288040131965806378914710259332289179701540134

#*P-112 Is waist circumference a useful indicator of markers of metabolic syndrome in South Asian women living in New Zealand?
#@Pamela Hurst,Christophe Matthys,Welma Stonehouse,Jane Coad
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index672098280059088783122207130196605322055777074968

#*P-113 The relationship of waist circumference muscular strength and cardiorespiratory fitness in New Zealand 10-15 year olds
#@C. Benson,A. Singh
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index707617342085010412618329576740082447771158268188

#*P-114 Low grade inflammation in individuals with the hypertriglyceridemic waist phenotype.Another feature of this atherogenic dysmetabolism
#@Itzhak Shapira,Ori Rogowski,Sharon Toker,Samuel Melamed,Arie Shirom,Shlomo Berliner
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index376510034243016836575588250133645798507085837377

#*P-115 Visceral adiposity and leptin are independently associated with CRP in Koreans with Type 2 diabetes
#@Jong Park,Ji Nam,Han Jung,Jeong Yoo,Jung Han,Min Cho,Chul Ahn,Bong Cha,Kyung Kim,Hyun Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1349161037776795181449036330333163660493982515023

#*P-116 Relation of C-reactive protein to Framingham risk score and UKPDS risk engine in Korean patients with Type 2 diabetes
#@Gwanpyo Koh,Dong-Mee Lim,Keun-Yong Park
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index754244464866747109176253283238461904219610976476

#*P-117 High-sensitivity C-reactive protein levels in obese women
#@Mala Dharmalingam,Nirmitha Dev,Sara Marcus
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index480496491320026756006449934044895566483994870640

#*P-118 Intra-abdominal fat measured by ultrasonography is representative of visceral obesity in Type 2 diabetes
#@Jihyun Lee,En Jung,Ho Shon,Duk Chung
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1249370337725432375909225918727536802823552828253

#*P-120 Association between obesity and accelerated erythrocyte sedimentation rate
#@Itzhak Shapira,David Zeltser,Ori Rogowski,Shlomo Berliner
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1266090282370470064785029887944068519843781185049

#*P-119 Decreased serum lysophosphatidylcholine as a marker of insulin resistance in non-diabetic subjects
#@Y. Kumon,S. Yamanaka,T. Ohguro,H. Takeuchi,T. Sugiura
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index305257840474519913309177994209806072081051098157

#*P-121 Morbid obesity association with increased erythrocyte adhesiveness/aggregation in the peripheral blood.Potential pathophysiological implications
#@Itzhak Shapira,David Zeltser,Ori Rogowski,Shlomo Berliner
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index31504044137577042524386485170425306968504350308

#*P-122 Fasting plasma glucose and metabolic syndrome in South Korean adults
#@Jin-Ho Park,Belong Cho,Hyuktae Kwon
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1252365577833606577759693168469801166567467947762

#*P-123 The association between liver enzyme activities and diabetes mellitus or metabolic syndrome; From the baseline study of community based cohort study
#@Ji Yoon,Sung Choi,Soo Lim,Young Park,Hak Jang
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index703528934757511195416031631647671437791810025729

#*P-125 The association between increased alanine aminotransferase activity and metabolic factors in Japanese college students
#@Ako Saito,Tetsuya Moriai,Ken Tsuji,Kazunari Miyauchi,Manabu Goto,Isao Makino,Masakazu Haneda
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index361720089895770428955460994140293110673118463226

#*P-126 Alanine aminotransferase as a predictor of metabolic syndrome in Korean people
#@In Kim,Ji Kwon,Seu Kim,Yong Ahn,Sang Kim,Yang Kang,Seok Son,Yong Kim
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index466992485172082910477432708784312578464156006574

#*P-127 Liver enzymes and inflammation-sensitive biomarkers: relevance for apparently healthy individuals and those with atherothrombotic risk
#@Itzhak Shapira,Ori Rogowski,Ran Oren,Shlomo Berliner
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index993680805433133744109369596736029911453528017171

#*P-128 Association between serum -glutamyltransferase activity and risk of Type 2 diabetes mellitus in subjects without fatty liver
#@Chul-Hee Kim,Joong-Yeol Park,Ki-Up Lee,Jin-Ho Kim,Hong-Kyu Kim
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1164114174359076560874553924463437449875394856073

#*P-129 The association between insulin resistance, plasma adiponectin and hepatic fat content in healthy individuals with normal transaminase concentrations
#@Jeong Mun,Seung Lee,Yeon Oh,Soon Shinn
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index63300067496218923015634904573385995214297887371

#*P-130 Nondiabetic first degree relatives of patients with Type 2 diabetes and risk of non alcoholic fatty liver disease
#@Mohsen Janghorbani,Atoosa Shayganfar,Masoud Amini
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index474783173962176514996485993921017434872733520713

#*P-131 Healthy Tuckshop model meets Ministry of Health Food and Beverage guidelines
#@Karen Pickering,Sue Pirrit,Jude Woolston
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index913369497216412318167865638042208241405852540915

#*P-132 Otara Healthy Kai programme
#@Kate Smallman,Alice Redward,Kai Tan,Judy Montgomery
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index840221612093746562386612875743344836257524722037

#*P-133 GetWize2Health Programme for youth goes do it yourself
#@Kate Smallman,Karen Pickering,Lama Saga,Rachel Rix-Trott
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index579341779524549728992102449515880002857832101101

#*P-134 The effect of dietary education on HBA 1C level in patients with Type 2 diabetes
#@Youngran Lee,Hyunsook Lim,Youngwoo Kwon,Mira No,Inseob Yeo,Kyunga Ok,Mihye Woo,Hyesook You,Jijung Lee,Jaewon Cho,Bokyung Han
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index930522658906172950336450973347753686820890436508

#*P-135 Fruit and vegetable intake, body mass index and risk for diabetes in Maori
#@Elaine Rush,Nic Crook,David Simmons
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index907677150077257296868288595359528834521427796726

#*P-136 Successful diet clinic for Japanese obese and pre-obese women using the diet balance sheet (DBS)
#@Kazuhisa Suzuki,Etsuko Ozaki,Akiko Suzuki,Kinue Umesaki,Aki Shimabukuro,Misako Masumura,Suzu Konishi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1185359925170906531009147534501908880483802818771

#*P-137 The effect of nutrition education on diabetes shared care
#@Lin-Chien Chan,Mei-Chu Chen,Chiu-Yen Chou,Meei-Shyuan Lee
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index330913772399908419576796801967270607310761871122

#*P-138 Developing nutrition resources for people with diabetes
#@Alison Pask
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1299998872050719969361180040738591596765672275112

#*P-139 The role of family nutritional support in Japanese patients with Type 2 diabetes
#@Naomi Kitatani,Takeshi Kurose,Takahiro Shimba,Akira Kuroe,Michihiro Ohya,Mitsuo Fukushima,Yutaka Seino
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1067563113489426193382297090765023869519785396103

#*P-140 Epidemiological and histopathological study of malnutrition related diabetes mellitus in Bangladeshi subjects
#@Tahminur Rahman,Harun Rashid,Hajera Mahtab,Yearul Kabir
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1142957159759047107762746892508621690584772080311

#*P-142 The effects of A. paniculata on pancreatic beta-cells, especially in the first phase of insulin secretion
#@Aris Wibudi,Bambang Kiranadi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index950792892853246169394019329150286660240109246981

#*P-143 Effect of oral magnesium supplementation on insulin sensitivity and blood pressure in apparently healthy overweight adults  a randomized double-blinded controlled trial
#@Chang Lee,Sangyeoup Lee,Hye Park,Seong Son,In Kim
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1079479249960200878025998581249403794661246004422

#*P-145 Ethanolic extract of Combretum decandrum Roxb. decreases blood glucose level and oxidative damage in streptozotocin-induced diabetic rats
#@Patchareewan Pannangpetch,Ormjai Taejarernwiriyakul,Bunkerd Kongyingyoes
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index145464097982543466646486427211353395535347145340

#*P-146 Ethanolic extract of Morus alba Linn. leaf increases glucose uptake and glucose transporter 4 translocation in adipose cells of streptozotocin-induced diabetic rats
#@Jarinyaporn Naowaboot,Patchareewan Pannangpetch,Veerapol Kukongviriyapan,Upa Kukongviriyapan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1011308206614546699969713594718296488896000506892

#*P-147 Higher dietary fat impairs anti-diabetic effects of onion (Allium cepa L.) in rats
#@Shahidul Islam,Du Loots,Haymie Choi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index655873103025581848905154086239902454203118703990

#*P-148 Antihyperglycemic and antihyperlipidemic effects off Mangifera indica L. in streptozocin induced adult male rats
#@Solati Jalal,Soleymani reza,Safavi Faranak,Pirayandeh Sormeh,Kamani Fatemeh
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index358057267996167976762438478572568775176714761997

#*P-149 Study of increased insulin activity by Salvia officinal Linn on liver cell regeneration in partially hepatectomised albino rats
#@Abdol Ebadi,Ali Taravati
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index892132833950645467948487778084113269389043130187

#*P-150 Dietary red chilli (Capsicum frutescens L.) is insulinotropic rather than hypoglycemic in a rat model of Type 2 diabetes
#@Shahidul Islam,Haymie Choi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index6171877150651135910471952895642256263356954701

#*P-151 Audit on length of hospital stay amongst inpatients with diabetes at North Shore Hospital
#@S. Yip,S Young,C McNamara,R Cutfield
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index444958635752791451970685194886404901277206689873

#*P-152 Elderly patients presenting with diabetes: why they need hospitalization? Is prevention possible?
#@Jean-Paul Ory,Cyril Faure,Olivier Messica
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index47634001545400439736915319191490250202254919548

#*P-153 Cost of care for low-income patients with diabetes mellitus inatertiaryhospital
#@Brenda Lim,W.L. Tan,Michelle Jong,Soon Cheow
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index657761651939905883665526503218643012578260329296

#*P-154 The effect of education utilization on Diabetes Shared Care
#@Huai-Yu Hu,Hsiu-Yuan Wang,Wei-Ning Wang,Lin-Chien Chan
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index382363632799654936568035253403914842507003735041

#*P-155 A multi-site randomized controlled trial of integrated versus single focus CBT intervention for co-morbid diabetes Type 2 and depression: the MADE-IT program
#@Leigh Underwood,Brian Kelly,Julia Lowe,Jenny Bowman,Wayne Burgess,Bradley Marney,Channa Perera
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index124822886059431786823491015308850164921434682099

#*P-156 An innovative process for the redevelopment of services for people with diabetes in a region of New Zealand
#@J. Cramp,Emma Davidson
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index696873335517588268563499200070254275242961091956

#*P-157 Challenges and learnings from implementing the Lets Beat Diabetes strategy
#@Chad Paraone,Beat Diabetes,Chris Mules,Brandon Orr-Walker
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index581107709493243152153690723587279726630732697802

#*P-158 Shared solutions: the primary health organisation and general practice team
#@Liz Dutton
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1202687807199456599656466753322964409022511922815

#*P-159 Diabetes Care Support Service GP Quality Improvement Audit 20072008
#@Karen Pickering,Sara Morton
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index214936316551968500353357180367489523922094465983

#*P-160 Management of post cardiac surgical patients with Type 2 diabetes using telecare
#@Idris Dahliana
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index795313129009682667139527786573400999541875885131

#*P-161 The quality of diabetes care: a comparison between patients enrolled and not enrolled on a regional diabetes register
#@Kirsten Coppell,Karen Anderson,Claire Lamb,Sheila Williams,Victoria Farmer,I. Mann
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index793919262168420192732816297716069643036889366138

#*P-162 Screening for undetected diabetes in Kuwait and evaluation of non invasive risk scores
#@M. Eid,M. khalaf,A.M. Najjar,M. Alhajry,Souhal Doi,Lukman Thalib
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1038267716179372843690715428893504688125027286438

#*P-163 Diabetes screening in Basrah, Iraq: a population-based cross-sectional study
#@Abbas Mansour,Header al-Kas,Ibrahem Hani,Akeal Abed-Alzahrea,Hameed Wanoose
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1286870211511685583441183524097507965776423514123

#*P-164 Integrated management of CVD and diabetes: early detection and risk factor intervention
#@I. Feisul,Zainal-Ariffin Omar,M.A. Samad,Fatanah Ismail,Anis-Salwa Kamarudin,Noor-Azah Daud
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index829127335493070601484773129079170420671849294641

#*P-165 Screening programme for microalbuminuria in asymptomatic Type 2 diabetes patients in the north Indian population
#@Rohit Kapoor,Atul Kapoor
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index953354100637527349451816034273265506898403273320

#*P-166 Development and validation of a questionnaire to identify people at increased risk for diabetes
#@Jin-hee Lee,Hyuk-sang Kwon,Yong-moon Park,Won-chul Lee,Ho-young Son,Kun-ho Yoon
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index942297067475005197265523937245696131658569636700

#*P-167 Identifying people at risk of Type 2 diabetes in the workforce: a workplace initiative in South Auckland
#@Diane Bermingham
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1213751725434084560507049444880933644233362674465

#*P-168 The Get Checked free annual diabetes review program in New Zealand: Who are we missing out?
#@Grace Joshy,David Simmons
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index406195871574577161450566075963982587317310527768

#*P-169 The activity of the Japan Association for Diabetes Education and Care
#@Nobuhide Ito,Yoichi Onishi,Hiroko Hotta,Midori Sawada,Minako Osaki,Kayo Onishi,Satoko Yamada,Atsushi Suhara,Noriko Takahashi,Yutaka Seino
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index550323521081829440867188089201577932058187443932

#*P-170 Evaluation of the questionnaire of members of the Japan Association for Diabetes Education and Care
#@Nobuhide Ito,Yoichi Onishi,Hiroko Hotta,Midori Sawada,Minako Osaki,Kayo Onishi,Satoko Yamada,Atsushi Suhara,Noriko Takahashi,Yutaka Seino
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index273398572899572596141381038426436580384283004629

#*P-171 ADEA standards of practice
#@Shirley Cornelius,Jane Giles
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1301397417751271807174257717196629460055704829658

#*P-172 Multiplier effects: a model for health professional development
#@Jane Giles,Patrick Phillips
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index224750119245129145639258869008785064597229095667

#*P-173 The effect of an educational program based on BASNEF model on Type 2 diabetes eye care
#@M. Hazavehei
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1231748073087619244648174838000060061358319070939

#*P-174 Nurse led starting insulin classes  an efficient and effective method of delivering group education
#@Helen Lunt,M.E. Greenslade,C. Prattley,C. Frampton
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index857690867623066076131570486031465018746434697595

#*P-175 Extended role of the diabetes nurse  the experience of setting up a diabetes patient support group in the hospital setting
#@S.W. Lau,K.M. Loo,Y.M. Wong,C.C. Chow
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1088602570160421153931074309987393254520396401382

#*P-176 Adolescent diabetes nurse specialist  a new role
#@Kirsty Newton
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index200929108919813730621198163753517177805989795488

#*P-177 Designing a quality Diabetes Self-Management Education (DSME) program for New Zealand
#@Teresa Cleary
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1086463125259814379167624442913877833943105532293

#*P-178 Effect of Diabetes Self-Management Education (DSME) on glycemic control in patients with Type 2 diabetes
#@Kang-Hee Sim,Sun-young Kim,Moon-Kye Lee,Myung-Shik Lee,Kwang-Won Kim
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index893396114803797649899772772978040642639648384308

#*P-179 Effectiveness of the Diabetes Self-Management Education programme
#@Sangeeta Shah
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1170176155804689448503263895832449347660401126242

#*P-180 Developing online communities to aid self-management for people with diabetes
#@Renima Malhotra,Rosemary Stockdale
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index479143224466304300083666584622081214959662640918

#*P-181 Know your enemy and tame it while respecting your body: Health for all through wisdom  Gaining the most optimal health while reversing the epidemic of obesity
#@Suresh Vatsyayann
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index738386433826259958144274271571227415216621695614

#*P-182 Spirituality and coping in young adults with diabetes
#@Nasrin Parsian,Trisha Dunning
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index206554592580407269915286039119386873053356556632

#*P-183 The successful development and implementation of a 2-year community led diabetes prevention intervention
#@Helen Pahau,David Tipene-Leach,Marina Ngatai,Teo Wilson,Ginny Reedy,B.J. Taare,Sarah Sykes,Kura Forrester,Nicola Maw
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index534085870298267834919628478829878693549359389333

#*P-184 Diabetes education and point of care testing clinics for the Noongar communities in the great southern region of Western Australia
#@Shirley Cornelius
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index603571150320644665577494547256385252361451764872

#*P-185 Maori and Diabetes: The Journey
#@Helen Pahau,Louie Katene,Luana Murray,Sonia Rapana,Ema Taungakore
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index181867624377640477173941697127854384697770982259

#*P-186 Diabetes control milestones in a Pasefika diabetes clinic
#@Tupu Ioane-Cleverley,Rachael O'Brien
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index763544533974150172528196909034257772723196390543

#*P-187 Singing from the same song sheet
#@Diane Bermingham
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index224213970980238148440788442814030646487322359001

#*P-188 Assessing attitudes towards diabetes prevention among Utah Pacific Islanders
#@Fahina Pasi,Ivoni Nash,Sione Lui,Richard Bullough,William Stinner,Carol Rasmussen,Brenda Ralls
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index850557149404115354313709791180738920393984061768

#*P-189 Diabetes awareness among Pacific Islanders in Utah
#@Fahina Pasi,Ivoni Nash,Kaisa Lui,Lupe Prescott,F. Stinner,Richard Bullough,Brenda Ralls
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index856705163850704153527583468498169723568853322048

#*P-190 Comparison of social support, self efficacy and psychological stress response between diabetes Type 2 patients in Jogjakarta, Indonesia and Kobe, Japan
#@Cahya Lestari,Sakiko Kanbara,Althaf Setyawan,Hiroshi Taniguchi
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index1173087551609929354971340342102446153575184973732

#*P-191 Community participation in managing chronic disease: defaulter tracing
#@Fatanah Ismail,Zainal-Ariffin Omar,M.A. Samad,Mustapha Feizul-Idzwan,Shahidan Hashim,Rahim Tahir
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index682890975760068833416253512685271845052496140726

#*P-192 The effect of rice-produced recombinant human IGF-I on membrane ruffling of L6 rat skeletal muscle cells
#@Chun-Kai Cheung,S.M. Sun,C.Y. Tong
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index285788780427376634657886831722571897144352434219

#*P-193 Diabetes in Kiribati
#@Karote Tauroba,Anthony Lewis
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index883675407019293964473817796149812282157870938223

#*P-194 Using a PDSA cycle works: Evidence from three cycles in the Midwest, Western Australia
#@Cythinia Porter,Marisa Giles,Charlie Greenfield
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index789389483444448344427420130618379773205699113272

#*P-195 The effects of antioxidants and immunosuppressive agent treatment on oxidative stress and antioxidant systems in thymus during experimental diabetes mellitus
#@Nagy Sadek,Khaled Gamal
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index773768919842870492896379210916549687145703884635

#*P-196 Anti-diabetic effects of cytopiloyne in db/db mice and its likely mechanism
#@Yi-Jou Hsu,Lee-Tian Chang,Yi-Mei Lee,Shu-Lin Chang,Chien-Yuen Pan,Ning-Sun Yang,Wen-Chin Yang
#year2008
#confDiabetes Research and Clinical Practice
#citation0
#index690334777319031995302650856092287253220883813667

#*Modulation of monocyte hyperresponsiveness to TLR ligands by 1,25-dihydroxy-vitamin D3 from LADA and T2DM
#@Tao Du,Zhi-Guang Zhou,Shuo You,Gan Huang,Jian Lin,Lin Yang,Xia Li,Wei-Dong Zhou,Chen Chao
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index519342846081474055169344451933667999684008872205
#%538942986053921728300116536329358074639767711255
#%1206349685902142109104223057814634748691152204367

#*Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in Type 2 diabetes mellitus
#@Wang Qiu-yue,Chen Fen-qin
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index708351456446640217514158655443070813753642628553
#%1161103661135881629412507119493969820154726164541
#%501361298293466591362410765757633708609113311174
#%1276550359790204287410732413591590335533584588117
#%862087246038978817532546358503901868161244009554
#%1248806716020556711694348799495672329152253554267
#%1250723833954633230508353214332373630520602930039
#%1250723833954633230508353214332373630520602930039

#*Serum indoxyl sulfate levels in patients with diabetic nephropathy: Relation to renal function
#@Keita Atoh,Hiroshi Itoh,Masakazu Haneda
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index791990146334017979226180622033194109751880524864
#%105774980630580704850323357784283643232061585314
#%352823760019863849604077094625714195938971408977
#%791784668653763535005513673360613222750156904530
#%157629320364407807150693430883099840246593693150
#%701226865595645657133035320955597158247442795124

#*Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: The role of reducing oxidative stress in its protective property
#@Min Nam,Young Lee,Hyun Koh,Ho Park,Yel Shin,Goo Shin,Baek Koh,Young Lee,Hee Chung
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index949888156405126847055357045065004120355485845355
#%1075435036547043725088442540103360605201528384886
#%1010076639933295832908402910931247545149695040616
#%794740234607098471807909273701196409206096978136
#%609655362715288344916696717289621817103688486743

#*A Leu184Val polymorphism in PCK1 gene is associated with type 2 diabetes in Eastern Chinese population with BMI < 23 kg/m 2
#@Yan Dong,Hongli Zhang,Xiao Wang,Qiwen Feng,Xueru Chen,Qing Su
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1205052713157578745964370954339675917391471526281
#%679671901549675576863438418411521858508832917306
#%613433414107277337323761330366433807011713827744
#%351323208818573040528730894100774623901596910745
#%351323208818573040528730894100774623901596910745
#%1308224721166240531311124766880099977698760485767

#*Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus
#@Masatoshi Kikuchi,Nobuyuki Abe,Mitsutoshi Kato,Shinji Terao,Nobuyuki Mimori,Hideo Tachibana
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1442829383694121676021945154028046296796081052858
#%175338537068949131109522161901533732814489247040
#%1176883983730903551420879898880523990719172024168
#%1222287489159964799902526025570129237619060768498
#%1222287489159964799902526025570129237619060768498
#%856537884140432138093842042156523599248953399383
#%271500039186883570677299651437704906629961327071
#%696970312526267721009096536762753932140593136071
#%1288034188437030632047517680099362354857761085656

#*Pleiotropic effect of pyridoxamine on diabetic complications via CD36 expression in KK-A y/Ta mice
#@Maki Murakoshi,Mitsuo Tanimoto,Tomohito Gohda,Shinji Hagiwara,Ikko Ohara,Hitoe Toyoda,Yuji Ishikawa,Satoshi Horikoshi,Yasuhiko Tomino
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index436794970603608424701320614374478154230911366448
#%836735634157171305428333558948867238975612255095
#%486347974735840415213647284470945840610823583345
#%461517626502421120407987161970806586947339964015

#*Upregulated IL-18 expression in type 2 diabetic subjects with nephropathy: TGF- 1 enhanced IL-18 expression in human renal proximal tubular epithelial cells
#@Kazunari Miyauchi,Yumi Takiyama,Jun Honjyo,Masatoshi Tateno,Masakazu Haneda
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index268527933596535042622783438919190281017933032871
#%999592154640225381704300430840736202728410017974

#*Prevalence and correlates of undiagnosed depression among U.S. adults with diabetes: The Behavioral Risk Factor Surveillance System, 2006
#@Chaoyang Li,S. Ford,Guixiang Zhao,B. Ahluwalia,S. Pearson,H. Mokdad
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index2962548152256488827502387896379207772790157244
#%29173829668317930628708875635637567665120768029
#%1354681859179470476379519137973397116751190387140

#*NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes
#@Hisafumi Yasuda,Zhenzi Jin,Maki Nakayama,Katsumi Yamada,Minoru Kishi,Yasuyo Okumachi,Takashi Arai,Hiroaki Moriyama,Koichi Yokono,Masao Nagata
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index399463319283358525560330779734639669595580206071
#%40583406211882465160336305517825145519637022046
#%1079589566224577835959651057563976196127656849076
#%594608359452107000781679890723469869126968345561
#%78795063786622445874496213177146069604460922091
#%704903568016197007749586674988249960509866470269
#%1278577010940358605908767298195748374671525587831

#*Relation between cardiovascular complications and blood pressure/blood glucose control in diabetic patients with hypertension receiving long-term candesartan cilexetil therapy: Challenge-DM study
#@Ryuzo Kawamori,Toshiro Fujita,Hiroaki Matsuoka,Satoshi Umemura,Yasushi Saito
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index22546551161833225396440093355251558297049141423
#%481570781244869144784002259840012820397148090045

#*Type 1 diabetes, the A1 milk hypothesis and vitamin D deficiency
#@R. Merriman
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index75503382109091812408617437065080678719552975854
#%1161088655371463508408347166948696212426121823610
#%1098452874451840445963494626464885870625082877648
#%1098452874451840445963494626464885870625082877648
#%554045820760219000817201593636166326732491156
#%1460200972744203670267462449237656521523097562993
#%697518477843698216241259397030986674495001650102
#%1424029266433330994077005635214352408516446859843
#%802519656832241614086139287950114821527482546377

#*Comparison of pre- versus post-meal administration of voglibose in men with or without impaired glucose tolerance
#@Kazutaka Aoki,Yuzuru Ito,Kaori Saito,Jun Shirakawa,Yu Togashi,Kouichiro Satoh,Tomonori Muraoka,Kazuaki Shinoda,Kiyomi Masuda,Mari Kimura,Yasuo Terauchi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index295778752576523684909401981727308552898257862275

#*Classical and model-based estimates of beta-cell function during a mixed meal vs. an OGTT in a population-based cohort
#@M. Rijkelijkhuizen,J. Girman,Andrea Mari,Marjan Alssema,Thomas Rhodes,Giel Nijpels,J. Kostense,P. Stein,M. Eekhoff,J. Heine,M. Dekker
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1093057985828107502855205156613288864070579303641

#*Effects of lifestyle modification on central artery stiffness in metabolic syndrome subjects with pre-hypertension and/or pre-diabetes
#@Kunihiko Aizawa,Kevin Shoemaker,J. Overend,J. Petrella
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index954997020565709592610106594465040543911132760946
#%645065595204707760807697954435677983266288018909
#%979666132106914015693832157098175140763111233600

#*Relationship between activated partial thromboplastin time, heparin and potassium levels
#@Giuseppe Lippi,Cesare Guidi,Massimo Franchini,J. Favaloro
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index667051139972084380161692583433425464350092517315
#%233188322031792815837883476880974777863355678373
#%233188322031792815837883476880974777863355678373

#*Immediate and long-term effects of glucomannan on total ghrelin and leptin in type 2 diabetes mellitus
#@S. Chearskul,W. Kriengsinyos,S. Kooptiwut,S. Sangurai,S. Onreabroi,M. Churintaraphan,N. Semprasert,W. Nitiyanant
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1036535401152026629146483883739301450340201231368

#*Altered levels of adipocytokines in type 2 diabetic cigarette smokers
#@M. Al-Daghri,S. Al-Attas,Tajamul Hussain,Shaun Sabico,Ahmed Bamakhramah
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1056698190279412854558472300102117863694064387293
#%754777293777453214165010962626748418626760830455
#%356723084956678048310110746609000713474666274552
#%950423704908944229606430687734649127811291051410

#*Disseminated Mycobacterium marinum infection in a patient with diabetic nephropathy
#@Sumihisa Imakado,Yuichi Kojima,Toru Hiyoshi,Shuhei Morimoto
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index901286518123189679070064314394427644329924730271

#*Serum and intracellular magnesium deficiency in patients with metabolic syndromeEvidences for its relation to insulin resistance
#@Lourdes Lima,Thomaz Cruz,Erlon Rodrigues,Olvia Bomfim,Juliana Melo,Raquel Correia,Mirna Porto,Alexandre Cedro,Elizer Vicente
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index203612757925306986033875988817375794936318758464
#%1149908803540754994568826940591325296623111593500
#%1250444615052130588527358577838298658316395908888
#%1173928064601662571584355060782837768057881892683

#*HemoglobinA1c level in healthy Thai adults: Reference interval and fasting plasma glucose
#@Karan Paisooksantivatana,Anucha Kongsomgan,Lakana Leohirun,Kalyanee Atamasirikul,Mongkol Kunakorn
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index211420070600216015562389736892210023615232720181

#*Cost of medical care among type 2 diabetic patients with a co-morbid conditionHypertension in India
#@Shabana Tharkar,Kumpatla Satyavani,Vijay Viswanathan
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1192447200414425203353100568265292167358997985654

#*Resistance training improves metabolic health in type 2 diabetes: A systematic review
#@B.A. Gordon,A.C. Benson,S.R. Bird,S.F. Fraser
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index573897717402557994375691754300409809330098475608
#%939364075204390518783510130263787822440859685126
#%728498731870276389668544046832198922017543849040
#%252494119906953000152577133869899712167309747959
#%1304308317987276117280526345179765712213574106286
#%1322993709181978981521636638667944242492831642866
#%165690252358486497844993174881209182342685681552
#%221737077756746272176175896776247511705527042762

#*Association of fasting and post-prandial hyperglycemia on the risk of cardiovascular and all-cause death among non-diabetic Chinese
#@Kuo-Liong Chien,Bai-Chin Lee,Hung-Ju Lin,Hsiu-Ching Hsu,Ming-Fong Chen
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index734111351337330372157253524030344046057547539412
#%1130806442441619753494497835647977061164189975327
#%1064628502079152143686129348381278928290381305148

#*Depression is greater in non-English speaking hospital outpatients with type 2 diabetes
#@Marnie Graco,John Berlowitz,Spiros Fourlanos,Suresh Sundram
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index638504963576145701633363858144676716126947742063
#%78318404885724385347140708162687682816350557850

#*Two cases of type 1 diabetic women with diabetic ketoacidosis presenting as alkalaemia
#@Yuko Watanabe,Kazushige Noda,Kenichiro Akazawa,Jiro Fukuyama
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index753599838291019734421361633522350993916064162786

#*Usefulness of serum cystatin C in Japanese patients with type 2 diabetes mellitus and nephropathy
#@Tetsuya Kimura,Hiroki Ikeda,Jun Fujikawa,Kazuhiro Nomura,Tomohisa Aoyama,Yoshiharu Wada,Koichiro Nabe,Yoshiyuki Hamamoto,Sachiko Honjo,Hiroyuki Koshiyama
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index794563803951346862645790282103991438853388195720

#*Identifying latent autoimmune diabetes in adults in Korea: The role of C-peptide and metabolic syndrome
#@Seung-Hwan Lee,Hyuk-Sang Kwon,Soon-Jib Yoo,Yu-Bai Ahn,Kun-Ho Yoon,Bong-Yun Cha,Kwang-Woo Lee,Ho-Young Son
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index55159587831463667313579323452264391907909528091
#%1112820460041912410184798912120359062894051410648
#%735009024663998479048138862737818215104111252409
#%415789436299534902247729529330715383950706408066

#*Risperidone-associated newly diagnosed diabetes and fatal diabetes ketoacidosis in a young schizophrenic patient
#@Chieh-Hsiang Lu,Horng Yan
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1439783297686689528990950078085260778678302410664

#*Retinal vessel response to flicker light in children and adolescents with type 1 diabetes mellitus and overweight or obesity
#@Ralf Schiel,Walthard Vilser,Felix Kovar,Guido Kramer,Anke Braun,Gnter Stein
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index402390213869388870849743560820505897189330378052
#%849983282422384407771576961629705349125539168017
#%92301026865382280562392501049925428816301619756

#*The status of glycemic control by general practitioners and specialists for diabetes in Japan: A cross-sectional survey of 15,652 patients with diabetes mellitus
#@Keiko Arai,Koich Hirao,Ikuro Matsuba,Masahiko Takai,Kiyokazu Matoba,Hiroshi Takeda,Akira Kanamori,Mikio Yamauchi,Hisao Mori,Yasuo Terauchi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index638662604124104485124189178591257350523709720423
#%74108759385361979204156615352365733346388426847

#*Hyperglycaemia following glucose challenge test during pregnancy: When can a screening test become diagnostic?
#@W. Wong,Frances Garden,Bin Jalaludin
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1090376574518929566921439199979357139307248566854
#%347165901288070027128815752702375773985739078209
#%330027731885425731540212117604319744241850177089

#*Four-fold increase in foot ulcers in type 2 diabetic subjects without an increase in major amputations by a multidisciplinary setting
#@Christoffer Hedetoft,Anne Rasmussen,Jesper Fabrin,Klaus Klendorf
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index529309832693878205076778769266416965640504391328
#%620734062614045220009425659573199915567426693537
#%164857836526599475044528315101323079556382880338
#%1287734256616221807845927827538897278202924016959
#%1354575089707344625229930549500889655952496867987
#%544838229555657885967335985372296034261791990127

#*Influence of hemoglobin E on measurement of hemoglobin A1c by immunoassays
#@K. Paisooksantivatana,A. Kongsomgan,W. Banyatsuppasin,K. Khupulsup
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1119471557624074860255951586521002393210737846827
#%374217230597442693844695154962663851183596072134

#*Risk factors for developing osteomyelitis in patients with diabetic foot wounds
#@A. Lavery,J.G. Peters,G. Armstrong,S. Wendel,P. Murdoch,A. Lipsky
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index756919121753407908128546072747480597222408090298
#%845499063016985801986966758596474890367149634175
#%338964718936987443776126030112652432828943193227
#%1019277354278746757047107212004463408862136729026
#%906503406843031589308883340733114887804391488041
#%41089581725754690405307032195520243476294895741

#*Characteristics of undiagnosed diabetes mellitus in a population undergoing health screening in Japan: Target populations for efficient screening
#@Yukihiro Bando,Hideo Kanehara,Keiko Aoki,Ken-ichiro Katoh,Daisyu Toya,Nobuyoshi Tanaka
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index104268823025299058791289287655307281467746054143
#%518381825873321838768289122541241610729062021546
#%997540535011446998871193915546101863446383772292
#%1006208790263277765056557897325621304903046763312
#%1164333541494692873676613597281444907280130855950

#*Classical PKC is not associated with defective insulin signaling in patients with impaired glucose tolerance
#@Min Kim,Ju Jang,Jin Han,Suk Ha,Kyung Kim,Won Park,Eun Song,Hye Jung,Mi Ahn,E. Choi,Jin Kim,Jung Kim,Chul Lee,Woo Lee
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index336372559595667770840670763828840211744194948328
#%1039500348172525475772065384827954784734546652221
#%1201509184450846305921030596394643291724781555947
#%1201509184450846305921030596394643291724781555947
#%180256341302757462029435389586832476999894067432

#*Training in flexible intensive insulin therapy improves quality of life, decreases the risk of hypoglycaemia and ameliorates poor metabolic control in patients with type 1 diabetes
#@Falconnier Bendik,U. Keller,N. Moriconi,A. Gessler,Ch. Schindler,H. Zulewski,J. Ruiz,J.J. Puder
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index152493705289997137864943870877196694251933178458
#%628905776483478496437160498435920933520919334137
#%422589765069933463796022628872874027181016323631
#%500832215165774590607791284438339952892171949738

#*Glycemic control and survival of diabetic hemodialysis patientsImportance of lower hemoglobin A1C levels
#@E. Ishimura,S. Okuno,K. Kono,Y. Fujino-Kato,Y. Maeno,S. Kagitani,N. Tsuboniwa,K. Nagasue,K. Maekawa,T. Yamakawa,M. Inaba,Y. Nishizawa
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index629979450658388441265443935348464208765435443589
#%1191806656971090178041131830400231109977786484040
#%478304485888748624244535900745152620083160245137
#%802084325393077343134446307964314513812351473339

#*Estimated incidence of gestational diabetes mellitus in Hungary
#@Attila Kun
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index963649288808130157302150353679375260573100392580

#*Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: Results from the ONTARGET/TRANSCEND Research Programme
#@Tali Cukierman-Yaffe,C. Gerstein,Craig Anderson,Feng Zhao,Peter Sleight,Lutz Hilbrich,H.D. Jackson,Salim Yusuf,Koon Teo
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index853332000975310589756149285832457595761334097975
#%619914298533366353236148522248289669390502022854
#%1367742372804159475110202842745898745234983117454
#%1416673711583656042926860923139304416356921315170
#%1242838747692446450551484827448699597855119973024

#*The Leu262Val polymorphism of presenilin associated rhomboid like protein (PARL) is associated with earlier onset of type 2 diabetes and increased urinary microalbumin creatinine ratio in an Irish casecontrol population
#@M. Hatunic,M. Stapleton,E. Hand,C. DeLong,V.E.F. Crowley,J.J. Nolan
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index920213719979462327851035750222072377391793872035
#%988612609716175021227626861369805498796648427971

#*Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes
#@Scherezade Momin,Sylvia Flores,Brbara B,Ethel D,Elena P,Francisco Perez-Bravo
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index205106573021452647085973284323320383979230201059
#%1280945665969923841870927996552835608797318253272
#%481561761373324694898976693226550044769828396165
#%504158171799402045884364594813536836654411672042
#%825428181175286782358368265430473286163894994568
#%555664970760935664298633588004789384759347341859
#%151630609589533017040811381271448344627130577669
#%713728089089416155360235558582685079467331210537

#*Two related cases of type A insulin resistance with compound heterozygous mutations of the insulin receptor gene
#@Wataru Ogawa,Kazuya Iwamoto,Hiroyuki Mori,Mitsuru Hashiramoto,Kazuaki Miyake,Kazuhiko Sakaguchi,Masato Kasuga
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1003222665355329048340642843655914379898811754299

#*Coronary flow velocity reserve and aortic distensibility in patients with different kinds of multivessel coronary artery disease with versus without diabetes mellitus
#@Attila Nemes,Mikls Csandy,Tams Forster
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1142788848206933466948135527429743099125512461928
#%1046740043772410847570750735511836857964401395333
#%601701254539151027394794842575003745696572220511

#*Novel mutations in GCK and HNF1A genes in Italian families with MODY phenotype
#@Alessia Cappelli,Stefano Tumini,Agostino Consoli,Silvia Carinci,Concettina Piersanti,Giuseppina Ruggiero,Graziano Simonella,Filippo Soletti,Paolo Staffolani,Luigi Pianese
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index72144714116035660093342410097413560451220013676
#%1174454970144394068341146255160004047106145782926

#*The relationship between 8503G/A polymorphism of adiponectin receptor 1 and insulin sensitivity in the Japanese population
#@Kenji Oki,Kiminori Yamane,Nozomu Kamei,Takako Asao,Tomokazu Awaya,Hiroshi Watanabe,Nobuoki Kohno
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index937994257888439432016881658655474629807289715660
#%936069583900768098272343450335544347261807063193

#*Multi-center intervention study on glycohemoglobin (HbA1c) and serum, high-sensitivity CRP (hs-CRP) after local anti-infectious periodontal treatment in type 2 diabetic patients with periodontal disease
#@S. Katagiri,H. Nitta,T. Nagasawa,I. Uchimura,H. Izumiyama,K. Inagaki,T. Kikuchi,T. Noguchi,M. Kanazawa,A. Matsuo,H. Chiba,N. Nakamura,N. Kanamura,S. Inoue,I. Ishikawa,Y. Izumi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index412498614187197204166474520057031938084646430303
#%857258101526021088940648318237026005740028604119
#%777125853342177893815085839700628327237149358415

#*Impaired left ventricular systolic and diastolic function in patients with metabolic syndrome as assessed by strain and strain rate imaging
#@Hui-ping Gong,Hong-wei Tan,Ning-ning Fang,Tao Song,Shao-hua Li,Ming Zhong,Wei Zhang,Yun Zhang
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index587587111073383267380093727523036751331975508991
#%394074846014723954118281930976347277725688325607
#%267787432646041115683477335071353028362029303595
#%1055106309085614217577064753904547437634873361465
#%780022019183928230851261556789322124181827468728
#%623025350338718386579352050740576820293309880793
#%1440267264540651346799856235532114837552605866771
#%936036470341253598949198681868081310715657978868
#%268288674211593544921842858060190672159108706810
#%1355355569009770599829780660300628864213635542502
#%95509397633466586674865889729410806033418855153
#%497100054818446648036899513176260515869493548717
#%734696234015905995309888597466761915897825458907
#%96972034248234847494623766715602791247893889056
#%370932592469225865292638725259041175743489334241

#*A pilot randomised controlled trial of resistance exercise bands in the management of sedentary subjects with type 2 diabetes
#@N.W. Cheung,N. Cinnadaio,M. Russo,S. Marek
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1319814888855730499861851448104926692882284408946

#*Impact of glucose metabolism and birth size on cognitive performance in elderly subjects
#@Maria Paile-Hyvrinen,Katri Rikknen,Eero Kajantie,David Darby,Hilkka Ylihrsil,K. Salonen,Clive Osmond,G. Eriksson
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index876909366522713246316745103368443455054613968541
#%1297263229291233960859100357902215322332051385929
#%505578034139418673898556852851542688036755998061
#%1222213477641576664381238215324284225329102861128
#%124076588781753814969839784806892816394871048477

#*Complete remission of diabetic nephropathy in a type 1 diabetic patient with near-nephrotic range proteinuria and reduced renal function
#@Kazutaka Haraguchi,Shigeko Hara,Yoshifumi Ubara,Shoichiro Tanaka,Ikuo Nukui,Hiroki Shimura,Kenichi Ohashi,Tetsuro Kobayashi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1210381177243611195186025471308224589681517581781
#%815698400384303336784517046020894911684280453276
#%789531180609918972058217678301758310873319885910
#%410539838733582650138864915473758130150119448754

#*Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: A prospective double-blind randomized placebo-controlled study
#@R.P. Agrawal,Jitender Goswami,Shreyans Jain,D.K. Kochar
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index507235022481276646156156802746811590753252133960
#%1401658726817650980555980106339926923078597274047
#%211754517450469810403999466848912351742893766523
#%771003142776402382501782957397790674480794363871
#%1431258448935863036299678115510843133370219571114
#%587738863469222904308391264900221771139529905716

#*Relation of Hemoglobin A1c to myocardial acoustic densitometry and left ventricular diastolic function in patients with Type 2 diabetes mellitus and without evident heart disease
#@Chun-Yan Guo,Lu-Hua Shen,Hong-Wei Li,Yi-Xing Teng,Shu-Mei Zhao
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index484229100752721709504214748470405125414599034270
#%285727351203512056007822315422285587971113006834
#%336081032792041167981618968745001794070240473883
#%336081032792041167981618968745001794070240473883
#%116507990772627593289246289236574696280786568959

#*Experience from a behavioural medicine intervention among poorly controlled adult type 1 diabetes patients
#@Susanne Amsberg,Therese Anderbro,Regina Wredling,Jan Lisspers,Per-Eric Lins,Ulf Adamson,Unn-Britt Johansson
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1256578816376086791697569723281198112910680345089
#%520821799504487760496001384829816031707940413347
#%562516969118477019251284100835972675786001512673
#%471958685254309972466127162734672025545680273342
#%949672236542385408236595427429416945618988525075
#%594786539020404012018499200119590111351517837315
#%32564119506676408410596688556537742145009710085
#%74291004910116869010405504603060080720189966753
#%157476035987130061489231368244329353047672253428
#%165989365355847300373939587813927949213615033292
#%1389758688593851072924645728942354338179999616687

#*Endothelial dysfunction and cardiovascular risk factors
#@Fernando Grover-Pez,Bertha Zavalza-Gmez
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1024291219520296996708747822635719254921845994760
#%231369590011664539577102717296369101273403120020
#%950346808113313538746489663499927115215462530179
#%1401196771419821112553934958794551429671642659672
#%840850977836029161803415282738174274562262397063
#%819354957008717779458500577077887287521288324576
#%1215948776164501552510622044433173115299661245790
#%831027201669201341123966872334427339529852351879
#%900421504973919606324317791527108030788210752392

#*Role of HNF-1 in regulating the expression of genes involved in cellular growth and proliferation in pancreatic beta-cells
#@Yuji Uchizono,C. Baldwin,Hiroya Sakuma,William Pugh,S. Polonsky,Manami Hara
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1260782479263807437978679419520783713734085074395
#%1426288629098905848236092823374555578737479647309
#%326721614715946073031434720706793381521641010474

#*Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome
#@V. Mohan,S. Farooq,M. Deepa,R. Ravikumar,C.S. Pitchumoni
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index511769212945294064643797631897969405676673722682
#%841054498873724604637368122438481852525857893604
#%788030914104964662212030151252267029921211436399
#%585118120109224617734523334417884767173547556438
#%102703727586433472694240895928992735120353712183
#%1327711365720790117535336334257743906560514072654
#%1429745055554746675565308543002929499141936767691
#%416657349830224052143622075798930827022672346545
#%1062102914805636190528624029436745766855225529621
#%1247584568640917432378988189365557209831242849121
#%459982748413977877749978568933015547217590155878

#*Late afternoon blood pressure increase is associated with diabetic retinopathy in normotensive type 2 diabetes mellitus patients
#@Kaercher Kramer,Bauermann Leito,Henrique Canani,Dalsasso Ricardo,Catani Pinto,Borba Valiatti,Luiz Gross
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index659132934785016541477829232875286672731266553286
#%998631945900394196440882696890238975802967988843
#%1134316742908806820439970403555300672044123021553

#*Persistence with statin therapy in diabetic and non-diabetic persons: a nation-wide register study in 1995-2005 in Finland
#@Arja Helin-Salmivaara,Piia Lavikainen,Pivi Ruokoniemi,Maarit Korhonen,Risto Huupponen
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index153247422094254088706544117796152406511841286905
#%643863261099280268253954766643868897934449043589
#%1145642763654211840626069910994098077136024372175
#%669201893690419350411248712843686324189734786989

#*Visfatin in gestational diabetes: Serum level and mRNA expression in fat and placental tissue
#@Beata Telejko,Mariusz Kuzmicki,Anna Zonenberg,Jacek Szamatowicz,Natalia Wawrusiewicz-Kurylonek,Agnieszka Nikolajuk,Adam Kretowski,Maria Gorska
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index578855159281524353094286368048426121627072923219
#%1046272452996965885366091707718019970832163851120
#%1052865035211547802003859227958217176598073096487
#%420678721583814257978460366381870733954688828022
#%380083092722546438450837430801350987518010267042
#%759327232589849136985956410532584601146125401894
#%982771805899213301359700692166756396511858716536

#*Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities
#@Qin Zhuo,Zhiqiang Wang,Ping Fu,Jianhua Piao,Yuan Tian,Jie Xu,Xiaoguang Yang
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index284718014334588981383816220857524686366050040149
#%205482879605682714091152743885205940042589099135
#%1232501439374062361965134784980106293045174871350
#%639985632551033912980344163437115694946281369965
#%502767553945109709813251466519181590253051650821
#%161287608412905677413134633972585854129011324747
#%1324973972417001029253325432822342429893670319200
#%303972967056662443548712452420849406184164352577
#%1459650687759683820803157461972786233740536588200
#%405202322424178852135201041449605125199774873196

#*Microalbuminuria and metabolic risk factors in patients with type 2 diabetes in primary care setting in Thailand
#@Wichai Aekplakorn,Supattra Srivanichakorn,Somkiat Sangwatanaroj
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index657150821087990010100873908716696843403187963785
#%702597924179108667189567141669212927055268974586
#%648013212173818776764264175347796364617199982618
#%125327012990841675178692992579721409047519483881
#%308445412264981347509325789491040674287475761659
#%607955034553306043739953329292263928317955255496

#*Severe hypoglycaemia during pregnancy in women with type 1 diabetes: Possible role of reninangiotensin system activity?
#@Ringholm Nielsen,U. Pedersen-Bjergaard,B. Thorsteinsson,F. Boomsma,P. Damm,E.R. Mathiesen
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index430335288313936512912631364016122187735953005078
#%382742355173574326867114815817254299180263406697
#%648266258690475116153277569146901541169112556648
#%1411732819876117639836139427579974201857296402349
#%372454553074134640162926612857553574714270015468

#*The usefulness and cost of a shorter duration of fasting in workplace screening for glucose intolerance and metabolic syndrome
#@K. McLellan,J. Comi,A. MacKenzie,A. Tilton,J. Dietrich
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index625274405255666716623568334359473533392400447262

#*Serum retinal-binding protein 4 is positively related to insulin resistance in Chinese subjects with type 2 diabetes
#@Xingbo Cheng,Hui Zhang
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index657201561330747907482881370081995169204653433800

#*Relationship between serum phosphate and cardiovascular risk factors in a large cohort of adult outpatients
#@Giuseppe Lippi,Martina Montagnana,Luca Salvagno,Giovanni Targher,Cesare Guidi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1084860305712707337675480541789767245028557251896
#%476008411006972074098083722774054870233198392305
#%371217179158630356482708198673208803686316520424

#*1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes
#@Chul Won,Cheol-Young Park,Hyo-Soon Park,Hoom Kim,Sook Choi,Jung Rhee,Young Lee,Won Oh,Woo Kim,Woo Park
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index414558295064672516380100827747990028107536503351
#%359983871423467149604546966883631992123781564777
#%67723564003301965803238749185968341800153456866
#%1035630632353132825605501487092498371038941011798

#*Control and management of diabetes in the Vanni District, Northern Sri Lanka
#@Smitha Addala,Sayan Srishanmuganathan,Karen Kung,Meera Rajah,Vijay Sivapalan,Rajan Namasivayam
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index981621249853033759954036552839501163650111801661
#%959141680592499676364478257422215784382897034838

#*Proliferative diabetic retinopathyThe influence of diabetes control on the activation of the intraocular molecule system
#@Joanna Adamiec-Mroczek,Jolanta Oficjalska-Myczak,Marta Misiuk-Hojo
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index850675505757301253870487052390495920328456681825
#%622363427512863739155763763551841085568828091946
#%1442993765390434605726108513133609248751433681384
#%560255666677914370575650153880625739156287397433

#*Association between atherosclerosis and newly classified chronic kidney disease stage for Japanese patients with type 2 diabetes
#@Risako Yamamoto,Akio Kanazawa,Tomoaki Shimizu,Takahisa Hirose,Yasushi Tanaka,Ryuzo Kawamori,Hirotaka Watada
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index815444930018575342724536357660176519836113985997
#%481133592538376784635822885743437248166688763925
#%1251661757847996709818536680583920967528971155718
#%671093360439160904149127465063166690323907052231
#%436085491475649523539458251948050020424170754022
#%371630171333444387608030246867002573176326850371

#*Whole blood aggregation, coagulation, and markers of platelet activation in diet-induced diabetic C57BL/6J mice
#@Melissa Henry,Lisa Davidson,Zoe Cohen,F. McDonagh,E. Nolan,S. Ritter
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index651685668538161970164807870324877976699210594527
#%789825611047965353832266668711550902828311568461
#%981637229705080772792344115131911086076534956853
#%1390770948675928563680079364792960811621908838972
#%1335580304266684225171020833892018588145106425887
#%737349936325288287551686867836405377544493668
#%586886287485133837049430956427088461891750538778
#%905995577802955902337756087818071062607330019586

#*Short-term oral treatment with the angiotensin II receptor antagonist losartan does not improve coronary vasomotor function in asymptomatic type 2 diabetes patients
#@Andreas Kjr,Sloth Kristoffersen,Lise Tarnow,Hans-Henrik Parving,Birger Hesse
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index457312154923348460662876885677282235632574867833
#%1212919109500454780375831979713810246633940656056
#%825488010840441768398216731757171449718059503067
#%1139452087872720716286256883461819861524771633736

#*Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar
#@Abdulbari Bener,Mahmoud Zirie,M. Janahi,O.A.A. Al-Hamaq,Manal Musallam,J. Wareham
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index681066098899804107563122679040667916743938844193

#*Polymorphism in resistin promoter region at 420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients
#@Takayoshi Tsukahara,Eitaro Nakashima,Atsuko Watarai,Yoji Hamada,Keiko Naruse,Hideki Kamiya,Nobuhisa Nakamura,Norihiro Kato,Nobuyuki Hamajima,Yoshitaka Sekido,Toshimitsu Niwa,Makoto Tomita,Yutaka Oiso,Jiro Nakamura
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index959550937049704242144439903284445263772241924407
#%554041389490638333108730034167281396549043148388
#%373301473434658671777505912202271130868799024613
#%343354983496997736269629370892521260460124002836
#%861266548754435870989625842530194364413113720105
#%250436578350970502761656235748030992491549012587
#%550806660826579196240334882143442528068465218911
#%664849445393066145024049322480533061842076132192
#%950423704908944229606430687734649127811291051410
#%951721772380926466597494634461018083891476291461

#*Systemic complications of posterior subtenon injection of triamcinolone acetonide in type 2 diabetes patients
#@Junko Toda,Harumi Fukushima,Satoshi Kato
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1139148270027649573174939957122557610948768332009
#%284161112291827012152135618246270661632457054867

#*Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients
#@D.A. Luis,Gonzalez Sagrado,R. Conde,R. Aller,O. Izaola,J.L. Castrillon,A. Dueas
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1128751609981264455166607885782910016038708606256
#%205482879605682714091152743885205940042589099135
#%462090242417370282444137807951869417821853287877

#*Preventing diabetic complications: A primary care perspective
#@Paul Zimmet
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index905319215110543961701496420283208702783823449454
#%817256778313934031949420523017093154160834658706
#%938273324743190397527608173600871034340668923565
#%735009024663998479048138862737818215104111252409
#%86448108200688236828990046032823779520797254538
#%939816543313503039404475280706549131639594916946
#%747494549459929334439546805110245830284331121758
#%1372234833018656585377712275893843699798964325470
#%821173177306970158571948803625674602890112834725
#%81213820779628439997771728246816137838544651559
#%479719591875633719029847314443711955932409718056

#*The effect of plant sterols or stanols on lipid parameters in patients with type 2 diabetes: A meta-analysis
#@L. Baker,L. Baker,I. Coleman
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index898622706616712561595114842063830003411830608905
#%1292110379918747549018322929657578770938902971112
#%806999650028062183539294847549091501669413301243

#*Arterial stiffness, carotid artery intima-media thickness and plasma myeloperoxidase level in children with type 1 diabetes
#@Kaire Heilman,Mihkel Zilmer,Kersti Zilmer,Mare Lintrop,Priit Kampus,Jaak Kals,Vallo Tillmann
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index895848085122940634172996275035119420606084699086
#%44528160611584587207774590258623804514144219168
#%145290544300892797038499315140594567980386018414
#%1348640370601254614485910988064121093372989877518
#%1348640370601254614485910988064121093372989877518
#%877109510198641184793984526188350798710116569740

#*Effects of thyroid hormone on serum glycated albumin levels: Study on non-diabetic subjects
#@M. Koga,J. Murai,H. Saito,S. Matsumoto,S. Kasayama
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1451416287998830693326812020083442038897251630570
#%456903332537576654681723741953127539545115503232
#%108415521816253696892379654487119819378864715688
#%900336596417037110728377340277067301900025752270
#%516063374164972390407511519209867235309995594236
#%773290049541987842368517098111829249911265406991

#*Persistent pain at multiple sitesConnection to glucose derangement
#@Pekka Mntyselk,Juhani Miettola,Leo Niskanen,Esko Kumpusalo
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index89953540527302012581350013446593681634430895177
#%561102917488050128748066096502875242051958000709
#%350587444709900776762643105800405028413820914950

#*Comparison of continual insulin or secretagogue treatment in type 2 diabetic patients with alternate insulinsecretagogue administration
#@Hong Li,Wenjun Li,Yao Gu,Yuqi Han,Jiying Wang,Bei Xu,Fang Li,Yongchun Yu,Guoting Wu
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1040956563144355761937241847129144142740736158979
#%63062596720788122659212089293285776441075637398
#%834396473701110945768836428917379518813373126215

#*Elevated serum -glutamyltransferase levels are independently associated with insulin resistance in non-diabetic subjects
#@Yel Shin,Jin Chang,Goo Shin,Kwang-Seok Seo,Hee Chung
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index490547008829810354778304963254239997873916395566
#%1135558370451843839063549741374418620677791300303
#%928670943840683491319615474360322243537244463157
#%586166765161940257096383759979825075010533481882
#%1162802027208184720239599200167042969624541491799

#*The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: Cardiovascular risks and adiponectin in IFG
#@J.S. Nam,J.S. Park,M.H. Cho,S.H. Jee,H.S. Lee,C.W. Ahn,W.L. Lowe,K.R. Kim
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index218877622811905119925819839270335625991838274522
#%798718960466278114635366482410674321074698856592
#%1079713304920013552858020554195746970270873074525
#%1079713304920013552858020554195746970270873074525
#%1298966567613050615070242557709876752222758336784
#%146688154634594598120234007596512071276683871100
#%242687513956832730888401273518713736991700440400
#%221134397841908909041128605737681214826418880507
#%1100672229428934302167616154631598278442313264879
#%653687469517096974656299347292189746828226199309

#*Cardiovascular rehabilitation increase arterial compliance in type 2 diabetic patients with coronary artery disease
#@L. Mourot,A. Boussuges,P. Campo,S. Maunier,X. Debussche,P. Blanc
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index989150730707792849720962295982242321680658827110
#%1352866179330232980705047798833446654614156817772
#%825616197341844949970601734864597392913546008300
#%1274852757982191122319645303872406043777393376842
#%979666132106914015693832157098175140763111233600
#%512235238262895760783862808335984948261346072139
#%1331714837610457018567026508058925583871378854183
#%739579494330595434198759060611437401770919379429
#%651292242654454240509625858915956339884825584496
#%724247832599927926792811953401553192750689986004
#%1499880760379459663764097664530945177463479377
#%622811077668982873822724564740822046441460921401
#%680420105362507649896918488504812717974695355412
#%465364628952528728360843744577131178134311198945

#*Glucose Tranporter-4 expression in monocytes: A systematic review
#@Yorgi Mavros,David Simar,Fiatarone Singh
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1309681979605803358568355980791482196830046822410
#%139444270446906068167097344469067977815593249624
#%139444270446906068167097344469067977815593249624
#%21611824503557032045609135908625101953921660234
#%1360604868856078972782325749373290066590399320207

#*Effects of patient volume on quality of outpatient diabetes care
#@Jun-Sing Wang,Shih-Yi Lin,H.-H. Sheu,I.-Te Lee,Li-Nien Tseng,Yu-Ming Song
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index522195459020192904849912927054466938099939662330
#%741472667357967036521698557437635045148869117616
#%1192415321430677255877494605401963094981109215500
#%1066639413747252171928946406273179615147554548866
#%1325606818630603206744819129432337768528142157669

#*Higher dose requirements with insulin detemir in type 2 diabetesThree cases and a review of the literature
#@G.H.A. Swinnen,Hans DeVries
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index25941386891273127369339061737250011438662763319
#%331125870934479234182160053302514815224859038971

#*Epidemiology and prevalence of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in patients with diabetic foot ulcers: Focus on the differences between species isolated from individuals with ischemic vs. neuropathic foot ulcers
#@Hanna Galkowska,Adrianna Podbielska,L. Olszewski,Ewa Stelmach,Miroslaw Luczak,Grzegorz Rosinski,Waldemar Karnafel
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index593048333324557889475218826324731761255740853711
#%242100088374053588581671592183846224365418032251
#%1153246217629299990100314894345899454640728283455
#%252937229940248038315317807533460149882811328183

#*Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodies
#@Tsuneo Ishizuka,Susumu Ogawa,Takefumi Mori,Kazuhiro Nako,Takashi Nakamichi,Yoshitomo Oka,Sadayoshi Ito
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index78565009313059810422365220609927358912829015931
#%329979441994722890758572730923992612677606609209

#*Waist circumference reduction after insulin detemir therapy in type 2 diabetes patients previously treated with NPH
#@E. Mandosi,M. Fallarino,M. Rossetti,A. Gatti,S. Morano
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index14013495396417796629186016243590778361052045255
#%133938427602232356244794374108572608242198287269

#*Preliminary evidence that regular vinegar ingestion favorably influences hemoglobin A1c values in individuals with type 2 diabetes mellitus
#@S. Johnston,M. White,M. Kent
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index427547196065395786778658428285488762635029685724

#*RAPGEF1 gene variants associated with type 2 diabetes in the Korean population
#@Kyung-Won Hong,Hyun-Seok Jin,Ji-Eun Lim,Ha-Jung Ryu,Jin Go,Jong-Young Lee,Jeong-Taek Woo,Kuk Park,Bermseok Oh
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index588192829700188695420448837531162360788236041625
#%178636823132885834441049153805314518954807889464

#*Thr54 allele of fatty-acid binding protein 2 gene is associated with obesity but not type 2 diabetes mellitus in a Caucasian population
#@A. Tavridou,K.I. Arvanitidis,A. Tiptiri-Kourpeti,I. Petridis,G. Ragia,S. Kyroglou,D. Christakidis,V.G. Manolopoulos
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index808333447922121202662143336212972721586977386486
#%100429348370909835019603497131547514355476161561
#%371122736185951693959284257512381621703896337471
#%810107488954471304060275761946553057648506946819
#%361438741527432440215235283555552225579725074595
#%1400196306804463100747571865017546956154629472723
#%1050313793818678153422850347114505502413159192148

#*ABC control of diabetes: Survey data from National Diabetes Health Promotion Centers in Taiwan
#@Neng-Chun Yu,Hsiu-Yueh Su,Shih-Tzer Tsai,J. Lin,Ruei-Shiang Shiu,Yu-Chuan Hsieh,Huey-Herng Sheu
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index749827365434910630056567550078805136344206542599
#%447749687038028763081430964556668726536825442523
#%1014050429518595887361295856904183858259214252958
#%741472667357967036521698557437635045148869117616
#%276535657305851626650864198797223094843350806525
#%276535657305851626650864198797223094843350806525
#%1309348636333508695254546525574021509910462819191
#%675685202535854623824109789067956851435485119937
#%675685202535854623824109789067956851435485119937
#%747494549459929334439546805110245830284331121758
#%791437010500835684446913673495202924917937619815
#%1066639413747252171928946406273179615147554548866
#%816288063008886026562690004102967508680265408781

#*Characteristics and mortality of type 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia
#@Paolo Fadini,Mauro Rigato,Antonio Tiengo,Angelo Avogaro
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index507879463740710254603253941246756219302200820818
#%768247779115369498662625639438801948530949825098
#%1134316742908806820439970403555300672044123021553
#%868097506677594926077865098251498284857521498103
#%334951279561298620689955659455655795510478998276
#%1202025465028684504518802402119786859056078800556

#*Administration of a new diabetes-specific enteral formula results in an improved 24 h glucose profile in type 2 diabetic patients
#@Antonio Ceriello,Mirian Lansink,H.F.C. Rouws,M.J. Laere,S. Frost
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1457509423636947350534029915481680667448388575349
#%375362792107943614923013276608327663170207999875
#%100559463776079310200646757243194464284781954056
#%279999983877944761980039202936569032539827604549
#%725818959678020602110884360361396034754604018046
#%866157480432504835236275951813568006811066350043
#%265394536105335703962656364178179069462317053567
#%1017125862752929396912297330594837520049935257609
#%375583971542829404457773432760275031942102911841

#*Autonomic nerve fiber function and bone mineral density in individuals with type 1 diabetes: A cross-sectional study
#@E. Maser,N. Stabley,James Lenhard,A. Provost-Craig
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1028685858074470024430754300069030289393311809181
#%338020624080117990225527994475738061584646961280
#%573108929116756356759227180643102058956495032804
#%1238985412441050879506887190749377080768869058632
#%1159346816714325081962435263791586781299197647283
#%366264501284994770395487568257785717271623720668
#%1021547765313165786711299415139958298490895048121
#%537911843575850245867969410105198293929219653041
#%988160052269411314015609111710487084298339212209
#%494810375177743367900507436536185144485059194155
#%131036540912052901941378504581447767779799060870

#*The influence of Thai culture on diabetes perceptions and management
#@Napaporn Sowattanangoon,Naipinich Kotchabhakdi,J. Petrie
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index452969600743989817926465561276518456839528983497
#%389062917905547150886526123506901661250799753152
#%985158163639836706609984849881021163008575934663
#%542173520210336393854966046421793205831146448029
#%1330895675734608919906353629351803541970894767549

#*Successful desensitization by glargine administration in a patient with insulin allergy: A case report
#@Masumi Hara,Yoshihiko Izumida,Nobuhiro Sato,Ken Ohashi,Jun-ichi Osuga,Kazuyuki Tobe,Kazuhisa Tsukamoto,Takashi Kadowaki
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index792672374842194787280225745812381393755694795569

#*Neuro-otologic symptoms in patients with type 2 diabetes mellitus
#@Kathrine Juregui-Renaud,Blanca Snchez,Alicia Olmos,David Gonzlez-Barcena
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1060335919429380748763379595501810958113580999920

#*Interrelationship between coagulation factor VII and obesity in diabetes mellitus (type 2)
#@R.A. Karatela,G.S. Sainani
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index914900541825658147840627842214343259356493569431
#%244317554478981276460522399120916449517540010964

#*Prevalence and risk factors for type 2 diabetes mellitus in the Chinese adult population: The InterASIA Study
#@Dongsheng Hu,Liang Sun,Pengyu Fu,Jing Xie,Jie Lu,Jing Zhou,Dahai Yu,K. Whelton,Jiang He,Dongfeng Gu
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index382091147107147995652947650889290148085744085563
#%1172677228348686885501689655071745393817660190684
#%1454377756196061205182006120966089088152990194303
#%1048649499482247989988652560390374984613590778886
#%597427274536570873221493587908764029851994050137

#*Sulfonylurea treatment in a girl with neonatal diabetes (KCNJ11 R201H) and celiac disease: Impact of low compliance to the gluten free diet
#@Maurizio Delvecchio,Clara Zecchino,Felicia Faienza,Angelo Acquafredda,Fabrizio Barbetti,Luciano Cavallo
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1033978855612636746217621067965476458181321453653
#%1229967057131146653163892682426539378199073545862

#*Relation between adiponectin 45 T/G polymorphism and dietary composition in the Czech population
#@Julie Bienertova-Vasku,Petr Bienert,Josef Tomandl,Martin Forejt,Anna Vasku
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1239626842836295206200875556376685178392646217513
#%152882712225312580693103153543445357106525028651

#*Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: The implication of metabolic syndrome to detect insulin resistance
#@Alireza Esteghamati,Haleh Ashraf,Abdoul-Reza Esteghamati,Alipasha Meysamie,Omid Khalilzadeh,Manouchehr Nakhjavani,Mehrshad Abbasi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1264829829203675377337961528130011833014587239121
#%46623283376592567648411043004350999272485192716
#%1324973972417001029253325432822342429893670319200

#*APM1 gene variants 11377C/G and 4545G/C are associated respectively with obesity and with non-obesity in Chinese type 2 diabetes
#@Xizhen Wang,Sizhong Zhang,Yuanzhong Chen,Hekun Liu,Cailian Lan,Xuexiang Chen,Shuguang Chi,Suyun Chen,Wei Zhang
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1065287583131941523698047662769852020211428709680
#%1115593705372859551486922054791061002443303081742
#%997813168373711276369796927049829448781053796308
#%1347131148159653833870809454228854616978879559695
#%639985632551033912980344163437115694946281369965
#%1042018037800177744614570243444212179861288525213
#%93505884654740132880746838689444380826855187165
#%853231008704022693341755006843081897716631355886
#%781627999874197010284636709764852094874371450292
#%7353049046563349778532149362124501124223511955

#*Serum trypsin inhibitory capacity in normal pregnancy and gestational diabetes mellitus
#@Minoo Yaghmaei,Mohammad Hashemi,Abdolsamad Shikhzadeh,Mojgan Mokhtari,Abbasali Niazi,Saeid Ghavami
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index252821997331431596244678058747327892062022153312
#%883711132617102132654367651286952697931570316106
#%505984882770876466430043087160425577254451500863
#%789872968133132471550356123006768669217657382874
#%403322150774168175730059469914477188331480132373
#%1240616732739366806458696586212628613110326869518
#%367450401774386850716652681499188918218910153874
#%818395055325945361191839167400275954213354201192
#%319076033388810036557274730087578157943718308067
#%914932087416901069057384094707364455873627644906
#%61407616985692146624782058671273204970394329433

#*Community-based population data indicates the significant alterations of insulin resistance, chronic inflammation and urine ACR in IFG combined IGT group among prediabetic population
#@Qingguo L,Nanwei Tong,Yupu Liu,Nali Li,Xialian Tang,Jianlin Zhao,Hongyi Cao,Daigang Li,Lingli Gou,Yuwei Zhang,Jun Wan,Li Jiang
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index386792621861605562304527740640692497632430742936
#%1223558766799509456069917065402361166560893443305
#%1232501439374062361965134784980106293045174871350
#%946693004380556650959884795485915568531977258972
#%946145500651395302405373971906932976818802151747

#*Plasma apelin and asymmetric dimethylarginine levels in type 2 diabetic patients with diabetic retinopathy
#@Arif Yonem,Cevdet Duran,Melih Unal,Metin Ipcioglu,Omer Ozcan
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index646867246956379072032394744760390614784467054291
#%101480524770518822874404911093287152122807588184
#%929735672091484205252045516428353443705159161988
#%697989770419308730203820565291271973336864339589
#%841755651553331213278894912406600466869492716812
#%155762115426289771630638514142936861061271917530

#*Sports activity and risk of type 2 diabetes in Chinese
#@Kuo-Liong Chien,Ming-Fong Chen,Hsiu-Ching Hsu,Ta-Chen Su,Yuan-Teh Lee
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index547722284895831384194054904910285649966924640894
#%781828135045863441455860341175210195323383746816
#%512210207101278531710065694487896887607672818172
#%1420936798300482831678452425531394016045143671933
#%1090619873554264050031059589877793387165607740112
#%631300152671499748615326939576873253154413712997
#%1304600205965406857477137708284533702758346961207
#%576033348932666881386354771463050886038079991730

#*Prevalence of glucose intolerance and associated risk factors in rural and urban populations of different ethnic groups in Kenya
#@D.L. Christensen,H. Friis,D.L. Mwaniki,B. Kilonzo,I. Tetens,M.K. Boit,B. Omondi,L. Kaduka,K. Borch-Johnsen
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index717376844047915956691600400183133438417963572162
#%1251461480705900620540742652492561435382880830719
#%965623351764089213424175684108145815594666716422
#%1367856573503546253929808889444004046907962773070

#*Vaspin and its correlation with insulin sensitivity indices in obese children
#@Selami Suleymanoglu,Emre Tascilar,Ozgur Pirgon,Serkan Tapan,Cihan Meral,Ayhan Abaci
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index531328289779138789481476763185444814793487750047
#%993975462982039772620563680962599306952278326853
#%80560929720269015465837046388124145934586444998
#%612996013956783174386016149695405911634332514289

#*A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody
#@Hajime Akatsuka,Yutaka Yano,C. Gabazza,John Morser,Ryoma Sasaki,Toshinari Suzuki,Ryoko Fujiwara,Akira Katsuki,Yoshiyuki Takei,Yasuhiro Sumida
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index897638537470494351029028596123499162349233831882

#*High sensitivity C-reactive protein is associated with the metabolic syndrome independent to viral and bacterial pathogen burden
#@Abdolali Ebrahimi,Iraj Nabipour,Katayoun Vahdat,Mojtaba Jafari,Moradali Fouladvand,Majid Assadi,Ali Movahed,Narges Obeidi,Zahra Sanjdideh
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index938630664545513194256047953704334364272553398276
#%51574571624217080245649272866868473303111769462
#%1399489749930063715646530398046551876474802246663
#%295204425973525546786984893544955815175884814477
#%1010808359737819455372775178022479651170014284991
#%253388253905518156036454404163844552780685939432

#*Interaction between HNF4A polymorphisms and physical activity in relation to type 2 diabetes-related traits: Results from the Quebec Family Study
#@Ruchat Stephanie-May,S. John,Rankinen Tuomo,Bouchard Claude,Vohl Marie-Claude,Prusse Louis
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1371657913711041859728805147726324893504859031764
#%1325187688033728821471216301664279293930714531575
#%767619494255997657982793467300584006062218134298
#%697112825289008408467223136368071950586174382960
#%522976188019132785232333343317031091663563374691

#*Obesity phenotype and intra-abdominal fat responses to regular aerobic exercise
#@Hiroyuki Sasai,Yasutomi Katayama,Yoshio Nakata,Hiroyuki Ohkubo,Kiyoji Tanaka
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index690228390405472911870024036720621001371646093434
#%469287249640791386517535195945360264582366894990
#%1028978993462610061266438805053111409710235367556
#%571363083570883003046483622709639163336826491457
#%543211782309761472376170111085800711602710177369
#%759174614125474775254365389203237480140205406573

#*Analysis of the method for conversion between levels of HbA 1c and glycated albumin by linear regression analysis using a measurement error model
#@Yasuhiro Tahara
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1406642977670755204002311738715363517998483631427
#%900336596417037110728377340277067301900025752270
#%659346669664977059904706732158788519367547351135
#%1228396982419087805432490414802004285309889486526

#*Prevalence of diabetes and impaired fasting glucose among 769 792 rural Chinese adults
#@Huiguang Tian,Guide Song,Hongxiang Xie,Hong Zhang,Jaakko Tuomilehto,Gang Hu
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1419413346172942688047174400944061887242157117914
#%923760739051123571119412390195306003161145403880
#%515979776088216495630450523859805409563518083469
#%1101387924464804961309612687235002104295226827515
#%57600490521702870368866949748386380068058430981
#%715783349862343521591858137044073981054526705544
#%279999983877944761980039202936569032539827604549

#*The prevalence of 6 weeks postpartum abnormal glucose tolerance in Caucasian women with gestational diabetes
#@Jarosaw Ogonowski,Tomasz Miazgowski
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index488981502262453478390432915875305032540870625325
#%435816954529985578833972916772015854770699495681
#%757785002236955676994035815991295373354947076196
#%93949877077390792474095774375359563743834617120

#*Erythropoietin during hypoglycaemia in type 1 diabetes: Relation to basal renin-angiotensin system activity and cognitive function
#@Lommer Kristensen,Thomas Hi-Hansen,Vidiendal Olsen,Ulrik Pedersen-Bjergaard,Birger Thorsteinsson
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1378817847128458537722441083958222744795593125380
#%435380281656722958553346291036647697798086446769
#%370427112703555880077864956698178339866726547759
#%1088185819627674974924637085654768929393900690484
#%430750151109150729607804285724218408356094785753
#%648266258690475116153277569146901541169112556648
#%456236221461814504738535695694913452992533436926
#%67639452831031567585705985630683875869172527841
#%52485343940395521619465923268084956183559316660
#%981956211573264341040263315169565277030288860217

#*GLP-1 receptor agonists: Targeting both hyperglycaemia and disease processes in diabetes
#@Juul Holst
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index931624457186963282170237101994585544158782257290
#%1125883236968947230792865653325336291251909538587
#%1090399099460434459948621931836741264087240795834

#*Usefulness of brachial-ankle pulse wave velocity as a predictive marker of multiple coronary artery occlusive disease in Korean type 2 diabetes patients
#@Jin Kim,Sun Nam,Suk Park,Minho Cho,Sik Kim,Woo Ahn,Moon Kwon,Kee Hong,Won Yoon,Soo Cha,Rae Kim,Chul Lee
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index856761854325046762861140378996968706260668846860
#%247354015900669634713413216378363560040920237900
#%434318596091108881965101491749824619381798533178
#%221134397841908909041128605737681214826418880507

#*Relationship between serum retinol-binding protein 4 and visfatin and the metabolic syndrome
#@Cheng-Chieh Lin,Ming-May Lai,Tsai-Chung Li,Chia-Ing Li,Chiu-Shong Liu,Ching-Chu Chen,Ming-Tsang Wu
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index896548908791774682788477310803425220876728796680

#*SUMO4 Met55Val polymorphism is associated with coronary heart disease in Japanese type 2 diabetes individuals
#@Takeshi Shimada,Yasushi Furukawa,Hiroto Furuta,Kazuki Yasuda,Shohei Matsuno,Akiko Kusuyama,Asako Doi,Masahiro Nishi,Hideyuki Sasaki,Tokio Sanke,Kishio Nanjo
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index522722288069505134991019850047812513084882687389

#*Identification of eight new mutations in the GCK gene by DHPLC screening in a Spanish population
#@Jess Solera,Pedro Arias,Cintia Amioso,Isabel Gonzlez-Casado,Pilar Garre,Lucrecia Herranz,Africa Villarroel,Marta Cruz,Mercedes Jez,Felipe Pallardo,Ricardo Gracia
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index810066616683423791201322806105273886157114859620
#%1141044102209217234044884353213035104714523918566
#%215577566323439230160970836523089352261802459834

#*Lower waist-circumference cutoff point for the assessment of cardiometabolic risk in Koreans
#@Hong-Kyu Kim,Chul-Hee Kim,Joong-Yeol Park,Ki-Up Lee
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index722686045832751232598632880762499740491640333575
#%608027367961477215758757976231510100673358964715
#%425359508911865790944680143974007765055061334363
#%1418558710248747573609417571891099389687633692249

#*Comparison of National Diabetes Data Group and American Diabetes Association diagnostic criteria for gestational diabetes in their identification of postpartum risk of glucose intolerance
#@Ravi Retnakaran,Ying Qi,Mathew Sermer,W. Connelly,Bernard Zinman,J.G. Hanley
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1102434826921840236706969548235939536675820196912
#%308332029178327338430345595053119872385356964187

#*Glucose tolerance in pregnancy and the long-term risk of cardiovascular disease
#@I. Dawson
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index433762711068180711124978386260439464099050078327
#%288991720279435843532385358842902572016138801443

#*Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study
#@Hadi Harati,Farzad Hadaegh,Maryam Tohidi,Fereidoun Azizi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1362835362349301477381598404188624936061584595096
#%597094394382311199554111259596402199372598177702
#%451681544669050786930466421814619270128777026726

#*A cross-sectional relationship between vital capacity and diabetes in Japanese men
#@Eiji Oda,Ryu Kawai
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1220225455399777667945611994250536665780104967027
#%258822578573329776986234033685345762417769561327
#%456617609660399521711311895516216058522340208481

#*Does glucose infusion exacerbate metformin-associated lactate acidosis? A case report
#@M.C.G.J. Brouwers,N. Schaper,L. Keeris
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index719574117950757593487293138954012103513272507391
#%845480872594018575170551246048268653549773932024
#%859422735022855156636460924594510400095563062244

#*Step-up therapy with biphasic insulin aspart-70/30Sapporo 1-2-3 study
#@N. Yoshioka,Y. Kurihara,N. Manda,K. Komori,M. Kato,H. Kijima,N. Wada,K. Yanagisawa,S. Aoki,Y. Ono,T. Koike
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index511916685844138759671585300886794848825639160406
#%1454173051140223056214004912298129667489991059702
#%1186346468612348943346164264824208867847496851823
#%956803042954471985366406152496359639505557671256

#*Cigarette smoking, smoking cessation, and diabetes
#@Serena Tonstad
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1329627353456935872006228366833009235440294265039
#%306232289460744045629162792646698523988624398614
#%761173292521054829160295289535933967351560705367
#%413378863530529251170002948548343502010321488761
#%509268860753399877151495208572998318119530328893
#%1244643268407683540091338947979002267577478311102
#%750947515418795898899540354840155509292567308297
#%326680035934979994271802941192088813006094268994
#%548580881608700436003243071396437748037308434052
#%1377114124730537215494613660425608326466780088209
#%1031188938861165138676392097749047372739725025134
#%512119972105341295357801373469560345565155968477
#%462150212797743232246929213093730912332382151623
#%7071578471608017574529457665230333669372317524
#%759576727906053993355294625014760073941080461608

#*Ethnic and gender differences regarding the insulinblood pressure relationship
#@I.M. Palmer,A.E. Schutte,H.W. Huisman
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index467680497626304741092746943580409998159496224934
#%281678017714416481652042666875300156586420354963
#%971669660048552419878489017971634846858544637145
#%37629072415916388592479987454571757928548157050
#%92883062140095460667118749404076989991246627927
#%976999115353026055556855685838053745413991561871
#%290148826825933085567877629391495731692115637709
#%1433296213854994450255123979499139302746680216499
#%1270612852405498674831754035979211279061447508886
#%587676094023113919820632864159085078915049828549
#%26293449665970940472384609817890079158069516450

#*Near-optimal glycemic control in Chilean women with pregestational type-2 diabetes: Persistent macrosomia relates to maternal pre-pregnancy overweight
#@R. Olmos,P. Araya-Del-Pino,A. Gonzlez-Carvello,Pablo Laso-Ulloa,I. Hodgson,Vernica Irribarra,R. Borzone,Cristin Belmar,Andrs Poblete,Cecilia Berros,Jorge Becker,M. Zajer-Amar,Alejandro Manzur,Milan Bozinovic,J. Miranda,Alberto Diez,Hernn Vidal,Renato Ramrez-Armijo,I. Olmos,Cristin Tabilo,Jessica Ahuad
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1421203861124810700746550473369461915552438437037
#%557502760685593264371640706687128397307596588305

#*Plasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type 1 diabetes mellitus
#@Brito Gomes,Arnold Cobas,Edson Nunes,Caire Castro-Faria-Neto,Bevilacqua Matta,Ricardo Neves,Eduardo Tibiri
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index343333303724554278771208629137610839730259404190
#%466760428522239713115395659803026782740014703094
#%1269803042723723184929316905283302123850009768834
#%1045034704475768431162737522502641664394817684968
#%1097230673122116155468480590685744445329070611472
#%208367722068874245101010250602118143559915968115

#*Evaluation of the effects of exercise on insulin sensitivity in Arabian and Swedish women with type 2 diabetes
#@F. Glans,K.-F. Eriksson,. Segerstrm,O. Thorsson,P. Wollmer,L. Groop
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1127889570121199552997538375781207933863617004837
#%1363720464846402832122769678882944767658140378001
#%259041572967594291942435069808507177610488956302
#%728498731870276389668544046832198922017543849040
#%453423001805215130705005176928310782135176402268

#*Clinical characteristics of Korean patients with new-onset diabetes presenting with diabetic ketoacidosis
#@Kyoung Kim,Hwan Lee,Hoon Kim,In Lee,Hyun Kim,Hee Jang,Kun-Ho Yoon,Woo Lee,Ki-Ho Song
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index708449503068774497161024372285834802033286918763
#%390371137728887586911880288885235639516434221172
#%390371137728887586911880288885235639516434221172

#*Blood glucose monitoring: Milking the finger and using the first drop of blood give correct glucose values
#@Heinrich Fruhstorfer
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index41581211897720426392148918403459718071049633895
#%1411153909353499077276478707769463946452107587002

#*Urinary tract infection, uropathogens and antimicrobial resistance in diabetic and nondiabetic patients
#@Athanasia Papazafiropoulou,Ioannis Daniil,Alexios Sotiropoulos,Dimitra Petropoulou,Stavroula Konstantopoulou,Theodoros Peppas,Stavros Pappas
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index671308008364317243544393761433814068651341858930
#%752184363544792058457478332439754596854748607288
#%950719104294799593486018995687658030070732540083

#*External validation of a clinical scoring system for the risk of gestational diabetes mellitus
#@M. Leeuwen,B.C. Opmeer,E.J.K. Zweers,E. Ballegooie,H.G. Brugge,H.W. Valk,G.H.A. Visser,B.W.J. Mol
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index385041741217296654476134128009562245923239038591
#%392009543080035335835662628453966582496913146840
#%432862859237627926470651959253022002927798296408
#%777227920895555908964319961315957122565191136572
#%946403906898716791310236132382293550028922358030
#%613642219583968135859356915425713819398826305072

#*TNF 308 G/A polymorphism and type 1 diabetes: A meta-analysis
#@Ren-Nan Feng,Ying Li,Chang-Hao Sun
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index818679413657106349444995111713408529100747433155
#%298124516810902300670030010727799596229354285359
#%1002074174875775658268654665077028407319781207731
#%1040516120269046946220745342196804306510017809055

#*Carotid atherosclerosis mediated by visceral adiposity and adipocytokines in type 2 diabetic subjects
#@Kazunori Konishi,Shigeru Nakano,Hiromi Seto,Shin-ichi Tsuda,Daisuke Koya
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index72267579652762101537995772442162067571306148785
#%324021310492296151580502224049622609425325114099
#%1302384256035412582860644693750793920754714517789
#%525536780685480756531513695580692897182912621805
#%1234111595999357570521962802221100629795874043207
#%432648096115100116114238917797827468681426179542
#%1040449746699821776333725840916757056771635252471

#*Meta-analysis of the association between SNPs in TCF7L2 and type 2 diabetes in East Asian population
#@Yingying Luo,Hongyuan Wang,Xueyao Han,Qian Ren,Fang Wang,Xiuying Zhang,Xiuqin Sun,Xianghai Zhou,Linong Ji
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index933958154217193312384636263627570368528319805126

#*Associations of coronary artery calcification and carotid intima-media thickness with plasma concentrations of vascular calcification inhibitors in type 2 diabetic patients
#@Masami Ishiyama,Eiji Suzuki,Jun Katsuda,Hiroshi Murase,Yoshitaka Tajima,Yukio Horikawa,Shinobu Goto,Tamio Fujita,Jun Takeda
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index894937963095751929419777980977358967846707475854
#%1019295311003677583817726196325719686806737641603
#%748136515849752103699890937860486415002965902053
#%1163559622095251254106696253998659506406816371575
#%438213828938194030738229426790900337763047308218
#%633461680371896292474213356432768461383201339245
#%1102436090681319296780943948352367869066696000570
#%433767329639828187796978675019726710810980835560

#*Frequency and motives of blood glucose self-monitoring in type 1 diabetes
#@M.V. Hansen,U. Pedersen-Bjergaard,S.R. Heller,T.M. Wallace,.K. Rasmussen,H.V. Jrgensen,S. Pramming,B. Thorsteinsson
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index31749928824163085914532755893042072605819381086
#%447432957791090693257412871396778845181448764791
#%1254176666401582433620745052946126439911983901742
#%648266258690475116153277569146901541169112556648
#%401480040670760425426087011405089160926487528678

#*Microalbuminuric anaemiaThe relationship between haemoglobin levels and albuminuria in diabetes
#@O.R. Adetunji,H. Mani,A. Olujohungbe,K.A. Abraham,G.V. Gill
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index500408092940385969174880321278299952761505213087
#%725663630140687978752151273052836166046100124684

#*Carbohydrate metabolism and cardiovascular risk factors 4 years after a pregnancy complicated by gestational diabetes
#@Eszter Madarsz,Gyula Tams,Gy. Tabk,Zsuzsa Kernyi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index852123664996728598019329089535002700906508900581
#%1046476648758725593222208851883308433346097974841
#%1438361308239152205343302480156715263383345379538
#%730910411722995366702217853985310374847265264466
#%340035279079324791840196450218319126054720600885
#%340035279079324791840196450218319126054720600885

#*Raised fasting plasma glucose a better predictor of diabetes than the IDF definition of the metabolic syndrome
#@Tomoko Nakagami,Naoko Tajima,Toshihide Oizumi,Shigeru Karasawa,Kiriko Wada,Wataru Kameda,Shinji Suga,Takeo Kato,Makoto Daimon
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1016557363423092520399753612519732792456829814127
#%1101387924464804961309612687235002104295226827515

#*Comparison the Carpenter and Coustan thresholds with the new thresholds obtained from Thai pregnant women for the diagnosis of gestational diabetes
#@Supamai Soonthornpun,Karanrat Soonthornpun,Jiraporn Aksonteing,Atchara Thamprasit
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1399890209353768728154445560655643202703682196304
#%1111911381265382572303518945336865303046821233274
#%757785002236955676994035815991295373354947076196
#%970668101894567159382530087570761771151771192627
#%970668101894567159382530087570761771151771192627

#*Can primary care professionals adherence to Evidence Based Medicine tools improve quality of care in Type 2 diabetes mellitus? A systematic review
#@A.G. Belvis,F. Pelone,A. Biasco,W. Ricciardi,M. Volpe
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index174084244565268145524610764216770667090762755884
#%149575629869246818475162515583602616855059383982

#*An accurate risk score for estimation 5-year risk of type 2 diabetes based on a health screening population in Taiwan
#@Feng Sun,Qiushan Tao,Siyan Zhan
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index926438238323731693267580522660447062290102699584
#%1172677228348686885501689655071745393817660190684
#%1164333541494692873676613597281444907280130855950
#%1334563013500754844151730810259755192160769503828
#%326680035934979994271802941192088813006094268994

#*The changes of platelet-derived growth factor-BB (PDGF-BB) in T2DM and its clinical significance for early diagnosis of diabetic nephropathy
#@Qiu-yue Wang,Qing-hua Guan,Fen-qin Chen
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index183524598389578768155321925119148038942402073184
#%1296698298400821008871017447198407581461787323716

#*Two-year results from a community-wide diabetes prevention intervention in a high risk indigenous community: The Ngati and Healthy project
#@J. Coppell,C. Tipene-Leach,L.R. Pahau,M. Williams,Sally Abel,Mark Iles,Harr Hindmarsh,I. Mann
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index986884453036757167757820463484846179850423136476
#%410461435904805580979497922458378530292878706418
#%192656187719348078911838862482417258485619675070
#%835391273568440819560824800480094275202321390664
#%789198489702586542926219084517612861962341004780
#%644872020111085547136069046582977243286906554485

#*The comparison of coronary angiographic profiles between diabetic and nondiabetic patients with coronary artery disease in a Chinese population
#@Ming-Hui Gui,Guang-Yi Qin,Guang Ning,Jie Hong,Xiao-Ying Li,An-Kang L,Wei-Feng Shen,Xin Gao
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index14717095636064412031900107429676594727429409796
#%89607145737205926900846310799035237293024730833
#%1232341410820764690229250185761787610625975594556
#%13759033241666076097581118090078456245337319251
#%1206839247013392477022353702824214199738538360945
#%1261191789066023357921687579878166272670512134780
#%1366233597070576623095934578849630686441200804332
#%476922557345332511550268461794216049075654388592
#%460594606812758299438775441160380286022936988705

#*Long-term improvements in insulin prescribing habits and glycaemic control in medical inpatients associated with the introduction of a standardized educational approach
#@Javier Ena,Rosa Casa,Teresa Lozano,Angela Leach,Toms Algado,Jos Navarro-Diaz
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index36010017001163079183835626693178677964080781674

#*Association study of 11-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in urban Japanese cohort
#@Yoshihiro Miyamoto,Hiroko Morisaki,Itaru Yamanaka,Yoshihiro Kokubo,Hiroaki Masuzaki,Akira Okayama,Hitonobu Tomoike,Kazuwa Nakao,Tomonori Okamura,Yasunao Yoshimasa,Takayuki Morisaki
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index589557828949910195648883073128369997893000406665
#%845758794842092994548585283910388983602030144926

#*Prospective assessment of continuous subcutaneous insulin infusion therapy in young children with type 1 diabetes
#@Mariola Minkina-Pedras,Przemyslawa Jarosz-Chobot,Joanna Polanska,Aleksandra Kalina,Adrian Marcinkowski,Ewa Malecka-Tendera
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index732313392150813061283405634641510407648758703555
#%1102613156242196161325740344827366488758088645827
#%951315813343190912827847859690774939603198546824
#%133795322647927502563049840929115152622733212295
#%487116035727043577492224145212814314064112769366

#*Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes
#@Yoshimasa Aso,Kenji Hara,Noriyuki Ozeki,Chikako Yatsuka,Tomoki Nakano,Sachiko Matsumoto,Mariko Suetsugu,Takafumi Nakamachi,Kohzo Takebayashi,Kohsuke Haruki,Toshihiko Inukai
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index366350730073123205918015139058121676101218742303
#%1162046703957847572843451792892755136499630628698

#*Is heat shock protein 60 associated with type 2 diabetes mellitus?
#@T. Imatoh,T. Sugie,M. Miyazaki,S. Tanihara,M. Baba,Y. Momose,Y. Uryu,H. Une
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index751167175286776428384891579458379179300132124566
#%1365614532601307704000998525773480883976473766109

#*NGSP and IFCC-derived NGSP HbA1c can be used interchangeably
#@K. Paisooksantivatana,A. Kongsomgan,K. Khupulsup
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index360890164555930565521287807563236848230001988079

#*Insulin pump therapy for type 1 diabetes treatment in a girl with Down's syndrome
#@E. Scaramuzza,Elisa Giani,Sara Riboni,Daniele Spiri,Alessandra Palma,Chiara Mameli,Vincenzo Zuccotti
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1293863929998234020847336176020989921877096602767

#*Implementing evidence based guidelines: Unlocking the secrets
#@Ruth Colagiuri
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index404529724983639238911749069562874707916191707100

#*Similar energy expenditure from resistance training at moderate and vigorous intensity in subjects with type 2 diabetes
#@Silvano Zanuso,Stefano Balducci,Jimenez Gutierrez,Marco Bergamin,Giuseppe Pugliese
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1034313765249715824227762327633409535770720232420

#*The relationship between generic and diabetes specific psychological factors and glycaemic control in adults with type 1 diabetes
#@C. Shaban,J.A. Fosbury,D.A. Cavan,D. Kerr,T.C. Skinner
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index926351979549266993758699690743879513597191780307
#%994275654840152262746276706875740482290798046148

#*Subcutaneous antihistamine injection is effective to control a local allergic reaction to human insulin
#@Sumihisa Imakado,Kazutoshi Hamada,Yoshihito Atsumi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1102056491624403030456462087688521071972621797665

#*Cardiorespiratory fitness and mortality in diabetic men with and without cardiovascular disease
#@Paul McAuley,Jonathan Myers,Brian Emerson,B. Oliveira,L. Blue,Jesse Pittsley,F. Froelicher
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index47867562954934418037526085294123882467270356487
#%564202107756324781375156314527007183180465810957
#%38634432618372884027988462239595763662143939176
#%762556026316590143553756268033501689051517993397

#*Lifestyle intervention reversed cognitive function in aged people with diabetes mellitus: Two-year follow up
#@Naomune Yamamoto,Gaku Yamanaka,Emiko Takasugi,Motonao Ishikawa,Takashi Yamanaka,Shougo Murakami,Toshiaki Hanafusa,Kozo Matsubayashi,Kuniaki Otsuka
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index514280553015636585046473981504539742833298128082
#%5148757091253187396657894467064054031854689856
#%971326225937465815235963534345054295515315023499

#*Associations of the CTLA-4 polymorphisms with type 1 diabetes in a Chilean population: Case-parent design
#@Brbara Angel,Ivn Balic,Luis Santos,Ethel Codner,Elena Carrasco,Francisco Prez-Bravo
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index894654806678612842203784066029377492989489669214
#%1118872595472427439885506667641743293065880519752
#%1055045771665328848139591748025323635186364344445

#*Ultrasonographic and thermographic screening for latent inflammation in diabetic foot callus
#@Kaoru Nishide,Takashi Nagase,Miho Oba,Makoto Oe,Yumiko Ohashi,Shinji Iizaka,Gojiro Nakagami,Takashi Kadowaki,Hiromi Sanada
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index423194601011875210930454186686007643693130711147
#%40199012582545677217074253559403120327742456468
#%776598155457561088843594246922368762290844976030

#*Lower frequency of the 5/5 homozygous CNDP1 genotype in South Asian Surinamese
#@A.L. Mooyaart,I.G.M. Valkengoed,Chandie Shaw,V. Peters,H.J. Baelde,T.J. Rabelink,J.A. Bruijn,K. Stronks,E. Heer
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1203026105547516416369565586088225230793241431814
#%521134760425127984824147414081020738348826825464
#%151684090061087666939096756938414999462521524690
#%593434828126547928381138612313966481621626729870
#%1053661166641701240762685397945858700242429660868

#*Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes
#@M.M. Ooi,W.K. Ng,C. Chan,F. Watts
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index749274722873172587759203095168687598774603930805
#%384291787838003246290925549834198884986827864046
#%1125090483701768695088434263475911921836184542546

#*Effects and clinical potential of very-low-calorie diets (VLCDs) in type 2 diabetes
#@Scott Baker,George Jerums,Joseph Proietto
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index119709465707862974037812722694479988146448270801
#%387214988192954058198705784009966453553186294415
#%74980068780726981378082091163570902265498282870
#%438228533015025679340320838141387263066534847002
#%1432617308402650955075663602340750117958469627900
#%1276167838821349937052906713907484655642484722047
#%677223948610281804968718610030521296171942108260
#%642123718911654533837580083492293604217175075852
#%316561068661832290389942316179543476051694169630
#%1300310178951758021039991694791382866835011366686
#%706855010935071232819660228752810465693575190476
#%308240083467275663649746352898269694595774950255
#%58090856361372031100198307804471984303059818135
#%1067344023869153904369771504658573822637530495299

#*Abnormal cold perception in the lower limbs: A sensitive indicator for detection of polyneuropathy in patients with type 1 diabetes mellitus
#@L. Hyllienmark,B. Jonsson,K. Ekberg,P. Lindstrm
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index39426985155380280320450077587152618116160610267
#%984207562112472268879869451741948651422407970166

#*The human leukocyte antigen class II gene has different contributions to autoimmune Type 1 diabetes with or without autoimmune thyroid disease in the Japanese population
#@Masahito Katahira,Harumi Maeda,Takahiro Tosaki,Satoko Segawa
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index568598748909978963122418338539748210189361901698
#%373662567380168520814397762871391166659185021390
#%904504503445604818640452692684476607154476537884
#%904504503445604818640452692684476607154476537884
#%904504503445604818640452692684476607154476537884
#%904504503445604818640452692684476607154476537884

#*A single nucleotide polymorphism (SNP) rs2072907 in the adiponutrin gene (ADPN) was not associated with obesity and type 2 diabetes in Chinese Population
#@Hua Liang,Mengyin Cai,Yan Bi,Yanhua Zhu,Jinhua Yan,Jianping Weng
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index885267776857998533782339758866676666215169619095

#*Erratum to Comparison of continual insulin or secretagogue treatment in type 2 diabetic patients with alternate insulinsecretagogue administration [Diabetes Res. Clin. Pract. 84 (2) (2009) 158162]
#@Hong Li,Wenjun Li,Yao Gu,Yuqi Han,Jiying Wang,Bei Xu,Fang Li,Yongchun Yu,Guoting Wu
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index425927932835708441239464226145658497561572493251

#*Metabolic syndrome defined by IDF and AHA/NHLBI correlates better to carotid intima-media thickness than that defined by NCEP ATP III and WHO
#@Wen-Ya Ma,Hung-Yuan Li,Sheng Hung,Mao-Shin Lin,Fu-Chun Chiu,Cheng-Hsin Lin,Shyang-Rong Shih,Lee-Ming Chuang,Jung-Nan Wei
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index295371147155979305084461595967901067401153995234
#%370559684785608661927662053096816486122320100653
#%1378232309151013105142487145858927163597592381276
#%238284364047277051048806493904008598891939491270
#%1143247054964945273405816221419647363121423316843
#%1143083828822900739253154137875068756671307541955
#%1087590640195649014213209567220552157576623161488
#%1381073059794766404269586648905202726599740137174

#*Evidence that even normal albuminuria may denote incipient GFR reduction in patients with type 2 diabetes mellitus
#@M. Kravaritou,A. Thanopoulou,B. Karamanos,A. Kofinis,M. Noutsou,E. Spanou,A. Varsou,A. Archimandritis
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1094718499182964427631254026742146435838791733513
#%266392361051386075876210298131949848099456522365

#*Transcription factor AP-2 inhibits glucose-induced insulin secretion in cultured insulin-secreting cell-line
#@Shuichi Tsukada,Masa-aki Kobayashi,Shintaro Omori,Hiroyuki Unoki,Shiro Maeda
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index241032152073772635004834537576675539989873471556
#%946509395359488207765361765196906783126650635943
#%671620389906514876132691917669897139606919030512

#*Distribution of immunochemically defined apoB-containing lipoprotein subclasses in T1D
#@John Bagdade,Carolyn Knight-Gibson,Carmen Quiroga,Maryjean Jacobson,Diana Lee
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1192547397656513548737538663689739614981284692106

#*The relation between moderate alcohol consumption and cognitive function in older women with type 2 diabetes
#@K. Townsend,Elizabeth Devore,Hee Kang,Francine Grodstein
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index541126995523126343323932545811225634139624917007
#%1391678818424462780198257900960799566460938816007
#%976059503486328788881888865005310872007959424317

#*Are low erythropoietin and 1,25-dihydroxyvitamin D levels indicative of tubulo-interstitial dysfunction in diabetes without persistent microalbuminuria?
#@K. Singh,Peter Winocour,Bev Summerhayes,Adie Viljoen,G. Sivakumar,Ken Farrington
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index498301868659585148731990969745320537090718402657

#*No mantle formation in rodent isletsThe prototype of islet revisited
#@Michael Kharouta,Kevin Miller,Abraham Kim,Pawel Wojcik,German Kilimnik,Arunangsu Dey,F. Steiner,Manami Hara
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index830062405498282185559454015810479109425141785464
#%1058101272584898786061574529877309118808110635263
#%114000571569285678134943062901379154947569425224

#*Insulin and non-insulin mediated vasodilation and glucose uptake in patients with type 2 diabetes
#@Celena Scheede-Bergdahl,Benee Olsen,Danny Reving,Robert Boushel,Flemming Dela
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1217287398565606912433963220088422427433559358038
#%689752975683639093443665056649756909636282756786

#*Prevalence of use and potential impact of increased use of primary care interventions to prevent cardiovascular hospitalizations in patients with diabetes
#@Cristine Luft,Camila Giugliani,Erno Harzheim,Ins Schmidt,Bartholow Duncan
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index631360550685107660138115993537664220072516628155
#%25164712369030488085139501256946558543375611597
#%1336490785485731934449097218187247661551271280654
#%237173328385186147509369945375297544693447758836

#*Correlations of sleep disturbance with the immune system in type 2 diabetes mellitus
#@Takahiro Tsujimura,Yoshinobu Matsuo,Takahiro Keyaki,Kumi Sakurada,Jiro Imanishi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index64529854443549766757802638164669969513714798505
#%197545535178220945045003258874273530948012534491
#%713540244543656635640617293931540976177290391992
#%538814751141590855653318411230329109572796900433
#%205678239479492614150255103606896922520365047286

#*The impact of family history of type 2 diabetes on pancreatic -cell function
#@Zhi-hong Wang,Su-Hua Zhang,Li-lin Gong,Wei Ren,Rong Li,Rui-zhi Zheng,Yu-feng Zhang,Mao-rong Wang,Qi-fu Li
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index240240451051045979084344016927729041663260596763
#%837462764070176344807057544144738417300224102511

#*Serum lipid and hsCRP levels in prediabetes  impaired fasting glucose (IFG) and impaired glucose tolerance (IGT)
#@Nevena Chakarova,Tsvetalina Tankova,Iliana Atanassova,Lilia Dakovska
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index376912127992832704594832733256845525847283471962
#%1092188121641455288891147688004469839427158894354
#%1092188121641455288891147688004469839427158894354
#%1321753673430474893306416348909014044013283173558
#%950935218462113895987553557600568515851854455100
#%690655494515084844752324213609763188112030774105
#%555659603761440447727764408500835060224308077506

#*Evidence-based insulin treatment in type 1 diabetes mellitus
#@Brock Jacobsen,J.E. Henriksen,O. Hother-Nielsen,W. Vach,H. Beck-Nielsen
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index681577334275131587614876315794935837921032938484
#%429802228692657563062243939154007495156216515620
#%255859210788461392511074623050357811231233841329
#%554804773359388555302608214374911474651578426092
#%554804773359388555302608214374911474651578426092
#%129205168417511811865194020792353620981205308325

#*Abnormal retinal autoregulation is detected by provoked stimulation with flicker light in well-controlled patients with type 1 diabetes without retinopathy
#@Aleksandra Mandecka,Jens Dawczynski,Walthard Vilser,Marcus Blum,Nicolle Mller,Christoph Kloos,Gunter Wolf,Alfons Mller
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index583406649814509676335152817607522809599233492760
#%757976559481852636054997764918168333712077021450
#%142009074030893854119214483261906753828406745625
#%176754665503464054777757230849577802367625225860

#*Anthropometric characteristics and type 2 diabetes in extremely obese Caucasian subjects: A cross-sectional study
#@Dag Hofs,Trond Jenssen,Jens Bollerslev,Jo Rislien,Helle Hager,Jran Hjelmesth
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1125719359477626583380699038642922149901707502787

#*Epidemiology of diabetes-related lower extremity amputations in Gran Canaria, Canary Islands (Spain)
#@Javier Aragn-Snchez,Amos Garca-Rojas,L. Lzaro-Martnez,Yurena Quintana-Marrero,Manuel Maynar-Moliner,Martn Rabellino,J. Hernndez-Herrero,J. Cabrera-Galvn
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index203187226092507032567311562817366714752189217065
#%593042637009300427299012652370141156292339790676
#%3108656602076373545538449944691169993743005609

#*Educational attainment and effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study
#@Katja Wikstrm,Markku Peltonen,G. Eriksson,Sirkka Aunola,Pirjo Ilanne-Parikka,Sirkka Keinnen-Kiukaanniemi,Matti Uusitupa,Jaakko Tuomilehto,Jaana Lindstrm
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1058164070216229568153441192379174058977529574218
#%772229459951514808976742079908121321047764310661
#%1020337846164904596135434715968030619151101492269
#%739248415651815902208962014073594155192825390738

#*Effects of bed-time insulin versus pioglitazone on abdominal fat accumulation, inflammation and gene expression in adipose tissue in patients with type 2 diabetes
#@Agns Hartemann-Heurtier,Marine Halbron,Jean-Louis Golmard,Sophie Jacqueminet,Jean-Philippe Bastard,Christine Rouault,Amine Ayed,Laurence Pieroni,Karine Clment,Andr Grimaldi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1162998403521883370269832441808232737741754849630
#%454244263268406964002465495630993847769567140794
#%1025870141257555363808391139833580926659252139891
#%272069843343924852280336555114090856988080877074
#%1414548789419485913486382715084414933958144171684

#*Effect of tight control of HbA1c and blood pressure on cardiovascular diseases in type 2 diabetes: An observational study from the Swedish National Diabetes Register (NDR)
#@Jan Cederholm,Bjrn Zethelius,M. Nilsson,Katarina Eeg-Olofsson,Bjrn Eliasson,Soffia Gudbjrnsdottir
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index849163727599319370204358451223903129784490276450
#%583136685607995677126304053148153695861661274149
#%81213820779628439997771728246816137838544651559
#%1052160633850366833305612854563651679101328092405
#%784142748632893177986606977259374919644987189014
#%741472667357967036521698557437635045148869117616
#%923754250541714216825809487847382885849683362305

#*Effect of rosiglitazone, metformin and medical nutrition treatment on arterial stiffness, serum MMP-9 and MCP-1 levels in drug naive type 2 diabetic patients
#@Sinem Kiyici,Canan Ersoy,Aysel Kaderli,Murat Fazlioglu,Ferah Budak,Cevdet Duran,Ozen Gul,Deniz Sigirli,Ibrahim Baran,Ercan Tuncel,Erdinc Erturk,Sazi Imamoglu
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index689973885723418867072555855607761517266996457017
#%680420105362507649896918488504812717974695355412
#%1412258303323388980238587028100117366555327319662
#%167500923633421713008809947050668782828011048328
#%1221625382447418887602658377813649635920456260181
#%1122327536781213650523100622806783251290637158361
#%1035356258410711644943874950706346811686582352933
#%1279871689382672313749855925500972798164053196964
#%610161966243308704640357965268798047328147007321
#%226031019630481747458327496527114344770585642650
#%1249071965007801939408564157994072874392119576749
#%1249071965007801939408564157994072874392119576749

#*Effect of sulfonylureas on switching to insulin therapy (twice-daily biphasic insulin aspart 30): Comparison of twice-daily biphasic insulin aspart 30 with or without glimepiride in type 2 diabetic patients poorly controlled with sub-maximal glimepiride
#@C. Ebato,T. Shimizu,M. Arakawa,T. Mita,Y. Fujitani,H. Watada,R. Kawamori,T. Hirose
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index724028279761409855789126188076078554447075906494
#%481570781244869144784002259840012820397148090045
#%956803042954471985366406152496359639505557671256

#*Development and validation of the Diabetes Management Orientation Scale (DMOS): Assessing culturally related approaches to diabetes self-management
#@K.Y. Wong,G.O. Stewart,S. Furler
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1448329055939320150124093692274353112977044629933
#%1053048091653539321186544287535027209351658141720

#*Association of glucose measures with total and coronary heart disease mortality: Does the effect change with time?
#@E. Cohen,Elizabeth Barrett-Connor,L. Wassel,M. Kanaya
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1284570462321007624583884025678764834921351525375
#%903579429826555522233662958138394485469277927507
#%1125212071862974339577295732754963990239899024482

#*Aldose reductase inhibitor counteracts the attenuated adhesion of human corneal epithelial cells induced by high glucose through modulation of MMP-10 expression
#@Takeshi Tomomatsu,Yoshihiro Takamura,Eri Kubo,Yoshio Akagi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index8030575255016937438850593822340764606965227102
#%601199860614882745041935596646364824427579314940
#%711068171533642187094917061737569470764915361633
#%806116008056188607604528652296111323998681746659
#%569379068456451807594775068729376536707979851258
#%63508773805864487860328827028108081669953266790
#%986328781052047736434487206710957591786778893233
#%353497817937336743688915675067013356658156825974
#%1266923444988952029130816616127789487715124576922

#*Excellent effect of three-dimensional culture condition on pancreatic islets
#@Yan Hou,Chun Song,Jun Xie,Zheng Wei,Ping Huang,Wei Liu,Ling Zhang,Bo Shi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index620661553456224179546865562000355974104989333228
#%1362193470628348583650253799206166881794014092452
#%1153385810140133046004971947330151162664940731042
#%1037900591002843205423220302204789603256657798558
#%238289082601676193167052494085685457179033952261
#%114623604642592360520645396843563797286763563161
#%1416230672087798575887461030626096060971483851045
#%782218586917349622603978169975154567959916108535
#%891965542315197768413975072934599898686667416869
#%890703802358593549074354516512562523521761939337

#*Application of fibrocytes in the treatment of diabetic foot: As a potential new therapeutic approach
#@Mohaddeseh Behjati,Mohammad Hashemi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1230134085512531879027446928461425359676527074855

#*Depression, depression treatment, and insulin sensitivity in adults at risk for type 2 diabetes
#@Julie Wagner,A. Allen,M. Swalley,D. Melkus,Robin Whittemore
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index480944814383538371012486309492603950565739588444
#%433513365266439636606227846414073596900410825731
#%1036626546844811950838465261819930322945756303597
#%1424422875653434294326574272704610570538816415040
#%78100085394508159455389973239002618446325025397
#%266369890967143799715843488704557677930048275922

#*The association of sleep duration and type 2 diabetes in Korean male adults with abdominal obesity: The Korean National Health and Nutrition Examination Survey 2005
#@Jongoh Kim,Man Kim,Min Kim,Jung Kim
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index564161175934491840629004626614555580262578840273
#%238833678911521896659698772768141671766599116145
#%238833678911521896659698772768141671766599116145
#%600729171836014079433319300461533078223380139900
#%1044773268853326443318063325647909917448559906155

#*Effect of delay on measurement of blood glucose levels in young subjects with type 1 diabetes
#@Daniela Elleri,L. Acerini,M. Allen,F. Larsen,E. Wilinska,B. Dunger,Roman Hovorka
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1307303531861753019636218383638749743006151390174
#%692911156690876115710174615964906968131826649860
#%1106680439985001364897502459357277321483492375705

#*Increased peripheral blood mitochondrial DNA in type 2 diabetic patients with nephropathy
#@N. Malik,Rojeen Shahni,M. Iqbal
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1153495477414404235342461163643147876497201015808
#%271823286840743651112033455714390003252086554522
#%1415153073861260342688797532374460909146710851989
#%1415153073861260342688797532374460909146710851989
#%341899485091760722702282247853127461730088886269

#*CDK4 IVS4-nt40G  A SNP and type 2 diabetes in Italians
#@Ramachandran Meenakshisundaram,Nunzia Piumelli,Laura Pierpaoli,Claudia Gragnoli
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index371296001441267307586476323897706892685398707598

#*Neonatal diabetes in a child positive for islet cell antibodies at onset and Kir6.2 activating mutation
#@Agnieszka Gach,Krystyna Wyka,Iwona Pietrzak,Olga Wegner,T. Malecki,Wojciech Mlynarski
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index819334986873555433055824243841829546472146846553

#*Diabetes and impaired fasting glucose in Mongolian population, Inner Mongolia, China
#@Shaoyan Zhang,Weijun Tong,Tan Xu,Burenbatu Wu,Yonghong Zhang
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index412614554432816579517333446969388015298201411113
#%792755149168693384455440658528468452189336763063
#%83601227522677886787379561658857657895968763595
#%83601227522677886787379561658857657895968763595
#%83601227522677886787379561658857657895968763595

#*The incidence of type 2 diabetes mellitus in the Philippines: A 9-year cohort study
#@B. Soria,G. Sy,S. Vega,Tommy Ty-Willing,Angela Abenir-Gallardo,Felicidad Velandria,Eduardo Punzalan
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1032061955309205124446370754133427106388848293021

#*Ethnicity, race, and clinically significant macular edema in the Veterans Affairs Diabetes Trial (VADT)
#@Nicholas Emanuele,Thomas Moritz,Ronald Klein,D. Davis,Kathleen Glander,Anuradha Khanna,Lizy Thottapurathu,Gideon Bahn,William Duckworth,Carlos Abraira
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index543449223407830342971728200124083261447754509160
#%1108285737248830368953346724399581105940096847396
#%242387973876321027482189695875948345387883685715
#%242387973876321027482189695875948345387883685715
#%198114669730316651982253571068540567423634541491
#%438053358132907791443048049181500638981777655316
#%399127220577660716701086921159612147398073658523
#%399127220577660716701086921159612147398073658523
#%870651381524712065084403491855958404044803635696

#*Insulin increases shedding of syndecan-1 in the serum of patients with type 2 diabetes mellitus
#@Jing-bo Wang,Juan Guan,Jing Shen,Li Zhou,Yan-jun Zhang,Yan-fang Si,Li Yang,Xiao-hong Jian,Yu Sheng
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index365559340081283110272428431577845011648541663986
#%1449806983458609219033539194585172872019509065684
#%756116858949913941145674086739005445396079697887
#%1019351636864092678827209416411711084717670813789
#%4749031579667446007024172589870048697964917613

#*Gender differences in the socioeconomic gradient in self-reported diabetes: Does health service access play a role?
#@M. Coeli,Eduardo Faerstein,Dra Chor,S. Lopes,L. Werneck
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1054154529764121297185792603738755596392386662344
#%1388199999888270658206031281977117061372576944264
#%78745451561530005132634802117761030988725077129
#%410295528475287455646610323507512726437266598576
#%1207898139698808940477135011016059419988736973519
#%663764450113577148646164104108111896643538953379
#%1238435011337295120414153707000317376459254379936

#*Racial differences in the discussion and treatment of depressive symptoms accompanying type 2 diabetes
#@A. Wagner,White Perkins,D. Piette,Bonnie Lipton,E. Aikens
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1334047132283627674834800227323405695440509025222
#%1073224360492482040788895289019629746736349906171
#%1178623934141896066702944384512505479841858157535

#*Fasting plasma glucose variability as a marker of nocturnal hypoglycemia in diabetes: Evidence from the PREDICTIVE study
#@Leo Niskanen,Antti Virkamki,B. Hansen,Tero Saukkonen
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1372208812701908090016492158120861378181356435284
#%1213970065150152242748918451103807760520145980868
#%153135027083811675275957213033104258400825579815

#*The relation of ADMA and apelin to endothelial dysfunction and angiogenesis in patients with type 2 diabetes mellitus
#@Ilker Tasci
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1143727327766777672774080670171115508286686901678
#%646867246956379072032394744760390614784467054291
#%430164031725457906829385292468055024134548036481
#%1388533968998212775614776761855444333761798334009
#%983966075089609554825712644879929034399397607526
#%136506090619909885398516246698690418624049167096

#*Waist circumference and impaired fasting glucose screening in a Mediterranean population
#@M. Baena-Dez,Roberto Elosua,F. Cano,Rafael Masi,Joan Sala,Jaume Marrugat,Helmut Schrder
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1122115937341155095717534568475483071194394313797

#*Microvascular diabetic complications are more prevalent in India compared to Mauritius and the UK due to poorer diabetic control
#@Rahul Potluri,Yanish Purmah,Mohammad Dowlut,Nilesh Sewpaul,Deepthi Lavu
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index246296821952790810520145390210687821347569564827

#*Dual onset of type 1 diabetes mellitus and Graves disease during treatment with pegylated interferon -2b and ribavirin for chronic hepatitis C
#@Masayuki Hayashi,Yuko Kataoka,Kazushige Tachikawa,Hiroki Koguchi,Hiroshi Tanaka
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index390247356987410324111803495819327873359955142623
#%376950518870617647835102342499665833567263402320
#%1309706384428672828725766546138402389802717029932
#%374909652120687702087454876807810700771683748530
#%1015880785328396225166527106142160750359964839496

#*Low plasma adiponectin level, white blood cell count and Helicobacter pylori titre independently predict abnormal pancreatic -cell function
#@Wing-Yee So,C. Tong,T. Ko,C. Ma,Risa Ozaki,P. Kong,Xilin Yang,Chung-Shun Ho,C. Lam,C. Chan
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index709109356418905642957929358214850888943787280519
#%943655438309010186556804025958717664014042861668
#%1410595711738053815857172636130944365581322905165
#%1410595711738053815857172636130944365581322905165
#%554399751864330034094849138796434760568429641671
#%814215237365334170656929726039434047999828097786

#*Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A 2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus
#@Kazuo Sonoki,Masanori Iwase,Nobuhiro Sasaki,Shigehiro Ohdo,Shun Higuchi,Naoto Matsuyama,Mitsuo Iida
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1437916316005947854607256684449709985930618963754
#%209071750560692789606308679920650330648349297946
#%209071750560692789606308679920650330648349297946
#%493392568596632008099581187302231805706904564520
#%393148510758597415570167079898924985970580662533
#%388411983158519110180124821448248385792989089489
#%153649755782507054781317362797388531807201761062
#%691435919700649000316917222904343249600024035731
#%214985680708368922746935302199144340928260015493
#%1261793862877367221025460825487096775151502856035

#*Aortic distensibility indices and coronary flow velocity reserve in patients with different kinds of single-vessel coronary artery disease with versus without diabetes mellitus
#@Attila Nemes,Mikls Csandy,Tams Forster
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index760533383862792852342030590288078002928447988484
#%601701254539151027394794842575003745696572220511

#*Improvements in life expectancy in type 1 diabetes patients in the last six decades
#@Sorin Ioacara,Radu Lichiardopol,Constantin Ionescu-Tirgoviste,Dan Cheta,Sorin Sabau,Cristian Guja,Eugenia Farcasiu,Cristina Tiu
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1432657249571172963421191401436317433353805726289

#*CCR532 genotype is associated with outcome in type 2 diabetes mellitus
#@L.H. Muntinghe,Sascha Gross,J.L. Bakker,W.D. Landman,Pim Harst,J.G. Bilo,Gerjan Navis,W. Zuurman
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index662919650078491507160600101868036914005279340911
#%752630803662875387127499415745768486798721217957
#%950346808113313538746489663499927115215462530179
#%1451012410253159393484242846846781720911658212823
#%670694010902075461683331905187059178162932226017

#*Swinnen and DeVries: Higher dose requirements with insulin detemir in type 2 diabetesthree cases and a review of the literature [Diab. Res. Clin. Pract. 84 (May (2)) (2009) e246 (Epub 2009 February 28)]
#@Jaime Davidson
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1238272341001778361302942150181398967343297995598

#*MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes
#@Sachiko Yuasa,Taro Maruyama,Yukihiro Yamamoto,Hiroshi Hirose,Toshihide Kawai,Seiko Matsunaga-Irie,Hiroshi Itoh
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index773383943446120937291082089914911743096865311706
#%1033943310004783297689716529555224391960539188187
#%211805592386661045191048515198371121409325291338
#%925100884752801486763812979182963063166506314822
#%925100884752801486763812979182963063166506314822
#%1276550359790204287410732413591590335533584588117

#*Variation in the perilipin gene ( PLIN) affects glucose and lipid metabolism in non-Hispanic white women with and without polycystic ovary syndrome
#@Toshihide Kawai,C.Y. Ng,Geoffrey Hayes,Issei Yoshiuchi,Takafumi Tsuchiya,Heather Robertson,J. Cox,S. Polonsky,I. Bell,A. Ehrmann
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index559564802144110409259224365314819742756296106484
#%1145764240608947092912941121044405389148298181265
#%855066336801553355069209241558867902162902335453

#*A pooled analysis of 29 patients with fulminant type 1 diabetes in Korea: A comparison with a nationwide survey in Japan
#@Hoon Kim,Young Kim,A Seo,Hee Kim,Mook Choi,Hyun Baik,Seop Choi,Gon Kim
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index837430307039090537953902302398765385574777450863
#%1177355478184434474529943742973299052156032996335

#*Utilization of Frontal Assessment Battery and Executive Interview 25 in assessing for dysexecutive syndrome and its association with diabetes self-care in elderly patients with type 2 diabetes mellitus
#@H. Thabit,S.M. Kennelly,A. Bhagarva,M. Ogunlewe,P.M.E. McCormack,J.H. McDermott,S. Sreenan
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1195993919730066610114789670534060889545685617576
#%30348166031858510394566137609083967813302374572

#*Innovative research for equitable diabetes care in India
#@K. Ali,Venkat Narayan,Viswanathan Mohan
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index721703952623690132221286120578949436782999063970
#%110181866365850053806320983122366293269718458036
#%416001486061048901239068946043907310924438335761
#%711599000368263004138323260382993387525511138418
#%363460850577070758160937417038947073231081967820
#%1273623560916037726226969149838290227108971747633
#%715783349862343521591858137044073981054526705544

#*Effect of treatment with losartan on salt sensitivity and SGLT2 expression in hypertensive diabetic rats
#@Horacio Osorio,Roco Bautista,Amelia Rios,Martha Franco,Jos Santamara,Bruno Escalante
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index297927874673944746927279068474789531489558398132
#%1086799415193514527949521471831755340522573107742

#*Serum superoxide dismutase activity correlates with the components of metabolic syndrome or carotid artery intima-media thickness
#@Akihiro Isogawa,Minoru Yamakado,Masao Yano,Teruo Shiba
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1369083724338893322484430770480650698996346999124
#%752554249607722146835878072235257283439264626733
#%1276184297400336257751032277077807109148404577424
#%1340779203365089972038082159900135413990217134126
#%245621254183390385748799185871928256132577691809

#*Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study
#@Mykola Khalangot,Mykola Tronko,Victor Kravchenko,Vladimir Kovtun
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index757493236399189478582594113877518691288913883452
#%630227562341490064079882525596520130850886976902
#%170989270154568200679810849881246319663239996818
#%1337619430985460415890491626993979901083737755048
#%489548489683606982560072023675414104656916946972
#%1068827015025077371091713296021472427550088881725

#*Ultrastructural changes in the glomerular filtration barrier and occurrence of proteinuria in Chinese patients with type 2 diabetic nephropathy
#@Wei-wei Zhu,Hui-ping Chen,Yong-chun Ge,Hong-lang Xie,Cai-hong Zeng,Lei-shi Li,Zhi-hong Liu
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index309598060578335355264734285695889042304345350874
#%1117551899645058245949631394855548988594791610864

#*Oral health knowledge and behavior among adults with diabetes
#@K. Yuen,J. Wolf,Dipankar Bandyopadhyay,M. Magruder,F. Salinas,D. London
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index514229432933197792529552657221143054379535376280
#%1450276914326282063486055997524052111660675717402
#%286946412576851770450248612069721982591484869739
#%1311203522515857931699627272857432654934828756065
#%1127606418944726163441687181544380694207525777034

#*Synergistic effects of ACE (I/D) and ApoE (HhaI) gene polymorphisms among the adult Asian Indians with and without metabolic syndrome
#@Mithun Das,Susil Pal,Arnab Ghosh
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index448946285752911980379595282163331954802862777460

#*Association of PTPN22 C1858T and CTLA-4 A49G polymorphisms with type 1 diabetes in Croatians
#@Marina Korolija,Pavli Renar,Mirko Hadija,Pape Medvidovi,Pajica Pavkovi,Mladen Joki,Popovi Hadija
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index559388763996408661401680270120462074403416047760

#*Impact of metabolic syndrome on the progression of intima-media thickening in JapaneseA follow-up study
#@Yuka Matoba,Toyoshi Inoguchi,Shizu Suzuki,Shigeru Nasu,Toshihiko Hashimoto,Toshihiko Yanase,Hajime Nawata,Ryoichi Takayanagi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1376718284035893988864589083491012555696376010510
#%111680806655278770860975650839310206983344838409

#*Risk factors associated with the presence of diabetes in Chinese communities in Beijing
#@Xianghai Zhou,Linong Ji,Yingying Luo,Xueyao Han,Xiuying Zhang,Xiuqin Sun,Qian Ren,Qing Qiao
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1155644342030521059159449115367862187280029461286

#*Intra-renal hemodynamics and carotid intima-media thickness in the metabolic syndrome
#@Silvio Buscemi,Salvatore Verga,A. Batsis,Santina Cottone,Alessandro Mattina,Andrea Re,Mariangela Arnone,Salvatore Citarda,Giovanni Cerasola
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index75545909114180205745424132777892619989434053595
#%1068680687666141179053396836482393400659273976711
#%1097511114712592551010228617179539992866166141467
#%701277481743767620152808949449902636655353666511
#%944940952388715148989370803828489774517505362952

#*Early insulin response and insulin sensitivity are equally important as predictors of glucose tolerance after correction for measurement errors
#@Lars Berglund,Christian Berne,Kurt Svrdsudd,Hans Garmo,Bjrn Zethelius
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index164368917757661442664484856165079656956348116655
#%901036165709901673305139135603446839180324020907

#*Improvements in risk factor control among persons with diabetes in the United States: Evidence and implications for remaining life expectancy
#@J. Hoerger,Ping Zhang,E. Segel,W. Gregg,Venkat Narayan,A. Hicks
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index761405825326761754173047309036322156713673356710
#%11925687116899364979995827655327918288352939177
#%741472667357967036521698557437635045148869117616

#*Role of asymmetric-dimethyl- l-arginine (ADMA) and nitrite/nitrate (NOx) in the pathogenesis of oxidative stress in female subjects with uncomplicated type 1 diabetes mellitus
#@Dario Pitocco,Francesco Zaccardi,Enrico Stasio,Federica Romitelli,Francesca Martini,Luca Scaglione,Dorina Speranza,Stefano Santini,Cecilia Zuppi,Giovanni Ghirlanda
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index923200733348639903466746211550299417321272791545
#%738698571953620059449250283900447806385856514937
#%674636989371401862456384648453813794516100156517
#%1097988215949627414314693405303301509799833917932
#%787878674572470336199799298584029860276983090665

#*Evaluation of the association between the PPARGC1A genetic polymorphisms and type 2 diabetes in Han Chinese population
#@Shuying Zhu,Yang Liu,Xin Wang,Xiaopan Wu,Xilin Zhu,Jingyun Li,Juan Ma,F. Gu,Ying Liu
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index399808255057084700711057851107048943576473534565
#%304672958441690931311961146010320083677206562087
#%963349673350857295936332881255038928716882387056

#*Relationship between albuminuria and hemoglobin level
#@Giuseppe Lippi,Cesare Guidi
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1072468504693535403306816593063528659654185970102
#%500408092940385969174880321278299952761505213087

#*Hypothesis: the metabolic memory, the new challenge of diabetes
#@Antonio Ceriello
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index340251326195541094179300864518711335461352835857
#%1384829414017059289313702271708616559021723869211
#%103420683645389836106655060587386652257683857317
#%1372323412962017462660626007290770734239724620241
#%31158590719800980299032178192401091945623174456
#%1064063100425375443904064099554448919054632380061
#%440868091736251483613207008228777296226721198637

#*The ToI- transgenic mouse: a model to study the specific role of NF-B in -cells
#@Roy Eldor,Ketty Baum,Roy Abel,Dror Sever,Danielle Melloul
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1173541427184859223054062676362995386436750985703
#%372068697621607889666436465959817327024926928867

#*The clinical application of non-genetic biomarkers for differential diagnosis of monogenic diabetes
#@R. Owen,Jan Skupien,T. Malecki
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index138234960415632268720771851096906368038279983694
#%1080902716855706170199920664443543347860255366900
#%1211684242362578270689067887487535595085573192746
#%1388838787409243794135778737570598988821731726999

#*Guidelines for the management of type 2 diabetes: is ADA and EASD consensus more clinically relevant than the IDF recommendations?
#@Leszek Czupryniak
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index303388924132108539778700719790489116931595961419
#%205095526006359705853227917870595119744416922791
#%720607076656472740772368571847273753308563502826
#%1052160633850366833305612854563651679101328092405

#*Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide
#@E. Genugten,H. Raalte,Michaela Diamant
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index215152898230164118228788822639040895830713856099
#%691045557249197370130424669278276088382916647433
#%11294555597995160451427388033719509315863908238
#%1090399099460434459948621931836741264087240795834
#%1288679046358000496834527565246018284252453138227
#%1247119334119372186190913879878136438733731106166
#%679363059156679446876518683204345765533717903749

#*Diabetes care targets in older persons
#@M. Abbatecola,Giuseppe Paolisso
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1306981129262484797459893896402200119027885035280
#%578557976221790878923758522917782859412010161174
#%353434187386866159965131847778208767675029510720
#%505578034139418673898556852851542688036755998061

#*Dietary strategies for patients with type 2 diabetes in the era of multi-approaches; review and results from the Dietary Intervention Randomized Controlled Trial (DIRECT)
#@Sivan Ben-Avraham,Ilana Harman-Boehm,Dan Schwarzfuchs,Iris Shai
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1023857544951275525578638517559038189463204530692
#%882938236857581361121750192590127354040452908254
#%1159987445930103591619637959297705591714507690938
#%375362792107943614923013276608327663170207999875
#%840672571807457633578748298453536506450112489678
#%863918360216293498175622457447826924141480091884
#%1373060684831879378604416683878850722709670287633
#%289549574168581856275628716448318415615133764815

#*Self-monitoring of blood glucose in treatment of type 2 diabetes
#@Aleksandra Szymborska-Kajanek,Anna Psurek,Robert Hese,Krzysztof Strojek
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index564659270881121670149500968130416587952634554959

#*How to interpret results of the HEART2D trial?
#@Ivan Tk,Zvonko Milievi,Gyrgy Jermendy
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1255532455544913600512169699709055416519758171943

#*Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials
#@Ivan Tk
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index1215840184907278077734201451765331439336106873716
#%1052160633850366833305612854563651679101328092405

#*Contrast-induced nephropathy in patients with type 2 diabetes during coronary angiography: Risk-factors and prognostic value
#@V. Zaytseva,S. Shamkhalova,V. Shestakova,T. Matskeplishvili,F. Tugeeva,I. Buziashvili,D. Deev,I. Dedov
#year2009
#confDiabetes Research and Clinical Practice
#citation0
#index511068094631973177590393177847954847421807573171
#%1445390500302607839223779711657136776172861893678
#%624703412605644033341260214874026820673022140141
#%865170445005436440916786191272552923367657983946
#%514443915921107125295330546696349573358000211042
#%1021491300173262610369667606531650296638185578568

#*Problems of diabetes management in the immigrant population in Germany
#@U. Plckinger,M. Topuz,M. Langer,T. Reuter
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index118449921804273553466343489771620398937084795567
#%1289708670178787789206048576347352321560997741650
#%1185042935223567511697132992209303757385621912539
#%650441871925002108128096553941316313883496920014
#%623878885078774687346240220885831613687917514919
#%737271970305635336618870672241469234954586098413

#*Bedside capillary blood glucose measurements in critically ill patients: Influence of catecholamine therapy
#@Fekih Hassen,S. Ayed,R. Gharbi,Ben Ali,S. Marghli,S. Elatrous
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index346937911040796602994650412681134513699060882724
#%1256276885199438123620265700552526530359339620004
#%1256276885199438123620265700552526530359339620004
#%1219673040788811158030058975727084722545639967391

#*Counting the cost of type 2 diabetes in Vanuatu
#@George Falconer,Alexandra Buckley,Ruth Colagiuri
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1458598446301441210498850233592454173371146677267
#%482987499303755795279606823904916230440087479446

#*Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: A retrospective database analysis
#@J. Lee,P. Yu,J. Johnson,G. Birnbaum,Pavel Atanasov,P. Buesching,A. Jackson,A. Davidson
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index764753434528791006821110417440136904483060550433
#%481570781244869144784002259840012820397148090045
#%334187055420048795246154006994225234899030878795
#%1080323394507706371858559207091704112322458824295
#%371156425094989491941511014210123288315006840278
#%630507425983902650216713361073070198705231366169

#*The effect of mosapride citrate on constipation in patients with diabetes
#@Naohiko Ueno,Akio Inui,Yoshiko Satoh
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1305647230305806994825107809795770722824165571983
#%28292005292737559182625419453382233445743783637
#%735257627266982848336698094821123100732301100849
#%1329836937637304486398665933585507237559522954381
#%607044644380711437005890536154549512452584374026
#%504786389418842122938240175961114465280683632407

#*Nephropathic complication of type-2 diabetes is following pattern of autoimmune diseases?
#@Kazemi Arababadi,Reza Nosratabadi,Gholamhossein Hassanshahi,Narges Yaghini,Vahid Pooladvand,Ali Shamsizadeh,Hamid Hakimi,Reza Derakhshan
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index747814119650414983082442055591897157682725960009
#%704505700467477591906653408092933847164212674642
#%1145408291198413799647132565487436702269203584271

#*Effects of resistance training combined with antioxidant supplementation on fat-free mass and insulin sensitivity in healthy elderly subjects
#@Florian Bobeuf,Mlissa Labont,Abdelouahed Khalil,J. Dionne
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index511437281065773501230343866838324452473807345793
#%884835363219071857139576507317038813552822721761
#%1217938785815410734434906240023767449584737954888
#%117020373393284174054034529119199295725353383338
#%831268837921107647046152710691100040530080560889
#%989454431439055939634299683570688809345427654104

#*Spirulina protects against Rosiglitazone induced osteoporosis in insulin resistance rats
#@Sumeet Gupta,H.J. Hrishikeshvan,K. Sehajpal
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index196256159072749401185814202595192390383229712306

#*The Kathmandu Declaration: Life Circle approach to prevention and care of diabetes mellitus
#@Mahen Wijesuriya,Rhys Williams,Chittaranjan Yajnik
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index865746978082424058379019906705819116699249067753
#%154636246195941173549765128191254276188908671050
#%118834104450711179762334938462336566032787187141
#%1364074114129473887147171972492441646000656079796

#*Mortality attributable to diabetes: Estimates for the year 2010
#@Gojka Roglic,Nigel Unwin
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1383203263462397047746830955155112701368611175624
#%354373567560664060513155636973291268862475928445
#%711599000368263004138323260382993387525511138418

#*Global estimates of the prevalence of diabetes for 2010 and 2030
#@J.E. Shaw,R.A. Sicree,P.Z. Zimmet
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1023416556401013546738459536790171081960361049040
#%303900149124019201451265916402058916722406014787
#%1261424796677217536941839876977393297343238104918
#%1251461480705900620540742652492561435382880830719
#%1367856573503546253929808889444004046907962773070
#%353085761349827517393290211771034809980635903232
#%1414519649302587451084247101981431991774536803237
#%19691795296066575247509290728062186066004815137
#%1241358283530080293186406245815498949670769666289
#%630227562341490064079882525596520130850886976902
#%697743872741174638642013174069746537235463555717
#%233977983668887543759705082774969369950628037536
#%20974908667366551872942389171008465367644595653
#%1238493761444858885847069673758032080571422578589
#%190510616491042557292033109300604148711716358231
#%391645723309965161953094572468833504202217435651
#%1324973972417001029253325432822342429893670319200
#%1241626994672215237132235215015212226354661321926
#%312437063547844994704215691347508289142373049282

#*Differing effect of statins on insulin sensitivity in non-diabetics: A systematic review and meta-analysis
#@L. Baker,Ripple Talati,Michael White,I. Coleman
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1190755152016270797493650290737989441767710400538
#%256221967466016273421307546449588268010180779567
#%727978340336125488899334526171458645223834462551
#%534386535802522742795778381804541205217117509152
#%293411413918312859087092519499788139656738102810
#%902449718329038511237497537076202157448911451897
#%590971384948407428453790847447012312834734933421
#%1379828070547430242619715970323457674341548549082
#%1280437390282561986647197638726324530688810290121
#%392175813192785784642900427166098402667080552092
#%1292110379918747549018322929657578770938902971112

#*Abnormal aortic elasticity in patients with liver steatosis
#@Zafer Ilak,Mustafa Aparc,Ejder Kardeolu,mer Yiiner,mer Uz,Onur Sildiroglu,Namk zmen,Murat Yaln,Ylmaz Cingzbay,Stk Cebeci
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index969800520596588771928794378082774513549379983905
#%1062102914805636190528624029436745766855225529621
#%777359860425037423222061898863267877498560855381
#%620284336876715563049876470413257916974345156928
#%355803185483656738421972752195520404073177687776

#*Serum N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) and homocysteine levels in type 2 diabetic patients with asymptomatic left ventricular diastolic dysfunction
#@U. Grm,D. zmen,B. zmen,Z. Parldar,. zdoan,I. Mutaf,O. Bayndr
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1179983395683619794576465785340875124536336217881
#%286391531369028371656778678596886305634984090774
#%1345797599075375794740889384824974231756478544081
#%614168602125192581508092285560578628512870079946
#%859642737370584067414979113383869259441052858025
#%1058877640050008632057956183855750322212961334761

#*Macrophage foam cell formation is augmented in serum from patients with diabetic angiopathy
#@Xinglong Cui,Akifumi Kushiyama,Masayasu Yoneda,Yusuke Nakatsu,Ying Guo,Jun Zhang,Haruya Ono,Machi Kanna,Hideyuki Sakoda,Hiraku Ono,Takako Kikuchi,Midori Fujishiro,Masashi Shiomi,Hideaki Kamata,Hiroki Kurihara,Masatoshi Kikuchi,Shoji Kawazu,Fusanori Nishimura,Tomoichiro Asano
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index711861581568407085219288777939560576452893727940
#%129815950086526015512399741673161951042363797140
#%550905301840827697778357556259984602742393061173
#%1198019412819410309369938648501822935646837681984
#%1045284823212771382967972344747561012906895312963
#%648927956402230930747496904462461689376409673445
#%504490300527536690891246793971411997877776315446
#%1105174649043134246601884829585975780196949048658
#%21459439016859310106531516661389554601903176389
#%530742815982948056355266956550925744819808900472

#*White blood cell count and reninangiotensin system inhibitors for the risk of cancer in type 2 diabetes
#@Xilin Yang,C.W. Ma,Yee So,T.C. Ko,P.S. Kong,Hailu Zhao,Gang Xu,C.Y. Tong,C.N. Chan
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index57239203648014067149975361863899447136908494517
#%169522163124293514732395031647425047735644962630
#%679037474316142082833615141394269516477614242424

#*Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated Type 2 diabetes
#@E. Schopman,Jacqueline Geddes,M. Frier
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1121145927386478654657882377615889731091303872258

#*Evaluation of DLG2 as a positional candidate for disposition index in African-Americans from the IRAS family study
#@D. Palmer,C. Mychaleckyj,D. Langefeld,T. Ziegler,H. Williams,Michael. Bryer-Ash,W. Bowden
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index780458458623276446442780768532326915430218359258
#%459018288165197652039502725410580491855448591730
#%1063087461122116481968108682423140141910594004103
#%800017830610853549012273463136499867416919430384
#%660578322480649725665135103145471190627536847486

#*Hemoglobin A1c in predicting progression to diabetes
#@Tomoko Nakagami,Naoko Tajima,Toshihide Oizumi,Shigeru Karasawa,Kiriko Wada,Wataru Kameda,Shinji Susa,Takeo Kato,Makoto Daimon
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index692261066715004219765759442379237259884795656977
#%730072577305037262807955773466283663531940931443
#%1016557363423092520399753612519732792456829814127

#*Prevalence of overweight and obesity in young adults aged 2040 years in North India (Kashmir Valley)
#@Rashid Masoodi,Ahad Wani,Iqbal Wani,Iftikhar Bashir,Ahmad Laway,Hamid Zargar
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index501052001070954162518016708195078660588445725201
#%1456685161226442277839440551194153729845734828992

#*January issue DRCP
#@Stephen Colagiuri
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1182369952505354856121317870756532544519305290194

#*The IDF Diabetes Atlas: Providing evidence, raising awareness and promoting action
#@Nigel Unwin,Delice Gan,David Whiting
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1202540066497849992000632041954239241759804021321

#*From yesterday to tomorrow: Making a difference to global diabetes
#@Claude Mbanya
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index548279377171517111230420378398464783495625941362

#*Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design
#@Kenichi Shikata,Masakazu Haneda,Daisuke Koya,Yoshiki Suzuki,Yasuhiko Tomino,Kenichi Yamada,Shiro Maeda,Norito Kawakami,Takashi Uzu,Motonobu Nishimura,Chikage Sato,Daisuke Ogawa,Hirofumi Makino
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1350581584748776773643341932675514041571809978041
#%496779553883743300455637468231370769565855684232
#%481570781244869144784002259840012820397148090045
#%431412729600776668789272016853046241948029539427

#*Neuropsychological status of elderly patients with diabetes mellitus
#@Hiroyuki Shimada,Takami Miki,Akiko Tamura,Suzuka Ataka,Masanori Emoto,Yoshiki Nishizawa
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index30593862408639640405861416181700091900833678986
#%1297263229291233960859100357902215322332051385929
#%705790687198596425933537098700744937109251112899
#%705790687198596425933537098700744937109251112899

#*Analysis of continuous patient data from the Czech National Register of patients with type 1 and type 2 diabetes using insulin pump therapy
#@Z. Jankovec,M. Hahn,S. Grunder,S. Lacigova,D. Cechurova,M. Krcma,M. Zourek,I. Haladova,Z. Rusavy
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1397791761044368177777036202365686504168189675063
#%463084979349877985092818976805371837725085253544
#%917167082748485527271020903299685341367066346578
#%659953914021137047923558798679114686209697671752

#*Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis
#@Chunyu Zhang,Aijun Sun,Peng Zhang,Chaoneng Wu,Shuning Zhang,Mingqiang Fu,Keqiang Wang,Yunzeng Zou,Junbo Ge
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index940758420850070730947058959840199605269121888358
#%582837888036975073134038422433561035225731180840
#%1336490785485731934449097218187247661551271280654
#%185336593502638285138376748100279233230327250021
#%1340547986067059492801342396034335177095471722667
#%1325768054296927391540792874831347730366909265496

#*International Diabetes Federation: An update of the evidence concerning the prevention of type 2 diabetes
#@R.K. Simmons,N. Unwin,S.J. Griffin
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1245749547711924353684255927617253077901919194606
#%715783349862343521591858137044073981054526705544
#%557909350748164098374098344033963591173297998821
#%1052160633850366833305612854563651679101328092405
#%295736870991608447671675602135022023132644672063

#*The status of national diabetes programmes: A global survey of IDF member associations
#@Ruth Colagiuri,Robyn Short,Alexandra Buckley
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1226137194228537022710182009267619811059731296265

#*On what evidence-base do we recommend self-monitoring of blood glucose?
#@Hubert Kolb,Kerstin Kempf,Stephan Martin,Michael Stumvoll,Rdiger Landgraf
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index62531312817334983440821736378463081347374466220
#%1395844524419465877465635594972154437971560499999
#%1354982482342425535957093386411328254772633809809
#%1459367975290918093957074119762127624669149450212
#%1459367975290918093957074119762127624669149450212
#%403036386727919795371067980306307893210688009338
#%132006025293531708744986051256604349682942815450
#%1104887923826044000599122491144282133731730369749
#%71592060726951169045066219072152965154404029908
#%992526920318358556758474114167285252592690879698
#%1017312434245197605084493976352294570879323261788
#%447432957791090693257412871396778845181448764791
#%481570781244869144784002259840012820397148090045
#%1325768054296927391540792874831347730366909265496

#*Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes
#@C. Rodrigues,Henrique Canani,S. Viatroski,H. Hoffmann,F. Esteves,L. Gross
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index806238071679885192225442994075292843086864722190
#%998631945900394196440882696890238975802967988843
#%979269151648417656245420627266800785313890021687
#%946329835672731115652832054705063314197961628780

#*Association between plasma high-sensitivity C-reactive protein and insulin resistance and white matter lesions in Japanese type 2 diabetic patients
#@Futoshi Anan,Takayuki Masaki,Hidetoshi Kikuchi,Tetsu Iwao,Tsuyoshi Shimomura,Yoshikazu Umeno,Nobuoki Eshima,Tetsunori Saikawa,Hironobu Yoshimatsu
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index474642843804424834679594585078909826182543305027
#%1438361308239152205343302480156715263383345379538
#%35302854989106334317335751479598397720581642190
#%237769300452252787810824693246791056522161252264

#*Plasma apelin levels and apelin/APJ mRNA expression in patients with gestational diabetes mellitus
#@Beata Telejko,Mariusz Kuzmicki,Natalia Wawrusiewicz-Kurylonek,Jacek Szamatowicz,Agnieszka Nikolajuk,Anna Zonenberg,Dorota Zwierz-Gugala,Wojciech Jelski,Piotr Laudaski,Jan Wilczynski,Adam Kretowski,Maria Gorska
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1159081295074384247713387920732859125498952288500
#%101480524770518822874404911093287152122807588184
#%407663931282759564749171242769122046662542255595
#%1032642518543860975426004494191542836877134446927
#%1067655961372270699035062562131136553110875672400
#%430164031725457906829385292468055024134548036481
#%1125060288708374107953433118447502684627269158836
#%92864881465055756624013080451846040699570800331
#%1454556365227717639232565540187785634159855283953
#%37857517196182700900264926112389954896917007828
#%688175443830177467854805690069084481551923126033
#%121731276005817471667579795747974718605741992299
#%578855159281524353094286368048426121627072923219
#%458976193958088492690555297656062264251303973794

#*Evaluation and comparison of guidelines for the management of people with type 2 diabetes from eight European countries
#@M.A. Stone,J.C. Wilkinson,G. Charpentier,N. Clochard,G. Grassi,U. Lindblad,U.A. Mller,J. Nolan,G.E. Rutten,K. Khunti
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index652274594728477370625007426391500738475347709404
#%369002531336197897775867139459149354667143424402

#*Evaluation of a simple policy for pre- and post-prandial blood glucose self-monitoring in people with type 2 diabetes not on insulin
#@Katia Bonomo,Alessandro Salve,Elisa Fiora,Elena Mularoni,Paola Massucco,Paolo Poy,Alice Pomero,Franco Cavalot,Giovanni Anfossi,Mariella Trovati
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1108623948897321922916953624607817806299764948709
#%1232222919111932326477733475353198304423723577899

#*Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms tumor-1 protein used as a podocyte marker
#@Jian Su,Shi-Jun Li,Zhao-Hong Chen,Cai-Hong Zeng,Hong Zhou,Lei-Shi Li,Zhi-Hong Liu
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index446995388033921276663997925634711862140651866431

#*Effects of antioxidants on glucose-induced oxidative stress and endoplasmic reticulum stress in endothelial cells
#@Mae Sheikh-Ali,Senan Sultan,Abdul-Razzak Alamir,J. Haas,D. Mooradian
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1405364534039067585482266552187864594582119157292
#%843842173784409105319533394411268626025327992078
#%395608685539093829549739826370280747358713918996
#%1373931371259881572573607362431139968524569106543
#%766151348254559866533138005486252341704684523640

#*Plasma sRAGE is not associated with urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage
#@Jiang-Yi Yu,Xiao-Fei An,Jing-Shun Liu,Shi-Chao Ten,Xin Wang,Yue Zhao,Sha Huang,Wan-Jian Gu,Feng Gao
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index845819444807606860018216417868945431406108525510
#%1438557600407683042277235801061437817073135744592
#%1139156988473115756633242732607555108582937722704

#*Hypomagnesaemia is associated with diabetes: Not pre-diabetes, obesity or the metabolic syndrome
#@David Simmons,Supriya Joshi,Jonathan Shaw
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index421251177094816129794017424842075737282755895652
#%1173928064601662571584355060782837768057881892683
#%1452515111770492633751051983221285439439317566129
#%1297077824919843009694482395414265861240395786061

#*Plasminogen activator inhibitor-1 (PAI-1) activity and retinal vascular calibre in type 2 diabetes
#@L. Brazionis,J. Yau,K. Rowley,C. Itsiopoulos,K. ODea,T.Y. Wong,A. Jenkins
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index456152320938831719444383009009433385072190906029
#%134842485281428825509548970708538123239024882330
#%821323590004811484660482598443033949674984677654
#%226031019630481747458327496527114344770585642650
#%685652554539443383359926445417468184875246144478

#*Involvement of the cholinergic pathway in glucocorticoid-induced hyperinsulinemia in rats
#@Ngela Angelini,Alex Rafacho,Carlos Boschero,Roberto Bosqueiro
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1086471817025890456942265813150167806921951479431
#%1094236466789143092552834555532570555474928409197
#%776802997629803071017540779722738831483879041119
#%215871804412403163411290189440696961019231155061
#%882768018062704908217556151468798423858897547602
#%21736712864163689053057198480552851967387501863
#%409634477818599096981936052454585931484270368246

#*Identification of two novel variants in PRKAG2 gene in Tunisian type 2 diabetic patients with family history of cardiovascular disease
#@S. Nouira,I. Arfa,I. Kammoun,A. Abid,H. Ouragini,I. Dorboz,W. Ghazouani,Ben Fadhel,M.M. Zorgati,Ben Ammar,S. Blousa-Chabchoub,S. Kachboura,S. Abdelhak
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index456196644824938576605206940194720066127635942159
#%766244720353094545727864237189152571638317019762

#*Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitusThe STOP-NIDDM risk-score
#@Jaakko Tuomilehto,Jaana Lindstrm,Martin Hellmich,Walter Lehmacher,Torsten Westermeier,Thomas Evers,Andreas Brckner,Markku Peltonen,Qing Qiao,Jean-Louis Chiasson
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1178234564007196524728953185073155193489378588881
#%798718960466278114635366482410674321074698856592
#%1186501341515059391140442800919395799048423877293
#%888194625503349146454870621356819007245801489985
#%631612601811352992178146197004509176967429294554
#%610933636802206784054441052388249503323609875906
#%530742815982948056355266956550925744819808900472

#*Glucose tolerance, insulin resistance and insulin secretion in young south Indian adults: Relationships to parental size, neonatal size and childhood body mass index
#@Palany Raghupathy,Belavendra Antonisamy,S. Geethanjali,Julia Saperia,D. Leary,G. Priya,Joseph Richard,J.P. Barker,H.D. Fall
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1013207547312284752573687677938807864569950694025
#%795602879152959170222181987208272407042044910697

#*Trends in lower extremity amputations in people with and without diabetes in England, 19962005
#@Panna Vamos,Alex Bottle,Azeem Majeed,Christopher Millett
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index695228680426226391066539080195995012392109566073
#%593042637009300427299012652370141156292339790676
#%1438722055857034958941658233292115225811594968877
#%74955917709517243616102452939684791212462089576
#%614082055154210359109643669568394060015762301806

#*Peripheral endomorphin-1 levels are suppressed in diabetic patients
#@Fang-zhen Xia,Ying-li Lu,Yi Chen,Ting Gu,Hui-xin Zhang,Jiao Yu,Li-juan Zhao
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index658459025794815337159143426043766133230655780597
#%436202034156450607534632526535779408055228971101
#%703362753568502673040599843339250538065109152278
#%855936997731698242148351040620794931580242357031

#*Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life
#@F. Pollack,W. Purayidathil,C. Bolge,A. Williams
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1124022632554215266228035969212754585687768212571
#%1320220961478646084193059187885727774618554915045
#%249110814702884669678870779883477990781402285163

#*A Telemedicine system based on Internet and short message service as a new approach in the follow-up of patients with gestational diabetes
#@Natalia Prez-Ferre,Mercedes Galindo,Dolores Fernndez,Victoria Velasco,Jos Cruz,Patricia Martn,Laura Valle,L. Calle-Pascual
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index527004061392545573039071084257136244306194123699
#%539416993328611371973842048292657002324106512311
#%275188013907453750606722365298902989571162545009
#%345467241203650626188278535863277109853064878366

#*Overcoming barriers to diabetes care: Perceived communication issues of healthcare professionals attending a pilot Diabetes UK training programme
#@Kylie Mosely,Aysha Aslam,Jane Speight
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index747033751372990617212727063771609665713401550331
#%170289603395519316114288876824524059889092176782

#*Beneficial effect of physical activity on blood pressure and blood glucose among Japanese male workers
#@Kazuko Ishikawa-Takata,Hirofumi Tanaka,Keiji Nanbu,Toshiki Ohta
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1336461548314882765108649241348320848671616358660
#%563779828617099299727050057216568413927171328724

#*Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts
#@E. Caughey,E. Roughead,I. Vitry,A. McDermott,Sepehr Shakib,L. Gilbert
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index325393500582593079722788466957942600553875786386
#%1237255810326370309016718926877286893134734457245
#%1325768054296927391540792874831347730366909265496
#%102725610907284364592628509794401292689118581863
#%102725610907284364592628509794401292689118581863

#*Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran Lipid and Glucose Study
#@Farzad Hadaegh,Gita Shafiee,Asghar Ghasemi,Parvin Sarbakhsh,Fereidoun Azizi
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1035546135432254430282488694076130040605509897346
#%454520002677779716637711304701531046833883314312
#%1354708381707947041261781207815005988261005557180
#%926089332955556849094971666856454675556206485431

#*Prevalence of non-diabetic renal disease in patients with type 2 diabetes
#@Shan Mou,Qin Wang,Jian Liu,Xiajing Che,Minfang Zhang,Liou Cao,Wenyan Zhou,Zhaohui Ni
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1322665479385253503209453163558491312004233273983
#%1039932601168272134028665846420456295133400633354
#%204162638528475001657292387539782427986528098481

#*A novel glucokinase gene mutation and its effect on glycemic/C-peptide fluctuations in a patient with maturity-onset diabetes of the young type 2
#@A. Loomba-Albrecht,Maryam Jame,A. Bremer
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index252449816479155127846069831139291111208666892912

#*Time lag characterization of two continuous glucose monitoring systems
#@K. Garg,Mary Voelmle,A. Gottlieb
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1030294973351055115816845536102902183615691569993

#*Molecular pathology of oxidative stress in diabetic angiopathy: Role of mitochondrial and cellular pathways
#@Zhirajr Mokini,Loredana Marcovecchio,Francesco Chiarelli
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index511018021491193630587940088904395695523418086013
#%831268837921107647046152710691100040530080560889
#%491923147554360283708762012113214417783702230614
#%923404394973241754160612207908301236607804630545
#%1269296112770648852045472085422958592662246330652
#%966012975091050574960978265385297063440804357915
#%965756233633280205557807770998251401626324124606
#%704423089953062110989969351908326937681410271048
#%1316037969624870555229849894771660555455758515233
#%126249688291280547645747213759917888261973734771
#%963349673350857295936332881255038928716882387056
#%231422036311550398724051550833968651849741585271
#%314222982348453199719277759912535694218568149773
#%312505160399916944751712840309961073038487399605
#%56530720048855446720821678055088384540646501242
#%533234185427804650744538040440699197859634240355

#*Serum fatty acid composition and insulin resistance are independently associated with liver fat markers in elderly men
#@Helena Petersson,Johan rnlv,Bjrn Zethelius,Ulf Risrus
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index971566625010441496195841487869385721749903403763
#%335614540147401356315720850472375963311249445812
#%1397990451676574710090872601175740955688976893258
#%138161028608047003386950877139665874436664240925

#*Vital sign triage to rule out diabetic ketoacidosis and non-ketotic hyperosmolar syndrome in hyperglycemic patients
#@Yasuharu Tokuda,Fumio Omata,Yusuke Tsugawa,Kyouko Maesato,Kazuhisa Momotura,Atsuko Fujinuma,H. Stein,Francis Cook
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index676863509420342445179767238953074025302053010191
#%1291785711615390325521362195740755846553600285406
#%738207368364154752733840814101563023602268066855
#%977424904542049257252183521452817362824214378798
#%628434967749961602960030491212689652314415578185

#*Impact of type 2 diabetes mellitus on prescription medication burden and out-of-pocket healthcare expenses
#@W. Rodbard,J. Green,M. Fox,Susan Grandy
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index689234026613799819869842974369337721303275641415
#%471822282047285361507009428342997394182504175400
#%198412595688686180003238739867464544109261470878

#*Leisure-time physical activity and risk of type 2 diabetes in patients with established vascular disease or poorly controlled vascular risk factors
#@B.G. Brouwer,Y. Graaf,S.S. Soedamah-Muthu,A.M.J. Wassink,F.L.J. Visseren
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index93062492594072516806100648871565372980224315988
#%1209915928043767877988071234305244160407052781159
#%1182317115796281980372922158863315735722199267305

#*Using anthropometric indices to predict cardio-metabolic risk factors in Australian indigenous populations
#@Ming Li,A. McDermott
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1404474581296997278343094748210255833608908424218
#%938273324743190397527608173600871034340668923565
#%690325874269266795336149405451579070955616357106
#%608027367961477215758757976231510100673358964715

#*Plasma sRAGE is independently associated with high sensitivity C-reactive protein in type 2 diabetes without coronary artery disease
#@Xiao-Fei An,Yue Zhao,Jiang-Yi Yu,Jing-Shun Liu,Wan-Jian Gu,Feng Gao
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1457455121987190968212090912888402153935767819780
#%1445684387059518461950874157291020790511226777186
#%516476764028129710612415089129033818103170785577
#%1438557600407683042277235801061437817073135744592

#*Transcription factor, SP1, in epiretinal membranes of patients with proliferative diabetic retinopathy
#@Natsuyo Yoshida-Hata,Yoshinori Mitamura,Toshiyuki Oshitari,Kazuhiko Namekata,Chikako Harada,Takayuki Harada,Shuichi Yamamoto
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index504646990854267540670795634539630654953679180598

#*Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: Implications for the diagnosis of diabetes
#@B. Davidson,L. Schriger
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1298380105709453288890802672315896184556384222713
#%481570781244869144784002259840012820397148090045

#*Glycemic control and its correlates in patients with diabetes in Venezuela: Results from a nationwide survey
#@Duarte Moreira,Silva Neves,Onofre Nunes,Chagas Almeida,Valverde Mendes,Saraiva Fittipaldi,Franklin Ablan
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1342169584254778547640119966643373693804327387805
#%741472667357967036521698557437635045148869117616
#%749827365434910630056567550078805136344206542599
#%74108759385361979204156615352365733346388426847
#%26644929067031441013076878678618881062789759471
#%342160771889902249778067326556199263702032340792
#%638662604124104485124189178591257350523709720423
#%1111619129422686229936081788557512223965395589827

#*Genetic association of the neuropilin-1 gene with type 1 diabetes in children: Neuropilin-1 expression in pancreatic islets
#@M. Hasan,A. Kendrick,R. Druckenbrod,K. Huelsmeyer,F. Warner,J. MacDonald
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index450895010793765981390968220979057508529061677039
#%418648830463837139165113491226514822496326413271
#%1167721712831931739371905555299062660532974462723

#*Lack of preservation of insulin gene expression by a Glucagon-Like Peptide 1 agonist or a Dipeptidyl Peptidase 4 inhibitor in an in vivo model of glucolipotoxicity
#@Ghislaine Fonts,K. Hagman,G. Latour,Meriem Semache,Vincent Poitout
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index881652494522526581464925506953127601922527486749
#%691045557249197370130424669278276088382916647433
#%1289512291783831034138403262452804885561315555789

#*The effect of mosapride (5HT-4 receptor agonist) on insulin sensitivity and GLUT4 translocation
#@J.S. Nam,J.Y. Nam,J.S. Yoo,M. Cho,J.S. Park,C.W. Ahn,B.S. Cha,E.J. Lee,S.K. Lim,K.R. Kim,H.C. Lee
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index454606806614647942087125871817897233059666022550
#%276055970780863910624801630963347742047280503592
#%1101804216499932815297295666675901200108049467748
#%1338507194886246850586240125110666486771835794316

#*Serum MMP-7 is increased in diabetic renal disease and diabetic diastolic dysfunction
#@C.R. Ban,S.M. Twigg,B. Franjic,B.A. Brooks,D. Celermajer,D.K. Yue,S.V. McLennan
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index67405770696740155459634874378889417533870450598
#%345628187882709171082113334271171968459229861793
#%707242671582599018051195005769591973833893673878
#%1271191119675469654981770968124638629129634799554
#%1451757237293831387988259704136678369480208157845
#%1194423504147999393781367739478973294783400890557
#%1296223645242513780119382221223118992662032215036

#*Diabetes Research and Clinical Practice Junior Research Prize: Conference report, 2009
#@Katherine Pinnick
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1219757395800983315005957478797681998900229379617

#*Diabetes and depression: Global perspectives
#@E. Egede,Charles Ellis
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index642574489513865928213336653157627917355606109834
#%782621665605969617781109814877265314913272519318
#%260838592768493440239480242607601174509266821607
#%1232315247709413748640036935234975415615890804506

#*Global healthcare expenditure on diabetes for 2010 and 2030
#@Ping Zhang,Xinzhi Zhang,Jonathan Brown,Dorte Vistisen,Richard Sicree,Jonathan Shaw,Gregory Nichols
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index474291835975547868210792200981479631231499856912
#%1448027472528253343847860025759224156702997012691

#*Global solidarity in a time of crisis: How IDF responded to the disaster in Haiti
#@Claude Mbanya
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index716257208943338679201517845683268029627164041787

#*Effects of Glimepiride on metabolic parameters and cardiovascular risk factors in patients with newly diagnosed type 2 diabetes mellitus
#@Dan-yan Xu,Shui-Ping Zhao,Qiu-xia Huang,Wei Du,Yu-hua Liu,Ling Liu,Xiao-mei Xie
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index204814933618505883481275107027443557626370235202
#%442612140638365600388303838037883757418677489767
#%1211822195613028469499144014137788249622959501863

#*Seasonal fluctuations of glycated hemoglobin levels in Japanese diabetic patients
#@Hiroshi Sakura,Yasutomi Tanaka,Yasuhiko Iwamoto
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index902051356665050423642705610463412292967476289810

#*Start improving the quality of care for people with type 2 diabetes through a general practice support program: A cluster randomized trial
#@Geert Goderis,Liesbeth Borgermans,Richard Grol,Carine Broeke,Benoit Boland,Geert Verbeke,An Carbonez,Chantal Mathieu,Jan Heyrman
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1247913383693694849433539033376370528658137794226
#%70713219964864387334685408482787227778160740272
#%119912244937932844452921433207443519794111546540

#*A survey of oral health education provided by certified diabetes educators
#@K. Yuen,Georgiana Onicescu,G. Hill,Carolyn Jenkins
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1253204145973067875267788876939236357484155742998
#%1311203522515857931699627272857432654934828756065
#%164793596942834589299547503228956733410686620311

#*Effects of short-term therapy with different insulin secretagogues on glucose metabolism, lipid parameters and oxidative stress in newly diagnosed Type 2 Diabetes Mellitus
#@Yan Li,Lijuan Xu,Jie Shen,Jianmin Ran,Yang Zhang,Min Wang,Li Yan,Hua Cheng,Zuzhi Fu
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index32464034462887294233119832686829957104038941556
#%1194214941893451568361826207104333394336588024125
#%1194214941893451568361826207104333394336588024125
#%265763351778222572235619359852433695144048919292
#%1034672378593879948569666925827007624471930394577
#%106976679855442672893757212173770388290312511721
#%802874848512892778262768393492242751485855322731

#*The effects of vigorous physical activity on intra-abdominal fat levels: A preliminary study of middle-aged Japanese men
#@Hiroyuki Sasai,Yasutomi Katayama,Yoshio Nakata,Miki Eto,Takehiko Tsujimoto,Hiroyuki Ohkubo,Kiyoji Tanaka
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1121230857229317298842248442940021989148257534797
#%469287249640791386517535195945360264582366894990
#%690228390405472911870024036720621001371646093434

#*C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance in patients with diabetes mellitus type 2
#@D.A. Luis,Gonzalez Sagrado,R. Aller,O. Izaola,R. Conde,E. Romero
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1008626523682750232901940676387035143688817469192
#%477924397507633074640802752150684609028172194606

#*Inverse associations of serum bilirubin with high sensitivity C-reactive protein, glycated hemoglobin, and prevalence of type 2 diabetes in middle-aged and elderly Japanese men and women
#@Keizo Ohnaka,Suminori Kono,Toyoshi Inoguchi,Guang Yin,Makiko Morita,Masahiro Adachi,Hisaya Kawate,Ryoichi Takayanagi
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index54325503192166997719613893231194345012902213905
#%1013391624896681551502864271274429268498290036537
#%346054916498333064062084334741531243795790752446
#%1288034188437030632047517680099362354857761085656
#%194216444566800699498668803036867006938726169337

#*Factors predicting the need for insulin therapy in patients with gestational diabetes mellitus
#@David Sapienza,Vieira Francisco,Coutheux Trindade,Marcelo Zugaib
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index458839715302655513238495485462589378267805496426
#%1355523126139526722897727659472809492088447184386
#%10326237413897886015081774807710064460389575175
#%271712231629043001651324818083558854223049839936
#%1395844524419465877465635594972154437971560499999
#%765079649313895269605970315627918013194826601100
#%1420290378682806714894110987945765825475531861547

#*Comparison of clinical-metabolic monitoring and outcomes and coronary risk status in people with type 2 diabetes from Australia, France and Latin America
#@J. Gagliardino,Line Kleinebreil,Stephen Colagiuri,Jeff Flack,E. Caporale,Fernando Siri,Charles Clark
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index631884836943540955019118220606060002064992639465
#%1325768054296927391540792874831347730366909265496
#%563663952211133352952952240690670904425928741097

#*Waist circumference has heterogeneous impact on development of diabetes in different populations: Longitudinal comparative study between Australia and Iran
#@Nassir Rostambeigi,E. Shaw,C. Atkins,Arash Ghanbarian,J. Cameron,Andrew Forbes,Amirabbas Momenan,Farzad Hadaegh,Parvin Mirmiran,Z. Zimmet,Fereidoun Azizi,M. Tonkin
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index897445432671787163075908194498396284818999635836
#%608027367961477215758757976231510100673358964715
#%66865259309889545584907194121638472402515008997
#%631612601811352992178146197004509176967429294554
#%291838046356786000689721084912131343504336782860
#%1103963952962088092769739423028161938502158005329

#*Nurse diabetes case management interventions and blood glucose control: Results of a meta-analysis
#@Garry Welch,Jane Garb,Sofija Zagarins,Irina Lendel,A. Gabbay
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index423105565421776922661662811305019095318618648883
#%918163783940722084103176719895654233968283347193
#%1208280504803671538971348917763386860791884429672
#%1198838675164825412735668110496905879476128256129
#%251419502436834773345681490804861255720993100280
#%1266835599150145199933689127408163952476066317988
#%161848468622699335669361529491448962072820821475

#*Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction
#@Ignacio Cruz-Gonzalez,Stanley Chia,C. Raffel,Maria Sanchez-Ledesma,Fred Senatore,J. Wackers,M. Nathan,Ik-Kyung Jang
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index958174970234861390012445296435283870250906209765
#%1160409944091387776546062791731830030184379938491
#%409562326928813714152669972341134724417512641817
#%831846220686485351928856554451433808188225644811
#%853933485861833442499417434581928900747598495651
#%815655823380324310302539656819293732504262690474
#%964086446870062858095579656229214022826824534951
#%1332030397419400531424071753401728392529381464597
#%301735838888651896427095926806789871671347225681
#%911508353376381808427724708339345213802136999941
#%1097847139526814450162254253615227131540992113945
#%523598588514361602677552655171290495351104010479
#%549239993803139946619095775760221407069574534366

#*Impact of ENPP1 and MMP3 gene polymorphisms on aortic calcification in patients with type 2 diabetes in a Korean population
#@Jung-Eun Lee,Yeon-Kyung Choi,Hyun-Ae Seo,Jae-Han Jeon,Ji-Yun Jeong,Seong-Su Moon,Jung-Guk Kim,Bo-Wan Kim,Su-Won Kim,Joon-Young Kim,In-Kyu Lee
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index290196473926225452457724835323493288309006833713
#%1112190330540780806896454211006751109264615101777
#%775057586733453889076576087887172170903554933911
#%1109878448291088009083918177935915569678259483533
#%695164606322996185304471893418009396957180596450
#%246918284536771840800509000452923907185914502935
#%1131887473782769708824108640103391413575980564528

#*Normal range of alanine aminotransferase concentration is associated with carotid atherosclerosis
#@Soo-Kyung Kim,Dae-Jung Kim,Se-Hwa Kim,Yeo-Kyung Lee,Seok-Won Park,Yong-Wook Cho,Kap-Bum Huh
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1234898681123638034918278216666794025639483574832
#%282631434623269146018353748493294384952338699016
#%1133938240078490757464937841929328487682146649491
#%121644856329596262676214199737726912237658571560
#%1432109859087019096059196242985285467491910474133
#%165406441060206632744837119550123100680351041522
#%825995287286490239453185157326515552702912846483
#%267126264023668718557157032650545125034922190504
#%569788867622931023461578051761203601399182474467
#%425359508911865790944680143974007765055061334363

#*A case of insulinoma following total gastrectomyEffects of an alpha-glucosidase inhibitor on suppressing GIP and GLP-1 elevations
#@Takehiro Sato,Takuma Narita,Mihoko Hosoba,Masafumi Kakei,Hiroshi Nanjo,Hiroshi Uchinami,Kohei Satoh,Yuzo Yamamoto,Yuichiro Yamada
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index310886580845352577021237510947075257920654167632

#*Automated detection of hypoglycemia-induced EEG changes recorded by subcutaneous electrodes in subjects with type 1 diabetesThe brain as a biosensor
#@B. Juhl,Kurt Hjlund,Rasmus Elsborg,Kjr Poulsen,E. Selmar,Juul Holst,Claus Christiansen,Henning Beck-Nielsen
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index287324674857323264585202473304816218853978681749

#*Prevalence of the metabolic syndrome among extremely obese adolescents in Italy and Germany
#@L. Lafortuna,Fulvio Adorni,Fiorenza Agosti,Alessandra Col,Kolja Sievert,Wolfgang Siegfried,Alessandro Sartorio
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index379087702786574345542874679021516469422897853898
#%1087407591549635776825908203621366101838833998963
#%131275381010178424108009516773409062393186087213
#%930199817071385370027210499190831691939519741892
#%1355414104276648256632939894065361854550586464201
#%1414421728871179737298836237577312472033227296150

#*Fat mass threshold associated with a significant deterioration of insulin sensitivity in postmenopausal women
#@Florian Bobeuf,Mylne Aubertin-Leheudre,Christine Lord,Mlissa Labont,Abdelouahed Khalil,J. Dionne
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1097048668692707535316954094035544756115617652265

#*Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes
#@Hong-Yan Pan,Lin Guo,Qiang Li
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index913314339294292150401180225249023323317672465768
#%1127956677808160097945284298980041188937972710753

#*Type 2 diabetes mellitus impairs bone healing of dental implants in GK rats
#@Feng Wang,Ying-liang Song,De-hua Li,Cui-xia Li,Yao Wang,Ning Zhang,Bao-gang Wang
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index501413536574123156177296973770683196047435999794

#*Predictors of diastolic dysfunction among minority patients with newly diagnosed type 2 diabetes
#@Rasa Kazlauskaite,Rami Doukky,Arthur Evans,Bosko Margeta,Arora Ruchi,Leon Fogelfeld,F. Kelly
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1189167562910839442852486242155676269145191698077
#%219951068730247266634539337525842782639940543841
#%942720736864868088578006117317406017829063146124
#%36627984978547370809450061931586662704505429369
#%536636167398556016050238123773960315477233236428
#%537654921084237783574123175573517709313380394995
#%1051818585656001054696685001240256957396559691754
#%58090856361372031100198307804471984303059818135

#*Three novel mutations in MODY and its phenotype in three different Czech families
#@Z. Bazalov,B. Rypkov,J. Bro,L. Brunerov,J. Polk,Z. Ruav,L. Trelov,M. Andl
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index125081373102416103744381542780977212386160788788
#%57634802169253476616999503607251153171917599163

#*Association between alcohol intake amount and prevalence of metabolic syndrome in Korean rural male population
#@Young Lee,Young Kim,Yi Kim,Hyun Kim,Hwan Kim,Yel Shin,Goo Shin,Ha Yun,Yeon Ryu,Yong Lee,Baek Koh,Hee Chung
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1313861430517338343646838926523887358478198762074
#%425359508911865790944680143974007765055061334363
#%1325002538821089813129503436677171318102324935367
#%1188427429197478996871403481209983980298145129013
#%1264594756500424596088893294243877127220546618779

#*Microvascular complications are associated with low levels of maternal sE-selectin and sVCAM-1 in pregnancy complicated with pregestational diabetes mellitus
#@Agnieszka Zawiejska,Ewa Wender-Oegowska,Jacek Brzert
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1438305951806730164784677515836017412793373234002
#%369528628134306144711377412109966978631557115903

#*Microinflammation is a common risk factor for progression of nephropathy and atherosclerosis in Japanese patients with type 2 diabetes
#@Nobuo Kajitani,Kenichi Shikata,Akihiko Nakamura,Tatsuaki Nakatou,Makoto Hiramatsu,Hirofumi Makino
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1259604908112601952010092319606326231578388127615
#%68054906965799901534740362906489102674349716057
#%167500923633421713008809947050668782828011048328
#%1161103661135881629412507119493969820154726164541

#*Prescription of physical activity is not sufficient to change sedentary behavior and improve glycemic control in type 2 diabetes patients
#@Willeke Wisse,Boer Rookhuizen,D. Kruif,Janny Rossum,Inge Jordans,Hugo Cate,J.C. Loon,W. Meesters
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index913099141855791695244662793257299641823525947570
#%804147032420352892152174185746480340852066612891
#%425025564183482137135209881342490253215478903676
#%1276758098634495635980818000480392249335080713488

#*Six year weight change and type 2 diabetes among Australian Indigenous adults
#@Ming Li,Sandra Campbell,A. McDermott
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1296571664079809896871922874272308919174204027662

#*Identification of a common autoantigenic epitope of protein disulfide isomerase, golgin-160 and voltage-gated potassium channel in type 1 diabetes
#@Alessandra Fierabracci,Francesca Saura
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1138469759449428621627709137602319313686874861350
#%74039881975585824154007161050028732582155645946
#%1069682365789031484866495541170536709479376421180
#%1337243145795832250027959795401171235751257449066

#*New diagnosis criteria for diabetes with hemoglobin A1c and risks of macro-vascular complications in an urban Japanese cohort: The Suita Study
#@Makoto Watanabe,Yoshihiro Kokubo,Aya Higashiyama,Yuu Ono,Akira Okayama,Tomonori Okamura
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index785963514837445098723391037883168200128055537766
#%718056816015127310877469897971801294949051315608

#*Glucose control in patients with type 2 diabetes based on frequency of insulin glargine administration
#@K. Housel,F. Shaw,V. Waterbury
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1178470261307732662566685413650126229830866422456

#*Increased plasma adiponectin closely associates with vascular endothelial dysfunction in type 2 diabetic patients with diabetic nephropathy
#@Jianmin Ran,Xiaoqing Xiong,Wei Liu,Shunhua Guo,Qingmei Li,Renyi Zhang,Gancheng Lao
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index920110580584873276075810236914466403114559095880
#%889830362321075092082186166716252840174618665781
#%528133368890541850301612499763181496041298437299
#%1086690540860668714026344526526741772383357499803
#%674144155072933575098079692797539220110435616814
#%674144155072933575098079692797539220110435616814
#%768558136642982657406714316850142372794894345564
#%768558136642982657406714316850142372794894345564
#%41267310166356905841101547089239379039365805365
#%986418522345522666595273330566891137054925099514
#%573507818089871227120849374258230319481596315486

#*Prevalence of metabolic syndrome and optimal waist circumference cut-off points for adults in Beijing
#@Wei Wang,Yanxia Luo,Yunning Liu,Can Cui,Lijuan Wu,Youxin Wang,Hong Wang,Puhong Zhang,Xiuhua Guo
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1354140029613989261984834456356198349720105797465
#%509988506292110545056595094114047967974878925417
#%739302984889691781913641581576441657209822219271
#%608027367961477215758757976231510100673358964715
#%1434220097143893480680047037257414254809952161172
#%303972967056662443548712452420849406184164352577
#%722686045832751232598632880762499740491640333575
#%722686045832751232598632880762499740491640333575
#%485552785234323115571115524400782929431561797146
#%878398319368406743317669583879432282104752019069
#%439537735621063097613837696767552956893637932143
#%1087590640195649014213209567220552157576623161488

#*Association between polymorphisms in human tumor necrosis factor-alpha (308) and -beta (252) genes and development of gestational diabetes mellitus
#@Shabnam Montazeri,Sivalingam Nalliah,Kutty Radhakrishnan
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1175958964402664272841759519066409020519872460948
#%539231027140888356636452963351588992019550544201
#%915595794198860908891949774284903553316000889276
#%1203741823424404734325750582037934145866452946629
#%469346106143579334856446816840713275391173278760

#*The incorporation of family physicians in the assessment of diabetic retinopathy by non-mydriatic fundus camera
#@Pedro Romero,Ramon Sagarra,Jeroni Ferrer,Juan Fernndez-Ballart,Marc Baget
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index214275230196000457696265683675478451759973852420
#%1134316742908806820439970403555300672044123021553
#%671876141547420270831034331459544420080136074646

#*Patient perspectives on the role of weight management in type 2 diabetes
#@H. Polonsky,Lawrence Fisher,Danielle Hessler
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index741630232831726739077131522628600303526955219588
#%246218515000102227343435672771346126432835335933
#%341463972777006230950705767907049907784281079054

#*Comparative electrophysiological techniques in the diagnosis of carpal tunnel syndrome in patients with diabetic polyneuropathy
#@Ilker Yagci,Hakan Gunduz,Seda Sancak,Mehmet Agirman,Erkan Mesci,Gulseren Akyuz
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index420279676903343262637184244094721968003788050886
#%768093682967013800110574371276318304019173595249
#%638120066113590022421736029358114332055164366612
#%925034798824120770958498001963630226385056113617
#%395736221719553124661642802757794502569142740223
#%827116998501978092227912721164349473732018246297
#%1146869813873431035951366251241255506831150250663

#*Comparison of post amputation outcome in patients with type 2 diabetes from specialized foot care centres in three developing countries
#@Vijay Viswanathan,Rahim Wadud,Sivagami Madhavan,Seena Rajasekar,Satyavani Kumpatla,J.K. Lutale,G. Abbas
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index729204487816147600944743472797735461453229250897
#%80355669645989079063776476601951455380129723401

#*Inhibition of multifunctional dipeptidyl peptidase-IV: Is there a risk of oncological and immunological adverse effects?
#@Tomas Stulc,Aleksi Sedo
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index837152496833049606514732426389028726837059336741
#%380525015111613110200929282303873161575607123866
#%1102318938928248369924846212594519642224462478493
#%1385913632778037380518583682313339902123096773048
#%1332193538740675015643197057422808928380945073276
#%989205127712158692195198953402930232056923539765

#*How can observational trials inform and improve clinical practice?
#@D. Home
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1418378546744650117601144697972376744403993264213
#%1215789441064594302296108348696645162991109102901
#%1304132792554815564502800825710109046570705202392
#%482987499303755795279606823904916230440087479446
#%1383203263462397047746830955155112701368611175624
#%362935829961330133686986809197325547691557921444

#*Observational studies: going beyond the boundaries of randomized controlled trials
#@Wenying Yang,Alexey Zilov,Pradana Soewondo,Molskov Bech,Fawzia Sekkal,D. Home
#year2010
#confDiabetes Research and Clinical Practice
#citation1
#index1304132792554815564502800825710109046570705202392
#%1215789441064594302296108348696645162991109102901
#%1263172573414075701050399464616766099375123734074
#%662616802049268034586484760395134536151541264051

#*The A 1chieve study: a 60000-person, global, prospective, observational study of basal, meal-time, and biphasic insulin analogs in daily clinical practice
#@N. Shah,Len Litwak,Jihad Haddad,N. Chakkarwar,Issam Hajjaji
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1008054830017240907342906622646227499597045482194
#%1325768054296927391540792874831347730366909265496
#%741472667357967036521698557437635045148869117616
#%331125870934479234182160053302514815224859038971
#%1304132792554815564502800825710109046570705202392
#%106420527549510457866457710443259869393297128745
#%331184958784217527171867215943072764217041741741

#*Conducting cost-effectiveness analyses of type 2 diabetes in low- and middle-income countries: can locally generated observational study data overcome methodological limitations?
#@SeiHyun Baik,Roberto Chacra,Li Yuxiu,Jeremy White,Serdar Gler,A. Latif
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1385911221445241369267980960774699612401829993320
#%482987499303755795279606823904916230440087479446
#%1383203263462397047746830955155112701368611175624
#%362935829961330133686986809197325547691557921444
#%384592745934125286358802619964214477274762281784
#%1177404473368364883726688635644874135488875656333

#*A new non-invasive technology to screen for dysglycaemia including diabetes
#@Ambady Ramachandran,Anand Moses,Samith Shetty,Janakiraman Thirupurasundari,Catherin Seeli,Chamukuttan Snehalatha,Sunil Singvi,Jean-Paul Deslypere
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1147332569922563236104750860024257711414884378953
#%860022615160432358769576638139277096798571837825

#*Normalization of glucose intolerance in first-degree relatives of patients with type 2 diabetes
#@Mohsen Janghorbani,Masoud Amini
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index112449807861248965003629432441887219406860343538
#%1306731710798433348092086991441041750659382866965
#%994260621769770026678320956999014840330275855513
#%51724483505545559516973203660946048704648473726

#*High prevalence of diabetic neuropathy in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown
#@Bin Lu,Zhihong Yang,Mei Wang,Zhen Yang,Wei Gong,Yehong Yang,Jie Wen,Zhaoyun Zhang,Naiqing Zhao,Xixing Zhu,Renming Hu
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index392914021722836797950317933568286215456458449648
#%238284364047277051048806493904008598891939491270
#%125327012990841675178692992579721409047519483881
#%994663784910934664746043701368832524515418685389
#%547358930512710623846589533522993293435984688757
#%1134316742908806820439970403555300672044123021553
#%395938356635512198592180187340671234088926823676
#%1280810398534080879311131913168105721050711778401
#%472449700622665041541747987005333536750740376340

#*What happens after community-based screening for diabetes in rural and Indigenous individuals?
#@T. Oster,Kelli Ralph-Campbell,Tracy Connor,Mary Pick,L. Toth
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1180420536878066830528212284521001445149435481385

#*Prevalence and risk factors for albuminuria among type 2 diabetes mellitus patients: A Middle-East perspective
#@P. Prashanth,K.J. Sulaiman,G. Kadaha,N. Bazarjani,S. Bakir,El Jabri,Al Sabr,H. Mahmoud
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index816753928878706824180119506746648238767427697395
#%1373588097250043841744279517410457493594034270212

#*Determination of the BMI threshold that predicts cardiovascular risk and insulin resistance in late childhood
#@Chanwon Kim,Bomtaeck Kim,Namseok Joo,Yongwoo Park,Hyoungjune Lim,Youngsu Ju,Seiwon Yang,Suekyung Park,Belong Cho,Kyunghee Park
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index852010933262365715939184541589868656999512080396
#%628244059235156684012048307599121313241337103085
#%759078760739559420344668735808142132143159838110
#%928764211788914215413967975832186092996152061433
#%32355771887320871871732478114736023351402061418
#%703235714857918062852360523406073131966474660645
#%1131643039657693959094065022642816158142258607948
#%1438361308239152205343302480156715263383345379538
#%1319466522979354129263671780672252838083976338690

#*Association of statin use and development of renal dysfunction in type 2 diabetesThe Hong Kong Diabetes Registry
#@O. Luk,Xilin Yang,C. Ma,W. Ng,W. Yu,W. Lau,Risa Ozaki,C. Chow,P. Kong,C. Tong,C. Chan,Wingyee So
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index497840519593895085735417704899883192948660626934
#%768497743091318689334409897619512074813264049526
#%918947823318020149182577516226746967137319869623
#%357697853727337225109273314947659916084194532658
#%535214950781859989747336876441979658993335701311
#%431412729600776668789272016853046241948029539427

#*Achievement of management targets associated with incident and long-term diagnosed diabetes among a representative population sample
#@R. Chittleborough,L. Baldock,J. Phillips,W. Taylor
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index606878423031946991762320566086122331889859208693
#%473230005963336393934916009729934047313419670618
#%521378340721714846672028904585021850921386817554
#%741472667357967036521698557437635045148869117616

#*Development of a coronary heart disease risk prediction model for type 1 diabetes: The Pittsburgh CHD in Type 1 Diabetes Risk Model
#@C. Zgibor,Kristine Ruppert,J. Orchard,S. Soedamah-Muthu,John Fuller,Nish Chaturvedi,S. Roberts
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index35989442848028571542184623391736109461070552121
#%862657679846278038580576167863191047286304090527
#%1306054704710356267139720375747451044450239093884
#%663501753131419940438149704679470670996059841598

#*Predictors of metabolic control in children with Type 1 diabetes: The impact of Hurricane Katrina in a prospective study
#@L. Kamps,Enrique Varela
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index704001143590278620565146324269336576297636264572
#%949672236542385408236595427429416945618988525075
#%364265397803099657630294263305050815919276627503

#*Clinical efficacy and patient satisfaction with U-500 insulin use
#@M. Dailey,Sarah Williams,Deepa Taneja,R. Tannock
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index71914744863395205074709152721436846872439126593

#*Influencing factors of QTc among the clinical characteristics in type 2 diabetes mellitus
#@N.K. Subbalakshmi,P.M.R. Adhikari,K.N. Rao,P.S. Jeganathan
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index893324148558547551822362876035609976052121456586

#*Our experience of controlling diabetes in the peri-operative period of patients who underwent cardiac surgery
#@A. Emam,Andrew Allan,Khalied Eskander,Kareddula Dhanraj,El-Sayed Farag,Yasser El-Kadi,Wael Khalaf,S.R. Riad,R. Somia
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index893642048623108543317488364847666554169064068444
#%26576361320202139798868282952725625919226442781
#%117900702154208945923758161466289381646677532462

#*Initiation with once-daily BIAsp 30 results in superior outcome compared to insulin glargine in Asians with type 2 diabetes inadequately controlled by oral anti-diabetic drugs
#@Sanjay Kalra,Teresa Plata-Que,Dileep Kumar,Malik Mumtaz,Flemming Sndergaard,Plamen Kozlovski,Wan Bebakar
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index524987575636864861499534312910930971550969898265
#%657463036024543305612674721533784506688334612312
#%1204210450054912597786899191343141949179439576611
#%234464256120390197898967525223976092756457719098

#*Psychometric properties of the Chinese version of the SF-36 in older adults with diabetes in Beijing, China
#@Jie Hu,J. Gruber,Kuei-Hsiang Hsueh
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index618624483205774237093120498003282951453531407268
#%1172677228348686885501689655071745393817660190684
#%1070730794193622763939147865584561281660420962153
#%1203184378011942526137016375182877840360037027848
#%738576457366605796072771444720653649334789925506
#%518425603546493493940323555718715357998301512368

#*Hydrochloride pioglitazone decreases urinary monocyte chemoattractant protein-1 excretion in type 2 diabetics
#@Shandong Ye,Mao Zheng,Yuanyuan Hu,Lili Zhao,Yan Chen
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index419052571965905487769540169890530391976456284218
#%378592824191488941873337089412131523644313620029

#*Differences in associations between HSD11B1 gene expression and metabolic parameters in subjects with and without impaired glucose homeostasis
#@C. Karlsson,M. Jerns,B. Olsson,T. Lystig,A. Gummesson,L. Storlien,L. Groop,B. Carlsson
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index285282261331216708555591948724066902403645186407
#%845758794842092994548585283910388983602030144926
#%45693712075058604083262521461937058400343101427

#*Unregulated IL-23/IL-17 immune response in autoimmune diseases
#@Silva Costa,Colvara Mattana,Rossi Silva
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index465222468587238725059092415962613418040261798263

#*Computer use, free time activities and metabolic control in patients with type 1 diabetes
#@D. Benevento,C. Bizzarri,D. Pitocco,A. Crin,C. Moretti,S. Spera,C. Tubili,F. Costanza,A. Maurizi,L. Cipolloni,M. Cappa,P. Pozzilli
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index338860314907700945395361980365910671792914036579

#*Impact of metabolic syndrome on in-stent restenosis and clinical outcomes after percutaneous coronary stent implantation
#@Su Kim,Cheol Lee,Bo-Kyung Choi,Hye-Won Lee,Jin-Sup Park,Hwan Lee,Min-Soo Ahn,Jong Hong,Sang-Pil Kim,Sang-Kwon Lee,Dae Kim
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index978945678432899684683964298230568710407159051445
#%917370106707972150616340969217314093481886539993

#*Depressive symptoms in adolescents with type 1 diabetes: Associations with longitudinal outcomes
#@E. McGrady,K. Hood
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index915037181861567667399969544218331493719279669064

#*Looking beyond the issue of access to insulin: What is needed for proper diabetes care in resource poor settings
#@David Beran,S. Yudkin
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1195051521205815877007897003636603712656582345712
#%1236595399000451225394316664883946315448556887961

#*The importance of glycated haemoglobin (HbA 1c) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes
#@Chang Yu,Zsolt Bosnyak,Antonio Ceriello
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index459382981645200857653137860470226824236010934946
#%741287872941300850049028816652209747735441597402
#%595864865165273511500713115073613660416206010866
#%1052160633850366833305612854563651679101328092405
#%747494549459929334439546805110245830284331121758
#%1325768054296927391540792874831347730366909265496
#%279999983877944761980039202936569032539827604549
#%1428655331426423123915326107646609692500929096106

#*Latent class analysis of the metabolic syndrome
#@J. Boyko,A. Doheny,J. McNeely,E. Kahn,L. Leonetti,Y. Fujimoto
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1231814012010849632244139791798217350124175168829
#%608027367961477215758757976231510100673358964715
#%1457871129674784636971787357351421116735164726319
#%111638531386427442519038946629279256924432087071

#*Waist-to-thigh ratio and diabetes among US adults: The Third National Health and Nutrition Examination Survey
#@Chaoyang Li,S. Ford,Guixiang Zhao,S. Kahn,H. Mokdad
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index174441635909728393259041111722886672288217861266
#%160843041432479143389616145756950000257502006246
#%448257684075147968772168740617026716392441334856
#%1403802529782527972291903393236682178091057099254
#%913504029402112083160202840394080491890177092603
#%238311286876010250574220828262239206691569875416
#%623357985097201200514246953189538170009536044294

#*Association between screen time and metabolic syndrome in children and adolescents in Korea: The 2005 Korean National Health and Nutrition Examination Survey
#@Hee-Taik Kang,Hye-Ree Lee,Jae-Yong Shim,Youn-Ho Shin,Byoung-Jin Park,Yong-Jae Lee
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index238978628950019774100758335524411974596744796581
#%287227136494613963668205887747349397326892346058
#%1147173800783967659888297143886663796714935225541
#%1147173800783967659888297143886663796714935225541
#%1147173800783967659888297143886663796714935225541
#%959825847872985993892893916345975264253153535429
#%107532009928180433526143248240862021287443694112
#%1333341017597867411419816340479169542650753438907
#%1042163568998799130935035967598970197801370493566
#%373235547815391190549726032523082683318064842795

#*All-cause and CVD mortality in Native Hawaiians
#@Emmett Aluli,W. Reyes,Kalani Brady,U. Tsark,L. Jones,Marjorie Mau,J. Howard,V. Howard
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index597431427491365826573623332754297756693536149210
#%825299395053803870741699529812237389185512431231

#*Intra-abdominal fat accumulation is greatest at younger ages in Japanese-American adults
#@G. Lee,Y. Fujimoto,D. Brunzell,E. Kahn,J. McNeely,L. Leonetti,J. Boyko
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index776799554226265245238817816119479136213800746505
#%704588095685852637575296645659114689089850633596

#*A simple and promising tool to improve self-monitoring of blood glucose in patients with diabetes
#@Anagha Nadkarni,N. Kucukarslan,P. Bagozzi,Frank Yates,R. Erickson
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1055528322690730339255812228876851986283185202686
#%31749928824163085914532755893042072605819381086
#%275969524947030308517084762374324095653413669083
#%166642948392172250798293996620771276215481583675
#%741472667357967036521698557437635045148869117616

#*L-arginine attenuates high glucose-accelerated senescence in human umbilical vein endothelial cells
#@Weili Zhong,Guoliang Zou,Jianqiu Gu,Jin Zhang
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index634729623091667479342719760232335024330152479456
#%300319186236212145095555828217395346226978981536
#%965884781114850366499210702805506846699803327502
#%755530621540248826586413107083120773803176739489
#%1442849187192612138024046479624861328450630414934
#%348693458610226670889153523014169345329243828521
#%354726642743907423466745492384391902695546403204
#%62813785289161616413038097970135640729706809658
#%1003901021132360963587055204155704727574836102458
#%177098064109302223392268348187059605142937268708
#%1040112422669929188545005691239492743298628389943
#%187582325765224047949636317803795500900519149526
#%62813785289161616413038097970135640729706809658
#%755530621540248826586413107083120773803176739489

#*Glargine vs. NPH insulin therapy in pregnancies complicated by diabetes: An observational cohort study
#@A. Negrato,Alex Rafacho,Giovana Negrato,F. Teixeira,A.R. Arajo,Leila Vieira,A. Silva,K. Date,C. Demarchi,B. Gomes
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index686740474686787386495266165695734146385904065130

#*Long-term biomedical and psychosocial outcomes following DAFNE (Dose Adjustment For Normal Eating) structured education to promote intensive insulin therapy in adults with sub-optimally controlled Type 1 diabetes
#@J. Speight,S.A. Amiel,C. Bradley,S. Heller,L. Oliver,S. Roberts,H. Rogers,C. Taylor,G. Thompson
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index204435011759391712055797473135145947132818719506

#*Increased urinary orosomucoid excretion predicts preeclampsia in pregnant women with pregestational type 1 diabetes
#@M.S. Christiansen,D. Hesse,P. Ekbom,U. Hesse,P. Damm,E. Hommel,B. Feldt-Rasmussen,E. Mathiesen
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index954574820840441434670808454248070124941474926122
#%305929636058631362635009384150680954065687260483
#%912667771356176285078446185016246867299817310222

#*Distinct association of serum FGF21 or adiponectin levels with clinical parameters in patients with type 2 diabetes
#@Kazuhiro Eto,Bayasgalan Tumenbayar,Shu-ichi Nagashima,Fumiko Tazoe,Michiaki Miyamoto,Manabu Takahashi,Akihiko Ando,Kenta Okada,Hiroaki Yagyu,Shun Ishibashi
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1350427807153073468197149909397226182644198229908
#%119622326482886340595346954764799138549975445093
#%44456484203580109094570906925988228075938855958
#%833260003081799583322216151760742439457474627737
#%1339975228577140539627746529311789472983974443829
#%1350148846874809288912856128062504277245491482472
#%182870500034716053344034218511960681566427461441
#%58337085491338847478794167989758908808596665839
#%1209781577188131723125660263859337949330489453314

#*Effect of transcutaneous electrical nerve stimulation on symptomatic diabetic peripheral neuropathy: A meta-analysis of randomized controlled trials
#@Dong-mei Jin,Yun Xu,Deng-feng Geng,Tie-bin Yan
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1361555992058631721542573182751274444232505558320
#%415097072392951639301555533900409839481609567766
#%561521956436951045142330965458133706397964937272
#%142001996938216078008173002703829434504597223793
#%137291502596196227051192328331733243870562911864
#%433264488778230435936641752146302306523039894964

#*Characteristics and hospitalization costs of patients with diabetes in Spain
#@Ana Lopez-de-Andres,Pilar Carrasco-Garrido,Jess Esteban-Hernandez,ngel Gil-de-Miguel,Rodrigo Jimnez-Garca
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index69450507671254208235510757258822175616919620583
#%1026424198900390578543303288759255477509744900591
#%590350350465637847521261204695516723736606221578
#%874067424754753454575681778934663878448119916658
#%599837043519258494668977948963356643112093680425
#%191199662586636868722569800290056482582522367836

#*Synergistic effects of ACE (I/D) and ApoE  gene polymorphisms in metabolic syndrome: Larger samples are needed
#@Hong-Liang Zhang
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index420644400439704912334888753471315473628574584633
#%448946285752911980379595282163331954802862777460

#*Interests in beta-cell replacement therapies among Japanese patients with type 1 diabetes
#@Nobuyo Hatanaka,Morihito Takita,Takuhiro Yamaguchi,Masahiro Kami,Shinichi Matsumoto
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index528452434713038778064788398976297553408074039116
#%215881723320091263776547510057744297881045044355
#%210445596526288339623973833315959455716495745960

#*Insulin pump access issues for visually impaired people with type 1 diabetes
#@Lorraine Marom
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index79578926186378131570229684740023959366795201311

#*Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for diabetic retinopathy in Japanese patients with type 2 diabetes
#@Naoto Katakami,Munehide Matsuhisa,Hideaki Kaneto,Taka-aki Matsuoka,Kenichi Imamura,Fukashi Ishibashi,Tsutomu Kanda,Koichi Kawai,Takeshi Osonoi,Atsunori Kashiwagi,Ryuzo Kawamori,Iichiro Shimomura,Yoshimitsu Yamasaki
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index133946874906129905895013914284556068114296059724
#%211805592386661045191048515198371121409325291338
#%148152836964004046071576579695322566057375625391
#%148152836964004046071576579695322566057375625391

#*Validating ICD coding algorithms for diabetes mellitus from administrative data
#@Guanmin Chen,Nadia Khan,Robin Walker,Hude Quan
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1239634377672496081393398188109257550425766521145
#%630227562341490064079882525596520130850886976902
#%1275763294602772857392967135888324313959777194497
#%609842363946676933575137474567546640111821755306
#%687945407402549849910896926810000019568438345702

#*Prevalence and risk factors of metabolic syndrome among Asian Indians: A community survey
#@Muthuswamy Ravikiran,Anil Bhansali,P. RaviKumar,Shobhit Bhansali,Pinaki Dutta,J.S. Thakur,Naresh Sachdeva,Sanjay Bhadada,Rama Walia
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index516976162579008786790952858760577966721725912569
#%860022615160432358769576638139277096798571837825
#%848611662715273749258735016164807571071057995027
#%848611662715273749258735016164807571071057995027
#%280621376447546949238959467237765448492766065187
#%733205853001736720210436139937919689089776257132
#%1170639022131643724766852745794828738170769199627
#%706943070084111686836970286625697703259160048976

#*Visceral fat is negatively associated with B-type natriuretic peptide levels in patients with advanced type 2 diabetes
#@Takako Sugisawa,Ichiro Kishimoto,Yoshihiro Kokubo,Ayako Nagumo,Hisashi Makino,Yoshihiro Miyamoto,Yasunao Yoshimasa
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index793608764765763148049724809704860864559313611454
#%84830374607748303856554603506783606361947981931
#%710170996031016648045984283766279322444019836760
#%829914524963639929066180645080472249535907359188
#%1213547092929118048600567064207738975604969254602

#*Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients
#@Sun Kang,Kyoung Song,Hwa Lee,Jee Ko,Ryong Cha
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1201391890948303627779268366296216426513518294464
#%1339118030089354802237220255046308357942963267493
#%359704911589716698767639707562984061012562867961
#%420678721583814257978460366381870733954688828022
#%1124698017437239944129260319755797072529734218770
#%1153490058384933982965594265204671172234029044673

#*Endothelial dysfunction in myometrial arteries of women with gestational diabetes
#@H. Chirayath,Mark Wareing,J. Taggart,N. Baker
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index454835846956702411940794231181333562372563441569
#%1049425178057562601739563562780706142060565422745
#%1355523126139526722897727659472809492088447184386
#%1460626813716399393708913910760448991330798311891
#%1424130954822199658099707262773167966322654265477
#%483437318479860065383818214321196462644381100488
#%1021982513613603056835415360792543806276663437056
#%263877116466338027438921821215631920550238003771
#%815419293567878470727062983931188479246122240528

#*Diagnosing microalbuminuria and consequences for the drug treatment of patients with type 2 diabetes: A European survey in primary care
#@M. Aakre,Geir Thue,Sumathi Subramaniam-Haavik,John Cooper,Tone Bukve,A. Morris,Mathias Mller,V. Lovrencic,Inger Plum,Kaja Kallion,Alar Aab,Marge Kutt,Philippe Gillery,Nathalie Schneider,R. Horvath,Rita Onody,Wytze Oosterhuis,Carmen Ricos,Carmen Perich,Gunnar Nordin,Sverre Sandberg
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index318294673750126392958357905927904193193991507918
#%1014050429518595887361295856904183858259214252958

#*Relation of resistin levels with cardiovascular risk factors, insulin resistance and inflammation in nave diabetes obese patients
#@D.A. Luis,Gonzalez Sagrado,R. Conde,R. Aller,O. Izaola,B. Fuente,Perez Castrilln,E. Romero
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index498352712697982430339665591811588743225985378633
#%205482879605682714091152743885205940042589099135
#%201712715006645054724818682206171624173823853789

#*Gestational diabetes mellitus screening based on the gene chip technique
#@Zhaoxia Liang,Minyue Dong,Qi Cheng,Danqing Chen
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1000237118027318165874351874209292337268644796464
#%211919430021184492961666656555611494915940157015
#%1324474406605269693562543839116415977553405549468
#%373226729588159950851977478598105957854873312532

#*Effects of insulin initiation on patient-reported outcomes in patients with type 2 diabetes: Results from the DURABLE trial
#@J. Lee,L. Fahrbach,M. Nelson,D. McLeod,A. Martin,Peter Sun,S. Weinstock
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index744759777518847686862153681715454472365711700103
#%657463036024543305612674721533784506688334612312
#%731268011334607010926451422076713538272179240222
#%1362981196669584779628147082833983475046744812134
#%1223233905761656090765928906726754137677495278040
#%925331882877914920841993609463955669153169935195

#*Salicylate prevents hepatic oxidative stress activation caused by short-term elevation of free fatty acids in vivo
#@Bing He,Sheng Zhao,Wei Zhang,Yan Li,Yan Lu,Ping Han
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index876735463760552025438737175262648696423903569085
#%1295172049694566087759897108668994520034812438668
#%1138706179720810147066714459447862291796102851443

#*Evaluation of error levels in hemoglobin A1c and glycated albumin in type 2 diabetic patients due to inter-individual variability
#@Yasuhiro Tahara,Kenji Shima
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1133252180265081062811473986874935548048578446959
#%481570781244869144784002259840012820397148090045
#%900336596417037110728377340277067301900025752270
#%659346669664977059904706732158788519367547351135
#%773290049541987842368517098111829249911265406991
#%1226769975846320613185823131049269893758757059221

#*Is insulin pump therapy better than injection for adolescents with diabetes?
#@P. Wu,M. Graves,C. Roberts,C. Mitchell
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1256575227363753698594573060031447968204010933471

#*Prevention and control of type 2 diabetes by Mediterranean diet: A systematic review
#@Katherine Esposito,Ida Maiorino,Antonio Ceriello,Dario Giugliano
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index509341899298332918740872757494570870539461618009
#%306232289460744045629162792646698523988624398614
#%414828350807897057955276061968479010395854068814
#%414828350807897057955276061968479010395854068814
#%812184743054108837267801815717942132035461795635

#*Enhancement of glucose transport by selected plant foods in muscle cell line L6
#@K. Noipha,S. Ratanachaiyavong,P. Ninla-aesong
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index181504774373014156002973712041366689379864667160
#%699300150118933199348167947815351667759830445001
#%1219198025093324082714581237674650736733173960110
#%861375623907526310444189906456852647096828620666
#%1187609998575823301592841793534035809987543793881

#*Distribution of 7-year risk of diabetes mellitus among United States adults
#@S. Ford,Chaoyang Li,Guixiang Zhao,S. Pearson,W. Gregg
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1300397358713841865464283252320154945117311512862
#%593278508426615700564096658807807234883906851846

#*Long survival in RabsonMendenhall syndrome
#@M. Fuente
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1436290496524177833884050282069240823105431617294

#*Response of interleukin-6 during euglycaemic and hyperglycaemic exercise in patients with type 1 diabetes mellitus
#@S. Jenni,S. Wueest,D. Konrad,C. Stettler
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1461101640345888096499494365474796206748144428913

#*A case of chronic hepatitis C developing insulin-dependent diabetes, thyroid autoimmunity and stiff-person syndrome as complications of interferon therapy
#@G. Scavone,F. Zaccardi,A. Manto,S. Caputo,D. Pitocco,G. Ghirlanda
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index550513135690479744639797012978398862429918694341
#%30177415347470612980815922478517933673817355087
#%590729973287640398467589803773701053179037000615

#*Urinary type IV collagen excretion predicts subsequent declining renal function in type 2 diabetic patients with proteinuria
#@Pisut Katavetin,Paravee Katavetin,Paweena Susantitaphong,Natavudh Townamchai,Khajohn Tiranathanagul,Kriang Tungsanga,Somchai Eiam-Ong
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index559062873495995560232092494963193664419019304070
#%256572151333539523084302546418682420858007797381
#%332289710411316825347276008376754024880464179608
#%521557923207207864159686404846520601413569193947

#*Hypoglycemic symptoms in patients with type 2 diabetes in Asia-PacificReal-life effectiveness and care patterns of diabetes management: The RECAP-DM study
#@Siew-Pheng Chan,Li-Nong Ji,Wannee Nitiyanant,Hyun Baik,H.-H. Sheu
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index638857685880944813006472851475693742316494048105

#*The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial
#@S. Zoungas,J. Chalmers,A.P. Kengne,A. Pillai,L. Billot,B. Galan,M. Marre,B. Neal,S. Harrap,N. Poulter,A. Patel
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index951850840460952804901615617144607467473582557004
#%398966926411729416063166796594408977831586910264
#%81213820779628439997771728246816137838544651559
#%1325768054296927391540792874831347730366909265496

#*The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: Retrospective long-term follow-up
#@Toshiko Takao,Takehiko Ide,Hiroyuki Yanagisawa,Masatoshi Kikuchi,Shoji Kawazu,Yutaka Matsuyama
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index867696603377951439510374623655603777674394066220
#%481570781244869144784002259840012820397148090045
#%1213970065150152242748918451103807760520145980868
#%69159425794833166306006455822754594954190726175
#%698950333732119918328679556934817248354220382342

#*Regional adiposity and risk for coronary artery disease in type 1 diabetes: Does having greater amounts of gluteal-femoral adiposity lower the risk?
#@M. Shay,M. Secrest,H. Goodpaster,F. Kelsey,S. Strotmeyer,J. Orchard
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index466949176763483334564734743082424921813585485427
#%783656410178030155486506678919977842787145649839
#%531854250562861170312385164139104694826374719406

#*Impaired fasting glucose and cardiovascular risk factor clustering among Mongolian population in rural and animal husbandry area, Inner Mongolia, China
#@Shaoyan Zhang,Weijun Tong,Guiyan Wang,Tan Xu,Yonghong Zhang
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index575289589699214360664106711374806140673790832058
#%1035896340218987600276986099612941558703214507895
#%412614554432816579517333446969388015298201411113
#%412614554432816579517333446969388015298201411113
#%454520002677779716637711304701531046833883314312

#*The magnitude of association between overweight and obesity and the risk of diabetes: A meta-analysis of prospective cohort studies
#@Asnawi Abdullah,Anna Peeters,Maximilian Courten,Johannes Stoelwinder
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index99096373254890049840935174836274860932767034510
#%1212059967549430580003849904766684121974038431831

#*Prevalence of insulin resistance and its relationship with cardiovascular disease risk factors among Thai adults over 35 years old
#@D. Do,Vitool Lohsoonthorn,Wiroj Jiamjarasrangsi,Somrat Lertmaharit,A. Williams
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1233361980568405392849732397139224159345479356902
#%266219080691623424426114637308467601024351808099

#*The association of masked hypertension in treated type 2 diabetic patients with carotid artery IMT
#@Jiri Charvat,Jaromir Chlumsky,Marcela Szabo,Eva Zakovicova,Vaclav Zamrazil
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1052334959721479140152068119385891930023817679678
#%335417718758461100193264160636284380338948393794

#*A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 2436 weeks of gestation
#@zlem Karacay,Aylin Sepici-Dincel,Deniz Karcaaltincaba,Duygu Sahin,Serdar Yalva,Mesut Akyol,mer Kandemir,Nilgn Altan
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index415061960226839523277218402189753546737731685043
#%546877946015766689296634685237832811201418984507
#%546877946015766689296634685237832811201418984507
#%636277255565220745167168264150568140655885898710
#%145290544300892797038499315140594567980386018414
#%12328640779886241563459272358458278825408919481
#%818395055325945361191839167400275954213354201192
#%200129032356938284455270144965411906590123221256
#%853882391960178529080463255213932452897641056170
#%157318090736396434556618853197910090935323616619
#%214495172274237966003468790890801782305223628376
#%861342479680535670243755341819213809079932105454

#*Oral mucosal lesions in non oral habit diabetic patients and association of diabetes mellitus with oral precancerous lesions
#@Rajan Saini,Ali Al-Maweri,Deepti Saini,Mastura Ismail,Rashid Ismail
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1148138363934732425513136359305686236958629491783
#%1359957065898492114794661847309358431476544830086
#%155666481839187790988081815994473556546502054405
#%427962274508513906619623139718282967057550081499
#%128421982744218939148888521085809958069127540917
#%1411103057713904437887079674967679232944898458159
#%528643843273247563244034689916204634827293507508
#%42390597974218062434454396586331883003069044731
#%419680721650588934035052106718935742680148552306
#%1284039198182893933948277309696781454134466476908

#*Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with Type 2 diabetes mellitus
#@Masatoshi Kikuchi,Masakazu Haneda,Daisuke Koya,Kazuyuki Tobe,Yukiko Onishi,Andre Couturier,Nobuyuki Mimori,Yoko Inaba,Matthew Goodman
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index256412337679430516970336213916908483640399324533
#%1442829383694121676021945154028046296796081052858
#%14241206387526043709591094328425913038730939200
#%169356184805010065904536626380402235372415592169

#*Effect of high-dose valsartan on inflammatory and lipid parameters in patients with Type 2 diabetes and hypertension
#@Ulrich Kintscher,Nikolaus Marx,Peter Martus,Martina Stoppelhaar,Julia Schimkus,Anna Schneider,Daniel Walcher,Andreas Kmmel,Robin Winkler,Kai Kappert,Yvonne Drffel,Jrgen Scholze,Thomas Unger
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1179118539976408562954498430516892686532892020268
#%1418919768796748916083431282854536392753572910033
#%842498980017533687207488737127263878632351325165
#%1113350275667656905260457847798005852437086367630

#*Population analysis of ethnicity and first-phase insulin release
#@Lanyi Xie,P. Hoffman,Peter Veng-Pedersen
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index464402762887762976563601331913079489873223497178
#%716759959801103486568332130519705522017740536658
#%665027829614194322865483224997844174365590817780
#%181837738072462181771024690942233659559569446901
#%259113702024283329961940377839006995273137432116
#%1232981212175725159502407341315981013726448935405

#*Performance of different definitions of metabolic syndrome for children and adolescents in a 6-year follow-up: Tehran Lipid and Glucose Study (TLGS)
#@Parvin Mirmiran,Roya Sherafat-Kazemzadeh,Jalali Farahani,Golaleh Asghari,Mahtab Niroomand,AmirAbbas Momenan,Fereidoun Azizi
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1155748114486987533008678751095304943308218593646
#%1010222040799964209743600689124671903096339153206
#%61576465696274777277568808736033775625599920534
#%120164318105580360079948316181739986058637616391
#%1374310210571094178812676785082365325858134197455

#*Characteristics of insulin resistance and insulin secretory capacity in Korean subjects with IFG and IGT
#@Youl Rhee,Jeong-taek Woo,Suk Chon,Cheol Hwang,Seungjoon Oh,Jeung Ahn,Yeon Chung,Woon Kim,Jin-Woo Kim,Seol Kim
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1164776928829090581339948690531518721693553266918
#%94577769714666607732098930324025695866280610384
#%735009024663998479048138862737818215104111252409

#*Systematic care to reduce ethnic disparities in diabetes care
#@W. Kenealy,S. Eggleton,M. Robinson,F. Sheridan
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index525074631889042009260283256755029796617204369963

#*Circulating glycolaldehyde induces oxidative damage in the kidney of rats
#@Rodrigo Lorenzi,Everton Andrades,Calixto Bortolin,Ryoji Nagai,Felipe Dal-Pizzol,Fonseca Moreira
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1100579039515683306208636306652941389871919013645
#%591816103727956891889629260889177013924384695930
#%703711043685577536687392481998096228454787663338
#%1098144179829421639042084536125523179231106568885
#%871420606657034159502840525265017798389063525778
#%318969296395222389962906774195833477355901686537
#%121821839612718109604739379728819850336779032719
#%1412789661308233998001509685814598751485634142181

#*The socioeconomics of diabetes from a developing country: A population based cost of illness study
#@Shabana Tharkar,Arutselvi Devarajan,Satyavani Kumpatla,Vijay Viswanathan
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index405268131376917214119599767721317061797388672932
#%63683625744383308659447598622299026105049590389
#%1145022552978190951841373146593219489488316552320

#*Silencing inducible nitric oxide synthase protects rat pancreatic islet
#@Li Bai-Feng,Liu Yong-Feng,Cheng Ying
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index844313526248871114037250964809598146105833009961
#%486644926216132260934646052089292585138892598158
#%444680268123955537508245015278320797627431383150
#%822691380425283595634179616536152589449100184808
#%117472772081134069798838461373625071005835973570
#%663522154016588592270513110172293886391290539052
#%1363692288196182488946202738669605820183942200824

#*Caesarean section and macrosomia increase transient tachypnoea of the newborn in type 1 diabetes pregnancies
#@Rany Al-Agha,T. Kinsley,M. Finucane,Sharon Murray,Sean Daly,Michael Foley,Coulter Smith,G. Firth
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index81304680780255271544169249379718588864828943390

#*Targeting educational interventions to clinician's stage of change
#@H.Y. Yu,P. Batty
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index618676795066034849325683761627626911600700481328

#*Follow-up survey of all participants at the first and second juvenile diabetes summer camp in Japan in 1963 and 1964
#@Toshika Otani,Yasuko Uchigata,Tadasu Kasahara,Hiroko Takaike,Hiroshi Maruyama,Yasuhiko Iwamoto
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index570430616365578832225339684581538409483968560527

#*Type III hypersensitivity to insulin leading to leukocytoclastic vasculitis
#@B. Rachid,M. Rabelo-Santos,E. Mansour,R. Zollner,L.A. Velloso
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index281321239550446614678904238663254018004498841942
#%1311446238657046142018249175065928081612030681331

#*The clinical and cost effectiveness of bee honey dressing in the treatment of diabetic foot ulcers
#@A.M. Moghazy,M.E. Shams,O.A. Adly,A.H. Abbas,M.A. El-Badawy,D.M. Elsakka,S.A. Hassan,W.S. Abdelmohsen,O.S. Ali,B.A. Mohamed
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1370911809964272093270553518325818051909062631511
#%939071976484888742467899368597290159070148187372
#%385333706783023252072423969711410032430735667115
#%472578087980685742009856843374898707364646974396
#%1246363663188075673891327209582113975238847011577
#%1196161609750116684341889703007950459537063158028
#%811912538759059665130438456107175989726224196916

#*The cardiorenal syndrome in diabetes mellitus
#@H. Karnib,N. Ziyadeh
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1443520484852259725534268834918761863520350142070
#%1372234833018656585377712275893843699798964325470
#%481133592538376784635822885743437248166688763925
#%373885281132533842359156762868935694981375668052
#%834093727965383474358000171413779837108968362594
#%725026284937588445739635918850808716130794854699
#%6384125789347502402683642588631155602576072027
#%1047004463905509489441304828147215633833156113199
#%153649755782507054781317362797388531807201761062
#%1137919802797302309333426739699747127842252866534
#%1310564006108690170254597413910550252616292304899
#%583136685607995677126304053148153695861661274149

#*The association between quality of life, depressive symptoms and glycemic control in a group of type 2 diabetes patients
#@M. Papelbaum,H.M. Lemos,M. Duchesne,R. Kupfer,R.O. Moreira,W.F. Coutinho
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1460273173211578371552182051220514298603076862419
#%667705353135585269797078176625868308446903294004

#*Safety and effectiveness of flexor tenotomies to heal toe ulcers in persons with diabetes
#@P. Kearney,A. Hunt,A. Lavery
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1167260568571514995871587805501094238720871203663
#%805063041606917592355295062141060318063735377683
#%1069432759615744513336434907756321425805517335452
#%1287734256616221807845927827538897278202924016959
#%1239761542208354469665503399837924842420133040560

#*Acarbose reduces the risk of pre-lunch hypoglycemia in elderly people with diabetes eating rice porridge for breakfast
#@Jung Hsieh
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index879529872513452449001229390959696971111610718050
#%1213970065150152242748918451103807760520145980868
#%752554249607722146835878072235257283439264626733
#%501173907790204679117197642773113401964105078350

#*The relationship between arterial elasticity and lipid profile in people with type 1 diabetes mellitus
#@Carvalho Rond,S. Freire,Homero DAbronzo,Ivan Macedo,Nilda Chavez-Jauregui,Alves Luzia
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1409724218545491151232456052332943456660873134762
#%135578403436295102833630232412131147640480256069
#%213610509050544202676359481800307951294170978894

#*Increased levels of 8-hydroxydeoxyguanosine in the vitreous of patients with diabetic retinopathy
#@Yoshihiro Wakabayashi,Yoshihiko Usui,Yusuke Shibauchi,Hiroyuki Uchino,Hiroshi Goto
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index280296538057186223462273279553789934044411018781
#%1403763027417994643087616683344415689880782057917
#%1061700206762932383581031666194399403986059183709

#*Clinical and genetic analysis of the insulin receptor gene in a Chinese patient with extreme insulin resistance
#@Guo-Qing Yang,Bao-An Wang,Wen-Rui Zhao,Wei-Jun Gu,Zhao-Hui Lui,Jing-Tao Dou,Yi-Ming Mu,Ju-Ming Lu
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1050995503463177491160474593661425398813343321281
#%1003222665355329048340642843655914379898811754299
#%927614198217650014150524726056504235907188177403

#*Comparison of agouti-related peptide levels in peripheral blood of postpartum pre-eclamptic and non pre-eclamptic women and in umbilical cord blood from their pregnancies
#@Julie Bienertova-Vasku,Petr Bienert,Josef Tomandl,Jolana Lipkova,Filip Zlamal,Zuzana Dostalova,Anna Vasku
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index729832115467173712895539400902463764254322756500

#*Incretin secretion and serum DPP-IV activity in Korean patients with type 2 diabetes
#@Jin Han,Jin Kim,Sung-E Choi,Yup Kang,Woo Lee,Jung Kim
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index734026310387176550037390494208671364471662435923
#%397483178502355707894639326670138164173548659357
#%735009024663998479048138862737818215104111252409
#%390371137728887586911880288885235639516434221172
#%390371137728887586911880288885235639516434221172

#*Progression of cardiac autonomic dysfunction in newly detected type 2 diabetes
#@P. Jyotsna,Ksh Singh
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1239080740089487735083875436995510435547969092327
#%91554233075046003730115208026121429802977433051

#*Physical activity and health-related quality of life in individuals with prediabetes
#@M. Taylor,C. Spence,Kim Raine,C. Plotnikoff,K. Vallance,M. Sharma
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index887613091157157733926571340540186854556096528872
#%1416900979806298534274095805332476678748494702884
#%1362510813644908322004693719298042814553605484216
#%738576457366605796072771444720653649334789925506

#*Autoantibodies found in type-2 diabetes with AIT test may be associated with its nephropathic complication
#@EelG-You Park,Think-You Kim
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index413146020018038778006238602230323509964243846003
#%747814119650414983082442055591897157682725960009

#*Correlation between glucose fluctuations and carotid intima-media thickness in type 2 diabetes
#@Xiao-min Chen,Yan Zhang,Xing-ping Shen,Qun Huang,Hong Ma,Yang-Ling Huang,Wen-Qiang Zhang,Hao-Jie Wu
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index747541474875056861855202716841648565473476759261
#%911755951773234834098825170837027664281776361715

#*Sample stability for the measurement of hemoglobin A1c
#@Mariella Mercadanti,Alberta Caleffi
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1222745306694389566211561704428000356101496314960

#*Improvement of psoriatic arthritis by pioglitazone treatment in a type 2 diabetic patient
#@M. Takahara,T. Shiraiwa,H. Kaneto,T. Yasuda,A. Kuroda,F. Sakamoto,T. Naka,K. Miyashita,K. Sakamoto,T. Matsuoka,I. Shimomura,M. Matsuhisa
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index976661365260461670080729315484639089836268197723

#*Newly diagnosed hyperglycemia and stress hyperglycemia in a coronary intensive care unit
#@M.E. Ertorer,F.E. Haydardedeoglu,T. Erol,I. Anaforoglu,S. Binici,N.B. Tutuncu,A. Sezgin,N.G. Demirag
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1356584929613456925261534845980948899368004710872
#%1161120964422855144299156923873534315787448207822
#%750559553037628900028430023505020919612650287551
#%409562326928813714152669972341134724417512641817
#%1449005384960677540707614895751154616790243102417
#%568150017270434545539404471826851638608000780449

#*Association between the -634 C/G polymorphisms of the vascular endothelial growth factor and retinopathy in type 2 diabetes: A meta-analysis
#@Tongfeng Zhao,Jiangpei Zhao
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index671578476425325663810938506255358140608141147323
#%1359655863985557271767284743098753789223016885012
#%451046350379264081173793291935464964333849344849
#%1196568100140970470324782063841478186443019579626
#%1341971400198420472171157471571326564473764055601

#*Continuous interstitial glucose monitoring in non-diabetic subjects with end-stage renal disease undergoing maintenance haemodialysis
#@E. Sobngwi,G. Ashuntantang,E. Ndounia,M. Dehayem,M. Azabji-Kenfack,F. Kaze,E. Balti,J.C. Mbanya
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1211698453816534486534969209959908249676236341487

#*Candesartan attenuates fatty acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic -cells
#@Yukie Saitoh,Wang Hongwei,Hiroaki Ueno,Masanari Mizuta,Masamitsu Nakazato
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1225072902915412723117374245056820397520969790531
#%1223002607115507954737894631300716985624118855646
#%145494803527952742798402898733067053319302116306
#%1451424283701518034303325675555658716726674159618
#%665963967976244337786742792392728785403029311246

#*Effect of a continuous diabetes lifestyle intervention program on male workers in Korea
#@Yeon Kang,Woon Cho,Hee Sung,Kyoung Park,Mi Paek,In Choi
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index188288049813809059120366155829456932923188295940
#%789198489702586542926219084517612861962341004780
#%1382418450614098050663389260378438796173418950574
#%608923037981491863674742545909698724822871461976
#%1186428801436723530684320505823618748494406511998
#%840672571807457633578748298453536506450112489678
#%79975017337134443886350592736358265955027260239
#%557727824308545739921668888144258738284575909388
#%141987134788408700971400737562569424832603657279
#%294399694518901391286705218908215767596925694309

#*Are active sun exposure habits related to lowering risk of type 2 diabetes mellitus in women, a prospective cohort study?
#@G. Lindqvist,Hkan Olsson,Mona Landin-Olsson
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index850039278170397623293792025532707736296276250210
#%1387425293230024525857896665944316118743528977993
#%743337159850451227312050452619247260029330493505

#*The potential impact and optimal cut-points of using glycated haemoglobin, HbA1c, to detect people with impaired glucose regulation in a UK multi-ethnic cohort
#@A. Mostafa,Kamlesh Khunti,Thiagarajan Srinivasan,David Webb,J. Gray,J. Davies
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index647335492723636123197665076580632592205736038961

#*Identification of metabolic syndrome using decision tree analysis
#@Apilak Worachartcheewan,Chanin Nantasenamat,Chartchalerm Isarankura-Na-Ayudhya,Phannee Pidetcha,Virapong Prachayasittikul
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index382595631158006278975036283504076684408838785166
#%928709109943345810247802106108301886995376825257
#%860022615160432358769576638139277096798571837825
#%89825535862273513836487335569468385150687388833
#%503901599642392621345830021616073880407976205170
#%60132564672801738696820977742853925209897213203

#*The changes of visfatin in serum and its expression in fat and placental tissue in pregnant women with gestational diabetes
#@Yao Ma,Yan Cheng,Jue Wang,Haidong Cheng,Shufeng Zhou,Xiaotian Li
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1110180756824738491573178964332107130915003003240
#%1052865035211547802003859227958217176598073096487
#%982771805899213301359700692166756396511858716536
#%578855159281524353094286368048426121627072923219
#%535218107156222139789744983331637950633339279224

#*Diabetes incidence for all possible combinations of metabolic syndrome components
#@A. Nichols,J. Moler
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index287901311571127449830163323202110713223651651454
#%944940952388715148989370803828489774517505362952
#%608027367961477215758757976231510100673358964715
#%1438361308239152205343302480156715263383345379538

#*Incretin action maintains insulin secretion, but not hepatic insulin action, in people with impaired fasting glucose
#@Leigh Perreault,Dalla Man,M. Hunerdosse,Claudio Cobelli,C. Bergman
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index602509027097184702319127622435760809281943924819
#%217987051208699077260578840099100010521856316616
#%1140052528248452183811209182661711909149689504987

#*The impact of health insurance coverage on pediatric diabetes management
#@A. Wintergerst,M. Hinkle,N. Barnes,O. Omoruyi,B. Foster
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index157180371009971990570986155895759539017642903678
#%647207352993700572949540616003108104467853498106
#%524058293979636223849246697946658268114675212136
#%783267048096737865008707104394912889782661580499
#%1224821979801933820269147961689819787013377991728
#%1147644852122334371973108127623964785571490361836

#*Periodontal disease and risk for neuropathic foot ulceration in type 2 diabetes
#@Luciana Abrao,Kliemann Chagas,Helena Schmid
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index477517575142531915172891658837291548179334234433
#%1174367991750034239797262406838112313659882521362
#%1299132414953617378733412174120815819955689190808
#%848853432529379999243816841395751352340912957078
#%908434305429191075985544034535289953954565709160

#*Candida-associated denture stomatitis in type 2 diabetes mellitus
#@Barbara Dorocka-Bobkowska,Dorota Zozulinska-Ziolkiewicz,Bogna Wierusz-Wysocka,Wieslaw Hedzelek,Anna Szumala-Kakol,Ejvind Budtz-Jrgensen
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1438094439570648741135259863592695578864508059993
#%1023416556401013546738459536790171081960361049040
#%359493634449375151082718103978853611080610713101
#%470664039984512272966203559748367948134307291850
#%470664039984512272966203559748367948134307291850

#*NF-B binding activity and pro-inflammatory cytokines expression correlate with body mass index but not glycosylated hemoglobin in Chinese population
#@Lan He,Ming He,Xiaohong Lv,Dan Pu,Peihe Su,Zhiquan Liu
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index858529529039362446302605286180365258135059002191
#%420678721583814257978460366381870733954688828022
#%1299132414953617378733412174120815819955689190808

#*Higher recent A1C in diabetic patients with acute non-ST elevation myocardial infarction as compared to other critical illnesses
#@Prasanna Santhanam,Todd Gress,K. Driscoll,S. Chertow
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index906284867384212661319740284726083284039612519348

#*Erratum to Comparison of clinical-metabolic monitoring and outcomes and coronary risk status in people with type 2 diabetes from Australia, France and Latin America [Diabetes Research and Clinical Practice 2010;88:713]
#@J. Gagliardino,Line Kleinebreil,Stephen Colagiuri,Jeff Flack,E. Caporale,Fernando Siri,Charles Clark
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index524801492633997688290036311598411603918043509133

#*Erratum to Interaction between HNF4A polymorphisms and physical activity in relation to type 2 diabetes-related traits: Results from the Quebec Family Study [Diabetes Res. Clin. Pract. 84 (2009) 211218]
#@Stephanie-May Ruchat,S. Weisnagel,Tuomo Rankinen,Claude Bouchard,Marie-Claude Vohl,Louis Prusse
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index359094482835343671792681958557187129749733395562

#*The clinical use of the 10 g monofilament and its limitations: A review
#@S. Tan
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1210181743408412758669549918049781950014248120719
#%488851795397444772764511863423335212564713105815
#%472449700622665041541747987005333536750740376340
#%221565544527553065836723450023767130133968435987
#%22036618186945693653251872431758220153637837294
#%450609503557736606923972960149555318426215806122

#*Habitual intake of dairy products influences serum 1,5-anhydroglucitol levels independently of plasma glucose
#@Masafumi Koga,Jun Murai,Hiroshi Saito,Mikio Mukai,Soji Kasayama
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index824349076608096687422863354040091202027890763586
#%67723564003301965803238749185968341800153456866
#%1331370477287209515069199807493724967119462477550
#%516063374164972390407511519209867235309995594236
#%1110945548312757225644606303795962903786415808708

#*Aspirin for people with diabetes: A misleading inference in a recent meta-analysis?
#@Pilar Martin-Carrillo,Almudena Aino,Oscar Pinar,Inmaculada Fernandez,Antonio Saenz,Monica Ausejo
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1234596807835125434383509317363760266423461120114

#*Response to Letter to Editor from Dr. Martn-Carrillo
#@Yu Zhang
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index468427671244415496966071363058354255134369828118

#*Acceleration of diabetic wound healing by collagen-binding vascular endothelial growth factor in diabetic rat model
#@Xin Yan,Bing Chen,Yue Lin,Yunjian Li,Zhifeng Xiao,Xianglin Hou,Qian Tan,Jianwu Dai
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index477389291119259545175622040898546305552004653406
#%310541365107287042513365597843424143739429729513

#*Clinical determinants of aspirin resistance in diabetes
#@N. Yassine,Grace Davis-Gorman,S. Stump,S. Thomson,Justin Peterson,F. McDonagh
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index374872359934647977539438666492298845745086233257
#%74514690106146515016262042995553126080227251272
#%280224768222527887767654662218414665749530021490
#%546822923610767440350528706219175821813066658001
#%1336490785485731934449097218187247661551271280654
#%237173328385186147509369945375297544693447758836

#*Factors related to insulin resistance in type 1 diabetic patients treated with intensive insulin therapy from the onset of the disease
#@Aleksandra Araszkiewicz,Aleksandra Uruska,Dorota Zozulinska-Ziolkiewicz,Stanislaw Pilacinski,Bogna Wierusz-Wysocka
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index309276159136907150361549606372216614274713880658
#%809594857376646873621307149094691989352355338060

#*2010 Consensus statement on the worldwide standardization of the hemoglobin A 1c measurement
#@Ragnar Hanas,Garry John
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index160844225485793473819966834619749051718918862428

#*Angiotensin converting enzyme inhibitor or angiotensin II receptor blocker for the prevention of type 2 diabetes mellitus?
#@Ching-Chu Chen
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1144028216893847248519322542042216770446922541309
#%1270282163096867041371585035091614981907072503036

#*No association of the SUMO4 polymorphism M55V variant in type 2 diabetes in Iranian subjects
#@Soudabeh Fallah,Mehrzad Jafarzadeh,Mehdi Hedayati
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1449594713701077483374833883185960945179348646230
#%271845570443723718868656992326092496189995988328
#%416239453092030068801044255050107253008464055300
#%1376128039547590719016639119207105235232200211033
#%722987308684699754845054671936016296690563138393

#*Safety and tolerability of vildagliptin vs. thiazolidinedione as add-on to metformin in type 2 diabetic patients with and without mild renal impairment: A retrospective analysis of the GALIANT study
#@M.A. Banerji,D. Purkayastha,B.H. Francis
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1421322403029977998013190942983249838283562945267
#%93341555077175330307605321565496046930391561843

#*Depression and hemoglobin A1c in type 1 and type 2 diabetes: The role of self-efficacy
#@P. Sacco,A. Bykowski
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index592439734524515675990935982377713363839799040199
#%71201257812875487310804424255142813027035678934
#%792880159858138870983132573927576553265604612497
#%667110945830871638214507257570041476866351949206
#%895367653276566786570487166962071952291114968449
#%814501079846700669200851426849797200067126829801

#*Predictors of success to weight-loss intervention program in individuals at high risk for type 2 diabetes
#@Weilin Kong,Marie-France Langlois,Carole Kamga-Ngand,Claudia Gagnon,Christine Brown,Jean-Patrice Baillargeon
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index273084363000649351882818945762974446964819563371

#*Glucose intolerance and cardiovascular risk factors in Hong Kong: Data from two occupation-based cross-sectional surveys
#@K. Simmons,T. Ko,C. Chan,S. Cockram,H. Nan,J. Griffin
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index828998963160522825559084491408429446043160747014
#%735009024663998479048138862737818215104111252409
#%394074846014723954118281930976347277725688325607
#%1265570923990906635963580774041901725817555574248
#%1028104678760348867799281722786810629351696645568

#*DPP-4 inhibitors: What may be the clinical differentiators?
#@John Gerich
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index201433807443775313798029292303107048495391857192
#%398966926411729416063166796594408977831586910264
#%1052160633850366833305612854563651679101328092405
#%1328265497189903278113317821785655305646347493685
#%1124022632554215266228035969212754585687768212571
#%761308341925447003703416426269323888011385713276
#%696970312526267721009096536762753932140593136071

#*Cost-effectiveness of administering oral adsorbent AST-120 to patients with diabetes and advance-stage chronic kidney disease
#@Yasuaki Hayashino,Shunichi Fukuhara,Tadao Akizawa,Yasushi Asano,Takafumi Wakita,Yoshihiro Onishi,Kiyoshi Kurokawa
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index4352058722122168177029552285602729551579448028
#%431412729600776668789272016853046241948029539427
#%902086195276690834614816865576911521546355533867
#%765938033170780603607462298137227933503379141677
#%309453043187022392557274830028852274720734561115
#%899795249477142576113145567298572145610719995276
#%899795249477142576113145567298572145610719995276
#%899795249477142576113145567298572145610719995276
#%655989601088478270170417453105297816087898394444

#*Association between the rs4880 superoxide dismutase 2 (C>T) gene variant and coronary heart disease in diabetes mellitus
#@D.A. Jones,S.L. Prior,T.S. Tang,S.C. Bain,S.J. Hurel,S.E. Humphries,J.W. Stephens
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index162166697567012132224252803635673028201209890939
#%1247305171998119308321715850789404635900420090296
#%1398020159207202926660166837072050936127521028875
#%1345083958627317129411164991344443227319047664465
#%860352396999676264172172908227511752648678368137
#%260837417977423219340018184300416815754745218074
#%837921765406650140104122394303026034238297271485
#%527541706527266539995581634961843658088090873269

#*C-reactive protein as an outcome predictor for percutaneous transluminal angioplasty in diabetic patients with peripheral arterial disease and infected foot ulcers
#@Cheng-Wei Lin,Lung-An Hsu,Chun-Chi Chen,Jiun-Ting Yeh,Jui-Hung Sun,Chia-Hung Lin,Szu-Tah Chen,Ray-Sea Hsu,Yu-Yao Huang
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index935995491585713150970040365720020821002820070040
#%630294703047880493320225839848264730083665134179
#%1329904890741093650637225357195374174049579820535
#%598830506486355576088757109109317268996190371397
#%174751271562755270032906451301432662524083937651
#%938069023395319029080264653367057178059585532274
#%103892439074854864650540546819726827083801365039
#%603173277786203475973797359249256962438129408223
#%1294245960549018883031704856476546403935313980800

#*Knowledge, attitudes and practices of persons with type 2 diabetes in a rural community: Phase I of the community-based Diabetes Self-Management Education (DSME) Program in San Juan, Batangas, Philippines
#@A. Ardea,Elizabeth Paz-Pacheco,A. Jimeno,Lina Lantion-Ang,Elizabeth Paterno,Noel Juban
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index336530547337220579038143786883337458965115395659

#*Impact of diabetes and hypertension on left ventricular longitudinal systolic function
#@Piercarlo Ballo,Matteo Cameli,Sergio Mondillo,Elisa Giacomin,Matteo Lisi,Margherita Padeletti,Arianna Bocelli,Maurizio Galderisi
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index995597673881619524535536366821518331849696566994
#%465788963884161818069725620343783106557552333647
#%1316911078657289469250095843829804912694838902679
#%90638912924607541162725549785341490661219986387
#%555690157020591982316454085852280377685720249528
#%1263487629585926544889554861430685914383367864472

#*The prevalence and risk factors for coeliac disease among children and adolescents with type 1 diabetes mellitus
#@Kostas Kakleas,Christina Karayianni,Elena Critselis,Asteroula Papathanasiou,Vassilis Petrou,Aspasia Fotinou,Kyriaki Karavanaki
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index906541282772780984898471146669498046854914065374
#%904365085061295243625922950109557800800419148256

#*Foot ulceration in a secondary care diabetic clinic population: A 4-year prospective study
#@R. Thomas,K. Brenton,B. Harris,R. Ham,G. Rees,T. Gorvett,K. Boregowda,J.W. Stephens,D.E. Price
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index506051605806531947915424845416124660249258094563

#*Sex-differences in adiponectin levels and body fat distribution: Longitudinal observations in Afro-Jamaicans
#@S. Boyne,R. Bennett,S. Cooper,Y. Royal-Thomas,I. Bennett,Amy Luke,J. Wilks,E. Forrester
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1233465689167159874700367817353725265053881606022

#*Fulminant type 1 diabetes associated with pregnancy: A report of 2 cases from Malaysia
#@Florence Tan,Khean Loh
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1332688671491749322566011698831162913060957018574
#%1383405615181023038452769884268968436760532532657

#*Perceived risk and the willingness to enroll in a diabetes prevention lifestyle intervention in Arab-Americans
#@R. Pinelli,H. Herman,B. Brown,A. Jaber
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index679367655433972943932149961131310175499285558481

#*The eight-item Morisky Medication Adherence Scale MMAS: Translation and validation of the Malaysian version
#@Kh. Al-Qazaz,A. Hassali,A. Shafie,A. Sulaiman,Shameni Sundram,E. Morisky
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index466843435864512793780876875224144497834418386274
#%1255282070929296872133600065480496176131895045523
#%960602569768989208474174462026983082201104910421

#*Clinical characteristics of diabetic ketoacidosis in newly diagnosed adult patients
#@Yotsapon Thewjitcharoen,Sarat Sunthornyothin
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index477743063169163093074311561004661441290742347676
#%1028295899854543258934585716591971368048608679900

#*Autoantibodies in Type 1 diabetes
#@Panagiotis Heras,Marios Mantzioros,Dimitrios Mendrinos,Vasilios Heras,Antonios Hatzopoulos,Vasilios Xourafas,Konstantinos Kritikos,Stefanos Karagiannis
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index531761660821899977293993073739272120450835232357
#%60424318087793302907467684362517384352780679356
#%1067867645342588193618307980951697721001512459694

#*Cultural variations in attitudes towards family risk of diabetes
#@L. Whitford,Manal Al-Sabbagh
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index528341822885807692533826863914868793307621258886
#%1298888924721350131033295591530302217923025041749

#*Clinical approach to the patient with diabetes mellitus and very high insulin requirements
#@F. Ovalle
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1125798882894292039305476477275637209016057112015
#%930948113590462534043381560870483521187856442463
#%118949373504108685952908488442338661251903101027
#%644340289512134339929559799451340581917150616608
#%813045411556141654276621050189584513835348746310
#%132763052411227490079848273145421527381341589136
#%1028424416278229242533819779997054264819956901753
#%1028424416278229242533819779997054264819956901753
#%930247671508176502438900922498076603087418031573
#%731918666972209022452331134511629933371569233486

#*Diabetes awareness in general population in Cameroon
#@Leopold Fezeu,Emma Fointama,George Ngufor,George Mbeh,Jean-Claude Mbanya
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index170428308078099015695778913639629913334445154714
#%482987499303755795279606823904916230440087479446
#%1127606418944726163441687181544380694207525777034

#*Assessing treatment barriers in young adults with type 1 diabetes
#@M. Lancaster,Beth Pfeffer,Maxine McElligott,T. Ferguson,Marilyn Miller,Dustin Wallace,T. Lane
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index204253458784010375804124223957391178493423717420
#%1040414381661929386084123696124727537455093133371
#%1040414381661929386084123696124727537455093133371
#%233348800180956254557470760951739287866444444481

#*Increased red cell count in diabetes and pre-diabetes
#@D. Simmons
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index441442835545095121915590661017910508107215824295
#%1377437551252641267423982173225963239122539309257
#%51882599454885415517292108591838561145447662355

#*Fulminant type 1 diabetes mellitus with rhabdomyolysis: Have we overlooked the situation?
#@Zhimin Huang,Lijuan Xu,Fengzhen Li,Wanping Deng,Yanbing Li
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index706823627421088654888147897931209375944278205057
#%947103413000427987386174508661303113556483369299

#*Distinct pharmacodynamics of insulin glargine and insulin detemir: Crossover comparison in Type 1 and Type 2 diabetic patients on basal-bolus regimen
#@Tomoko Kato,Ichiro Tokubuchi,Kazuhisa Muraishi,Shuichi Sato,Tamotsu Kato,Kento Hara,Kayo Tanaka,Hiroo Kaku,Yuji Tajiri,Kentaro Yamada
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index575579462977437175623036519379378438176767979676
#%497708998244205723171236061580448431567300017522

#*A novel approach to diabetes prevention: Evaluation of the Group Lifestyle Balance program delivered via DVD
#@Kaye Kramer,M. Kriska,M. Venditti,N. Semler,G. Miller,Teresa McDonald,M. Siminerio,J. Orchard
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1334148664974370501286657663272173396481138153720
#%562796616619783595888481977576951399122057831669

#*Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes
#@Moya Chimenti,Herranz Morena,Martn Vaquero,Lourdes Sez-de-ibarra,Garca Domnguez,Pallardo Snchez
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1037382767909476929261860721035576518921084802626

#*Taurine prevents free fatty acid-induced hepatic insulin resistance in association with inhibiting JNK1 activation and improving insulin signaling in vivo
#@Na Wu,Yan Lu,Bing He,Yongyan Zhang,Jingfeng Lin,Sheng Zhao,Wei Zhang,Yan Li,Ping Han
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index737499647261346189581670530765516506728702011905
#%614623911789222107993680514190701916394550174647
#%69613278235882052827163213177063212422920259838
#%507016146663724773712640347772050012593190566663
#%209521112105716364623824729276237804999860194599
#%876735463760552025438737175262648696423903569085
#%140459925966913907786232013554946870259322954100

#*Use of sulphonylurea and cancer in type 2 diabetesThe Hong Kong Diabetes Registry
#@Xilin Yang,Yee So,C.W. Ma,W.Y. Yu,T.C. Ko,P.S. Kong,W.S. Ng,O.Y. Luk,Risa Ozaki,C.Y. Tong,Chun-Chung Chow,C.N. Chan
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1128865471056417637852211232644134666885847305426
#%1435164350558636082742970305952140471597796392576
#%572727525772630144321044703739631273925125269109

#*Change in the number of patients after the adoption of IADPSG criteria for hyperglycemia during pregnancy in Japanese women
#@Mamoru Morikawa,Takashi Yamada,Takahiro Yamada,Rina Akaishi,Ryutaro Nishida,Kazutoshi Cho,Hisanori Minakami
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index829824110113389381313335666701009459772235664746
#%1355523126139526722897727659472809492088447184386

#*Phenotypic and metabolic characteristics of women with isolated hyperglycemia in pregnancyIs the time-point important?
#@Eleni Anastasiou,Vasiliki Vasileiou,Anastasia Athanasiadou,Charalampos Stavrianos,Katerina Saltiki,Maria Alevizaki
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index220919971576541026218863640884233665155349757669
#%648153601351842828468314390061198750413998493841
#%271712231629043001651324818083558854223049839936

#*Association between cardiorespiratory fitness and arterial stiffness in men with the metabolic syndrome
#@Young Jae,S. Heffernan,Bo Fernhall,Sung Oh,Hah Park,Moon-Kyu Lee,Yoon-Ho Choi
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index277910787486367638843696331632712847251326678735
#%712815281374150375198839063860399959653837070767
#%472560527849606491961515142684232675127779658703

#*Evidence on the applicability of the ATPIII, IDF and CDS metabolic syndrome diagnostic criteria to identify CVD and T2DM in the Chinese population from a 6.3-year cohort study in mid-eastern China
#@Hui Zhou,Zhi-rong Guo,Lu-gang Yu,Xiao-shu Hu,Bao-hui Xu,Hai-bo Liu,Ming Wu,Zheng-yuan Zhou
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index138920685465673348714951491127278964291894314080

#*Exendin-4 protects murine pancreatic -cells from dexamethasone-induced apoptosis through PKA and PI-3K signaling
#@Lin-Xi Wang,Yan-Ping Wang,Zhou Chen,Xiao-Ying Liu,Xiao-Hong Liu,Liang Liu,Wen-Jia Chen,Li-Bin Liu
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index224689886974398462789848760360960146827775764563
#%1394729434712255558498291314556720315953401820155
#%1059268386580755878033349900655743671871954585311
#%577658467890712852376830824081511854308614382036

#*Carbazoles and coumarins from Clausena harmandiana stimulate glucose uptake in L6 myotubes
#@Kusumarn Noipha,Tula Thongthoom,Uraiwan Songsiang,Chantana Boonyarat,Chavi Yenjai
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index49652942299486041128318812420476833738638369971
#%181504774373014156002973712041366689379864667160
#%1169986791195568789974363211084437570342072516374
#%59305255930900938648041898532825160441437294707

#*Serum 14-3-3; matrix metalloproteinases and their inhibitors levels before and after cardiovascular surgery in diabetic and non-diabetic patients
#@Alireza Mohajerani,Aziz Ghahary,Mohammadreza Khuramizadeh,Bagher Larijani
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1211459434777819059206871392568222858913989332331
#%1438168822943491097124345257522106614915906092439
#%813127254268939139365316219689451299802719638995

#*Treatment with a proton pump inhibitor improves glycaemic control in type 2 diabetic patients - a retrospective analysis
#@D. Hove,Kristine Frch,B. Bdvarsdttir,E. Karlsen,S. Petersen,Allan Vaag
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1316120182963326731252568123788029551466753861603
#%1040576966495271824458965014458880890323906827857

#*Relation between serum high molecular weight adiponectin and serum ferritin or prohepcidin in patients with type 2 diabetes
#@Yoshimasa Aso,Kohzo Takebayashi,Sadao Wakabayashi,Atsushi Momobayashi,Naoto Sugawara,Tomoko Terasawa,Rika Naruse,Kenji Hara,Mariko Suetsugu,Kimio Morita,Toshihiko Inukai
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index342366700402320716806985666532165810985432296490
#%1101110655211790554429852699980818493373976105483
#%94085685605167341766597949548028695664701067701
#%945684570226357865064522905417048595508096731989
#%659329357734917602343954072300520945984101236109

#*Asthma, chronic obstructive pulmonary disease, and type 2 diabetes in the Women's Health Study
#@Yiqing Song,Anna Klevak,E. Manson,E. Buring,Simin Liu
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index137249525754715645513830211745490527224861792571

#*The impacts of thiazolidinediones on circulating C-reactive protein levels in different diseases: A meta-analysis
#@Yulan Zhao,Xuelian He,Chengjin Huang,Xiaonan Fu,Xuegui Shi,Ying Wu,Yijie Han,Naishi Li,Yanxiang Wu,Chew-Kiat Heng
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1194691863725453208503767469539944425533729848533
#%1391376541239926940695617681323080381967836030940
#%791437010500835684446913673495202924917937619815
#%2722899990349951405435239992786214158946279853
#%1114146292979652769375009358000878628604531009579
#%1236504569250480266687973760564522168766873289599
#%1088847129731102877604617238685840987313897313812
#%872189951631881369331367218961359009908511926449
#%426929442876239556158559938213427102535741117015
#%481378556153466324499906822914216519879564028506

#*Effect evaluation of a Motivational Interviewing based counselling strategy in diabetes care
#@Evelien Heinrich,J.J.M. Candel,C. Schaper,K. Vries
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1370167902675088755244056815240483469310226952726
#%1134230811901116932091467758964057835599089265767
#%998820510202353494948434408532365732425166378935
#%293330053947968642943575314471126854990216870214
#%314920319934551949436427159058862829259361681003
#%275040445741582534110559139691206501523990957386

#*Prevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetes
#@Yijun Zhou,Yan Li,Dan Zhang,Jiahe Wang,Hongwu Yang
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index798859481050047289496528593275169397338790489238
#%303972967056662443548712452420849406184164352577
#%18672949178306121223506607979332033306313677441
#%254847714127009309890196252462709271242879889716
#%342823563870012229508290426251919931254315405179

#*The effect of obesity on the assessment of diabetic peripheral neuropathy: A comparison of Michigan patient version test and Michigan physical assessment
#@Ozgur Boyraz,Mehmet Saracoglu
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1139085151486874967904194453343639559806305073384
#%445117425220766101181856737566140801370602571204

#*Cardiovascular risk prediction in adults with type 1 diabetes: The Fremantle Diabetes Study
#@A. Davis,M.E. Davis
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index170295044560905379153811255309597565604168923034
#%1306054704710356267139720375747451044450239093884
#%663501753131419940438149704679470670996059841598

#*Serum gamma-glutamyl transferase, ferritin and the risk of type 2 diabetes in women from a Chinese minority
#@Tao Chen,Yan Ren,Yuanyuan Liu,Yang Long,Xiangxun Zhang,Hongling Yu,Jin Xu,Ting Yu,Haoming Tian
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index923689816100431277361594726476878368215169514238

#*Remission of diabetes mellitus type 2 with severe hyperglycemia after Exenatide treatment
#@F. Al-Jebawi
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index494603741948734445038375532139235864552755607840
#%900911360928902256607486434225034756362621365148

#*Insulin resistance in the middle-aged women with Tigerish Back and Bearish Waist
#@Jen-Kuang Lee,Cho-Kai Wu,Lian-Yu Lin,Chia-Lin Cheng,Jou-Wei Lin,Juey-Jen Hwang,Fu-Tien Chiang
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index540603537339665023208357866225146591973525549657
#%174441635909728393259041111722886672288217861266
#%1010024824594308627455647652891401491007443770950

#*Oral health content in diabetes self-management education programs
#@K. Yuen,M. Marlow,Samantha Mahoney,Elizabeth Slate,Carolyn Jenkins,Steven London
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index216312111433753745825845605154506093048219886136
#%514229432933197792529552657221143054379535376280
#%1253204145973067875267788876939236357484155742998
#%535750748220453966782339306629859917350229096640
#%286946412576851770450248612069721982591484869739

#*Is endovascular revascularisation worthwhile in diabetic patients with critical limb ischemia who also have end-stage renal disease?
#@Martn Rabellino,Javier Aragn-Snchez,Gabriela Gonzlez,Tobas Zander,Sebastin Baldi,Luis Garcia-Nielsen,Silvia Armas-Suarez,Pablo Barbero,Desir Luis-Rodrguez,Manuel Maynar
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index1320114401712504722694498965158445471413908757797
#%938069023395319029080264653367057178059585532274
#%943475788602701778816882042760937712803625897516
#%1246272108874161643545874733566414900239064129835
#%403915621987167693530211961319364202974842933153

#*Efficacy of occasional self-monitoring of postprandial blood glucose levels in type 2 diabetic patients without insulin therapy
#@Toshihiko Shiraiwa
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index963928959319797777605748201684008548018749667022

#*Gender differences in trends in diabetes prevalence from 1993 to 2008 in Taiwan
#@Hsing-Yi Chang,Chih-Cheng Hsu,Wen-Harn Pan,Wen-Ling Liu,Ying-Chi Cheng,Chin-Hsiao Tseng,Chyi-Huey Bai,Wen-Ting Yeh,Baai-Shyun Hurng
#year2010
#confDiabetes Research and Clinical Practice
#citation0
#index306309970745420918497128232035075465949995812382
#%90229471756574567171887310413860126801042272562
#%190614546759806919205507377971261334742457303601
#%537648169284478256516904428848186820635018557219
#%305452114356837938993644657975535192998526460869

#*Behavioral strategies in diabetes prevention programs: A systematic review of randomized controlled trials
#@K. Baker,Kylie Simpson,Bradley Lloyd,E. Bauman,Fiatarone Singh
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1144075470151932335252540030931436279652643977355
#%789198489702586542926219084517612861962341004780
#%530742815982948056355266956550925744819808900472
#%1245749547711924353684255927617253077901919194606

#*Type 2 diabetes does not attenuate racial differences in coronary calcification
#@N. Wade,Sean Fedyna,N. Mehta,Caitlin Clair,Naeema Ginwala,K. Krishna,N. Qasim,Seth Braunstein,Nayyar Iqbal,H. Schutta,P. Reilly
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index346406318219422229141745839807121613296468318803
#%1273521807361383431061971991921743917696802551953
#%951994800850747197126582542491782596998601967892
#%425778856221552667896580891471888071410233706718
#%910374368652809399473777334609065544076959420451
#%417304632311095445018519630839233660058548828111
#%553067429062295987878866411756358152655645501506
#%506693767148187728183654611419267256110642419849
#%1102846568113455735630658541101595158743165650887
#%1163559622095251254106696253998659506406816371575
#%1128034028517187695662761861519304904684594090574

#*High prevalence of glucose intolerance in Japanese patients with peripheral arterial disease
#@M. Takahara,H. Kaneto
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index485919941729783724174863892485791480229037446838

#*Effect of a low glycaemic index diet on blood glucose in women with gestational hyperglycaemia
#@M. Grant,M.S. Wolever,L. OConnor,Rosane Nisenbaum,G. Josse
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1218115753020078954145734975684465952484403579237
#%1305508947780438464848351314253740067095527973460
#%1164117634803004850882913710933743105494900825602
#%904631308035525276006751573906762847622339662208
#%906838914606264905111072427470173647768505611851

#*Long-term effects of cilostazol on the prevention of macrovascular disease in patients with type 2 diabetes mellitus
#@Youl Rhee,Seol Kim,Suk Chon,Seungjoon Oh,Jeong-taek Woo,Woon Kim,Jin-Woo Kim
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index257369244030805144746704815417859196085982096471
#%483710742656513722204015282956855170516812835255
#%80569167242191052576435286791903194174878450105
#%74514690106146515016262042995553126080227251272
#%528246404809242546705929668131281903425069606916
#%880969251481791390942081300752650683661168232142

#*Chronic interdigital dermatophytic infection: A common lesion associated with potentially severe consequences
#@Olivier Vanhooteghem,Gregory Szepetiuk,Dilshad Paurobally,Franoise Heureux
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index562222216310935548601706613429457945928847162494
#%1012178047170490097403453521473455781304598883695

#*Relationship between advanced glycation end products and increased lipid peroxidation in semen of diabetic men
#@J. Karimi,M.T. Goodarzi,H. Tavilani,I. Khodadadi,I. Amiri
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index636250628616281603029193806049455026891101225146
#%660910627802624200208853565886921054174141376212
#%36442770995400653236251080349860862125782826308
#%480291026676578747628313583805344013170618836403
#%1409372262414308433988348060554590971054874203047
#%227953711910105297133101392678167237296903797068
#%666327856723659265309261198424206520171913034160
#%450747532932145938228131453777063113232272868439
#%1069759816784749335798118943383118398260147727563
#%245244602951828369408376889424836474119333068132
#%1267042816996018581837233311990735717220681233494

#*Discordance between fasting glucose-based and hemoglobin A1c-based diagnosis of diabetes mellitus in Koreans
#@Chul-Hee Kim,Hong-Kyu Kim,Sung-Jin Bae,Joong-Yeol Park,Ki-Up Lee
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1385123141102750502982748193428363365679567003627

#*Comparison of fasting capillary glucose variability between insulin glargine and NPH
#@Panwei Mu,Hongyun Lu,Guochao Zhang,Yanming Chen,Jingyi Fu,Manman Wang,Jiong Shu,Longyi Zeng
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index572224913805997653384994319368534330646600017410
#%577627670790964619534747916243025622870075561238
#%489492364411039582692672593339264515066517318891
#%1191230052741013353371928460626229012852521361534

#*Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation
#@M. Jei,D. Jei,Svjetlana Maglajli,Silvija Saji,Svetislav Neci
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1093639080751483424950533319467169099369868196747

#*Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome
#@Baris Akinci,Aygul Celtik,Faize Yuksel,Sinan Genc,Serkan Yener,Mustafa Secil,Ali Ozcan,Sena Yesil
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index683696038825782692735312509192698863903854044102
#%1356048878399365074593681383990691992212676859369
#%973901328585985540851826005097180927510826814562
#%1019295311003677583817726196325719686806737641603
#%509594842920952678725508142429248068685566069190
#%1131887473782769708824108640103391413575980564528
#%188884052767810721775018399085832414433002268712
#%142467793937568304750362101029326417925193921935
#%178510061305898591424248183901418797975962035060
#%1449724338992268406737705604610288039020892221716
#%1163559622095251254106696253998659506406816371575
#%1338421880100598708642307800944431456889491895906
#%1222914026835510717602194310921414090431752835901
#%1220078403686308574871405728211877128401518317522
#%508515629483873136736767235185161448765575858137
#%1403284029393254947896904300109892640956650036806

#*Nocturnal hyperglycaemia in type 2 diabetes with sleep apnoea syndrome
#@Salha Fendri,Dominique Rose,Sonia Myambu,Sandrine Jeanne,Jean-Daniel Lalau
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index601638523276884602474334554700673039072141995315
#%1147599069371876638735352154933233256970060837231

#*Peripheral neuropathy, decreased muscle strength and obesity are strongly associated with walking in persons with type 2 diabetes without manifest mobility limitations
#@T. Sloten,H.C.M. Savelberg,G.P. Duimel-Peeters,Kenneth Meijer,M.A. Henry,D.A. Stehouwer,C. Schaper
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1037031724149497262777602059988928072963156258768
#%707230906118122326590685957962152313148479756672
#%245326062829082488189033973058745343788714246976
#%1024883404889065483292301491395446642090496904457
#%649202465972985833857769073325697674163627272094
#%974057091029062018871471225983667384734411685181

#*Risk factor associations with clinical distal symmetrical polyneuropathy and various neuropathy screening instruments and protocols in type 1 diabetes
#@G. Pambianco,T. Costacou,Elsa Strotmeyer,T.J. Orchard
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1190372572960603600529926998179125177535924304481

#*The reliability and validity of the Japanese version of the Appraisal of Diabetes Scale for type 2 diabetes patients
#@Yoriko Hara,Satoshi Koyama,Toru Morinaga,Hisao Ito,Shusuke Kohno,Hiroyuki Hirai,Toshio Kikuchi,Toru Tsuda,Isao Ichino,Satoko Takei,Kentaro Yamada,Koji Tsuboi,Raoul Breugelmans,Yoko Ishihara
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index257286141550628364342471604628862822614102828993

#*Fasting blood glucose and diagnosis of type 2 diabetes
#@Shahidul Islam
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1019590253679394089202942455929066683857806492686

#*Motivational interviewing delivered by diabetes educators: Does it improve blood glucose control among poorly controlled type 2 diabetes patients?
#@Garry Welch,E. Zagarins,G. Feinberg,L. Garb
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index715005313717341284402431150015574828860000190330
#%894693412094674470063699893402577505859474085887

#*Increased epicardial adipose tissue in type 1 diabetes is associated with central obesity and metabolic syndrome
#@Prado Momesso,Isabela Bussade,Antonio Epifanio,Sahione Schettino,Tavares Russo,Rosane Kupfer
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index944499495087946310936891531264322752793860331905
#%336566141779515571270818395157127971914833586405
#%510342119826177583119557928189730182651742411576
#%510342119826177583119557928189730182651742411576
#%612996013956783174386016149695405911634332514289
#%1411558370591809567918222752553566006860934904584

#*Impairment of insulin action in non-obese, normal-glucose tolerant, first-degree relatives of Chinese type 2 diabetic patients
#@Chun Wang,Huiwen Tan,Hongling Yu,Xiangxun Zhang,Lixia Suo,Zhiming Lu,Su Pu,Yerong Yu
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index274275234154321488263581939671927842887714275501
#%856537884140432138093842042156523599248953399383
#%1401607269839429390408309751866937438263484975134
#%455035088570047233635922846275300873837934425440

#*Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain
#@Pedro Conthe,Manuel Mata,Domingo Orozco,Francisco Pajuelo,Sofa Barreto,Fernndez Anaya,Ramn Gomis
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index165105279589417618015822146478543965588720115852
#%62012766425604347874773006054494159727173147508

#*The association between co-morbidity and the use of antidiabetics or adjunctive cardiovascular medicines in Australian veterans with diabetes
#@Ying Zhang,Agnes Vitry,Gillian Caughey,E. Roughead,Philip Ryan,Andrew Gilbert,Sepehr Shakib,Robyn McDermott
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1099044865846057680363577914937249348815015663926
#%199159938454212530482640962738773775098162714756
#%528008173562538590652207914005267491304001443792
#%325393500582593079722788466957942600553875786386
#%341614798843069667969529538116335393841926612663

#*Use of the UKPDS Outcomes Model to predict all-cause mortality in U.S. adults with type 2 diabetes mellitus: Comparison of predicted versus observed mortality
#@May Song,M. Alexander,Panagiotis Mavros,A. Lopez,Shaista Malik,M. Phatak,D. Wong
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1344964293587798538971753138223808968712027951131

#*A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing -cell replication and neogenesis
#@Min Cho,Won Jang,Hwanju Cheon,Taek Jeong,Do-Hoon Kim,Yu-Mi Lim,Song-hyen Choi,Eun-kyoung Yang,Chang-Yell Shin,Ho Son,Hoe Kim,Heung-Jae Kim,Myung-Shik Lee
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1434275987277260756292160574036601102315190361193
#%889923740193043015076273459006991200299749370279
#%11294555597995160451427388033719509315863908238
#%976849139207568638415084025300574617276160573037

#*The use of a low glycaemic index diet in pregnancy: An evolving treatment paradigm
#@G. Moses
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index328304041103016843403075741544573337623861329773
#%1218115753020078954145734975684465952484403579237

#*Role of quantitative chest perfusion computed tomography in detecting diabetic pulmonary microangiopathy
#@K. Kuziemski,J. Piekowska,W. Somiski,K. Specjalski,K. Dziadziuszko,E. Jassem,M. Studniarek,R. Kalicka,J.M. Somiski
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1177535317523941891320863168973461907345546186694
#%1377963583244814308760375394473042143732212984294
#%1420711615567395582087861649670468366302030107432

#*MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression
#@Liang-Liang Sun,Bei-Ge Jiang,Wen-Tong Li,Jun-Jie Zou,Yong-Quan Shi,Zhi-Min Liu
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1243785003953217063703557364089426602756303725621
#%1289259866325431588924572400514809341503860616586
#%523681168813165421722503415349214504132067189703

#*Dose Adjustment for Normal Eating: A qualitative longitudinal exploration of the food and eating practices of type 1 diabetes patients converted to flexible intensive insulin therapy in the UK
#@J. Lawton,D. Rankin,D.D. Cooke,M. Clark,J. Elliot,S. Heller
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1003700735784021647034720512733034054563721117034
#%1100851425852609610925765389288422433432017348775
#%372394670358369010169714986243919921183780246756
#%768517966836609718844156055314196417273122385878
#%1272134485530052747995608181655454946423592641194
#%204435011759391712055797473135145947132818719506

#*Diabetes and sleep: A complex cause-and-effect relationship
#@T.U. Barone,Luiz Menna-Barreto
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1130149867721633854267939392078332091885403468587
#%885262345181938599381791965689825681580920329048
#%197545535178220945045003258874273530948012534491
#%1374323426143264095075184937402775632463749505705
#%713540244543656635640617293931540976177290391992
#%1380420016642512513235623130219785681278842583981
#%1147599069371876638735352154933233256970060837231
#%753007754582794310624158109308785210175254190808
#%950661056750575682230496316321929596138971246281
#%763231246530918660985266873519320778604535985113

#*Hyperglycemic hyperosmolar state and rhino-orbital mucormycosis
#@E. Pinto,A. Manrique,Ximena Guevara,Max Acosta,E. Villena,Jos Sols
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index706344853764448432144186156041469375862634868791
#%1327848156204156544170798703228126477210104969209
#%105961913014975559976131583600523931005386920469

#*Men with hyperferritinemia and diabetes in the Mediterranean area do not have a higher iron overload than those without diabetes
#@Nria Freixenet,Carme Vilardell,Gemma Llaurad,Olga Gimnez-Palop,Eugenio Berlanga,Cristina Gutirrez,Assumpta Caixs,Joan Vendrell,Miguel Gonzlez-Clemente
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1026502024166672108882205718335193799819079896248
#%315958155532541161326016844508585315395127643988

#*Severe leucopenia associated with Sitagliptin use
#@Dario Pitocco,Francesco Zaccardi,Francesca Martini,Giuseppe Scavone,Tittania Musella,Salvatore Caputo,Giovanni Ghirlanda
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index215116256328977128582354867790677737374877112481
#%1102318938928248369924846212594519642224462478493
#%837152496833049606514732426389028726837059336741

#*Trends in deliveries in women with gestational diabetes in Spain, 20012008
#@Ana Lopez-de-Andres,Pilar Carrasco-Garrido,ngel Gil-de-Miguel,Valentn Hernandez-Barrera,Rodrigo Jimnez-Garca
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index456105422326753949487454029851179909109220423360
#%1111911381265382572303518945336865303046821233274
#%1091462735477144412483323861081534999765430014136
#%1091462735477144412483323861081534999765430014136

#*Contribution of glimepiride to basalprandial insulin therapy in patients with type 2 diabetes
#@Hiroki Yokoyama,Hirohito Sone,Daishiro Yamada,Jun Honjo,Masakazu Haneda
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index857935770775063259839176924890849068634187100377
#%204814933618505883481275107027443557626370235202

#*Association between type 1 diabetes mellitus and remitting seronegative symmetrical synovitis with pitting edema: A case report
#@Hideyuki Sakoda,Shizuo Ito,Hiroko Kanda,Midori Fujishiro,Jun-ichi Osuga,Kazuhisa Tsukamoto,Kohjiro Ueki,Takashi Kadowaki
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1382823191784325637105293355446642253959049725724
#%119173664952093144648588933583550344227919676577
#%246805660655216807742185511352895232117403085516

#*The effects of fasting plasma glucose variability and time-dependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patients
#@Toshiko Takao,Takehiko Ide,Hiroyuki Yanagisawa,Masatoshi Kikuchi,Shoji Kawazu,Yutaka Matsuyama
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1251497593174677748871494384212629275094183920489
#%867696603377951439510374623655603777674394066220

#*Association of the cell death-inducing DNA fragmentation factor alpha-like effector A (CIDEA) gene V115F (G/T) polymorphism with phenotypes of metabolic syndrome in a Chinese population
#@Ling Zhang,Ying Dai,Lili Bian,Wei Wang,Wei Wang,Masaaki Muramatsu,Qi Hua
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index494672721713339104771161768965469151723324412764
#%1344687493766751582197524167495914153508188487891
#%1196936071405152768231314263988714627450646046098
#%447350970576774219290973271286495235581550563502
#%417757012019019650382676497289490919690773158388
#%1087590640195649014213209567220552157576623161488

#*Cumulative glycemia and microangiopathy in subjects with impaired glucose regulation in the Inter99 study
#@Christine Munch,Michael Larsen,Line Kessel,Knut Borch-Johnsen,Henrik Lund-Andersen,Charlotte Glmer
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1119773151782526391278220737332237351425878860974
#%1409372262414308433988348060554590971054874203047
#%368095699036782845006820242476344327615887896689

#*Effects of multiple doses of the DPP-IV inhibitor PF-734200 on the relationship between GLP-1 and glucose in subjects with type 2 diabetes mellitus
#@M. Gustavson,Haiqing Dai,M. Preston,Veena Somayaji,Boaz Hirshberg,A. Calle
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index126738589657838987075323102781258874071071528247

#*Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity
#@Alireza Esteghamati,Azam Alamdari,Ali Zandieh,Seerat Elahi,Omid Khalilzadeh,Manouchehr Nakhjavani,Alipasha Meysamie
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1345897331010038269177089682437769345914047701943
#%288097708770743419393073808430945307435332794847
#%1365614532601307704000998525773480883976473766109
#%161287608412905677413134633972585854129011324747
#%1452587202457107023030152607790541450093887520015
#%366350730073123205918015139058121676101218742303
#%298465903358185535245989142208357486306734047975
#%359704911589716698767639707562984061012562867961
#%205482879605682714091152743885205940042589099135

#*Diabetic retinopathy is associated with subclinical atherosclerosis in newly diagnosed type 2 diabetes mellitus
#@Jang-Won Son,Eun-Hee Jang,Mee-Kyoung Kim,Tae Kim,Jung Roh,Ki-Hyun Baek,Ki-Ho Song,Kun-Ho Yoon,Bong-Yun Cha,Kwang-Woo Lee,Ho-Young Son,Hyuk-Sang Kwon
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1203851989136667641552089581891222259420142434324
#%653543153858443458583474512175846463985023305325
#%1150284805627011368930584849180530287370518470057

#*Altered nerve excitability in subclinical/early diabetic neuropathy: Evidence for early neurovascular process in diabetes mellitus?
#@Seok Bae,Kyu Kim,Moon Kim
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1191342702288366027070338503925400866989696194635
#%450609503557736606923972960149555318426215806122
#%355649675295455413491790500234186917625270049613
#%100011194854147630864029955406671901390335920889
#%396970631896614524176750794598548259537132925179
#%168922962011522808806182961772935825688021361268
#%826299854791256348970220724062623962143716647111
#%1214220797719033961394045427162497686633369830913

#*High dose human insulin and insulin glargine promote T24 bladder cancer cell proliferation via PI3K-independent activation of Akt
#@S. Liu,Y. Li,T. Lin,X. Fan,Y. Liang,U. Heemann
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index55925274460159419512766584314563781105063608143
#%922973486202645269642962712011008123844451192482
#%265104853044866199217580417842754965426843067202
#%960494743773312586318026626294576292587233943119

#*The relationship between adipocyte fatty acid binding protein-4, retinol binding protein-4 levels and early diabetic nephropathy in patients with type 2 diabetes
#@Fusun Toruner,E. Altinova,Mujde Akturk,Meral Kaya,Emre Arslan,Neslihan Bukan,Erdal Kan,Ilhan Yetkin,Metin Arslan
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index187414468483450181080081942780261933638852372028
#%830455549772563233896027777773970712779981637854
#%1325023640971543188586260350142917720951932608252
#%995367548758129235039960106635211209030491484537
#%821825746112646728673895554913343814007391126555
#%824779821623124255858943841904446894169253107592
#%1152679178696082327563590393716256725440715189401

#*Association between rs13266634 C/T polymorphisms of solute carrier family 30 member 8 (SLC30A8) and type 2 diabetes, impaired glucose tolerance, type 1 diabetesA meta-analysis
#@Kuanfeng Xu,Min Zha,Xiaohong Wu,Zhangbin Yu,Rongbin Yu,Xinyu Xu,Heng Chen,Tao Yang
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index971286183939423986783065958663787895439687406287
#%848738872315518220513933529210941852192077432041
#%465860360212651999033568875145727598419597624810
#%733206802520732394045325580140128533549058760345

#*dGlucose is linked to renal function changes in diabetes
#@K. Mandal,M. Hiebert,Harry Khamis
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index382824681915068954452077321542630901087154267500
#%481570781244869144784002259840012820397148090045

#*Haemoglobin A1c is superior to fasting glucose in predicting the incidence of diabetes over 8 years among Chinese
#@S.C. Law,W.K. Tso,Sidney Tam,M.S. Wat,M.Y. Cheung,S.L. Lam
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index560531497572127519453191052231766657153249629369
#%692261066715004219765759442379237259884795656977

#*YKL-40, a new biomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patients
#@Tetsuyuki Yasuda,Hideaki Kaneto,Naoto Katakami,Akio Kuroda,Taka-aki Matsuoka,Yoshimitsu Yamasaki,Munehide Matsuhisa,Iichiro Shimomura
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index171443926110814381524256402146320878126694988131
#%4656961360725316482188609226200372869020351674
#%225553991500717426265020354405360164160887526809
#%1329893035788621974050532185877151379085275046189

#*Elevated serum chemerin concentrations are associated with renal dysfunction in type 2 diabetic patients
#@Wenchao Hu,Ping Feng
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index808753231935503664126495560725517515742283808972

#*Analysis of a primary care led diabetes annual review programme in a multi ethnic cohort in Wellington, New Zealand
#@Robert Smith,Jeremy Krebs,Mark Weatherall,Lynn McBain,Micheal Hullah,Michael Shapleski
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index224515708358041182045873091849589292435020142554

#*Association between polymorphisms in RAPGEF1, TP53, NRF1 and type 2 diabetes in Chinese Han population
#@Lili Qu,Bangshun He,Yuqin Pan,Yongfei Xu,Chan Zhu,Zhipeng Tang,Qian Bao,Fuliang Tian,Shukui Wang
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index995313656980760498477334587617556562829623659545
#%187686427266860962946068145087344372765249938068
#%588192829700188695420448837531162360788236041625
#%68383620282369490322012574816764623377493790479
#%548155748784642079516777965423904503882069391629
#%777903643388301232586348601590565230115150194
#%76466416232052066326909061139125784460667818217

#*Risk of progression of nephropathy in a population-based sample with type 2 diabetes
#@S. Vupputuri,G.A. Nichols,H. Lau,P. Joski,M.L. Thorp
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1229312518629032000091361661979677409379534312764
#%872850500455086376322209885720006713071133591128
#%597138904566458234105880400099646881244542397908

#*HNF1 alpha gene coding regions mutations screening, in a Caucasian population clinically characterized as MODY from Argentina
#@Pablo Lopez,Andrea Foscaldi,Silvia Perez,Martn Rodriguez,Mercedes Traversa,Miguel Puchulu,Ignacio Bergada,Daniel Frechtel
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index338561961124730584901216856869604991246525531620
#%1211684242362578270689067887487535595085573192746

#*Prevalence of metabolic syndrome and its risk factors in adult Malaysians: Results of a nationwide survey
#@Wan Mohamud,al-Safi Ismail,Amir Sharifuddin,Shah Ismail,Imran Musa,Abdul Kadir,Azmi Kamaruddin,Azwany Yaacob,Norlaila Mustafa,Osman Ali,Siti Harnida,Wan Bebakar
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index162797266162478629929909234084795198816158825872
#%731951810301996354737974581221314481843404671356
#%303972967056662443548712452420849406184164352577
#%860022615160432358769576638139277096798571837825

#*Coronary disease risk and fasting glucose levels in a non-diabetic population
#@Altan Onat,Gnay Can,Gkhan iek,Yksel Doan,Hsniye Yksel
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index588480657146545062241233245152856020860066309648
#%711599000368263004138323260382993387525511138418
#%169267919619958558745487984021796449290084773205
#%497154820998809335539084658697723802665880515807
#%291838046356786000689721084912131343504336782860
#%207078774663588993548062444642892205734943375795

#*Analysis of urinary proteomic patterns for type 2 diabetic nephropathy by ProteinChip
#@Jing Wu,Yi-Ding Chen,Jie-Kai Yu,Xiao-Li Shi,Wei Gu
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1351683794284080449717906799125617604178500086632
#%920049761838135696448334761641545944835336111548

#*From evidence to practicethe IMAGE projectnew standards in the prevention of type 2 diabetes
#@E.H. Schwarz
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1414415050926922334907194842594758495602109117355
#%1023416556401013546738459536790171081960361049040

#*Factors associated with the maintenance or achievement of the weight loss goal at follow-up among participants completing an adapted diabetes prevention program
#@K. Vanderwood,O. Hall,S. Harwell,Diane Arave,K. Butcher,D. Helgerson
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index174999193459810925262561877978971968803937976236
#%789198489702586542926219084517612861962341004780
#%610933636802206784054441052388249503323609875906

#*Thiazolidinediones plus metformin association on body weight in patients with type 2 diabetes
#@G. Derosa,P. Maffioli
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index405100178244118777883077584035442002771738471085
#%791437010500835684446913673495202924917937619815
#%365622746162703714779886393427968481072489997589
#%1380649750762894317422131002348448960892056433262
#%920241321889669665287705793802399032889517257662
#%270659814422014433735562862294382923401002109181

#*Validity of the primary care diagnosis of diabetes in veterans in the southeastern United States
#@G. Twombly,Qi Long,Ming Zhu,Lisa-Ann Fraser,E. Olson,W.F. Wilson,Venkat Narayan,S. Phillips
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index225716641345404530417643000536452728289056349442

#*Prevalence of obesity and associated risk factors in Northeastern China
#@X.D. Shi,S.M. He,Y.C. Tao,C.Y. Wang,Y.F. Jiang,X.W. Feng,J. Sun,J.Q. Niu
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1088160655003435819798413549347698723838767839184
#%837198783763783816831346456434338031298081739614

#*Health-related quality of life in metabolic syndrome: The Korea National Health and Nutrition Examination Survey 2005
#@Shin Park,Sook Yoon,Woo Oh
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index748564654416152942217019490006810731925504511627
#%748420474020516029707290327095389330137039534276
#%645065595204707760807697954435677983266288018909
#%1397822004002386523154972365127593960344893567637
#%425359508911865790944680143974007765055061334363
#%590294867616490604160584578756798242989857451182
#%1103924529085950198441017741492821012604977227659
#%1384101213905901745856852666187316297158386550749
#%417420791239315597640728484321588689975321152973
#%217344448168591282479129004854226000655404236922
#%1428221517527741307273859672213080646036177845618

#*Sasang constitutional types can act as a risk factor for insulin resistance
#@Kyungju Choi,Jiwon Lee,Junghee Yoo,Euiju Lee,Byunghee Koh,Junhee Lee
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index166309315247834954221300484180901474480728182905
#%425359508911865790944680143974007765055061334363

#*Weight loss in obese patients with type 2 diabetes: Effects of telemonitoring plus a diet combination  The Active Body Control (ABC) Program
#@Claus Luley,Alexandra Blaik,Kirsten Reschke,Silke Klose,Sabine Westphal
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index587805405511058653802393942115150713102188499678
#%375362792107943614923013276608327663170207999875
#%228387717993145986263721026876393218448658027082

#*Contrasting cardiovascular risk profiles and prescribed cardio-protective therapies in newly-diagnosed type 2 diabetes identified through screening and standard practice
#@D.R. Webb,L.J. Gray,K. Khunti,S. Campbell,H. Dallosso,M.J. Davies
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1317357716552752769284366758946935581618832925347

#*Impact of dose adjustment for normal eating in Australia (OzDAFNE) on subjective wellbeing, coping resources and negative affects in adults with type 1 diabetes: A prospective comparison study
#@L. Engel,R. Cummins
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index182118999101404771382033829105526023424397060396

#*Severe localized lipoatrophy related to therapy with insulin analogs in type 1a diabetes mellitus
#@Diego Peteiro-Gonzlez,Beatriz Fernndez-Rodrguez,Manuel Cabezas-Agrcola,David Arajo-Vilar
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index814057405459782450722020946975935305121355723949

#*Glucometabolic state in Chinese patients undergoing elective coronary angiography
#@Zhu-Zhi Wen,Dong-mei Jin,Ya-mei Zhang,Jing-Feng Wang,Deng-Feng Geng
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index453394024300109828064118506439450363236037483374
#%1115546612368748492760101406587118160531195534166
#%607337758935875862481337551852459512354209940631
#%687115685271157334604494975939476788096103521238
#%14717095636064412031900107429676594727429409796
#%1381073059794766404269586648905202726599740137174
#%1459459143664323134102535070556711335920996275602
#%1409774246366679244502068346117227476587584422346
#%1185618701147495662012379253111750425942791044956
#%1261191789066023357921687579878166272670512134780
#%566866795581575654774923218563720884928940365110

#*Insulin glargine compared to NPH among insulin-nave, U.S. inner city, ethnic minority type 2 diabetic patients
#@H. Hsia
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index637378558271570135387682162397080031978777160747
#%1204210450054912597786899191343141949179439576611
#%1071600986827864669940529472070420702990062425008
#%406627268008390124287429037767430188735742044826
#%764753434528791006821110417440136904483060550433

#*The change points of HbA 1C for detection of retinopathy in Chinese type 2 diabetic patients
#@Jia-Ning Hou,Yu-Fang Bi,Min Xu,Yun Huang,Xiao-Ying Li,Wei-Qing Wang,Yu-Hong Chen,Guang Ning
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1432402410593565425649610415997882799587872082934
#%474291835975547868210792200981479631231499856912
#%474291835975547868210792200981479631231499856912
#%1134316742908806820439970403555300672044123021553

#*Is there a role of p53 codon 72 polymorphism in the susceptibility to type 2 diabetes in overweight subjects? A study in patients with cardiovascular diseases
#@F. Gloria-Bottini,M. Banci,P. Saccucci,A. Magrini,E. Bottini
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1247283483392217918378370638459854459382233398433
#%1141521181552156220529151544100519020491235324457

#*Feasibility of group lifestyle intervention for diabetes prevention in Arab Americans
#@A. Jaber,R. Pinelli,B. Brown,M. Funnell,Robert Anderson,Adnan Hammad,H. Herman
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1144728081859903209192472661586105917732660327395

#*Additive hypoglycaemic effect of nateglinide and exogenous glucagon-like peptide-1 in type 2 diabetes
#@P.M. Bell,J. Cuthbertson,S. Patterson,F.P.M. OHarte
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1076211335371606592314529337701564864492251987172
#%1117975296114705716330984601115292146468629554009

#*Association of serum TRAIL levels with atherosclerosis in patients with type 2 diabetes mellitus
#@Naoya Kawano,Katsuhito Mori,Masanori Emoto,Eiko Lee,Ikue Kobayashi,Yuko Yamazaki,Hiromi Urata,Tomoaki Morioka,Hidenori Koyama,Tetsuo Shoji,Yoshiki Nishizawa,Masaaki Inaba
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1100220680869818769321356550278485242906268040560
#%974840622755778290312051268777069449013002963428
#%1447542941410805140629489034164173445367423219401
#%151144873321747961462749378612671764165141088666
#%267818012050367148569016739639014641031755389576
#%1188722073482511767918514260549742665698794498380
#%1018045894263073898043262406620842787558815261525
#%263466680051890278899811576525055947740698280096

#*Mismatch between diabetes diagnosis in primary care and recommended diagnostic criteria
#@Stephen Colagiuri
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index372385698393671241363844997355138405772611618030

#*Development and validation of The Personal Diabetes Questionnaire (PDQ): A measure of diabetes self-care behaviors, perceptions and barriers
#@Barbara Stetson,David Schlundt,Chelsea Rothschild,E. Floyd,Whitney Rogers,Prakash Mokshagundam
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1238381978545669957040148219741516842208685205050
#%1202540066497849992000632041954239241759804021321
#%1096016295484343649058979883315663747399115317380
#%293279928835047647469842694013809511598381717566
#%514229432933197792529552657221143054379535376280
#%692512996029345358121321262731264092315617506768

#*Diabetes-related change in physical disability from midlife to older adulthood: Evidence from 19962003 Survey of Health and Living Status of the Elderly in Taiwan
#@Ching-Ju Chiu,A. Wray,Beth Ofstedal
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index129198689608186994015468933296280841538707450935
#%1272864811655343475629376813558706569820901830581
#%1272864811655343475629376813558706569820901830581
#%816288063008886026562690004102967508680265408781
#%975962216655531544477981780070315644250803395806
#%1159357881706417711315269276479422651287495233823
#%944910519342983037862933992163802296070999104653
#%310201876372068698953811294088695769482506074111
#%97133081603098039762172135984964935695420293784
#%1331472407635481696451963440337008901633076060913

#*The impact of dyslipidaemia on incidence of coronary heart disease in Finns and Swedes with different categories of glucose tolerance
#@Lei Zhang,Qing Qiao,Tiina Laatikainen,Stefan Sderberg,Pekka Jousilahti,Altan Onat,Peter Nilsson,Jaakko Tuomilehto
#year2011
#confDiabetes Research and Clinical Practice
#citation0
#index1229745890520450067951915199056824498896446138518
#%1432144291413142848311220109848646110278424827889
#%166279991298876119078880303695280668963251332311
#%258630001898905027115590243972701489296407659817
#%1323093333428627634260067159921176046379251515180
#%1367091855781754099020743777306938128399562047706

